Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRP,Agouti-related protein,40054,0.228656576031092,0.00482409603347552,0.21920134780548,0.238111804256704,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN1,CCN family member 1,39754,0.303882376982745,0.00695090137987614,0.290258610278188,0.317506143687303,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLR,Low-density lipoprotein receptor,39878,0.375918575926901,0.00408674029407201,0.36790856495052,0.383928586903283,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFGE8,Lactadherin,39854,0.171531711805407,0.003994462416548,0.163702565468973,0.179360858141841,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPY,Pro-neuropeptide Y,40026,0.259479804500144,0.00604787562822894,0.247625968268816,0.271333640731473,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLTP,Phospholipid transfer protein,39972,-0.134226099746547,0.00329136059472485,-0.140677166512208,-0.127775032980886,0
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD4,T-cell surface glycoprotein CD4,39835,0.10014538965686,0.00266572879321936,0.0949205612221496,0.105370218091569,4.6499427969318e-296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES2,Retinoic acid receptor responder protein 2,39945,0.161677761081863,0.00436411159622335,0.153124102353266,0.170231419810461,2.25743468858023e-288
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC1,SPARC-related modular calcium-binding protein 1,40026,0.108627283460604,0.00303098797770464,0.102686547024303,0.114568019896905,9.55196108940943e-271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL27,C-C motif chemokine 27,39864,0.207570589175507,0.00580492895847479,0.196192928416896,0.218948249934117,1.78658218064751e-269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR1,Asialoglycoprotein receptor 1,39745,0.0928658979449572,0.00270479481992549,0.0875645000979032,0.0981672957920112,2.87514059062783e-249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G7,Platelet-activating factor acetylhydrolase,39854,0.0949896025996755,0.00283902431674634,0.0894251149388527,0.100554090260498,2.6991128050377e-237
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HHEX,Hematopoietically-expressed homeobox protein HHEX,37384,0.238394208377484,0.00713590830441363,0.224407828100833,0.252380588654135,3.3456111026561e-235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPL,Lipoprotein lipase,39864,-0.146834601056758,0.00441195870413979,-0.155482040116872,-0.138187161996644,6.81466188361345e-235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR37,Prosaposin receptor GPR37,39581,0.199292488328012,0.00599961661979273,0.187533239753218,0.211051736902806,6.73259360543721e-234
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH,Parathyroid hormone,37035,0.237209466728412,0.00747227340853549,0.222563810847682,0.251855122609141,3.53538695465621e-213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAP1,Proline-rich acidic protein 1,37433,0.118406295200952,0.00375692932091546,0.111042713731958,0.125769876669947,1.78574507429997e-210
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS3,"Nitric oxide synthase, endothelial",39485,0.148586427652256,0.00477039297622228,0.13923645741886,0.157936397885652,1.07658541196716e-206
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,40026,0.0982760506834827,0.00317201874634856,0.0920588939406395,0.104493207426326,8.66940586065517e-205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VMO1,Vitelline membrane outer layer protein 1 homolog,39784,0.19217417781068,0.00622708279329921,0.179969095535813,0.204379260085546,3.64395635323976e-203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL23,C-C motif chemokine 23,39927,0.118630151364812,0.00385676661692314,0.111070888795643,0.126189413933982,6.32917647243024e-202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIP2,Cysteine-rich protein 2,39745,0.103329733530229,0.00336005966779365,0.0967440165813538,0.109915450479105,8.89479159282869e-202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES1,Liver carboxylesterase 1,39850,0.226691694461429,0.00744312307654649,0.212103173231398,0.24128021569146,4.26717714431648e-198
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,39927,0.121170466015278,0.00398375578732458,0.113362304672122,0.128978627358434,1.28662718939036e-197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F7,Coagulation factor VII,39895,0.0842320331234521,0.00280463659572353,0.078734945395834,0.0897291208510703,7.61768753886703e-193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB1,DnaJ homolog subfamily B member 1,39784,0.240134325001119,0.0081466062096338,0.224166976830236,0.256101673172001,5.47148345304132e-186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCG,Pro-glucagon,39473,0.339473242658779,0.0115137150793437,0.316906361103265,0.362040124214292,5.50808692032994e-186
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APCS,Serum amyloid P-component,37329,0.0959954261414022,0.00326399215380607,0.0895980015199423,0.102392850762862,2.53806919129771e-184
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,39679,0.126769423566024,0.00436550837439662,0.118213027152207,0.135325819979842,1.12910817230942e-180
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADIPOQ,Adiponectin,37449,-0.180024045869066,0.00619778437323497,-0.192171703240606,-0.167876388497525,5.08953133575796e-180
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,39784,0.0819436042027794,0.00282822621621822,0.0764002808189918,0.0874869275865671,6.39338580884177e-180
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL13,C-X-C motif chemokine 13,40005,0.159409795993212,0.00552304231011886,0.148584633065379,0.170234958921045,1.17206266511849e-178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FURIN,Furin,39909,0.0915309367903901,0.00318380350821312,0.0852906819142924,0.0977711916664878,2.81726538485516e-177
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP5,Retinol-binding protein 5,39784,0.150913349641733,0.00525949428035272,0.140604740852241,0.161221958431224,1.38621070877481e-176
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,39581,0.22632797430245,0.00795465962117281,0.210736841444951,0.241919107159949,1.11480697310211e-173
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF9,Protein turtle homolog A,37433,0.218753404136365,0.00773734224298997,0.203588213340104,0.233918594932625,6.44059982829584e-171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF8,Immunoglobulin superfamily member 8,39864,0.0801687996937189,0.00284448269182838,0.0745936136177353,0.0857439857697025,1.31246953383721e-170
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON3,Serum paraoxonase/lactonase 3,39927,-0.0745220280461827,0.00265198678138195,-0.0797199221376913,-0.0693241339546741,1.19200782080193e-169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,39581,0.14320328231053,0.00514044702184885,0.133128006147706,0.153278558473354,9.37017513089477e-167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHR,Growth hormone receptor,37120,0.0742019754250301,0.00271002048760039,0.0688903352693333,0.0795136155807269,1.30873344105591e-160
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS9,Galectin-9,39855,0.0806300475300878,0.002970621104469,0.0748076301653286,0.0864524648948471,1.19323267358205e-158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUSB,Beta-glucuronidase,39915,0.149357403390706,0.00552448355436511,0.13852941562415,0.160185391157261,1.85588142505018e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBP,Protein AMBP,39999,0.0491934748709582,0.00182069411235144,0.0456249144107494,0.052762035331167,2.72845076914878e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD1,Mothers against decapentaplegic homolog 1,39473,0.210412564006642,0.00778643898566037,0.195151143594747,0.225673984418536,3.20985375269406e-157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB1,BPI fold-containing family B member 1,39782,-0.160780181868576,0.00596322146175282,-0.172468095933611,-0.14909226780354,1.32772227167616e-156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RN,Interleukin-1 receptor antagonist protein,39816,0.135713443991638,0.00504895853276147,0.125817485267426,0.14560940271585,1.09516892806047e-155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPY30,Protein dpy-30 homolog,39975,0.149103221441911,0.00558551121973322,0.138155619451234,0.160050823432588,1.16947796812761e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MXRA8,Matrix remodeling-associated protein 8,37120,-0.0756470144338835,0.00283588427783778,-0.0812053476184455,-0.0700886812493214,9.50866546440625e-153
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGRN,Agrin,39927,0.0818142942860587,0.00307960115901533,0.0757782760143886,0.0878503125577287,3.15343833018137e-152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOMO1,Nodal modulator 1,39854,0.0593503344020522,0.0022388546220984,0.0549621793427394,0.0637384894613651,1.40145878383529e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF9,Multiple epidermal growth factor-like domains protein 9,39998,0.052825435810337,0.00199555451606824,0.0489141489588432,0.0567367226618307,3.42213377002413e-151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL6,C-X-C motif chemokine 6,40054,0.190727070392728,0.00723704564122401,0.176542460935928,0.204911679849527,6.53318866243227e-150
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB4A_DEFB4B,Beta-defensin 4A,39581,0.358262369893654,0.0136636717275042,0.331481573307745,0.385043166479562,2.38274360431813e-148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCA,Alpha-synuclein,37120,0.284032785038487,0.0109556657700636,0.262559680129162,0.305505889947812,1.32971547433181e-144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,39473,0.151857745735503,0.00589568148154199,0.14030221003168,0.163413281439325,2.57462658942994e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYNU,Kynureninase,40054,0.110375088278961,0.004291709076341,0.101963338489332,0.118786838068589,5.35107913979136e-143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRCP,Lysosomal Pro-X carboxypeptidase,39944,0.074905411888931,0.00293140705132009,0.0691598540683436,0.0806509697095183,3.31437903285822e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLUL1,Clusterin-like protein 1,39836,-0.109245360483432,0.00427755866990464,-0.117629375476445,-0.100861345490419,4.82343866886248e-141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,40005,0.125843061356108,0.00493700091970246,0.116166539553491,0.135519583158725,1.51919369217253e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL16,Pro-interleukin-16,40054,0.0990462555149801,0.00388827498059492,0.0914252365530141,0.106667274476946,2.24705523629746e-140
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFH,Complement factor H,36759,0.056430614539295,0.00221958772027338,0.0520802226075592,0.0607810064710308,3.5600100606166e-139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA1,Glutathione S-transferase A1,39837,0.203488096751456,0.00803774705794663,0.187734112517881,0.219242080985031,1.12124071940118e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR2,Fibroblast growth factor receptor 2,39909,0.0515964917673536,0.00203903635546607,0.0475999805106401,0.0555930030240671,1.46898675999842e-138
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGF,Hepatocyte growth factor,40054,0.0802557362402808,0.00320934561961116,0.0739654188258429,0.0865460536547187,1.88745561962026e-135
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCS1,Neuronal calcium sensor 1,40026,0.0661177877838148,0.00265809246336105,0.0609079265556271,0.0713276490120024,4.64394906228389e-134
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST3,Cystatin-C,39893,0.0622748261788798,0.00251293234170484,0.0573494787891384,0.0672001735686213,4.4498656991785e-133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL18A1,Collagen alpha-1(XVIII) chain,39889,0.05270352192249,0.00213212434518103,0.0485245582059352,0.0568824856390448,2.00340957133453e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPM,Carboxypeptidase M,39951,0.0803774726601066,0.00325665588905126,0.0739944271175662,0.0867605182026471,4.82811884657284e-132
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18R1,Interleukin-18 receptor 1,40054,0.0753100967990493,0.003077809667668,0.06927758985042,0.0813426037476786,7.17878439794921e-130
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGF,Placenta growth factor,40054,0.0594360399494913,0.00243254337328578,0.0546682549378512,0.0642038249611314,1.64202052112317e-129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN1A,Cyclin-dependent kinase inhibitor 1,39784,0.24556654513154,0.010080637445214,0.22580849573892,0.265324594524159,1.01362923482904e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPB1,Beta-ureidopropionase,37433,0.212145762827299,0.00870228674599451,0.19508928080515,0.229202244849449,1.65728553767083e-128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP1,Src kinase-associated phosphoprotein 1,39709,0.16501896047155,0.00681655856297561,0.151658505688118,0.178379415254982,3.64427345553488e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,37433,0.162844301313478,0.00671980496996191,0.149673483572352,0.176015119054603,4.84568324824306e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,39583,0.0957917020392915,0.00396264944466302,0.088024909127752,0.103558494950831,8.58376893330773e-127
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CANT1,Soluble calcium-activated nucleotidase 1,39812,0.0453255732924827,0.00188969082483551,0.0416217792758051,0.0490293673091603,6.32515360318757e-125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFI,Complement factor I,37449,0.0452785305308681,0.00188986515656134,0.0415743948240079,0.0489826662377283,2.79073069788979e-124
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4R,Reticulon-4 receptor,40026,0.0748785532274608,0.00313778003853533,0.0687285043519316,0.0810286021029901,1.00131904396515e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR2,Cadherin-related family member 2,39784,0.164582994107141,0.00690839274134855,0.151042544334098,0.178123443880184,2.70424963924775e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS8,Prostasin,39801,0.090509013562011,0.00380175679940715,0.083057570235173,0.0979604568888491,3.93223182443814e-123
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL16,C-C motif chemokine 16,40048,0.116685687100458,0.00493395188342967,0.107015141408936,0.12635623279198,1.3648439063484e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH3,Neurogenic locus notch homolog protein 3,40048,-0.0758990517415208,0.00321556066018672,-0.0822015506354867,-0.0695965528475548,3.89766015222915e-121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFP,Properdin,37449,0.0514082986001395,0.00219307707736112,0.0471098675285117,0.0557067296717673,3.70808136151777e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL10,C-X-C motif chemokine 10,39927,0.14611501783237,0.00625298524653897,0.133859166749153,0.158370868915586,8.74073761759495e-119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI,Tissue factor pathway inhibitor,39839,0.0694709174131389,0.0029757324931895,0.0636384817264875,0.0753033530997903,1.45443387179961e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG2,Desmoglein-2,39854,-0.0590117232230408,0.00253007873086269,-0.0639706775355316,-0.0540527689105499,2.36851795634792e-118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,P4HB,Protein disulfide-isomerase,39772,0.0857803913285442,0.00368775010167611,0.078552401129259,0.0930083815278294,1.00795342566274e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY1,Aminoacylase-1,39864,0.136137644135874,0.00585825573619909,0.124655462892924,0.147619825378824,1.62432114702363e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLI1,Friend leukemia integration 1 transcription factor,39473,0.242407867060776,0.0104404813599592,0.221944523595256,0.262871210526296,2.87550259145524e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS37A,Vacuolar protein sorting-associated protein 37A,39784,0.174409933349458,0.00752814085574195,0.159654777272204,0.189165089426713,8.17085469186312e-117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIT1,Signaling threshold-regulating transmembrane adapter 1,39583,0.1202321066194,0.00519233536008636,0.110055129313631,0.130409083925169,1.13163873952484e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTA3,Glutathione S-transferase A3,39473,0.16755798410517,0.00724852754449101,0.153350870117968,0.181765098092372,2.83173426803532e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KITLG,Kit ligand,39864,-0.0812562508068874,0.00351940256813509,-0.0881542798404322,-0.0743582217733427,4.76897620219536e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5,T-cell surface glycoprotein CD5,39999,0.0719108660896586,0.00311546268819656,0.0658045592207934,0.0780171729585239,5.28220308100482e-116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,37120,0.106941016533196,0.00464721778561863,0.0978324696733838,0.116049563393009,6.24067893307229e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL22,C-C motif chemokine 22,39682,0.109823202380139,0.00478205285783995,0.100450378778773,0.119196025981505,7.69318165554172e-115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3F,Semaphorin-3F,39864,0.0555253342114402,0.00242430730364552,0.050773691896295,0.0602769765265855,2.91997317540673e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUCB2,Nucleobindin-2,39991,0.0812698620573995,0.00355413857525363,0.0743037504499024,0.0882359736648966,6.47494861405578e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS15,Enteropeptidase,39784,0.193197788130512,0.00844919674377094,0.176637362512721,0.209758213748303,6.89479571150575e-114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAT,Tissue-type plasminogen activator,39998,0.107195541084845,0.00469884034347711,0.09798581401163,0.11640526815806,2.09592787766727e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB3,Receptor tyrosine-protein kinase erbB-3,39805,0.0417003699274934,0.00183166219663846,0.038110312022082,0.0452904278329047,6.19262366847747e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,39909,0.075206680748694,0.00330522019382271,0.0687284491688015,0.0816849123285865,7.95036641195754e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSRC1,Proline/serine-rich coiled-coil protein 1,39473,0.127753528084799,0.00561496651697368,0.11674819371153,0.138758862458067,9.21075834237235e-113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHBP,Corticotropin-releasing factor-binding protein,39858,0.0605637461342478,0.00266310441587492,0.055344061479133,0.0657834307893627,1.05246259431305e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROC,Vitamin K-dependent protein C,39904,0.0555315590906801,0.00244290155845695,0.0507434720361045,0.0603196461452557,1.29675342823874e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA1,Ephrin type-A receptor 1,39900,0.0719658338368378,0.00317093013628171,0.0657508107697257,0.07818085690395,2.89035458825004e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LG,CMRF35-like molecule 9,39854,-0.0787735354022478,0.00347656761972054,-0.0855876079369,-0.0719594628675955,6.61245726087372e-112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPC,C-type natriuretic peptide,39862,0.0972649576243408,0.00433463402348028,0.0887690749383194,0.105760840310362,8.05246681964723e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F9,Coagulation factor IX,39904,0.0386917145401135,0.00172443376038575,0.0353118243697575,0.0420716047104696,8.26972725385794e-110
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB14,EF-hand calcium-binding domain-containing protein 14,37378,0.0553604052818668,0.00246488466474784,0.0505292313389611,0.0601915792247726,1.03561520898891e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,39881,0.0624146500356848,0.00278745802656226,0.0569512323036227,0.0678780677677468,2.26909415215108e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,39745,0.157164413285293,0.00702982965821132,0.143385947155199,0.170942879415388,4.95580637612593e-109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELN,Elastin,37433,0.0711434050561355,0.00318577091250832,0.0648992940676192,0.0773875160446518,1.62348026404234e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR5,Cadherin-related family member 5,39864,0.0821357811702449,0.00368684622553531,0.0749095625681957,0.0893619997722942,2.65699780711083e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP4,"Fatty acid-binding protein, adipocyte",40048,0.102379628245468,0.00460315814345654,0.0933574382842931,0.111401818206643,5.65969965836995e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT18,"Keratin, type I cytoskeletal 18",39784,0.171651810363039,0.00771869351134517,0.156523171080802,0.186780449645275,6.37578917777544e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP2,Lysosome-associated membrane glycoprotein 2,39379,0.0407008713199714,0.00183062698640679,0.037112842426614,0.0442889002133287,7.84931380378614e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAMR1,Inactive serine protease PAMR1,39854,0.0584618465375451,0.00263123042657419,0.0533046349014597,0.0636190581736305,9.6661810651743e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR3,Anterior gradient protein 3,39460,0.124407558634056,0.00559858243396548,0.113434337063484,0.135380780204629,9.97983414911083e-108
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK9,Proprotein convertase subtilisin/kexin type 9,40048,0.082600085098223,0.00371927129161627,0.0753103133666551,0.0898898568297909,1.14230949949394e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBC,Inhibin beta C chain,39854,0.0872417159467754,0.00393690626091526,0.0795253796753815,0.0949580522181693,3.41230986614868e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL17,C-X-C motif chemokine 17,40054,0.0901622200583814,0.0040701104148609,0.082184803645254,0.0981396364715087,3.85037150478709e-107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA5A,"Carbonic anhydrase 5A, mitochondrial",39581,0.191508038227997,0.00866219865666743,0.174530128860929,0.208485947595065,1.10006713881829e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP4,Insulin-like growth factor-binding protein 4,39581,0.083281453795532,0.0037674203619925,0.0758973098860267,0.0906655977050373,1.1678198400404e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,37081,0.0809632816548449,0.0036686829879565,0.0737726629984502,0.0881539003112396,5.11965476075183e-106
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTYMK,Thymidylate kinase,37433,0.143433356180982,0.00651327973501691,0.130667327900349,0.156199384461616,1.25007847006942e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN3A2,Butyrophilin subfamily 3 member A2,39862,0.0766276564066619,0.00349106869703254,0.0697851617604781,0.0834701510528456,3.1011802023462e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",39473,0.173044071461121,0.00788407659732386,0.157591281330366,0.188496861591875,3.46208642595865e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",40048,0.0601589873310524,0.00274703691863438,0.054774794970529,0.0655431796915758,8.66362754292572e-105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCLY,Selenocysteine lyase,39980,0.102150030567113,0.00467033042059277,0.0929961829427512,0.111303878191475,1.57793005931184e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FETUB,Fetuin-B,39904,0.0697916785306067,0.00319407099203321,0.0635312993862216,0.0760520576749918,2.54657961302031e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSD,Cathepsin D,38717,0.0817439384521448,0.00374295909791892,0.0744077386202237,0.0890801382840659,4.2273600820462e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FTCD,Formimidoyltransferase-cyclodeaminase,37364,0.175310507697891,0.00802866680809636,0.159574320754023,0.19104669464176,6.62463745728868e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LATS1,Serine/threonine-protein kinase LATS1,37052,0.178929345388225,0.00819413138844542,0.162868847866872,0.194989842909579,7.17903930064517e-104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF1,Pigment epithelium-derived factor,37250,0.0528243371866883,0.00242957682786845,0.0480623666040661,0.0575863077693105,4.91106998101223e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP3,Fibroblast growth factor-binding protein 3,37384,0.0757500648807927,0.00348592806653654,0.068917645870381,0.0825824838912043,6.07040663780322e-103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELT,Tumor necrosis factor receptor superfamily member 19L,39854,0.0547103762059779,0.00252771096134531,0.0497560627217411,0.0596646896902147,2.02151467275891e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,39473,0.13899152682965,0.0064225068081053,0.126403413485764,0.151579640173537,2.33061168077809e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPIND1,Heparin cofactor 2,37420,0.0579486619977017,0.00267579757727106,0.0527040987462504,0.063193225249153,2.82278043053688e-102
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP1,Neuropilin-1,39945,-0.0565281249906904,0.00263083250146873,-0.0616845566935691,-0.0513716932878116,5.4181384694046e-101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF21,Fibroblast growth factor 21,40007,0.24272079114834,0.0113249144056279,0.220523958913309,0.264917623383371,1.66644626949357e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11R,Junctional adhesion molecule A,39854,0.115056907169961,0.00537826254226049,0.104515512587131,0.125598301752792,3.91633466823766e-100
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP44,Endoplasmic reticulum resident protein 44,39754,0.052727988274837,0.00247031826870173,0.0478861644681816,0.0575698120814924,1.09281110599898e-99
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREG1,Protein CREG1,39656,0.0757908809513934,0.0035775448575922,0.0687788930305127,0.0828028688722741,3.03218835702445e-98
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPL,N-acetylneuraminate lyase,37433,0.0882705073350667,0.00418083563328791,0.0800760694938224,0.0964649451763109,2.20047860464569e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD72,B-cell differentiation antigen CD72,37120,0.0834207573890126,0.0039515517756197,0.075675715908798,0.0911657988692273,2.50328919823717e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,37110,0.0951741283181162,0.00451317237856785,0.0863283104561232,0.104019946180109,4.00266589297876e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MVK,Mevalonate kinase,39583,0.158544350918337,0.00752830125377492,0.143788880460938,0.173299821375736,4.06409750699864e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL2,Angiopoietin-related protein 2,39873,0.0788333808857157,0.00374505704797286,0.0714930690716889,0.0861736926997426,4.70442435618755e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YTHDF3,YTH domain-containing family protein 3,39583,0.1707220380819,0.00811188521682856,0.154822743056917,0.186621333106884,5.40162090070615e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORD,Sorbitol dehydrogenase,39959,0.136954294893827,0.00651066644211251,0.124193388667287,0.149715201120368,6.24942995195722e-97
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUOM,Fucose mutarotase,37120,0.12716503081048,0.00604507372509568,0.115316686309293,0.139013375311668,1.15315104714801e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",39759,0.20823991908676,0.00992670267263432,0.188783581848396,0.227696256325123,2.11130972766385e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPD1,Glycerol-3-phosphate dehydrogenase,37364,0.104550639732183,0.00498978153938315,0.0947706679149921,0.114330611549374,5.89169096208401e-96
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLA,Alpha-galactosidase A,37084,0.0749859884165981,0.00360023459763666,0.0679295286052303,0.082042448227966,7.96119102199855e-95
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA5,Plasma serine protease inhibitor,37279,0.0629498304304934,0.00302536942704238,0.0570201063534904,0.0688795545074965,1.15248465074968e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB2,Lysosome membrane protein 2,39482,0.0566689872432537,0.00273385349512285,0.0513106343928129,0.0620273400936945,3.52782121957395e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH2,Cadherin-2,39864,0.0691988955745228,0.00334269101600842,0.0626472211831463,0.0757505699658994,5.69431172316988e-94
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSP1,Lymphocyte-specific protein 1,39862,0.0794223299962709,0.00384325001102599,0.07188955997466,0.0869551000178818,1.18182742977016e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,37017,0.134644428796325,0.0065090664537563,0.121886658546963,0.147402199045687,1.42718126378339e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC1,Stanniocalcin-1,40005,0.0822458140144959,0.0039846428108488,0.0744359141052323,0.0900557139237596,1.89821792115114e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EZR,Ezrin,40005,0.0470701580822776,0.00228368741921591,0.0425941307406144,0.0515461854239408,3.42009073659378e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA1,von Willebrand factor A domain-containing protein 1,40007,0.0834996707997527,0.00406050496081291,0.0755410810765594,0.091458260522946,8.90519977597115e-93
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABL1,Tyrosine-protein kinase ABL1,39784,0.133525995790008,0.00650346631185391,0.120779201818774,0.146272789761242,1.76966394132382e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NHLRC3,NHL repeat-containing protein 3,36834,0.0624439881698046,0.0030397951129556,0.0564859897484117,0.0684019865911976,2.64169579720161e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA4,Kallistatin,37237,0.0456285568718482,0.00222324598160934,0.0412709947478939,0.0499861189958025,3.47791485012198e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G10,Group 10 secretory phospholipase A2,39745,-0.115029622938594,0.00561531717839017,-0.126035644608239,-0.104023601268949,4.52419546656435e-92
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYOU1,Hypoxia up-regulated protein 1,40048,0.0417460856307185,0.00204214075727082,0.0377434897464677,0.0457486815149693,1.00948960871272e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE4,Ribonuclease 4,37047,0.0505218073436576,0.00247579532354051,0.0456692485095182,0.055374366177797,3.73634377849139e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAB2,Stabilin-2,37433,0.0543802211083726,0.00266809207900865,0.0491507606335157,0.0596096815832296,5.56215956173868e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,39745,0.104616646599351,0.00514127147328001,0.0945397545117223,0.11469353868698,6.89243421441981e-91
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB1,Transforming growth factor beta-1 proprotein,40036,0.0741856229802132,0.00365856462994404,0.0670148363055229,0.0813564096549035,2.70048934310346e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLM2,Protein GOLM2,40005,0.0426457524282962,0.00210507753904742,0.0385198004517633,0.0467717044048292,3.93297169229853e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C1A,Cytosolic 5'-nucleotidase 1A,37384,0.059153634236433,0.00292234569305427,0.0534258366780466,0.0648814317948194,8.91532989441901e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAO1,Hydroxyacid oxidase 1,40026,0.247995850683954,0.0122692218179436,0.223948175920785,0.272043525447124,9.67690436537561e-90
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4A,C-type lectin domain family 4 member A,39862,-0.0667717139946137,0.00330559670302319,-0.0732506835325391,-0.0602927444566882,1.28985961001345e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLN,Promotilin,39862,0.170421417890153,0.00847416211696682,0.153812060140898,0.187030775639408,7.43310620096977e-89
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA5,Integrin alpha-5,39854,0.0473960697138363,0.00236099409116947,0.0427685212951442,0.0520236181325285,1.51217730398061e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK1,Dickkopf-related protein 1,40005,0.113841882088899,0.00567830704487784,0.102712400280938,0.124971363896859,2.46426832944038e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A5,Zinc transporter ZIP5,39862,0.100790486632799,0.00502893683799945,0.0909337704303197,0.110647202835278,2.85809073629433e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS1,Galectin-1,39864,0.0639298257984952,0.00319628267056085,0.057665111764196,0.0701945398327945,6.35198492574325e-88
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,37378,0.0564305696599084,0.00282672615140963,0.0508901864031455,0.0619709529166712,2.0810931038121e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTS,6-pyruvoyl tetrahydrobiopterin synthase,39415,0.103456890938643,0.00518898381975189,0.093286482651929,0.113627299225356,2.35372768743736e-87
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA4,Ephrin-A4,39716,0.052299213752859,0.00263617266161869,0.0471323153360864,0.0574661121696317,1.53272495662425e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM20A,Pseudokinase FAM20A,37433,0.0533214461418525,0.00268894162109108,0.048051120564514,0.058591771719191,2.72586540830335e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA1,GDNF family receptor alpha-1,40007,0.0506158470335144,0.00256035839635343,0.0455975445766617,0.0556341494903671,5.70584832265426e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18,Interleukin-18,39792,0.0858704116328462,0.0043441456351879,0.0773558861878779,0.0943849370778145,6.13227673333329e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,39784,0.0736219377980179,0.00372644561361093,0.0663181043953405,0.0809257712006953,7.49494114807316e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,39784,0.0844664179460249,0.00427821467246013,0.076081117188003,0.0928517187040468,9.67892279151754e-86
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT2,Linker for activation of T-cells family member 2,39784,0.233854004867394,0.0118542758799181,0.210619624142755,0.257088385592034,1.31791906948351e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BA,Platelet glycoprotein Ib alpha chain,39813,0.0611680647118472,0.00310186491507288,0.0550884094783044,0.0672477199453901,1.52052877278782e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD5,Programmed cell death protein 5,40005,0.108719224429751,0.00551511174455779,0.0979096054104174,0.119528843449084,1.6869392323928e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN2,Ficolin-2,39806,0.0759694847662032,0.00385753974317265,0.0684087068695848,0.0835302626628216,2.51340157472004e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCXR,L-xylulose reductase,39909,0.100955580871943,0.00513330170958286,0.0908943095211607,0.111016852222725,4.16436483638031e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD2,Protein disulfide isomerase CRELD2,39904,0.0975676601061688,0.00496380141803859,0.0878386093268132,0.107296710885524,5.14586422376543e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPC2,NPC intracellular cholesterol transporter 2,37264,0.0557632587567193,0.00283408454200903,0.0502084530543816,0.0613180644590571,5.46165693517072e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD83,CD83 antigen,39862,0.0613318129514326,0.00312336700432357,0.0552100136229584,0.0674536122799068,7.51670379539765e-85
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCAT,Phosphatidylcholine-sterol acyltransferase,37441,0.0409349480620951,0.00208460494943921,0.0368491223611942,0.0450207737629959,1.11625109434908e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAXX,Protein PAXX,37120,0.0860572004564693,0.00438465913986963,0.0774632685423249,0.0946511323706138,1.43842086122503e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP5,Fatty acid-binding protein 5,39968,0.127200056128211,0.00649041056128244,0.114478851428098,0.139921260828325,1.54519340953244e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPDC1,Neural proliferation differentiation and control protein 1,39864,0.0551224435510199,0.00281433759911393,0.0496063418567566,0.0606385452452832,1.96820619724423e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP20,Centrosomal protein 20,39473,0.137828066692813,0.00703751859070449,0.124034530255032,0.151621603130594,2.14405292668743e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP29,Synaptosomal-associated protein 29,39909,0.170281901675604,0.00869847009878315,0.153232900281989,0.187330903069219,2.37924875837475e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5E,5'-nucleotidase,39909,0.103126485023076,0.0052693902457503,0.0927984801414051,0.113454489904746,2.62948073467738e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDR,Vascular endothelial growth factor receptor 2,39909,0.047545943112358,0.00243280509011534,0.042777645135732,0.0523142410889841,4.42577456238014e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,37378,0.263184882086151,0.0134574739133288,0.236808233216026,0.289561530956275,5.21141428207328e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEG1,Protein HEG homolog 1,37120,0.0505327552757331,0.00258607459467067,0.0454640490701786,0.0556014614812876,7.50220529610649e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME1,Proteasome activator complex subunit 1,39734,0.0686442674455944,0.0035189157709495,0.0617471925345334,0.0755413423566555,9.10368877502569e-84
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA1,Apolipoprotein A-I,37449,-0.0506480737807623,0.00260328422123679,-0.0557505108543865,-0.0455456367071382,3.53353712954969e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARP1,Poly [ADP-ribose] polymerase 1,39862,0.10125793883511,0.00521235654015469,0.0910417200164063,0.111474157653813,4.16634634672043e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOA,Elongin-A,39784,0.0943839286635395,0.00486811834608895,0.0848424167052052,0.103925440621874,8.72795415831877e-83
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTR,Transthyretin,37305,0.0465992365516034,0.00240249028066953,0.0418903556014912,0.0513081175017157,1.11538881682962e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGLN1,Egl nine homolog 1,39862,0.0982139944354984,0.00508015420805385,0.0882568921877128,0.108171096683284,2.46521345664294e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OCLN,Occludin,37408,0.0792955599660658,0.00409729923274684,0.071264853469882,0.0873262664622496,2.47041164422884e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THOP1,Thimet oligopeptidase,39794,0.0561314772292987,0.00290357957399527,0.0504404612642679,0.0618224931943294,2.53798984939932e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LECT2,Leukocyte cell-derived chemotaxin-2,37433,0.118944380150015,0.00614836372719368,0.106893587244715,0.130995173055314,2.82944498184008e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT2A1,Bile salt sulfotransferase,39862,0.10274540270573,0.00531873671190354,0.0923206787503988,0.113170126661061,3.29009714384535e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,39745,0.0582428324023382,0.00301957873513017,0.0523244580814831,0.0641612067231934,5.80907309728849e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN3,Contactin-3,39854,0.0600290915584349,0.00311246316541219,0.053928663754227,0.0661295193626428,5.91403264114111e-82
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP1G2,AP-1 complex subunit gamma-like 2,37364,0.147126555198283,0.00763908899872604,0.13215394076078,0.162099169635786,1.44773830709981e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC6,Putative tyrosine-protein phosphatase auxilin,37039,0.155512542604902,0.00808053671048162,0.139674690652358,0.171350394557446,2.01538066270126e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA2,DnaJ homolog subfamily A member 2,40005,0.150414042772489,0.00783578607820774,0.135055902059202,0.165772183485776,3.22022825573469e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUMB,Protein numb homolog,37052,0.155333070418456,0.00808437996799637,0.139487685681183,0.171178455155728,3.6193447503122e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSIP1,PC4 and SFRS1-interacting protein,39862,0.11547998427876,0.00601929658094513,0.103682162980107,0.127277805577412,4.01997279717656e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP2,Insulin-like growth factor-binding protein 2,40008,-0.113390515468479,0.00591114055380465,-0.124976350953936,-0.101804679983022,4.13190651371327e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFA,Vascular endothelial growth factor A,39989,0.103944117293178,0.00542410819556608,0.0933128652298684,0.114575369356487,5.93685686858621e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD63,CD63 antigen,39716,0.0939847624438173,0.00490570108711593,0.0843695883130701,0.103599936574565,6.76479696932959e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MME,Neprilysin,39784,0.143513282246353,0.00749623551334004,0.128820660640206,0.158205903852499,8.64876278994468e-81
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHK,Ketohexokinase,37039,0.117970524715911,0.00616497438439142,0.105887174922504,0.130053874509318,1.57150432930439e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFA,Protransforming growth factor alpha,39862,0.0833262479364654,0.00437137628776527,0.0747583504124455,0.0918941454604854,4.04649630616181e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADH1B,All-trans-retinol dehydrogenase,37120,0.137884831611141,0.00723573260369172,0.123702795707905,0.152066867514376,6.81171699796553e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EEF1D,Elongation factor 1-delta,37433,0.165587095845643,0.00869753928487383,0.148539918847291,0.182634272843996,8.95785800621989e-80
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,40054,0.0656128318347453,0.00345640777405306,0.0588382725976013,0.0723873910718893,1.71987319084124e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX2,Heme oxygenase 2,39485,0.0854692254332139,0.00450193880854891,0.076645425368458,0.0942930254979698,1.77851845316167e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRP,Gastrin-releasing peptide,37039,0.0942563689479445,0.00496226516638934,0.0845303292218214,0.103982408674068,2.16470147281244e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBEGF,Proheparin-binding EGF-like growth factor,39980,0.130611905811219,0.00690061716340947,0.117086696170937,0.144137115451502,4.86001279156852e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,39842,0.20486532134906,0.0108237123754842,0.183650845093111,0.226079797605009,4.95277316980231e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,39881,0.0573932277784478,0.00303455443004874,0.0514455010955523,0.0633409544613433,6.41822999270646e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYAP1,Synapse-associated protein 1,37120,0.104009696358468,0.0054933527754813,0.0932427249185244,0.114776667798411,6.58615856998794e-79
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RB,Interleukin-10 receptor subunit beta,39927,0.0504544527639315,0.00267467906818386,0.0452120817902912,0.0556968237375719,1.5968047943893e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRELD1,Protein disulfide isomerase CRELD1,37120,0.0670729968952772,0.00355370910357386,0.0601077270522724,0.074038266738282,1.98091420531922e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRPEL1,"GrpE protein homolog 1, mitochondrial",39784,0.110065729186036,0.00584679096861073,0.0986060188875594,0.121525439484513,3.32594480756074e-78
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT1,Glutathione hydrolase 1 proenzyme,39822,0.0888606002674055,0.00474101858044814,0.0795682038497272,0.0981529966850839,1.50179946531873e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFM,Afamin,37449,0.0339574260127194,0.00181047809748015,0.0304088889416584,0.0375059630837805,1.64068055627066e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL7,C-C motif chemokine 7,39862,0.104020669339487,0.00555409330147918,0.0931346464685879,0.114906692210386,1.94365626391461e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBR,Delta(14)-sterol reductase LBR,40005,0.118955159877852,0.00636213179172998,0.106485381566061,0.131424938189643,3.39531670868994e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD2,Mothers against decapentaplegic homolog 2,37364,0.124052039217952,0.00663050232203924,0.111056254666755,0.137047823769149,3.91636005558251e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF3,Immunoglobulin superfamily member 3,39784,0.0630763790580278,0.00337773547708161,0.0564560175229479,0.0696967405931078,5.33190363180403e-77
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFA2,BPI fold-containing family A member 2,36589,-0.193170413160509,0.0103546545925461,-0.213465536161899,-0.172875290159119,1.19624771509569e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",39784,0.0781940605261157,0.00419928360276209,0.069963464664702,0.0864246563875294,1.41556873139415e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IPCEF1,Interactor protein for cytohesin exchange factors 1,39716,0.158905664033814,0.00854041842107654,0.142166443928504,0.175644884139124,1.85955386405392e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEP,Leptin,39864,0.120383802865914,0.00647166456425061,0.107699340319983,0.133068265411845,1.98949283281404e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",37384,0.0682720555469826,0.00367323150950912,0.0610725217883447,0.0754715893056205,3.67110080913259e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",37039,0.101567434477476,0.00546626595291264,0.090853553209767,0.112281315745185,4.29906213042488e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBI,Transforming growth factor-beta-induced protein ig-h3,39801,0.0473381503755129,0.00255334172701439,0.0423336005905647,0.0523427001604611,6.20393552110042e-76
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOST,Sclerostin,39842,0.0674403564058836,0.00365351646659851,0.0602794641313505,0.0746012486804167,2.67257275883009e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGDS,Prostaglandin-H2 D-isomerase,39758,0.0497986481100534,0.00270304036029492,0.0445006890038754,0.0550966072162315,5.16130565292075e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH1A1,Retinal dehydrogenase 1,39854,0.0922709414649011,0.00501491261194138,0.082441712745496,0.102100170184306,7.8653372709754e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT4,Vascular endothelial growth factor receptor 3,39909,0.0596675449292036,0.00324436551332861,0.0533085885230795,0.0660265013353276,9.06399609124332e-75
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL5,C-C motif chemokine 5,39927,0.176885904295134,0.00962542788241373,0.158020065645603,0.195751742944664,1.16884205515848e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1,Macrophage colony-stimulating factor 1,39927,0.0458983423028439,0.00250088328450633,0.0409966110652115,0.0508000735404763,1.80497397930281e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE2,Angiotensin-converting enzyme 2,39581,0.0874539335705688,0.0047646032029409,0.0781153112928046,0.0967925558483329,1.80616614267331e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM2,Paralemmin-2,37384,0.0664058733505637,0.00361633553088329,0.0593178557100324,0.0734938909910949,2.08898164719348e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF3,Trefoil factor 3,39835,0.0846626395825143,0.00461729309852384,0.0756127451094076,0.093712534055621,2.47030830509088e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",39784,0.05693467253825,0.0031083293974835,0.0508423469191824,0.0630269981573177,3.5084696954117e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK9,Mitogen-activated protein kinase 9,39862,0.0758374549985274,0.00414109324778172,0.0677209122328752,0.0839539977641796,3.69969520137665e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MENT,Protein MENT,37120,-0.0388886753707672,0.00212400567319919,-0.0430517264902377,-0.0347256242512968,5.69339981057541e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,36760,0.0867363147326898,0.00473712206682333,0.077451555481716,0.0960210739836635,5.94495013937935e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD74,HLA class II histocompatibility antigen gamma chain,40005,0.0589524019307095,0.00322710093957638,0.0526272840891398,0.0652775197722792,8.2510371540807e-74
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP3,Lysosome-associated membrane glycoprotein 3,40036,0.0872666216421622,0.00478143764000737,0.0778950038677478,0.0966382394165766,1.11155316318947e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXT,Oxytocin-neurophysin 1,40005,0.240953030144578,0.0132073718081609,0.215066581400583,0.266839478888573,1.27104478844679e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTBS,Di-N-acetylchitobiase,37292,0.0481187989483004,0.00263899749732284,0.0429463638535476,0.0532912340430532,2.13441165323117e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBLD,Phenazine biosynthesis-like domain-containing protein,39485,0.0895051073804714,0.00491440225114833,0.0798728789682207,0.0991373357927221,2.3417257590998e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMNDC1,Survival of motor neuron-related-splicing factor 30,37378,0.103995919513676,0.00570840946746668,0.0928074369574415,0.115184402069911,2.78973715143442e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FYB1,FYN-binding protein 1,39832,0.158881104598107,0.0087585291560298,0.141714387452289,0.176047821743926,8.25868406138306e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIGR,Polymeric immunoglobulin receptor,39673,0.0629386590877971,0.00347048023866897,0.056136517820006,0.0697408003555883,9.135565884337e-73
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCHE,Cholinesterase,37204,0.0479000546147325,0.00263995486667326,0.0427257430760529,0.0530743661534121,1.06354975049414e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH9,Myosin-9,37433,0.192918796354325,0.0106352769666366,0.172073653499718,0.213763939208933,1.11926143080027e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGFR,Opioid growth factor receptor,39784,0.0565057564905065,0.00311801510881878,0.0503944468772217,0.0626170661037913,1.13998969257506e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM1,Intercellular adhesion molecule 1,39818,0.0490843630557276,0.00270998098992707,0.0437728003154706,0.0543959257959847,1.35520246230314e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PENK,Proenkephalin-A,37120,0.050496813731001,0.00278513193273529,0.0450379551428398,0.0559556723191621,1.36662776251471e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTBDN,Retbindin,39784,0.0505159736148312,0.00279693740093222,0.0450339763090041,0.0559979709206584,3.38303291062395e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSO,Cathepsin O,40054,0.0513898461545322,0.00285420663705442,0.0457956011459055,0.0569840911631589,8.92157387667364e-72
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP6,Charged multivesicular body protein 6,37433,0.097403204729951,0.00541303347596062,0.0867936591170682,0.108012750342834,1.4647403602281e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,39975,0.0986174348267641,0.00548757385890803,0.0878617900633044,0.109373079590224,1.63786140130111e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HJV,Hemojuvelin,37408,0.0762691035923421,0.00424359387239154,0.0679516596024547,0.0845865475822295,2.14435703197487e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL17,C-C motif chemokine 17,39832,0.154551706514992,0.00861167070124486,0.137672831940552,0.171430581089432,2.55014985764089e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNMT,Histamine N-methyltransferase,39665,0.0792079754092122,0.00441345862505229,0.0705575965041098,0.0878583543143147,2.58683601063186e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELP,P-selectin,39927,0.098133581131938,0.00547192749133559,0.0874086032489202,0.108858559014956,3.16450723561605e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YOD1,Ubiquitin thioesterase OTU1,37017,0.10496629157675,0.00586299741121852,0.0934748166507613,0.116457766502738,7.69642839753148e-71
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA80,N-alpha-acetyltransferase 80,37035,0.207100037434819,0.0115986157306641,0.184366750602717,0.229833324266921,1.76648926367181e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSZ,Cathepsin Z,39861,0.0526600116077315,0.00295841425020269,0.0468615196773342,0.0584585035381288,3.3510412364144e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2R,Cation-independent mannose-6-phosphate receptor,39854,0.0399013034985996,0.00224213093936368,0.0355067268574468,0.0442958801397524,3.5920248946714e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BID,BH3-interacting domain death agonist,39862,0.112060604688527,0.00630791322065962,0.0996970947760339,0.12442411460102,6.1803179936472e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK11,Serine/threonine-protein kinase STK11,39581,0.124425050134649,0.00700385578217506,0.110697492801586,0.138152607467712,6.3358269350377e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FN1,Fibronectin,37449,0.0452247852136036,0.00254412815676642,0.0402382940263414,0.0502112764008658,6.67921996160087e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP1,Metalloproteinase inhibitor 1,39694,0.0467617360330029,0.00263325163228355,0.0416005628337272,0.0519229092322787,7.08720286387932e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFC,Vascular endothelial growth factor C,39909,0.0941909090692785,0.00530512903695899,0.0837928561568389,0.104588961981718,7.37828370641885e-70
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXN,Paxillin,39485,0.0873941132744675,0.00492989345901986,0.0777315220947886,0.0970567044541464,1.23795869631377e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAB2,Disabled homolog 2,40026,0.188116609381254,0.0106430615065506,0.167256208828415,0.208977009934093,2.92505824718729e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN2,CCN family member 2,39876,0.0987512274311515,0.00558969817630366,0.0877954190055963,0.109707035856707,3.43228571839866e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD274,Programmed cell death 1 ligand 1,39745,0.0565603305847397,0.00320245368133854,0.0502835213693162,0.0628371398001633,3.79591601775216e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4G,C-type lectin domain family 4 member G,39862,0.055823244218907,0.00316695154619598,0.0496160191883629,0.0620304692494512,6.86449722578272e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST2,Bone marrow stromal antigen 2,40005,0.0894346645435649,0.00507720386958269,0.0794833449591828,0.0993859841279469,8.32280360903437e-69
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2,Ribonucleoside-diphosphate reductase subunit M2,39473,0.0853030447122135,0.0048540870008363,0.0757890341905744,0.0948170552338526,1.79399061970589e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCAMP3,Secretory carrier-associated membrane protein 3,39784,0.141722343901215,0.00806796993538014,0.12590912282787,0.15753556497456,1.9801015611144e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCLS1,Hematopoietic lineage cell-specific protein,40054,0.0936332841455621,0.00534445237166928,0.0831581574970903,0.104108410794034,4.3012694401971e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBKS,Ribokinase,39500,0.0828981715339859,0.00473098877137859,0.0736254335420838,0.0921709095258879,4.32134091621872e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPRC5C,G-protein coupled receptor family C group 5 member C,37364,0.0957892164695612,0.00546354698781572,0.0850806643734424,0.10649776856568,4.59123386743879e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIAE,Sialate O-acetylesterase,39871,0.0789436487885882,0.00450888147715422,0.0701062410933659,0.0877810564838105,5.30673414524034e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNF,Tumor necrosis factor,39551,0.063531928703315,0.00363085918411469,0.0564154447024502,0.0706484127041798,6.57189413360062e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN2,Nectin-2,39842,0.0471756575108919,0.00269693674058554,0.0418896614993443,0.0524616535224396,7.02923519056601e-68
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAT,Linker for activation of T-cells family member 1,40054,0.126402473865723,0.00723604514402712,0.11221982538343,0.140585122348017,1.04022042644098e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORT1,Sortilin,39842,0.0622407748048514,0.00356516230789758,0.0552530566813721,0.0692284929283306,1.26736198343215e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G1,V-type proton ATPase subunit G 1,37039,0.121181814224365,0.00693833925129715,0.107582669291823,0.134780959156908,1.50872919415275e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NSFL1C,NSFL1 cofactor p47,40005,0.107979739222925,0.00619788408348611,0.0958318864192918,0.120127592026557,2.31878729576703e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGXT,Serine--pyruvate aminotransferase,39864,0.129677987466629,0.00744726956094155,0.115081339127183,0.144274635806074,2.74923668075569e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOD,Apolipoprotein D,36777,-0.0722071940845915,0.00414465021677378,-0.0803307085094681,-0.0640836796597149,3.30126502401771e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNCG,Gamma-synuclein,39745,0.107585893666922,0.00620186291248293,0.0954302423584559,0.119741544975389,8.51841429065527e-67
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSS,Cathepsin S,36540,0.0403106608063219,0.00232263099279402,0.0357583040604456,0.0448630175521982,1.05327199513997e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRP14,Signal recognition particle 14 kDa protein,39784,0.0985321166746763,0.00569631265364583,0.0873673438735304,0.109696889475822,1.98605613153618e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BECN1,Beclin-1,37039,0.0998714624560667,0.00577764893380097,0.0885472705458168,0.111195654366317,3.22616237753529e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPKOW,G-patch domain and KOW motifs-containing protein,39485,0.0447772151852525,0.00259588322994518,0.0396892840545599,0.049865146315945,4.6292380391554e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2D1A,SH2 domain-containing protein 1A,39862,0.0929957786812095,0.00539927844875974,0.0824131929216404,0.103578364440779,6.91625116014744e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSB,Arylsulfatase B,39784,0.0907999634860776,0.00527667661130196,0.0804576773279258,0.101142249644229,9.12423736322971e-66
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON2,Serum paraoxonase/arylesterase 2,39581,0.0565733405090311,0.00329013826653177,0.0501246695066288,0.0630220115114334,1.15668783095987e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP5,Tartrate-resistant acid phosphatase type 5,39915,0.0543971996356731,0.00316444996232682,0.0481948777095125,0.0605995215618336,1.21797680530345e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL3,C-C motif chemokine 3,39862,0.102978613876663,0.00599349242282919,0.0912313687279178,0.114725859025408,1.40936573832871e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COCH,Cochlin,37433,0.0749575259742446,0.00436784637762472,0.0663965470741002,0.0835185048743891,2.52994716452434e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QDPR,Dihydropteridine reductase,39786,0.071128384864037,0.00415466957377987,0.0629852324994284,0.0792715372286455,4.01842753608218e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2AP,CD2-associated protein,39864,0.103728235585782,0.00605925078546856,0.0918521040462638,0.115604367125301,4.06865722524541e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC5,Thioredoxin domain-containing protein 5,40005,0.111863144020929,0.0065402768241049,0.0990442014456837,0.124682086596175,5.20201497600849e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,39854,0.044882434584864,0.00262409854062009,0.0397392014452486,0.0500256677244794,5.24762056080618e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE1,Plasminogen activator inhibitor 1,40048,0.110361901915681,0.00645565171049562,0.0977088245631098,0.123014979268253,5.96633589703512e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINH1,Serpin H1,37165,0.210465267714842,0.0123076953047736,0.186342184917486,0.234588350512199,7.27215650422087e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_E,,39862,0.0446489723413215,0.00261421276460801,0.0395251153226898,0.0497728293599532,7.9396413690428e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHS1,"Enoyl-CoA hydratase, mitochondrial",37039,0.158667147588216,0.00928433888987869,0.140469843364054,0.176864451812378,8.80997043807984e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDT,D-dopachrome decarboxylase,37433,0.0655548787866529,0.00383802701069812,0.0580323458456845,0.0730774117276212,9.85274639114772e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C3,Complement C3,36812,0.0753439404565747,0.00441014802884417,0.0667000503200401,0.0839878305931093,9.93970084247681e-65
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK,Neuroblast differentiation-associated protein AHNAK,37039,0.0509991667052457,0.00298721879747664,0.0451442178621914,0.0568541155482999,1.17758694800657e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD6,T-cell differentiation antigen CD6,40036,0.0851308163246527,0.00500266718202775,0.0753255886478783,0.0949360440014271,2.22780592617682e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YES1,Tyrosine-protein kinase Yes,39784,0.185258871795029,0.0108880037012689,0.163918384540542,0.206599359049516,2.35595477824901e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT5,ADP-sugar pyrophosphatase,39854,0.083643734572357,0.00493109007798312,0.0739787980195101,0.0933086711252039,5.63618550234984e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN1,Dynactin subunit 1,40026,0.10522616430988,0.00620898771661466,0.0930565483853151,0.117395780234445,7.16049459511832e-64
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRN,"Attractin, Isoform 2",37449,0.0263757638431479,0.00155772692085625,0.0233226190782697,0.0294289086080262,1.16900548213361e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL5,C-X-C motif chemokine 5,39801,0.184143091134812,0.0108956218117169,0.162787672383847,0.205498509885777,1.5896870591621e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP4,Metalloproteinase inhibitor 4,39854,-0.0632599204894727,0.00374919773891877,-0.0706083480577535,-0.0559114929211919,2.51181780460944e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EREG,Proepiregulin,39709,0.128584421890046,0.00762693464217497,0.113635629991383,0.143533213788709,3.18888003982453e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,40054,0.159902091360258,0.00950933870842339,0.141263787491748,0.178540395228768,6.44521589218554e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML2,Trem-like transcript 2 protein,39854,0.05323893914212,0.00316683380438436,0.0470319448855267,0.0594459333987133,6.97632124288984e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMA,Granzyme A,40054,0.054231522086671,0.00322770079740617,0.0479052285237549,0.0605578156495871,8.04376914361632e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TALDO1,Transaldolase,37411,0.0719422603423029,0.00427855788800479,0.0635562868818136,0.0803282338027923,8.25398479653788e-63
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDCP1,CUB domain-containing protein 1,39745,0.0799954308486585,0.00476561206272137,0.0706548312057246,0.0893360304915923,1.07218139685576e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG3,Proteasome assembly chaperone 3,39862,0.0795112414277366,0.00474435547524276,0.0702123046962608,0.0888101781592125,1.65665417764761e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTDH,Protein LYRIC,37052,0.148559839646055,0.00887238551984199,0.131169964027165,0.165949715264946,2.74644712266658e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99L2,CD99 antigen-like protein 2,39854,0.038510426807092,0.00230294984415544,0.0339966451125473,0.0430242085016367,3.04885700733811e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUS,RNA-binding protein FUS,39451,0.0626536156172815,0.00375151810866381,0.0553006401243004,0.0700065911102625,4.47076926264255e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR1,Hepatitis A virus cellular receptor 1,39999,0.0956475240013314,0.00572833118545338,0.0844199948778428,0.10687505312482,4.5498390733297e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A4,Protein S100-A4,39909,0.090612700240861,0.00543342783001022,0.079963181694041,0.101262218787681,6.40601385507664e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP1,Guanylate-binding protein 1,37372,0.101597187044412,0.00609035597391109,0.0896600893355467,0.113534284753278,7.39985782741112e-62
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFB,Platelet-derived growth factor subunit B,39927,0.136311294537289,0.00819361432069621,0.120251810468725,0.152370778605854,1.24688204950041e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF14,Tumor necrosis factor ligand superfamily member 14,39745,0.0913097026511631,0.00549138500595282,0.0805465880394956,0.102072817262831,1.45226580941519e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA1,Interleukin-13 receptor subunit alpha-1,39593,0.0358674285745976,0.00216097818012419,0.0316319113415542,0.040102945807641,2.40292904098617e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,37408,0.0758467915433733,0.00456985574407633,0.0668898742849837,0.0848037088017629,2.93645979364729e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,37362,0.130429271790866,0.00786007503296006,0.115023524726264,0.145835018855468,3.1134706544905e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBIN,Erbin,39784,0.162625105823395,0.00981747772254955,0.143382849487198,0.181867362159592,4.05906899309475e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC8,Sialic acid-binding Ig-like lectin 8,37039,0.0727964077287462,0.00439462505837485,0.0641829426143315,0.0814098728431609,5.1681842002748e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASET2,Ribonuclease T2,39970,0.0401843574274913,0.00243183821867436,0.0354179545188895,0.044950760336093,7.76890244890499e-61
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKBIE,NF-kappa-B inhibitor epsilon,39473,0.077818624860434,0.00471352242985337,0.0685801208979214,0.0870571288229466,1.02222143409479e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARBP2,RISC-loading complex subunit TARBP2,39485,0.125447927184037,0.00760114160722993,0.110549689633867,0.140346164734208,1.12294931482791e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO3,Beta-enolase,37039,0.0952523126078694,0.00576891282188214,0.0839452434769804,0.106559381738758,1.23478762522814e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD22,B-cell receptor CD22,40054,0.0631150779012425,0.00383055100831499,0.0556071979249452,0.0706229578775399,1.67435131109958e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES3,Carboxylesterase 3,39784,0.108345280021829,0.00657841507712847,0.0954515864706575,0.121238973573001,1.91050137607199e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FST,Follistatin,39904,0.0809980184310484,0.00492117702763394,0.0713525114568859,0.090643525405211,2.25555203555747e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4B,Eukaryotic translation initiation factor 4B,39745,0.0911973920965773,0.00554605227812429,0.0803271296314537,0.102067654561701,2.92981667953313e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F10,Coagulation factor X,37441,0.0417307132301985,0.00253774011267338,0.0367567426093586,0.0467046838510383,3.52754955244537e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP11,Low-density lipoprotein receptor-related protein 11,39864,0.0546865832594155,0.00333255965338847,0.0481547663387741,0.0612184001800569,5.03169134810171e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYN,Tyrosine-protein kinase Lyn,39784,0.132516207502848,0.0080910268116701,0.116657794951975,0.148374620053722,8.43954276937533e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPK2,SRSF protein kinase 2,39862,0.131526975220773,0.00803335907463792,0.115781591434482,0.147272359007063,9.18462697897978e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP3,Metalloproteinase inhibitor 3,39927,0.202961440287668,0.0123984783755785,0.178660422671534,0.227262457903802,9.55658175705424e-60
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCC1,GRIP and coiled-coil domain-containing protein 1,37384,0.170201577697566,0.0104026594420758,0.149812365191097,0.190590790204034,1.34772493566198e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAPIN,SNARE-associated protein Snapin,37408,0.0908368684009,0.00555519028706143,0.0799486954382596,0.10172504136354,1.5703976023895e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,39784,0.0681257502415877,0.00417058674719382,0.0599514002170878,0.0763001002660876,1.69959158512149e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300E,CMRF35-like molecule 2,39987,0.0600225643429473,0.00367502749342787,0.0528195104558287,0.0672256182300659,1.7385080827533e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN1,Perilipin-1,39485,0.0539867626853855,0.00330577541248548,0.047507442876914,0.060466082493857,1.8444846817667e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GLB2,Endophilin-B2,37384,0.103545590242233,0.00634423157953299,0.091110896346348,0.115980284138117,2.57010994814407e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX15,Sorting nexin-15,37120,0.0842678158525462,0.0051631570398104,0.0741480280545178,0.0943876036505746,2.64668346748133e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEBP1,Phosphatidylethanolamine-binding protein 1,39854,0.0897970458986154,0.00551158067153657,0.0789943477824037,0.100599744014827,3.34738490654609e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYY,Peptide YY,37017,0.14423236412764,0.00884905223708142,0.126888221742961,0.16157650651232,3.79381905172178e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB2,Receptor tyrosine-protein kinase erbB-2,39909,0.0390437110287045,0.00239794872531718,0.0343437315270828,0.0437436905303261,3.93586456494358e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,39745,0.0831551859911031,0.00510716623490009,0.0731451401706989,0.0931652318115073,3.98440448271364e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXLNA,Alpha-taxilin,39745,0.138780759162934,0.00852422738892217,0.122073273480647,0.155488244845222,4.06960922480813e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,37120,0.0432945639773361,0.00265753091091215,0.0380858033919483,0.0485033245627239,4.26333613566277e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12A_IL12B,Interleukin-12,39784,0.114502290786995,0.00704008943950999,0.100703715485555,0.128300866088435,5.28403308544638e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAG1,Dystroglycan,39927,0.0753905289293696,0.00464465384452417,0.0662870073941022,0.084494050464637,8.83612143713402e-59
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL11,C-X-C motif chemokine 11,40005,0.120566609215958,0.00743331440671058,0.105997312978805,0.135135905453111,1.06401486747663e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9,Complement component C9,37441,-0.0821632463371683,0.00507861510742041,-0.0921173319477123,-0.0722091607266243,2.51675970355593e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDUA,Alpha-L-iduronidase,40026,0.0708553606643808,0.00438530122188623,0.0622601702694838,0.0794505510592778,2.8773026287742e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA6,Carbonic anhydrase 6,39813,-0.0981884018888862,0.00607983646162931,-0.11010488135368,-0.0862719224240928,3.29490018838807e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAS,Tumor necrosis factor receptor superfamily member 6,39998,0.0491747129848773,0.00304686487080574,0.0432028578380981,0.0551465681316566,3.84250161270792e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1B,C-type lectin domain family 1 member B,40005,0.14846347881682,0.00919881956995229,0.130433792459714,0.166493165173927,3.84329670030811e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSL,Cathepsin L1,39864,0.0369087323713642,0.00228729535278154,0.0324256334799124,0.0413918312628161,4.06832163282825e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP2B,DNA topoisomerase 2-beta,37052,0.123172704200654,0.00763298277144628,0.108212057968619,0.138133350432688,5.04057750327465e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",37378,0.158538343985341,0.00982742526102799,0.139276590473726,0.177800097496956,5.26587966160264e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3S2,AP-3 complex subunit sigma-2,37384,0.0728099936352646,0.00451376613032065,0.0639630120198361,0.081656975250693,5.39707890553314e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,37433,0.0985849632989792,0.0061200916421833,0.0865895836803,0.110580342917659,7.64859820823767e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSTB,Cystatin-B,39615,0.065133044183319,0.00404828708457281,0.0571984014975563,0.0730676868690817,8.78902492680459e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASGR2,Asialoglycoprotein receptor 2,37441,0.0390463757451237,0.00242585206533119,0.0342917056970745,0.0438010457931728,9.31471438605135e-58
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP8,Ubiquitin carboxyl-terminal hydrolase 8,39581,0.14923593334917,0.00928458222350456,0.131038152191101,0.167433714507239,1.12705783551631e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40,Tumor necrosis factor receptor superfamily member 5,39855,0.0773410487644892,0.00482299141778359,0.0678879855856334,0.086794111943345,2.01024656062429e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS2,Trypsin-2,39927,0.0786830602876214,0.00490684405195984,0.0690656459457801,0.0883004746294626,2.01822306537251e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,39784,0.0429332028786124,0.00267836070762743,0.0376836158916626,0.0481827898655621,2.22960296649988e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,37408,0.129983353500774,0.00810356874549926,0.114100358759596,0.145866348241953,2.25537703854793e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A2,Secretoglobin family 3A member 2,39904,-0.118334112538144,0.00738775938724495,-0.132814120937144,-0.103854104139144,2.67832940674505e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,37384,0.0633068498200962,0.00395193888957627,0.0555610495965268,0.0710526500436657,3.15259030173844e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHBP1,EH domain-binding protein 1,37433,0.114850973896585,0.00718225646476042,0.100773751225654,0.128928196567515,4.90119562127656e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF41,E3 ubiquitin-protein ligase NRDP1,39473,0.1026362822659,0.00643116851593357,0.0900311919746704,0.11524137255713,6.92606398464707e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USO1,General vesicular transport factor p115,39784,0.13673949365891,0.00858059739796485,0.119921522758899,0.153557464558921,9.80091285403693e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRB1,Killer cell lectin-like receptor subfamily B member 1,40054,0.0549590111463304,0.00344918498165103,0.0481986085822944,0.0617194137103664,9.94460911457452e-57
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",37354,0.166955457116163,0.0104761641031001,0.146422175474087,0.187488738758239,1.1582088598566e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLSCR3,Phospholipid scramblase 3,37369,0.0907464872046618,0.00571002656556458,0.0795548351361552,0.101938139273168,2.31408717130662e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,39745,0.143531366571718,0.00904543551366213,0.12580231296494,0.161260420178495,2.86345512882254e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD7B,OTU domain-containing protein 7B,37408,0.0976269607933465,0.00615097732069475,0.0855710452447848,0.109682876341908,3.18897742502287e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAK4,Serine/threonine-protein kinase PAK 4,39485,0.0932026556785427,0.00587945407242892,0.081678925696582,0.104726385660503,3.7144450206364e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,39909,0.143347044109882,0.00905615196054308,0.125596986267217,0.161097101952546,5.23290180073881e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,39745,0.0587162696257267,0.00371083611775232,0.0514430308349322,0.0659895084165213,5.78458780229623e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBPL,FK506-binding protein-like,37378,0.0904018842374103,0.00571325182559964,0.079203910659235,0.101599857815586,6.82908391069982e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,37433,0.115503873655139,0.00730448131055619,0.101187090286449,0.129820657023829,8.00077827890278e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G15,Phospholipase A2 group XV,39909,0.0399979203321969,0.00253138145685603,0.035036412676759,0.0449594279876347,8.08985673291068e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD302,CD302 antigen,39784,0.0438695535469221,0.00277789159173737,0.0384248860271169,0.0493142210667274,9.29840638079783e-56
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDK,Midkine,39839,0.076376334160695,0.00484105329224178,0.0668878697079011,0.0858647986134889,1.18202300027453e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,39473,0.117781947718838,0.00748659702828668,0.103108217543396,0.13245567789428,2.41423465086531e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAAM1,Disheveled-associated activator of morphogenesis 1,37120,0.12449603864618,0.00792555216074314,0.108961956411124,0.140030120881237,4.16911929472475e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,37120,0.0325308739171563,0.00207259705842787,0.0284685836826377,0.0365931641516749,5.05736680579864e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT1S1,Proline-rich AKT1 substrate 1,39485,0.100794187692444,0.00643367975673784,0.088184175369238,0.11340420001565,6.68987769931419e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STIP1,Stress-induced-phosphoprotein 1,39822,0.096932176956115,0.00619392724863805,0.0847920795487845,0.109072274363446,8.54382414243503e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS1,Protein MTSS 1,37378,0.165856702378479,0.010593691563288,0.145093066914435,0.186620337842524,9.11951075422785e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFER,FAD-linked sulfhydryl oxidase ALR,39473,0.0970373511615616,0.00620296605736293,0.0848795376891302,0.109195164633993,9.54878088683721e-55
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4D,Semaphorin-4D,40005,0.0447421379272472,0.0028618470429796,0.0391329177230071,0.0503513581314872,1.07526273081833e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGK,N-acetyl-D-glucosamine kinase,37022,0.0859953610757219,0.005503697613498,0.0752081137532658,0.096782608398178,1.51865020323365e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT2,Omega-amidase NIT2,37373,0.112721020975516,0.00721865370431783,0.0985724597150527,0.126869582235979,1.71507409764837e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R9B,Neurabin-2,40054,0.1410357632349,0.00905201532954079,0.123293813189,0.1587777132808,2.44598998244007e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,37165,0.169267930008024,0.0108779006809693,0.147947244673324,0.190588615342724,4.03286906757232e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,39745,0.0660694731190878,0.00424935891366456,0.0577407296483052,0.0743982165898703,4.10436435967096e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINK1,Misshapen-like kinase 1,37384,0.138609155950865,0.00891573041838839,0.121134324330823,0.156083987570906,4.92214431102005e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE6,Ribonuclease K6,37382,0.0411266851975771,0.00264856140482169,0.0359355048441266,0.0463178655510276,6.55202484740804e-54
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORCS2,VPS10 domain-containing receptor SorCS2,39473,0.0506744222799878,0.00327228113199113,0.0442607512612852,0.0570880932986904,1.08200278985707e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC13,Mucin-13,39485,0.074919935149978,0.00484059219948473,0.0654323744389879,0.084407495860968,1.23210760132141e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB17,Zinc finger and BTB domain-containing protein 17,39581,0.0600290264275895,0.00388388488697869,0.0524166120491113,0.0676414408060677,1.70271414025077e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARF6,ADP-ribosylation factor 6,37378,0.157738569682947,0.0102120898191023,0.137722873637507,0.177754265728388,2.28304617685507e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT5B,Signal transducer and activator of transcription 5B,39784,0.203163357454584,0.0131666968445022,0.17735663163936,0.228970083269808,2.49785343116046e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKAP4,Cytoskeleton-associated protein 4,39987,0.0374449518225285,0.00242771598900768,0.0326866284840734,0.0422032751609835,2.71352782283578e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB2,Carboxypeptidase B2,37420,0.0333638290770197,0.00216280464484222,0.029124731973129,0.0376029261809105,3.08955715325667e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COLEC12,Collectin-12,39858,0.0366253214434663,0.00237941225590499,0.0319616734218925,0.04128896946504,4.40715839259085e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPHOSPH8,M-phase phosphoprotein 8,39581,0.111926033748243,0.0072722696352831,0.0976723852630878,0.126179682233398,4.59892928959061e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LDLRAP1,Low density lipoprotein receptor adapter protein 1,37408,0.144376521894877,0.00937653547766984,0.125998512358644,0.16275453143111,4.77370026700633e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGBP1,Immunoglobulin-binding protein 1,37408,0.0891275883668336,0.00579077481392335,0.0777776697315438,0.100477507002123,5.25593793739931e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SARG,Specifically androgen-regulated gene protein,37386,0.161292121657726,0.0104892644791026,0.140733163278685,0.181851080036767,6.55420551740294e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPK1,Thiamin pyrophosphokinase 1,37433,0.0406032157580143,0.00264119521144924,0.0354264731435737,0.0457799583724548,6.92199109794154e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBTB16,Zinc finger and BTB domain-containing protein 16,39473,0.10432374251432,0.00679137304758843,0.0910126513410467,0.117634833687593,7.25642040654226e-53
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM7,PDZ and LIM domain protein 7,39927,0.185460213178455,0.0120969509482762,0.161750189319834,0.209170237037077,1.11736232247408e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINF2,Alpha-2-antiplasmin,37220,0.0198214768246065,0.00129234066988676,0.0172884891116284,0.0223544645375846,1.2026479216024e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL4,C-C motif chemokine 4,39878,0.0914311088174696,0.00596816193063471,0.0797335114334256,0.103128706201514,1.33059230341132e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCTD5,BTB/POZ domain-containing protein KCTD5,37161,0.0642731588633427,0.00419390438834785,0.0560531062621809,0.0724932114645045,1.45476720785712e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB1,Pleckstrin homology-like domain family B member 1,37378,0.0783462244383052,0.00511390329128408,0.0683229739873884,0.088369474889222,1.54669341700095e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCK2,Cytoplasmic protein NCK2,39927,0.15574525436359,0.0101732793297678,0.135805626877245,0.175684881849934,1.55758632612054e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF1,Rho guanine nucleotide exchange factor 1,37384,0.133090186894765,0.00870758696454844,0.116023316444251,0.15015705734528,2.65687163386101e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELPLG,P-selectin glycoprotein ligand 1,39862,0.040615098766474,0.00265997596448593,0.0354015458760816,0.0458286516568664,2.87502182096403e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESAM,Endothelial cell-selective adhesion molecule,40048,0.0456168898192843,0.00298835081976524,0.0397597222125444,0.0514740574260242,3.02794783114608e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCAM,Cell surface glycoprotein MUC18,39927,-0.0476746161888251,0.00312693932574843,-0.053803417267292,-0.0415458151103582,4.02833215059078e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CES2,Cocaine esterase,39784,0.0789703459584157,0.00517989105655748,0.0688177594875631,0.0891229324292684,4.11120020943823e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1RL,Complement C1r subcomponent-like protein,37428,0.0281074556561233,0.00184313286484474,0.0244949152410276,0.031719996071219,4.45917857441763e-52
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNLR1,Interferon lambda receptor 1,39862,0.0543029098897065,0.00357690560086398,0.0472921749120131,0.0613136448674,1.0739701151623e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR,GMP reductase 1,40054,0.0720061037549348,0.00474395513999706,0.0627079516805406,0.0813042558293291,1.11323798069888e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL8,C-C motif chemokine 8,39999,0.0876030503385717,0.00577221803354399,0.0762895029928255,0.0989165976843179,1.14736987278456e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KYAT1,Kynurenine--oxoglutarate transaminase 1,39846,0.0823841821681753,0.00542919757373058,0.0717429549236634,0.0930254094126872,1.19855976714696e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKB,Creatine kinase B-type,37433,-0.0846148250569721,0.00557290561364559,-0.0955377200597175,-0.0736919300542267,1.21207301026028e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZFYVE19,Abscission/NoCut checkpoint regulator,37378,0.132544807656208,0.00873064775024025,0.115432738065737,0.149656877246679,1.24818405584637e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMSB10,Thymosin beta-10,39854,0.112148812486697,0.00739675900118557,0.0976511648443728,0.12664646012902,1.44324575238282e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC4,Syndecan-4,39864,0.0658129184875998,0.00434899169820225,0.0572888947591234,0.0743369422160762,2.22751868995594e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGP1,SURP and G-patch domain-containing protein 1,37378,0.0583263821919634,0.00385487202079278,0.0507708330312096,0.0658819313527173,2.67754011225633e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL15,C-C motif chemokine 15,40048,0.0626005475757699,0.00414296572115194,0.054480334762312,0.0707207603892277,3.10685400125513e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",37039,0.0375806666387568,0.00248728419062831,0.0327055896251253,0.0424557436523883,3.77952703876573e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP2,Methionine aminopeptidase 2,40007,0.0833812935142616,0.00552402586986837,0.0725542028093196,0.0942083842192036,3.94201274571165e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL18,C-C motif chemokine 18,39711,0.101830048037612,0.00674941425334664,0.0886011961010526,0.115058899974171,4.445874274256e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCPEP1,Retinoid-inducible serine carboxypeptidase,36991,0.0734551072972122,0.00486825713710408,0.0639133233084882,0.0829968912859362,5.15110765247238e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD46,Membrane cofactor protein,39773,0.040841481410329,0.00270920283722585,0.0355314438493663,0.0461515189712917,5.31362282718902e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP43,Centrosomal protein 43,39472,0.10105342463773,0.00670299245083442,0.0879155594340945,0.114191289841365,5.33443590274146e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHACTR2,Phosphatase and actin regulator 2,37408,0.165699900650544,0.0109966054037385,0.144146554059217,0.187253247241872,6.76462834082154e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMNL1,Formin-like protein 1,39485,0.0877198298199822,0.00582685572501762,0.0762991925989476,0.0991404670410167,7.34219900698135e-51
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGFL2,Hepatoma-derived growth factor-related protein 2,37384,0.0904559863461497,0.00601474000367109,0.0786670959389544,0.102244876753345,1.04642834996958e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSR1,Macrophage scavenger receptor types I and II,40005,0.0656257002875228,0.00436803495140132,0.0570643517827762,0.0741870487922694,1.12363097719205e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDRKH,Tudor and KH domain-containing protein,39485,0.122286876745078,0.00815570341074642,0.106301698060015,0.138272055430141,1.80233013399415e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDNF,Cerebral dopamine neurotrophic factor,39784,0.0452921132825216,0.00302093272230185,0.03937108514681,0.0512131414182332,1.8093414149883e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT2,NAD-dependent protein deacetylase sirtuin-2,39784,0.127288555885759,0.00849113322030042,0.11064593477397,0.143931176997548,1.86377252089903e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP8,Vesicle-associated membrane protein 8,37052,0.127451119147529,0.0084988633540684,0.110793346973555,0.144108891321503,2.02090731186659e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHMT1,"Serine hydroxymethyltransferase, cytosolic",39904,0.124672022230179,0.00833175575817698,0.108341780944153,0.141002263516206,2.77749268165298e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP85,Centrosomal protein of 85 kDa,39473,0.0914738920185153,0.00611502877599896,0.0794884356175573,0.103459348419473,3.03800357078966e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPD52L2,Tumor protein D54,37120,0.156788519135563,0.0104776275172092,0.136252369201833,0.177324669069293,3.23522732733048e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",37408,0.111241642947461,0.00743577027059986,0.096667533217085,0.125815752677836,3.35425148112101e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFC,Platelet-derived growth factor C,39473,0.0417203846154538,0.00279250476474963,0.0362470752765446,0.0471936939543631,4.00905023795146e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL16,C-X-C motif chemokine 16,40030,0.033172329140119,0.00222197850275308,0.0288172512747229,0.037527407005515,4.58727686740585e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP3B1,AP-3 complex subunit beta-1,37378,0.109973390047728,0.00737148822132692,0.0955252731339268,0.124421506961528,6.21020806069175e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIA1,Nucleolysin TIA-1 isoform p40,39370,0.175391054999173,0.0117755429228263,0.152310990870434,0.198471119127913,7.90543164608989e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSNA1,Sjoegren syndrome nuclear autoantigen 1,37378,0.0722879292177819,0.00485303558922042,0.0627759794629098,0.0817998789726539,8.75918761534661e-50
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYDGF,Myeloid-derived growth factor,37433,0.144253211844419,0.00970323495353893,0.125234871335483,0.163271552353355,1.33494382470899e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLOD4,Glyoxalase domain-containing protein 4,39828,0.0509523969988026,0.00343085898270847,0.044227913392694,0.0576768806049112,1.46324670452553e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,40036,0.0510056731328777,0.00343777152275675,0.0442676409482745,0.0577437053174809,1.79009338971554e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",37039,0.0993923780993347,0.0067017275095485,0.0862569921806196,0.11252776401805,2.31265661096114e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC7,Sialic acid-binding Ig-like lectin 7,39864,0.0398181489641133,0.00269184290087123,0.0345421368784057,0.0450941610498209,3.4774511463996e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",39854,0.0659233018614307,0.00445830604154946,0.0571850220199937,0.0746615817028676,3.77257162825181e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLA2,Src-like-adapter 2,37408,0.149482553148776,0.0101173673336267,0.129652513174868,0.169312593122684,5.12101924196187e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,40005,0.0789773528121406,0.0053503447433535,0.0684906771151677,0.0894640285091134,5.43882531733816e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNA1,Ephrin-A1,39822,0.0372480262836364,0.0025235139278662,0.0323019389850187,0.0421941135822542,5.5482125551663e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18BP,Interleukin-18-binding protein,39927,0.0417122916227236,0.00282699936407831,0.0361713728691301,0.0472532103763171,5.97626620099281e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG16L1,Autophagy-related protein 16-1,37378,0.121954243900129,0.00826106599129601,0.105762554557189,0.13814593324307,6.1416516123659e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",39784,0.137852037416462,0.00934434208672102,0.119537126926489,0.156166947906436,6.24047411522032e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJAP1,Tight junction-associated protein 1,39909,0.11731181315074,0.00795301107823945,0.10172391143739,0.132899714864089,6.37434662674302e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHBG,Sex hormone-binding globulin,37441,-0.0729370884300435,0.00494310645993278,-0.0826255770915118,-0.0632485997685753,6.79630719913771e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRB,Receptor-type tyrosine-protein phosphatase beta,37433,0.0413302164290685,0.00280495842260002,0.0358324979207725,0.0468279349373646,9.18376247163634e-49
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB2,Calretinin,39485,0.0410312635017782,0.00279016546681028,0.0355625391868301,0.0464999878167264,1.25277568503214e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3C,Protein FAM3C,39842,0.0408073508323627,0.00277562495217943,0.035367125926091,0.0462475757386343,1.29919762835081e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL6A3,Collagen alpha-3(VI) chain,40048,0.0450136346164951,0.00306203007084403,0.0390120556776408,0.0510152135553494,1.31486572826641e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTP4A3,Protein tyrosine phosphatase type IVA 3,37052,0.0730433620578887,0.00496770311477842,0.063306663952923,0.0827800601628544,1.47892760577484e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS53,Vacuolar protein sorting-associated protein 53 homolog,39784,0.107885188324001,0.0073472462206151,0.0934845857315954,0.122285790916407,1.70000006605992e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAMD9L,Sterile alpha motif domain-containing protein 9-like,39862,0.102872560991999,0.00700685473311917,0.0891391257150855,0.116605996268913,1.74545275352224e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3,Galectin-3,39897,0.041340084310168,0.00281821143370534,0.0358163899001055,0.0468637787202305,2.09924850565983e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFE2,Transcription factor NF-E2 45 kDa subunit,37039,0.104780458509734,0.00713830583280537,0.0907893790774357,0.118771537942033,2.12901447924253e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,39425,0.122290833867008,0.00833729304663798,0.105949739495598,0.138631928238419,2.1759952822789e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAMBP,STAM-binding protein,39709,0.0904028225322985,0.00616508686574682,0.0783192522754348,0.102486392789162,2.28451984762391e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XCL1,Lymphotactin,40026,0.076889339611954,0.00524895905539267,0.0666013798633844,0.0871772993605236,2.80825453014608e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA1A,Heat shock 70 kDa protein 1A,39900,0.100274600737056,0.00684826305798944,0.0868520051433966,0.113697196330715,3.08772325147631e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIAP1,TP53-regulated inhibitor of apoptosis 1,40026,0.0890673010454642,0.00609196633561891,0.0771270470276512,0.101007555063277,4.21831719513553e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12B,Interleukin-12 subunit beta,40054,0.0732047195306751,0.00500706801883775,0.0633908662137531,0.0830185728475971,4.22392997458593e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEFTY2,Left-right determination factor 2,40007,0.0746100049669017,0.0051067269958445,0.0646008200550465,0.0846191898787569,4.90213472546878e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP1,Insulin-like growth factor-binding protein 1,40013,-0.171201986990666,0.0117454748275342,-0.194223117652633,-0.148180856328699,8.03264640675586e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST13,Hsc70-interacting protein,37120,0.0773922216522333,0.00530636569625363,0.0669917448875762,0.0877926984168904,8.22893551886461e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,39745,0.0537644475896537,0.00368889204494224,0.0465342191815669,0.0609946759977404,8.28219701991703e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",37433,0.105706470119795,0.00725066144416843,0.0914951736892248,0.119917766550365,8.78934427871938e-48
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACVRL1,Serine/threonine-protein kinase receptor R3,39716,0.0323608162981028,0.00222358301034761,0.0280025935978215,0.0367190389983841,1.12679203540549e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAX,Protein max,39485,0.146653409479776,0.0100868242648144,0.126883233920739,0.166423585038812,1.40024502923398e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF15,Growth/differentiation factor 15,40048,0.058868691751801,0.00405604234262271,0.0509188487602604,0.0668185347433415,1.96638613890594e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCTN3,Tectonic-3,37433,0.0410368734383291,0.00282627540945224,0.0354973736358027,0.0465763732408555,2.05770914380809e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC2,WAP four-disulfide core domain protein 2,39013,0.0497323134515441,0.00342742867179067,0.0430145532548344,0.0564500736482538,2.1733585428278e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPY,Pancreatic prohormone,39822,0.139123574788036,0.0095912636173878,0.120324698097955,0.157922451478116,2.24648009683355e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMOC2,SPARC-related modular calcium-binding protein 2,39927,0.0527498301887668,0.00363779021534901,0.0456197613666827,0.0598798990108509,2.39366370783321e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROS1,Vitamin K-dependent protein S,37449,0.0340416848282708,0.00234897431349438,0.0294376951738218,0.0386456744827198,3.05593474397044e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIRBP,Cold-inducible RNA-binding protein,37378,0.134242837286501,0.00926514505290275,0.116083152982811,0.15240252159019,3.20979539654694e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2,Complement C2,39904,0.0327335648201189,0.00226206651958324,0.0282999144417358,0.0371672151985021,3.67992405639991e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,A1BG,Alpha-1B-glycoprotein,37449,0.0237126012264301,0.00163804812855499,0.0205020268944624,0.0269231755583979,3.84441487477256e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFX1,Transcriptional repressor NF-X1,37017,0.0935456851572027,0.00646168824493643,0.0808807761971273,0.106210594117278,3.89937733062711e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSG,Basigin,40036,0.0268851416576887,0.00186054795644823,0.0232384676630502,0.0305318156523272,4.91246812056046e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG4,BAG family molecular chaperone regulator 4,37052,0.0693816461265373,0.00479838301354903,0.0599768154199811,0.0787864768330934,5.00464085414232e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,39784,0.0528246541908468,0.00365712283561803,0.0456566934330355,0.0599926149486581,5.39491751910044e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS2,RNA-binding protein with multiple splicing 2,37039,0.142645275526081,0.00986901865664705,0.123301998959053,0.161988552093109,5.42115761801325e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANG,Angiogenin,39839,0.0466315704160614,0.00323048379002203,0.0402998221876183,0.0529633186445046,6.16357781801748e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK1,Interleukin-1 receptor-associated kinase 1,39583,0.0973426944713,0.00674734084297696,0.0841179064190651,0.110567482523535,6.99074147336843e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP6,Insulin-like growth factor-binding protein 6,39821,0.038054414790875,0.00264013698094643,0.03287974630822,0.04322908327353,8.33629790866174e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK10,Kallikrein-10,39852,0.0543889288503279,0.00377470570506949,0.0469905056683917,0.061787352032264,8.94440284791143e-47
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6AP2,Renin receptor,39473,0.0562104056859819,0.00390313824711587,0.0485602547216348,0.063860556650329,1.01115673656383e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP1,"Fatty acid-binding protein, liver",39858,0.129243432656817,0.00897839874306755,0.111645771120405,0.14684109419323,1.08993826715836e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDC1,Syndecan-1,39864,0.0548378337847511,0.00381041977525632,0.0473694110252487,0.0623062565442535,1.14361555892958e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AAMDC,Mth938 domain-containing protein,37039,0.0737366833819098,0.00512006210535022,0.0637013616554234,0.0837720051083962,1.14390304942945e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNMBP,Dynamin-binding protein,39745,0.0853191413778409,0.0059381155746471,0.0736804348515326,0.0969578479041492,1.60690406077533e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB6,DnaJ homolog subfamily B member 6,37009,0.118182970514135,0.00822102490030289,0.102069761709541,0.134296179318728,1.6550642356549e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPB1,Carboxypeptidase B,40048,0.0789096643939141,0.00549423290822237,0.0681409678937983,0.0896783608940299,1.72323938145035e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP12,Macrophage metalloelastase,39896,0.0690406518150463,0.00480908247741789,0.0596148501593072,0.0784664534707853,1.88775926415543e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTD,Biotinidase,37449,0.0282695469348719,0.00196904522902535,0.0244102182859822,0.0321288755837616,2.10424685717156e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LZTFL1,Leucine zipper transcription factor-like protein 1,37120,0.0994812519382085,0.00692911059364631,0.0859001951746618,0.113062308701755,2.14441622395194e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SETMAR,Histone-lysine N-methyltransferase SETMAR,39695,0.0408949306082175,0.00285092706772979,0.0353071135554671,0.0464827476609679,2.25403718745814e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARCO,Macrophage receptor MARCO,39864,0.0360580698943917,0.00251528215313261,0.0311281168742518,0.0409880229145316,2.53810963047371e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIP2,CAP-Gly domain-containing linker protein 2,39862,0.155249695268784,0.0108369988531699,0.134009177516571,0.176490213020996,2.91376749391492e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRD54,Ankyrin repeat domain-containing protein 54,39473,0.0774793305173868,0.00541180541690131,0.0668721919002602,0.0880864691345133,3.37350177296432e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLK1,Protein delta homolog 1,40048,0.0763488658135065,0.00533497529504729,0.0658923142352138,0.0868054173917992,3.57317930795999e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD1,Superoxide dismutase [Cu-Zn],39483,0.0664047610006068,0.00464171501733178,0.0573069995666365,0.0755025224345771,3.92192061853718e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH2,Neutral ceramidase,39745,0.0716781219837467,0.00501580965267138,0.0618471350645107,0.0815091089029825,4.84292984662525e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMN,Protein amnionless,39583,0.0652752210186096,0.00456853026821428,0.0563209016929096,0.0742295403443096,5.04610585969235e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSME2,Proteasome activator complex subunit 2,39662,0.0494883580418724,0.00346448572097597,0.0426979660287595,0.0562787500549853,5.28821601841541e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSG,Alpha-2-HS-glycoprotein,37441,0.0364940121447659,0.00255797029454074,0.031480390367466,0.0415076339220657,7.55546540694435e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,39837,0.0839639783055273,0.00589104921677789,0.0724175218406426,0.095510434770412,8.22088293743179e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,37433,0.0851892966306726,0.00597380694946171,0.0734806350097277,0.0968979582516175,8.26382793048085e-46
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IST1,IST1 homolog,37283,0.136631573138201,0.0095932867890713,0.117828731031622,0.155434415244781,1.07513003376515e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAPGEF2,Rap guanine nucleotide exchange factor 2,37165,0.0733866395818141,0.00515632970672764,0.0632802333566279,0.0834930458070003,1.24750387148142e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLB1,Beta-galactosidase,39745,0.0573889919219997,0.0040377251926337,0.0494750505444377,0.0653029332995618,1.44360852758233e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP1,Fibroblast growth factor-binding protein 1,39909,0.0434885003022361,0.0030621107130581,0.0374867633046422,0.0494902372998299,1.67644374664968e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXIN1,Axin-1,39862,0.129704741973159,0.00913424331734468,0.111801625071163,0.147607858875154,1.73481960687822e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT5,"Keratin, type II cytoskeletal 5",39485,0.0685945485559783,0.00483237771349152,0.0591230882375349,0.0780660088744217,1.89133879698642e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEC31A,Protein transport protein Sec31A,37039,0.104661186661201,0.0073817407863597,0.0901929747199365,0.119129398602467,2.68316046041929e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK2,Docking protein 2,39864,0.166664154666689,0.0117692872973085,0.143596351563964,0.189731957769413,2.99882218583947e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL3,C-X-C motif chemokine 3,39855,0.128623587114406,0.00908359923858648,0.110819732606777,0.146427441622036,3.04054691394766e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHISA5,Protein shisa-5,37433,0.0311248568466385,0.00219805613880287,0.0268166668145849,0.0354330468786921,3.38902369815447e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRD1,Natural killer cells antigen CD94,40054,0.0618575402704007,0.00437230182588257,0.0532878286916708,0.0704272518491305,3.59099452149869e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY4,Protein canopy homolog 4,39784,0.102494756590706,0.00724586522631132,0.0882928607471353,0.116696652434276,3.74855457442264e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUOX,"Sulfite oxidase, mitochondrial",37408,0.0853076880611893,0.00602765899165721,0.0734934764375412,0.0971218996848374,3.7681343073791e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARK7,Parkinson disease protein 7,39854,0.0710905453209111,0.00502658668808795,0.0612384354122587,0.0809426552295635,3.86471972605332e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER2,Low affinity immunoglobulin epsilon Fc receptor,39854,0.0646597141983399,0.00457755235548567,0.055687711581588,0.0736317168150918,4.94126348621289e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTSS2,Protein MTSS 2,37364,0.135452568603826,0.00958713721903104,0.116661779654526,0.154243357553127,5.29580922889585e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIGYF2,GRB10-interacting GYF protein 2,37408,0.103775304295348,0.00736062684526404,0.0893484756786301,0.118202132912065,8.020900127567e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM1,Isthmin-1,39862,0.0537722985918496,0.00381705011807164,0.0462908803604291,0.06125371682327,8.40914415594199e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPI,Mannose-6-phosphate isomerase,39784,0.116451046277021,0.0082694884572761,0.10024284890076,0.132659243653282,9.09365180229541e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1S,Complement C1s subcomponent,37449,0.028289794442954,0.00200848479774315,0.0243531642393774,0.0322264246465306,9.67143104055769e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRY2,Protein sprouty homolog 2,39583,0.125021270858456,0.00888181971499604,0.107612904217064,0.142429637499849,9.95644857696001e-45
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCBP2,Poly(rC)-binding protein 2,37408,0.0980491944218998,0.00696776228271513,0.0843923803477781,0.111706008496021,1.16689355194673e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMC1,COX assembly mitochondrial protein homolog,37433,0.122186136519787,0.00868828766438276,0.105157092697596,0.139215180341977,1.31221830079424e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNA4,Plexin-A4,39862,0.109138471155084,0.00777400682078858,0.093901417786338,0.124375524523829,1.65508792594154e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFA,Platelet-derived growth factor subunit A,40048,0.096453213713383,0.00687325643332915,0.0829816311040579,0.109924796322708,1.78150297324837e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBXN1,UBX domain-containing protein 1,37120,0.0936304096809903,0.00666781143199894,0.0805614992742724,0.106699320087708,1.79160184910965e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB1,Nuclear factor NF-kappa-B p105 subunit,37017,0.100880536337391,0.0071890534460939,0.0867899915830467,0.114971081091735,2.0598854627159e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAP18,Chromatin complexes subunit BAP18,37384,0.087795315459154,0.00625747610610657,0.0755306622911851,0.100059968627123,2.07793171418374e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC80,Coiled-coil domain-containing protein 80,39864,0.0439156783213424,0.00313367108201086,0.0377736830006011,0.0500576736420837,2.33647681056103e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300A,CMRF35-like molecule 8,37120,0.0389140284978987,0.00277748536062127,0.033470157191081,0.0443578998047164,2.77988063946059e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",37378,0.19863273881824,0.0141821800097431,0.170835665999144,0.226429811637336,2.92788574748306e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL13,C-C motif chemokine 13,40020,0.0920729497643366,0.00658244027640129,0.07917136682259,0.104974532706083,3.35638862404558e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,39854,0.0466597151017252,0.00333609424207396,0.0401209703872602,0.0531984598161901,3.44000837656115e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCR,Breakpoint cluster region protein,39862,0.123038315455465,0.00880051032378543,0.105789315220845,0.140287315690084,3.71261889359992e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD59,CD59 glycoprotein,39169,0.0281923849432552,0.00201650066742146,0.0242400436351091,0.0321447262514012,3.81206848133331e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GORASP2,Golgi reassembly-stacking protein 2,37378,0.0636409266221696,0.00455989926884966,0.0547035240552243,0.072578329189115,5.78362092955709e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNRPB2,U2 small nuclear ribonucleoprotein B'',37384,0.0542543684741069,0.00388874911263554,0.0466324202133412,0.0618763167348725,6.197995166633e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILP,Rab-interacting lysosomal protein,39980,0.0792328632164173,0.0056830579278101,0.0680940696779095,0.0903716567549251,6.33677248144615e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP5,Microfibrillar-associated protein 5,40048,0.0536199683805998,0.00385078106636689,0.0460724374905207,0.0611674992706789,8.05363265694313e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNIP1,TNFAIP3-interacting protein 1,37384,0.118102263294857,0.00847702442174779,0.101487295428231,0.134717231161482,8.12335302037936e-44
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX4,Syntaxin-4,39784,0.0789770338740959,0.00567821264338703,0.0678477370930573,0.0901063306551345,1.00950653455483e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",39583,0.0964543833250755,0.00693637387758565,0.0828590905250076,0.110049676125143,1.06291007147652e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH1,Somatotropin,39842,-0.24053843767209,0.0173144576246133,-0.274474774616332,-0.206602100727848,1.26398134375769e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMMT,MICOS complex subunit MIC60,37364,0.0586628321916936,0.00422046219772459,0.0503907262841534,0.0669349380992338,1.27153145104273e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL9,C-X-C motif chemokine 9,39927,0.0867670902782673,0.00625010926667357,0.0745168761155871,0.0990173044409475,1.44357645878255e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1,Programmed cell death protein 1,39994,0.0544228888648704,0.00392144699328299,0.0467368527580357,0.062108924971705,1.5265068559986e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GYS1,"Glycogen [starch] synthase, muscle",39581,0.124225965643629,0.0089509879848451,0.106682029193333,0.141769902093926,1.54539955842791e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASHC3,WASH complex subunit 3,37384,0.101114869944117,0.00728743580012982,0.086831495775863,0.115398244112372,1.77689986280836e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSNL1,Visinin-like protein 1,37384,0.0503707193344259,0.00363104375186575,0.043253873580769,0.0574875650880827,1.85148617332408e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOF,Apolipoprotein F,37441,-0.0344666441361013,0.0024853657860639,-0.0393379610767865,-0.0295953271954161,1.96151932108765e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC10,Sialic acid-binding Ig-like lectin 10,39862,0.043494641422317,0.00314130257067234,0.0373376883837993,0.0496515944608348,2.38985024732555e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPSE,Heparanase,37302,0.125004539629268,0.00902685067315748,0.10731191230988,0.142697166948657,2.59094705914121e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IQGAP2,Ras GTPase-activating-like protein IQGAP2,39784,0.0725415714087049,0.00524142084503068,0.0622683865524448,0.0828147562649651,2.60242571434726e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEXIM1,Protein HEXIM1,39862,0.108123475396179,0.00781653605018878,0.0928030647378094,0.123443886054549,2.87298422561025e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO1,Forkhead box protein O1,39862,0.113702910645848,0.00823341304757935,0.0975654210725927,0.129840400219104,3.92476220601358e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,39473,0.0599356150873572,0.00434366099460985,0.0514220395379219,0.0684491906367925,4.66177505380545e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPPED1,Serine/threonine-protein phosphatase CPPED1,40005,0.0864941504389481,0.00627813791870441,0.0741890001182875,0.0987993007596087,6.12952996026048e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100P,Protein S100-P,39581,0.0695927642006184,0.00505249844468294,0.0596898672490399,0.079495661152197,6.49225052448644e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN9,Septin-9,39784,0.0373558235107682,0.00271400783700459,0.0320363681502393,0.0426752788712972,7.37487698111365e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP3R1,Calcineurin subunit B type 1,39745,0.0546799894449357,0.00397857918001644,0.0468819742521035,0.062478004637768,9.77010276237419e-43
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD2,Polycystin-2,37017,0.0786904843918359,0.0057258396352767,0.0674678387066936,0.0899131300769782,1.10501836734562e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDHB,Succinate dehydrogenase,37378,0.0927045117113385,0.0067485361973128,0.0794773807646054,0.105931642658072,1.17885643210772e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AP2B1,AP-2 complex subunit beta,37035,0.0649829556995853,0.00473392664620378,0.0557044594730259,0.0742614519261448,1.37216577336595e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,39864,0.0836371898091108,0.00609902831005413,0.0716830943214047,0.0955912852968168,1.47286920129954e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD244,Natural killer cell receptor 2B4,40054,0.0350649201044112,0.00255731869505411,0.0300525754621052,0.0400772647467173,1.49572541470002e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESYT2,Extended synaptotagmin-2,37384,0.108615060712938,0.00791814250556543,0.0930955014020296,0.124134620023846,1.54175057003913e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP3,Latent-transforming growth factor beta-binding protein 3,39473,0.0722369928461112,0.005271086974249,0.0619056623765832,0.0825683233156392,1.68376098294798e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS8,Galectin-8,40005,0.0802410478270449,0.00585633587986392,0.0687626295025116,0.0917194661515782,1.7171952628296e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC27,Cell division cycle protein 27 homolog,39473,0.0805451609722002,0.00587843120784713,0.0690234358048198,0.0920668861395806,1.7437127539386e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ORM1,Alpha-1-acid glycoprotein 1,37385,0.0261196338487348,0.00190655266169271,0.0223827906318171,0.0298564770656525,1.95067488509559e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APP,Amyloid-beta precursor protein,39825,0.0873362561097436,0.00638072832768302,0.0748300285874849,0.0998424836320023,2.09238877578062e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB3,Plexin-B3,39808,0.0625591824613706,0.00457377696609209,0.0535945796078302,0.0715237853149111,2.3890964864626e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RWDD1,RWD domain-containing protein 1,40005,0.0835631245177667,0.0061106695473859,0.0715862122048904,0.0955400368306431,2.46665466970273e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASC3,Protein CASC3,37035,0.0553160823308397,0.00404571625378811,0.047386478473415,0.0632456861882644,2.86902287639058e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR2,TGF-beta receptor type-2,39909,0.0390039887637676,0.00285643588299361,0.0334053744331001,0.0446026030944351,3.25471379739878e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF10,Tumor necrosis factor ligand superfamily member 10,40054,0.0339503676978782,0.00248694712046506,0.0290759513417667,0.0388247840539897,3.38975239267303e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT16,U8 snoRNA-decapping enzyme,37362,0.115991629373696,0.00849290056957196,0.0993455442573348,0.132637714490057,3.47287886024058e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,37120,0.0764768091985911,0.00560661719494155,0.0654878394965056,0.0874657789006765,4.42396906420119e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP7,Matrilysin,39559,0.0646434176341814,0.00474242712768944,0.0553482604639101,0.0739385748044527,4.55448035376818e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP23,Synaptosomal-associated protein 23,39864,0.113596433882449,0.00834782382214879,0.0972346991910372,0.12995816857386,6.15019002797411e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1R,Huntingtin-interacting protein 1-related protein,37361,0.0548464973514052,0.00402869756976934,0.0469502501146573,0.0627427445881531,6.25654300691956e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,37378,0.116675805610155,0.00857239810924848,0.0998739053160279,0.133477705904282,6.53767902032583e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164,Sialomucin core protein 24,39854,0.0341718808697958,0.00251285246871856,0.0292466900311074,0.0390970717084841,6.95475601898802e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTNB,Dystrobrevin beta,37344,0.0575147012677729,0.00422718045388458,0.0492294275781591,0.0657999749573867,6.97804895143289e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABHD14B,Protein ABHD14B,39683,0.0749209729111196,0.00551073606548946,0.0641199302227602,0.0857220155994789,7.32215437117853e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FARSA,Phenylalanine--tRNA ligase alpha subunit,37035,0.09000417469826,0.00661693336171396,0.0770349853093007,0.102973364087219,7.45719850238577e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL11,Eotaxin,40054,0.0496431729385241,0.00365348311892427,0.0424823460254325,0.0568039998516157,8.00967715265341e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA1,Carboxypeptidase A1,40048,0.0769125135360743,0.0056615338729368,0.0658159071451182,0.0880091199270304,8.32008192637879e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2,Microtubule-associated protein 2,37384,0.0601718557029751,0.00442785751820128,0.0514932549673006,0.0688504564386496,8.70572654237845e-42
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BANK1,B-cell scaffold protein with ankyrin repeats,39862,0.138168284021034,0.0101814888333264,0.118212565907715,0.158124002134354,1.01888685326607e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYTL4,Synaptotagmin-like protein 4,37433,0.0941043706059599,0.00693108226361356,0.0805194493692773,0.107689291842643,1.02419899044292e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53I3,Quinone oxidoreductase PIG3,36870,0.0697924274469252,0.00514188931609555,0.059714324387378,0.0798705305064725,1.10804806754209e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT2,Kunitz-type protease inhibitor 2,39927,0.053440832426565,0.00394202219806773,0.0457144689183523,0.0611671959347778,1.22516828686975e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAL,Integrin alpha-L,37052,0.05575517497061,0.00411167025586459,0.0476963012691154,0.0638140486721046,1.30945113231735e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B2M,Beta-2-microglobulin,37449,0.0400624158573313,0.00295503214207094,0.0342705528588722,0.0458542788557903,1.33595746366416e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,37052,0.0584031621768832,0.00430994367803246,0.0499556725679396,0.0668506517858268,1.48641377017619e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300C,CMRF35-like molecule 6,40005,0.0430869071813486,0.00318382848813834,0.0368466033445975,0.0493272110180997,1.68047430657133e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRA,Paired immunoglobulin-like type 2 receptor alpha,39854,0.053877647474253,0.00398176489000187,0.0460733882898493,0.0616819066586567,1.73362530476168e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM21,E3 ubiquitin-protein ligase TRIM21,39862,0.0973698452228517,0.00719619235146826,0.0832653082139739,0.11147438223173,1.74139626668534e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,39502,0.102441137028986,0.0075743102765845,0.0875954888868799,0.117286785171091,1.90870258195763e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM3,Dynamin-3,37408,0.0712990935462469,0.00527680633127742,0.0609565531369431,0.0816416339555506,2.46766697990381e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN2A1,Butyrophilin subfamily 2 member A1,39927,0.0323378773257353,0.00239514773574064,0.0276433877636836,0.0370323668877869,2.57721138396911e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB8,Serpin B8,40054,0.0710784541116494,0.00527347294614962,0.0607424471371962,0.0814144610861027,3.49073759836774e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL2,Interleukin-1 receptor-like 2,39583,0.0513619157890664,0.00381099949070168,0.0438923567872911,0.0588314747908417,3.6020275738586e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,39858,0.0487281019531863,0.00361942934349354,0.041634020439939,0.0558221834664337,4.32667377485469e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPT,Dermatopontin,40048,0.0345363262138864,0.002566338227002,0.0295063032889625,0.0395663491388104,4.62871699366204e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,39883,0.0304633025930256,0.00226595720128269,0.0260220264785115,0.0349045787075397,5.57592989221433e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GALT1,"Beta-1,4-galactosyltransferase 1",39927,0.0346446559523628,0.00257837019078801,0.0295910503784183,0.0396982615263073,6.13474266620988e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C19orf12,Protein C19orf12,39485,0.0833959547289778,0.00621779624750259,0.0712090740838728,0.0955828353740829,8.59363787809729e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIRC2,Baculoviral IAP repeat-containing protein 2,39473,0.0819907434946204,0.00611369873074101,0.070007893982368,0.0939735930068728,8.76757448348723e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD27,CD27 antigen,39909,0.0500088927200873,0.00373015146550116,0.042697795847705,0.0573199895924695,9.15853007039007e-41
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARC,SPARC,39909,0.0905526644457448,0.0067615375906499,0.0773000507680709,0.103805278123419,1.10878367774105e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALCAM,CD166 antigen,40048,0.0248830061813718,0.00185838794270221,0.0212405658136754,0.0285254465490681,1.14527480729587e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZN,Kazrin,37378,0.134232839944758,0.0100200310025411,0.114593579179778,0.153872100709739,1.15222618917043e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLEKHO1,Pleckstrin homology domain-containing family O member 1,37384,0.0894221225361746,0.0066752460300139,0.0763386403173473,0.102505604755002,1.15761370103705e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLNK,B-cell linker protein,37052,0.0503889204835051,0.00376388568976287,0.0430117045315698,0.0577661364354403,1.31727316640143e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN3,Centrin-3,37378,0.101684515593471,0.00759972657343568,0.0867890515095366,0.116579979677404,1.43324272753356e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABGAP1L,Rab GTPase-activating protein 1-like,39583,0.0763719499628921,0.00571405031452149,0.06517241134643,0.0875714885793542,1.59751745407573e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMPER,BMP-binding endothelial regulator protein,37120,0.0288773025578586,0.00215968707270254,0.0246443158953616,0.0331102892203556,1.63289690354576e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGCC,Regulator of cell cycle RGCC,37408,0.0973272684020757,0.00728291916656587,0.0830527468356066,0.111601789968545,1.77588967654531e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C4BPB,C4b-binding protein beta chain,39909,0.0507817294327131,0.00380264872856886,0.0433285379247181,0.0582349209407081,1.8382458780151e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDH1,"Malate dehydrogenase, cytoplasmic",37393,0.0516610631603337,0.0038665264609833,0.0440826712968064,0.059239455023861,1.84102557843669e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX8,Syntaxin-8,39862,0.0623729558967417,0.00467269908632599,0.0532144656875427,0.0715314461059406,1.99161516856609e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7R,Interleukin-7 receptor subunit alpha,39854,-0.0665803029102153,0.00499109738260288,-0.076362853780117,-0.0567977520403137,2.23193406686848e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBI,Acyl-CoA-binding protein,39789,0.102132522790974,0.00766350235509913,0.0871120581749798,0.117152987406968,2.64585070880224e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R2,Protein phosphatase inhibitor 2,39864,0.103289139805153,0.00775173670850629,0.0880957358564803,0.118482543753825,2.72826915557322e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMPR2,GMP reductase 2,37120,0.085894767499641,0.00644331480187282,0.0732658704879703,0.0985236645113118,2.78206758470354e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXADR,Coxsackievirus and adenovirus receptor,39862,0.0646815082828979,0.00485542207351603,0.0551648810188065,0.0741981355469894,2.84451474119078e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL7,Angiopoietin-related protein 7,40026,0.0475385142714434,0.00357014386863616,0.0405410322889165,0.0545359962539703,3.06158636504084e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB2,DnaJ homolog subfamily B member 2,37120,0.0681401645231476,0.00512274419284338,0.0580995859051746,0.0781807431411206,4.09950366231237e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL1,Fc receptor-like protein 1,39864,0.0560122152356936,0.00421392636891245,0.0477529195526252,0.064271510918762,4.19354624898381e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB11FIP3,Rab11 family-interacting protein 3,37433,0.137388712909661,0.0103316099706121,0.117138757367262,0.157638668452061,4.24111734997099e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TANK,TRAF family member-associated NF-kappa-B activator,39583,0.0902233891754066,0.00679573298665215,0.0769037525215684,0.103543025829245,5.20446801256262e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUB1,NEDD8 ultimate buster 1,39862,0.107166764878691,0.00807266945025265,0.0913443327561961,0.122989197001187,5.24372305549603e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFPI2,Tissue factor pathway inhibitor 2,39860,0.0510453155501612,0.00384555576446432,0.0435080262518111,0.0585826048485113,5.34267228643215e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA11,Annexin A11,39825,0.084956328710179,0.00640448029763709,0.0724035473268103,0.0975091100935477,5.99959200059532e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN3,Ataxin-3,37384,0.0781378833705149,0.0058968110925313,0.0665801336291536,0.0896956331118763,7.89797207506167e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREM2,Triggering receptor expressed on myeloid cells 2,39858,0.0656190179784121,0.00495621521490192,0.0559048361572043,0.0753331997996198,8.37693669951205e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLKB1,Plasma kallikrein,37183,0.0318170138783807,0.00240196779985723,0.0271091569906605,0.0365248707661009,8.46723892563662e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAT2,Signal transducer and activator of transcription 2,37052,0.100419943239927,0.00758146468985344,0.085560272447814,0.115279614032039,8.60275253187068e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,39709,0.142119479352271,0.0107363708785056,0.1210761924304,0.163162766274142,8.70140319443799e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2,Brorin,39680,0.0488834634742698,0.00369392562023701,0.0416433692586053,0.0561235576899344,9.14700379459589e-40
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELE,E-selectin,40048,0.0630592738891636,0.0047683552057571,0.0537132976858797,0.0724052500924476,1.01766217409461e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,40026,0.0376493364285259,0.00284977243790061,0.0320637824502407,0.0432348904068111,1.21111772882162e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",39784,0.0885312946174793,0.00670557986906324,0.0753883580741154,0.101674231160843,1.36781398883232e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID1,Nidogen-1,39888,0.0474540428548206,0.00359871023174216,0.040400570800606,0.0545075149090353,1.68733254204536e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A1,Collagen alpha-1(IV) chain,39864,-0.0494254712577334,0.00375113618888482,-0.0567776981879476,-0.0420732443275191,1.93194082737034e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL3,Follistatin-related protein 3,39799,0.0379180978834737,0.00287796158476194,0.0322772931773403,0.0435589025896071,1.95609961577852e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF6,SLAM family member 6,39473,0.0476796793200203,0.00361980363900168,0.040584864187577,0.0547744944524636,2.06637806064341e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,39745,0.0991634684378118,0.00753730873416197,0.0843903433188544,0.113936593556769,2.51225249925034e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,39981,0.0353352653256866,0.00268631560705864,0.0300700867358516,0.0406004439155215,2.57960227293953e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM13A,Protein FAM13A,37378,0.0858109575592826,0.00652135937895835,0.0730290931765242,0.0985928219420409,2.65381839025187e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,39465,0.0742159891223583,0.00564438807449099,0.063152988496356,0.0852789897483607,2.8026424773301e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BACH1,Transcription regulator protein BACH1,39862,0.0933357108362891,0.00710280803365662,0.0794142070903221,0.107257214582256,3.07334869803919e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ULBP2,UL16-binding protein 2,39745,0.0459812043894086,0.00349985811561941,0.0391214824827945,0.0528409262960226,3.19292397837259e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPACT,Protein IMPACT,37384,0.0699478194646515,0.00532657926711261,0.0595077241011108,0.0803879148281922,3.75460256599945e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASSF2,Ras association domain-containing protein 2,39473,0.0692595436828064,0.00528345769121272,0.0589039666080295,0.0796151207575833,4.71686014306878e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAX1BP1,Tax1-binding protein 1,37384,0.0795705126670285,0.00606999846419642,0.0676733156772035,0.0914677096568535,5.06836909410069e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC42BPB,Serine/threonine-protein kinase MRCK beta,37378,0.129194278532787,0.00985587162721722,0.109876770143441,0.148511786922132,5.1002257975887e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP1,Inactive pancreatic lipase-related protein 1,37384,0.0975392160578366,0.00744104532281235,0.0829547672251244,0.112123664890549,5.10487449601065e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSRA,Mitochondrial peptide methionine sulfoxide reductase,39909,0.0912778532756117,0.00697077776170224,0.0776151288626753,0.104940577688548,5.61828501912825e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,39994,0.0378442699450947,0.00289161182069958,0.0321767107765236,0.0435118291136659,6.12024525116567e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEP1,Rab GTPase-binding effector protein 1,37120,0.0980952626129834,0.0074933122421076,0.0834083706184525,0.112782154607514,6.45633958417002e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPP1,Tripeptidyl-peptidase 1,39763,0.0584344429534925,0.00446697448100415,0.0496791729707244,0.0671897129362606,6.67578584239599e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DFFA,DNA fragmentation factor subunit alpha,40054,0.0849136698196901,0.00649333209417396,0.0721867389151092,0.0976406007242711,7.00940556589453e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,39862,0.0762991450745069,0.0058344642804401,0.0648635950848443,0.0877346950641695,7.0234251710874e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH9,Protocadherin-9,37378,0.0417941049769316,0.0031997024058464,0.0355226882614727,0.0480655216923906,9.33146667005048e-39
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAL,Galanin peptides,39927,-0.080571807807781,0.00617604162663795,-0.0926768493959914,-0.0684667662195706,1.05514962911045e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN1,Pantetheinase,37441,0.09081571480564,0.0069603107420513,0.0771735057512195,0.104457923860061,1.11932539000201e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PZP,Pregnancy zone protein,37449,0.0688796904105986,0.00528075885842009,0.0585294030480952,0.079229977773102,1.1805125693577e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPSCR1,Tether containing UBX domain for GLUT4,37408,0.0850266207054113,0.00651955187023733,0.0722482990397462,0.0978049423710765,1.20924157938713e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PACS2,Phosphofurin acidic cluster sorting protein 2,37017,0.078331840650029,0.00600833340373313,0.066555507178712,0.0901081741213459,1.30369659106023e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARSA,Arylsulfatase A,39854,0.0560828720770239,0.00431310456779685,0.0476291871241421,0.0645365570299058,1.84535588871855e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP25,Ubiquitin carboxyl-terminal hydrolase 25,37364,0.0910355025129407,0.00700380291767333,0.077308048794301,0.10476295623158,2.13386674691577e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,39583,0.0696386237466123,0.00536055694557268,0.0591319321332899,0.0801453153599348,2.17098412265443e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK24,Serine/threonine-protein kinase 24,39485,0.0774033423653698,0.00596133154959597,0.0657191325281617,0.0890875522025779,2.37387278366313e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF1,Scavenger receptor class F member 1,40048,0.0531767705600894,0.00409722207090401,0.0451462153011176,0.0612073258190613,2.50881821352105e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHMP1A,Charged multivesicular body protein 1a,39745,0.0989631295896347,0.00763400090534214,0.0840004878151641,0.113925771364105,3.08110275607046e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",39862,0.12185553963209,0.00940080625634043,0.103429959369663,0.140281119894518,3.12005548249942e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMB,RGM domain family member B,40005,0.0316197987774147,0.00244174521608646,0.0268339781538852,0.0364056194009441,3.65503485347449e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD207,C-type lectin domain family 4 member K,39492,0.0467020795049507,0.00360772773297527,0.0396309331483191,0.0537732258615822,3.93694279547416e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CMIP,C-Maf-inducing protein,37364,0.103232037569216,0.00798418855663564,0.0875830279982106,0.118881047140222,5.15294837610299e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5IF1,"ATPase inhibitor, mitochondrial",39927,0.136507566599714,0.0105650737533176,0.115800022043211,0.157215111156216,5.32283311997565e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,37408,0.0816962889660799,0.00632521105317727,0.0692988753018524,0.0940937026303074,6.1244307536882e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT1,Angiopoietin-1,39790,0.104557914287042,0.00810111013261195,0.0886797384271222,0.120436090146961,6.39862614417066e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS1BP3,HCLS1-binding protein 3,37039,0.113423501042254,0.00878794075555128,0.0961991371613732,0.130647864923134,6.99592170008117e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LONP1,"Lon protease homolog, mitochondrial",37039,0.108165534892533,0.00838135313697041,0.0917380827440707,0.124592987040995,7.10650939118358e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPCDC,Phosphopantothenoylcysteine decarboxylase,40005,0.0583181693649216,0.00452320223316055,0.0494526929879269,0.0671836457419163,7.56618837595975e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPG,Macrophage-capping protein,39735,0.0717497919927995,0.00556727727804669,0.060837928527828,0.082661655457771,8.16246527307601e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCC,Tubulin-specific chaperone C,39745,0.10037013204756,0.0077938688149603,0.0850941491702379,0.115646114924882,9.23916761243534e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATG4A,Cysteine protease ATG4A,39473,0.0726767000121232,0.00564558554791845,0.061611352338203,0.0837420476860433,9.91201640699958e-38
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADM,Pro-adrenomedullin,40026,0.0324708920055856,0.0025232508640891,0.027525320311971,0.0374164636992003,1.03462700827513e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPBP,Platelet basic protein,37367,0.105000782487413,0.00816590731705476,0.0889956041459859,0.121005960828841,1.28169842445485e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA4,Protein disulfide-isomerase A4,37433,0.0759087598419433,0.00590429986986613,0.0643363320970057,0.0874811875868809,1.3101938325714e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS3BP,Galectin-3-binding protein,37449,0.0372088454057371,0.00289421123801143,0.0315361913792347,0.0428814994322395,1.31315153440873e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTF1,Cardiotrophin-1,39581,0.1046602909632,0.00814471016199434,0.0886966590456907,0.120623922880708,1.32826550485945e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRG1,Scrapie-responsive protein 1,37433,0.0326259591494376,0.00253867503725601,0.0276501560764158,0.0376017622224594,1.39576131749214e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4D,C-type lectin domain family 4 member D,39862,0.0745764275229111,0.00580690297787734,0.0631948976862715,0.0859579573595507,1.44860367069258e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTIF3,"Translation initiation factor IF-3, mitochondrial",37378,0.10830769978586,0.0084309184904878,0.0917830995445038,0.124832300027216,1.49236020259279e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BPIFB2,BPI fold-containing family B member 2,37401,0.0757195306350567,0.00589775822505527,0.0641599245139484,0.0872791367561651,1.64701085056468e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB6,Heat shock protein beta-6,40026,0.0460659493740103,0.00359336370471006,0.0390229565127785,0.053108942235242,1.93493047303239e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROD,Uroporphyrinogen decarboxylase,37120,0.085553527323694,0.00667177067000233,0.0724768568104894,0.0986301978368986,2.02785756531733e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC1,Sialoadhesin,39927,0.0513496948321356,0.00400958552709101,0.0434909071990373,0.059208482465234,2.28979023347294e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAUR,Urokinase plasminogen activator surface receptor,39753,0.0329184635985607,0.00257170047734917,0.0278779306629563,0.037958996534165,2.49784785893769e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WARS,"Tryptophan--tRNA ligase, cytoplasmic",39854,0.0461727943609055,0.003608062653199,0.0391009915606354,0.0532445971611755,2.59344741081029e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR1,Natural cytotoxicity triggering receptor 1,39831,0.0435057925973312,0.00340130125212033,0.0368392421431754,0.050172343051487,2.80793349200784e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA7,Thyroxine-binding globulin,37449,0.0227737063717532,0.00178108016571305,0.0192827892469557,0.0262646234965508,3.19793985640123e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBN,Nibrin,39583,0.0631803815083803,0.00494485087639297,0.0534884737906501,0.0728722892261105,3.37452445064438e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB2,Lamin-B2,37384,0.0336214861584234,0.00263154215241387,0.0284636635396922,0.0387793087771546,3.64503972882701e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAP,Prosaposin,37343,0.0343165593007826,0.00268677255586476,0.0290504850912876,0.0395826335102775,3.83746484407925e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP3,Insulin-like growth factor-binding protein 3,39927,0.0338715245408259,0.00265336150500666,0.0286709359910128,0.0390721130906389,3.87033773523333e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PF4,Platelet factor 4,37381,0.118462999240129,0.00927603127764415,0.100281977935947,0.136644020544312,3.90775227486673e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MITD1,MIT domain-containing protein 1,39745,0.118855788819549,0.00931833055938418,0.100591860923156,0.137119716715942,4.44163709490688e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1,Allograft inflammatory factor 1,39473,0.0645159003587055,0.00505826095431433,0.0546017088882494,0.0744300918291616,4.50188455111235e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAP3,Cytosol aminopeptidase,39583,0.0594635753277953,0.00466871765201161,0.0503128887298525,0.068614261925738,5.63806161820449e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",39862,0.101498174355612,0.00797096489783102,0.0858750831558627,0.11712126555536,5.82237257912505e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF12,Rho guanine nucleotide exchange factor 12,39862,0.126757897004877,0.00995786347707609,0.107240484589808,0.146275309419946,6.12993679064822e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZHX2,Zinc fingers and homeoboxes protein 2,37384,0.0381649954347698,0.00299722167295992,0.0322904409557684,0.0440395499137713,6.27861794521847e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRN,Progranulin,39783,0.0301080095738522,0.00236846421161966,0.0254658197190777,0.0347501994286267,7.6562099318845e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIF,Macrophage migration inhibitory factor,39822,0.0830904445738008,0.00653960007538234,0.0702728284260514,0.0959080607215502,8.2836180895141e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLO1,Lactoylglutathione lyase,39581,0.0705576812289317,0.00555405612795143,0.0596717312181469,0.0814436312397165,8.54123596538284e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PON1,Serum paraoxonase/arylesterase 1,37441,-0.0312113793019154,0.00245820236029684,-0.0360294559280972,-0.0263933026757336,9.95592589422779e-37
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACYP1,Acylphosphatase-1,37069,0.0802019035546567,0.00631905956401433,0.0678165468091886,0.0925872603001248,1.07161310774243e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,37039,0.0647037214571679,0.00509828527648927,0.054711082315249,0.0746963605990869,1.08357920930945e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLG,Plasminogen,37158,0.02754731055256,0.00217082260811288,0.0232924982406588,0.0318021228644613,1.09900965793967e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM3,Junctional adhesion molecule C,37120,0.0617074801865896,0.00486790901723844,0.0521663785128023,0.0712485818603769,1.30342341731339e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBD,Thrombomodulin,39864,0.0330771747061286,0.00261191419989906,0.0279578228743265,0.0381965265379308,1.40288091717037e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATOX1,Copper transport protein ATOX1,39909,0.0884113574612524,0.00698386352439022,0.0747229849534476,0.102099729969057,1.48469132911141e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2R,Proteinase-activated receptor 1,39904,0.0709528413424603,0.00561059256098181,0.0599560799229359,0.0819496027619846,1.75251097971486e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFB,Complement factor B,37216,0.0400202264965801,0.00316556412822146,0.033815720805266,0.0462247321878941,1.99299103794502e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCFD2,Multiple coagulation factor deficiency protein 2,39784,0.0544338377466781,0.00430877381060734,0.0459886410778877,0.0628790344154685,2.06973698551922e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK2A1,Casein kinase II subunit alpha,37408,-0.0546146504063748,0.00432269135695931,-0.063087125466015,-0.0461421753467345,2.18783838726045e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YAP1,Transcriptional coactivator YAP1,37384,0.0310068846932012,0.00245442708293889,0.0261962076106409,0.0358175617757614,2.22754017749481e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG4,V-set and immunoglobulin domain-containing protein 4,39827,0.0461089312344,0.0036531137718086,0.0389488282416552,0.0532690342271449,2.38749138120688e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CARHSP1,Calcium-regulated heat-stable protein 1,39485,0.0610801264557811,0.00484472310928512,0.0515844691615823,0.07057578374998,2.88087142271282e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRC1,Macrophage mannose receptor 1,37441,0.0333765601737443,0.0026463900036658,0.0281896357665593,0.0385634845809293,2.8913646493984e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CETN2,Centrin-2,39485,0.0817785146110983,0.00649027949092646,0.0690575668088824,0.0944994624133142,3.16153128356584e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA2,Apolipoprotein A-II,37441,-0.0576829045873512,0.00457726645146579,-0.0666543468322241,-0.0487114623424782,3.28037818747858e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,37039,0.0570496955293163,0.00452769212121694,0.0481754189717311,0.0659239720869015,3.40592196452234e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX58,Antiviral innate immune response receptor RIG-I,39473,0.0690103413379994,0.00548037832653943,0.0582687998179821,0.0797518828580167,3.49180066373893e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRKL,Crk-like protein,39877,0.129473740693295,0.0102835268005267,0.109318028164262,0.149629453222327,3.53798751048213e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",39862,0.116352136525427,0.00924441417571771,0.0982330847410208,0.134471188309834,3.73038454610658e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD36,Platelet glycoprotein 4,37052,0.0554134554820955,0.00440254722950482,0.046784462912266,0.0640424480519249,4.03080525181349e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5R2,NADH-cytochrome b5 reductase 2,37216,0.0675730350390331,0.00536888304964024,0.0570500242617382,0.078096045816328,4.03911738456557e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACC3,Transforming acidic coiled-coil-containing protein 3,39784,0.140817098223948,0.0112198922806447,0.118826109353885,0.162808087094012,5.83318564518152e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB3A1,Secretoglobin family 3A member 1,37120,-0.0295465683846294,0.0023542575780113,-0.0341609132375315,-0.0249322235317273,6.33822659509423e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLTA,Clathrin light chain A,39581,0.0560042463825295,0.00446938337218958,0.047244254973038,0.0647642377920211,7.52886312070089e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",37039,0.0551547941509286,0.00440168118850572,0.0465274990214574,0.0637820892803998,8.14447631099499e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAVCR2,Hepatitis A virus cellular receptor 2,39854,0.0403872014938851,0.00322671282293912,0.0340628443609244,0.0467115586268458,8.92059327509497e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D23,TBC1 domain family member 23,39784,0.108081676141283,0.00863529938339377,0.0911564893498313,0.125006862932735,8.96387135723482e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DXO,Decapping and exoribonuclease protein,37384,0.0547970427163991,0.00437725344924022,0.0462176259558883,0.0633764594769099,9.32304878423409e-36
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCA,Tubulin-specific chaperone A,37120,0.104037122466171,0.00831631802506551,0.0877371391370422,0.120337105795299,1.04692681953003e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD1,COMM domain-containing protein 1,37039,0.0744189070737239,0.00594957487131328,0.0627577403259499,0.086080073821498,1.07266742651715e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,37023,0.043891563717449,0.00350909987882699,0.0370137279549481,0.0507693994799499,1.07790662715875e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK3,NT-3 growth factor receptor,40005,-0.0255354576063495,0.00204276624923467,-0.0295392794548494,-0.0215316357578495,1.08623409393835e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFA1_DEFA1B,Neutrophil defensin 1,39533,0.0601498272305054,0.00481335010582357,0.0507156610230912,0.0695839934379196,1.15438937364155e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEL1L,Protein sel-1 homolog 1,37039,0.037576671515593,0.00300565579276146,0.0316855861617805,0.0434677568694054,1.15988106807416e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1A,T-cell leukemia/lymphoma protein 1A,39726,0.113632360111915,0.00910237680665133,0.0957917015708784,0.131473018652952,1.34479888040904e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKAP2,Src kinase-associated phosphoprotein 2,39927,0.124726042108396,0.00999290620320297,0.105139945950118,0.144312138266674,1.37814636476987e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSCAM,Down syndrome cell adhesion molecule,37408,0.0423501839435097,0.00339222667920123,0.0357014196522753,0.0489989482347441,1.42381856158192e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRADD,Death domain-containing protein CRADD,39709,0.0913235822716048,0.0073226390149099,0.0769712098023814,0.105675954740828,1.56981002919039e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXN,"Frataxin, mitochondrial",40026,0.0877615702610107,0.00703823813798605,0.073966623510558,0.101556517011463,1.60031499355568e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERMAP,Erythroid membrane-associated protein,37052,0.0535178185615089,0.00428993716679156,0.0451095417145975,0.0619260954084204,1.61704809905389e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCOF1,Treacle protein,37433,0.0364738997524604,0.00292472939160958,0.0307414301449057,0.0422063693600152,1.6846483318424e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAFA5,Chemokine-like protein TAFA-5,39784,0.0406776292179259,0.00326415924479063,0.0342798770981363,0.0470753813377156,1.76335265624876e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",37022,0.0953986879392798,0.00765873659073435,0.0803875642214405,0.110409811657119,2.04891306033559e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF149,E3 ubiquitin-protein ligase RNF149,37039,0.0352090365132392,0.00282671069237826,0.0296686835561779,0.0407493894703006,2.05681632990431e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTRA2,"Serine protease HTRA2, mitochondrial",39909,0.0734752028942755,0.00590203015643738,0.0619072237876582,0.0850431820008928,2.05995871020525e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GM2A,Ganglioside GM2 activator,37174,0.043230229463361,0.00347353153418342,0.0364221076563615,0.0500383512703605,2.32361668044966e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIT,Bis(5'-adenosyl)-triphosphatase,39485,0.0886606316553784,0.00712979755045121,0.0746862284564941,0.102635034854263,2.47287306208758e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLPBP,Pyridoxal phosphate homeostasis protein,39864,0.0812791898404265,0.00654035489051113,0.0684600942550246,0.0940982854258283,2.70218784049772e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD79B,B-cell antigen receptor complex-associated protein beta chain,40054,0.0498357159065147,0.00401170388397422,0.0419727762939252,0.0576986555191042,2.85363141916233e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL20,C-C motif chemokine 20,40054,0.100248814689052,0.0080737212548838,0.0844243210294794,0.116073308348624,3.06991509066835e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD80,T-lymphocyte activation antigen CD80,37433,0.0399929538660184,0.00322164245929274,0.0336785346458047,0.0463073730862322,3.41279351773215e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG2,Secretogranin-2,39945,0.0369754784942418,0.00298317819784982,0.0311284492264561,0.0428225077620274,4.04088257896773e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,37408,0.0930274778895831,0.00751170050960583,0.0783045448907556,0.10775041088841,4.91497592914929e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA,Adenosine deaminase,40054,0.0412435967468485,0.00333246438704265,0.0347119665482449,0.047775226945452,5.0563093055532e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC9,DnaJ homolog subfamily C member 9,37378,0.0904150935525935,0.00730719950702717,0.0760929825188202,0.104737204586367,5.62789959156192e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBNL,Drebrin-like protein,39927,0.110456698003985,0.00893461214272273,0.0929448582042488,0.127968537803722,5.990770257187e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGH,Gamma-glutamyl hydrolase,39569,0.0402315651179426,0.00325476850815317,0.0338522188419624,0.0466109113939228,6.18972768685991e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM106A,Transmembrane protein 106A,37364,0.0848515068718836,0.00686189970383537,0.0714021834523662,0.0983008302914009,6.1998422642675e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASAH1,Acid ceramidase,37336,0.0561733127145511,0.00454376269938921,0.0472675378237483,0.065079087605354,6.42843705780557e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,37364,0.0997544993499498,0.00807104592589824,0.0839352493351892,0.11557374936471,6.67889345697566e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLMH,Bleomycin hydrolase,40048,0.0378348873496168,0.00306615379236897,0.0318252259165736,0.04384454878266,7.9560929753738e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKA,Diacylglycerol kinase alpha,37052,0.0651383790114496,0.00527656724570022,0.0547963072098772,0.0754804508130221,8.08440613405844e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA2,Annexin A2,36875,0.0825091739774843,0.00668467823661561,0.0694072046337177,0.095611143321251,8.31578263792855e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOT,Angiomotin,37120,0.0490568189308143,0.00397506653047303,0.0412656885310872,0.0568479493305415,8.44211811432436e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,39784,-0.0234214674294268,0.00189886442378257,-0.0271432417000406,-0.019699693158813,8.51812696543289e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIB,Peptidyl-prolyl cis-trans isomerase B,39833,0.113596032691756,0.00921160412684049,0.0955412886031489,0.131650776780364,8.78716448222826e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",37408,0.108350459597169,0.00878253770238281,0.0911366857004984,0.125564233493839,8.79590821996778e-35
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WDR46,WD repeat-containing protein 46,37364,0.0428016045430349,0.0034738734302327,0.0359928126197788,0.049610396466291,1.07229334530309e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THPO,Thrombopoietin,39581,0.0450575514028815,0.0036613395459991,0.0378813258927233,0.0522337769130398,1.20941416971195e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF12,Tumor necrosis factor ligand superfamily member 12,40054,0.0340010601562079,0.00276314114939066,0.0285853035034022,0.0394168168090136,1.21258827122497e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LETM1,Mitochondrial proton/calcium exchanger protein,37408,0.0620298535967832,0.00504308927884591,0.0521453986102452,0.0719143085833212,1.38559358961674e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,39900,0.0598840445122183,0.00487539770420446,0.0503282650119776,0.0694398240124591,1.59954829712405e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,39854,0.0299066493412615,0.00243527303834775,0.0251335141860999,0.034679784496423,1.64672351242082e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDCCAG8,Serologically defined colon cancer antigen 8,37364,0.135423470914385,0.0110233729506738,0.113817659931065,0.157029281897706,1.66397560928522e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SF3B4,Splicing factor 3B subunit 4,39784,0.0858849891972037,0.00699688841356853,0.0721710879066094,0.099598890487798,1.77227209347181e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCA,Calcitonin,39709,0.0717692802776697,0.0058477639163115,0.0603076630016992,0.0832308975536402,1.81472181093624e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI5,Ecotropic viral integration site 5 protein homolog,37052,0.107701144509781,0.00877722124413955,0.0904977908712672,0.124904498148294,2.00865131260084e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTUS1,Microtubule-associated tumor suppressor 1,37165,0.0660149306065787,0.00538135671494524,0.055467471445286,0.0765623897678714,2.0808216314158e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HARS1,"Histidine--tRNA ligase, cytoplasmic",39854,0.0912701134749551,0.00745275856033129,0.0766627066967058,0.105877520253204,2.49959719653609e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL26,C-C motif chemokine 26,39862,0.100310100562093,0.00820495646546332,0.0842283858897853,0.116391815234401,3.22666559325635e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGMN,Legumain,39927,0.0421434106465558,0.00344878835083234,0.0353837854789244,0.0489030358141872,3.45717267690939e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,39862,0.118883680328855,0.00972875680897281,0.0998153169832687,0.137952043674442,3.45996786204893e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIFBP,KIF-binding protein,39784,0.0973188542255135,0.00796404026931247,0.081709335297661,0.112928373153366,3.46749151955481e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK2,Serine protease inhibitor Kazal-type 2,37120,0.0428793471383571,0.00350896797290928,0.0360017699114549,0.0497569243652593,3.7133943319688e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TST,Thiosulfate sulfurtransferase,39451,0.0895189952484714,0.00733025410523681,0.0751516972022072,0.103886293294736,3.82867043971448e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACTB2,Endoribonuclease LACTB2,39864,0.0781493259518742,0.00640040180195126,0.0656045384200497,0.0906941134836987,3.89648338970315e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,37120,0.101099904285087,0.00828459187145756,0.0848621042170299,0.117337704353144,4.54174954551069e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL1,Chordin-like protein 1,39904,0.0359146913137739,0.00294485134405551,0.0301427826794251,0.0416865999481227,4.63370092255664e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB1,Beta-crystallin B1,37433,0.0779705781758781,0.00639377613161963,0.0654387769579036,0.0905023793938526,4.99376707289995e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD1,Sushi domain-containing protein 1,39581,0.0569391746564124,0.00467127738251705,0.047783470986679,0.0660948783261458,5.05340570969702e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL14,C-C motif chemokine 14,39839,0.0454060797387291,0.00372689053416975,0.0381013742917564,0.0527107851857019,5.39447528232769e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53,Cellular tumor antigen p53,39473,0.0516445065562998,0.00423876522112918,0.0433365267228866,0.059952486389713,5.40612874019987e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF4E,Eukaryotic translation initiation factor 4E,37052,0.106921038376067,0.00878140566924008,0.0897094832643561,0.124132593487777,6.35595282892656e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CERT,Ceramide transfer protein,39485,0.0717611683831905,0.0059058500714051,0.0601857022432365,0.0833366345231445,8.06553991271562e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOCS2,Molybdopterin synthase catalytic subunit,37120,0.0796130252505965,0.00654987701245864,0.0667752663061775,0.0924507841950154,8.17494746923119e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN5,CCN family member 5,39854,0.0448495112172457,0.0036930696330277,0.0376110947365114,0.05208792769798,8.66961417237497e-34
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM24,Transcription intermediary factor 1-alpha,37131,0.0761230779379591,0.00627970332570155,0.0638148594195841,0.0884312964563342,1.21486962164057e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NADK,NAD kinase,39864,0.0621470458724979,0.00513020132810102,0.0520918512694199,0.0722022404755759,1.25028034370767e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL19,C-C motif chemokine 19,40005,0.13427120396681,0.0110876266974657,0.112539455639777,0.156002952293843,1.30762162748646e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA3,Annexin A3,39981,0.0809995790488409,0.00669188391624207,0.0678834865730064,0.0941156715246753,1.40409574805581e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL21,C-C motif chemokine 21,39927,0.0454445359077877,0.0037590143055472,0.0380768678689152,0.0528122039466602,1.67792184403877e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YWHAQ,14-3-3 protein theta,37120,0.0864063754772347,0.00714664323076158,0.072398954744942,0.100413796209527,1.778681183961e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPB1,Signal-regulatory protein beta-1,39831,0.051408316242541,0.00425441423387011,0.0430696643441556,0.0597469681409265,1.8065133124605e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN2,Neutrophil gelatinase-associated lipocalin,39368,0.0422788395861305,0.00350013468058712,0.0354185756121798,0.0491391035600813,1.92212769257174e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB1,Interleukin-12 receptor subunit beta-1,39583,0.0427168362578856,0.00354046376471556,0.0357775272790431,0.0496561452367281,2.26120740132423e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA4H,Leukotriene A-4 hydrolase,40026,0.0677559089009991,0.00562280586087449,0.0567352094136851,0.0787766083883131,2.68760182613201e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF19,Fibroblast growth factor 19,39927,0.088443480356486,0.00734909532585351,0.0740392535178131,0.102847707195159,3.24773835107166e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPB,CCAAT/enhancer-binding protein beta,39581,0.0431730465942961,0.00358826805440717,0.036140041207658,0.0502060519809341,3.3864684552222e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOLGA3,Golgin subfamily A member 3,37408,0.0899634943093075,0.00747671417898307,0.0753091345185006,0.104617854100114,3.53976956119929e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",37408,0.0930591581764262,0.00773506239219618,0.0778984358877217,0.108219880465131,3.6112851681174e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBL1X,F-box-like/WD repeat-containing protein TBL1X,39473,0.0982129597517075,0.0081679910407171,0.0822036973119019,0.114222222191513,3.71819819875438e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP10,Caspase-10,39485,0.0823636609586566,0.00685080969448985,0.0689360739574565,0.0957912479598567,3.79180284344371e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RILPL2,RILP-like protein 2,37433,0.113878696057584,0.00948633629154877,0.0952854769261486,0.13247191518902,4.94571988628165e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH2B3,SH2B adapter protein 3,39473,0.113424093811899,0.00945898455836021,0.0948844840775127,0.131963703546285,5.51948548471309e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC6A,C-type lectin domain family 6 member A,39473,0.0534361374727872,0.00445870680680279,0.0446970721314537,0.0621752028141207,5.96407571906328e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F13B,Coagulation factor XIII B chain,37376,0.0293909910412997,0.00245233620225974,0.0245844120848706,0.0341975699977288,6.26124190977749e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLF4,Krueppel-like factor 4,36987,0.0456464644951087,0.00380976741002173,0.0381793203714662,0.0531136086187513,6.59969195070448e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPL,Periplakin,37052,0.0370333120253344,0.00309209527072802,0.0309728052947074,0.0430938187559613,6.96368155932854e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TWF2,Twinfilin-2,37433,0.0973086787033901,0.00812750548000639,0.0813787679625775,0.113238589444203,7.22533998723431e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NACC1,Nucleus accumbens-associated protein 1,37364,0.0633577882455977,0.00530181302042293,0.0529662347255687,0.0737493417656266,9.47123810419668e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF1,Wiskott-Aldrich syndrome protein family member 1,39581,0.108025245677739,0.00904597253102491,0.0902951395169306,0.125755351838548,9.92616844953016e-33
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,37120,0.0738776783386761,0.00618470722736937,0.0617556521730321,0.08599970450432,1.01212515726509e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD160,CD160 antigen,40054,0.0513286406899149,0.00430008533699615,0.0429004734294025,0.0597568079504274,1.04549288642827e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,37433,0.102199539947041,0.00855961738643497,0.0854226898696285,0.118976390024454,1.07088618818081e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASH1,Tubulinyl-Tyr carboxypeptidase 1,39862,0.0938402838673748,0.00786269245219506,0.0784294066610725,0.109251161073677,1.07189441805152e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRG2,Developmentally-regulated GTP-binding protein 2,39784,0.0647222715431294,0.00542904313102707,0.0540813470063164,0.0753631960799425,1.25910370680039e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP13,Dual specificity protein phosphatase 13 isoform A,37364,0.048275525798962,0.00404979460071251,0.0403379283815655,0.0562131232163585,1.34874086452641e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RP2,Protein XRP2,39784,0.0477454489191685,0.00400697466291183,0.0398917785798613,0.0555991192584757,1.35068251257791e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDO1,"Indoleamine 2,3-dioxygenase 1",37039,0.0726335686872066,0.00609680294733163,0.0606838349104366,0.0845833024639766,1.48096206164376e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGCT,Gamma-glutamylcyclotransferase,37426,0.0550786373970871,0.00462849259825344,0.0460067919045103,0.0641504828896638,1.71895277089137e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA11,Integrin alpha-11,39862,-0.0387878784192764,0.00326132194506215,-0.0451800694315982,-0.0323956874069546,1.75745662765394e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEXN,Nexilin,37441,0.07875416379174,0.00661965233694761,0.0657796452113227,0.0917286823721573,1.77803028246054e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK1,Adenylate kinase isoenzyme 1,39864,0.0714377905401433,0.00601932812863615,0.0596399074080164,0.0832356736722702,2.37040378180687e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT1,Dynein light chain Tctex-type 1,37035,0.0916197786466454,0.00771694333195462,0.0764945697160144,0.106744987577276,2.40293350369488e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZI2,5-azacytidine-induced protein 2,37408,0.0633651265212025,0.00533769325443777,0.0529032477425044,0.0738270052999005,2.41472692484039e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRB1,Chymotrypsinogen B,39854,0.0608495268143071,0.00513032228752941,0.0507940951307495,0.0709049584978648,2.58514853827394e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",37039,0.104312768295554,0.00879246079048109,0.0870795451462113,0.121545991444897,2.66173945069306e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGRN,Neugrin,37384,0.0243164832712833,0.00205414739775546,0.0202903543716825,0.028342612170884,3.58986825851269e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD14,Monocyte differentiation antigen CD14,39560,0.0465643465697022,0.00393719567406965,0.0388474430485257,0.0542812500908787,3.88566672426891e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKG1,cGMP-dependent protein kinase 1,37120,0.144047909463803,0.0121848119499223,0.120165678041956,0.167930140885651,4.35761283795838e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM58,E3 ubiquitin-protein ligase TRIM58,37364,0.0972878930422231,0.00823222363588486,0.0811527347158888,0.113423051368557,4.53688315920025e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NIT1,Deaminated glutathione amidase,37039,0.053470169171732,0.00452535014668988,0.0446004828842198,0.0623398554592441,4.69974026602925e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRF5,Adhesion G protein-coupled receptor F5,37433,0.0323981937790349,0.00274288767673622,0.0270221339326319,0.0377742536254379,4.87309659006504e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKBKG,NF-kappa-B essential modulator,39862,0.104225483429714,0.00883666230216508,0.0869056253174702,0.121545341541957,5.64101915931221e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASP,Vasodilator-stimulated phosphoprotein,37441,0.0827042640156097,0.00702004608984868,0.0689449736795062,0.0964635543517131,6.97832400587044e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPI,Glucose-6-phosphate isomerase,37441,0.0537562102871488,0.00456658286250626,0.0448057078766366,0.0627067126976611,7.80241931868247e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPART,Spartin,37120,0.0884313226457662,0.00751381495339775,0.0737042453371066,0.103158399954426,8.10227571351896e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,39927,-0.0433535858865569,0.00368692854453175,-0.0505799658338392,-0.0361272059392747,8.59728907967682e-32
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGA,Protein O-GlcNAcase,37378,0.0806032445957164,0.00685987373422218,0.0671578920766409,0.0940485971147919,1.00781881963537e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIAPIN1,Anamorsin,39909,0.0711016586596663,0.00606216695375471,0.0592198114303071,0.0829835058890256,1.22225594542915e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",37165,0.0563218091645779,0.00480025376678405,0.0469133117816812,0.0657303065474747,1.23477785655439e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL1,Delta-like protein 1,39909,0.0319842089346865,0.00272774341130892,0.026637831848521,0.037330586020852,1.26942412523056e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,39583,0.0469075712937752,0.0040004181225867,0.0390667517735053,0.0547483908140452,1.27501735833834e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL1,Growth-regulated alpha protein,39835,0.106748996894524,0.00911101660728889,0.0888914043442381,0.124606589444811,1.41311401047966e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINE2,Glia-derived nexin,37433,0.0726519647871449,0.00620464886723144,0.0604908530073713,0.0848130765669185,1.61952363462853e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA4,Laminin subunit alpha-4,39927,0.037780419212545,0.00323055723932867,0.0314485270234608,0.0441123114016292,1.8195234634945e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,37449,0.0293576994944031,0.00251044709751091,0.0244372231832818,0.0342781758055245,1.93003289097389e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRAS,Ras-related protein R-Ras,37035,0.148845513802607,0.0127312709017967,0.123892222835085,0.173798804770128,2.01763179914431e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICA1,Islet cell autoantigen 1,39583,0.0899794850867425,0.00770588577802023,0.0748759489618228,0.105083021211662,2.25877189430909e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL32,Interleukin-32,39862,-0.047919038831149,0.00410781839382772,-0.0559703628830513,-0.0398677147792466,2.56636395259312e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MESD,LRP chaperone MESD,39854,0.136729775599009,0.0117236544628108,0.1137514128519,0.159708138346118,2.64563903712741e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXJ3,Forkhead box protein J3,37052,0.050443075727821,0.00432442045544293,0.0419672116351528,0.0589189398204891,2.74970909668165e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",39754,0.0836445623557108,0.0071790073688297,0.0695737079128046,0.097715416798617,3.02859870524861e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,37120,0.0680650479341599,0.00584006143341295,0.0566185275246706,0.0795115683436493,3.07777997320859e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL15A1,Collagen alpha-1(XV) chain,37433,0.0280057471519609,0.00240448399899865,0.0232929585139236,0.0327185357899983,3.33314545846788e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIT1,ARF GTPase-activating protein GIT1,37052,0.109545662124097,0.00941260854523553,0.0910969493754352,0.127994374872759,3.74173969061045e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM17,Splicing factor 45,37408,0.0858040812648986,0.00737599652409597,0.0713471280776705,0.100261034452127,3.94301189724365e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX,Glutaredoxin-1,39767,0.0626783348364725,0.00539134603601839,0.0521112966058764,0.0732453730670685,4.07453307441716e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXNB2,Plexin-B2,39980,0.0262908808721663,0.00226243888201958,0.0218565006634079,0.0307252610809246,4.308541385684e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM,Paralemmin-1,37295,0.0318181605042117,0.00273866877457353,0.0264503697060476,0.0371859513023758,4.69268177449785e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YJU2,Splicing factor YJU2,37364,0.0363541846422126,0.00312971160858962,0.030219949889377,0.0424884193950483,4.81029290038052e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO1,Roundabout homolog 1,39881,0.0263042735363087,0.00226817772567656,0.0218586451939826,0.0307499018786347,5.66797965134172e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK4,Dickkopf-related protein 4,39714,0.0503905006772064,0.00434973934505334,0.0418650115609019,0.058915989793511,6.56090231048365e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,39745,0.1055060889687,0.00910828487934699,0.08765385060518,0.12335832733222,6.64798330878714e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK1,Serine protease inhibitor Kazal-type 1,39854,0.044624861453162,0.00385256473627184,0.0370738345700692,0.0521758883362548,6.66380822186684e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MIA,Melanoma-derived growth regulatory protein,39909,0.0402026879312629,0.00347181468753876,0.0333979311436869,0.0470074447188389,6.92635344924663e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,37378,0.120826484753542,0.0104322053122827,0.100379362341468,0.141273607165616,7.10624167328113e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB6,Serpin B6,39966,0.0667493504536204,0.00577165825196539,0.0554369002797682,0.0780618006274725,8.20242242268822e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR7L,Aflatoxin B1 aldehyde reductase member 4,37052,0.078704259993662,0.00680329815051504,0.0653697956186525,0.0920387243686715,8.37524315303363e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GASK1A,Golgi-associated kinase 1A,37017,0.0476647572765554,0.00412032492450756,0.0395889204245206,0.0557405941285903,8.41589626549052e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,39864,0.0927295427734629,0.00802187048320852,0.0770066766263742,0.108452408920552,8.74891693407126e-31
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1A,Meprin A subunit alpha,37378,0.0795631027463659,0.00689841508328416,0.0660422091831289,0.0930839963096028,1.24348444887636e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC59,Leucine-rich repeat-containing protein 59,37433,0.0517633671547565,0.00448878683427909,0.0429653449595695,0.0605613893499435,1.268232889484e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,37408,0.11841698683939,0.0102728676326358,0.0982821662794236,0.138551807399356,1.33710893595196e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED18,Mediator of RNA polymerase II transcription subunit 18,39473,0.0850138453569693,0.00738288583310039,0.0705433891240925,0.099484301589846,1.47311005644597e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAK4,Interleukin-1 receptor-associated kinase 4,39862,0.115748063513596,0.0100536776601649,0.0960428552996731,0.135453271727519,1.49675448255667e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD300LF,CMRF35-like molecule 1,40026,0.0658730233791909,0.00572815491267072,0.0546458397503563,0.0771002070080256,1.73599510473712e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFL7,Epidermal growth factor-like protein 7,39473,0.0435314709340876,0.00378556943297577,0.0361117548454551,0.0509511870227201,1.76385154968711e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABRAXAS2,BRISC complex subunit Abraxas 2,37017,0.0738529798254793,0.00642434705777182,0.0612612595922466,0.0864447000587121,1.9354040412743e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM1,Probable carboxypeptidase X1,39909,0.0748773166343758,0.0065191944701977,0.0620996954727883,0.0876549377959633,2.04747172741451e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PQBP1,Polyglutamine-binding protein 1,39473,0.0603156783061319,0.00525250834418512,0.050020761951529,0.0706105946607347,2.12205093028586e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RETN,Resistin,39786,0.0448975580936329,0.00391234609352831,0.0372293597503174,0.0525657564369484,2.29602791077063e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3B,Protein FAM3B,39784,0.039515410945406,0.00344604208438814,0.0327611684600052,0.0462696534308068,2.54470317043748e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRAP2,GRB2-related adapter protein 2,39864,0.14150659525395,0.0123496336051044,0.117301313387945,0.165711877119954,2.8021841723487e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSR,"Glutathione reductase, mitochondrial",37399,0.0248454247735586,0.00216869962832839,0.0205947735020349,0.0290960760450822,3.01133014291575e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC9,Thioredoxin domain-containing protein 9,37384,0.0592986842869369,0.00517920334038765,0.0491474457397771,0.0694499228340967,3.2627704287349e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UMOD,Uromodulin,40008,-0.0577850158323733,0.00505277442875988,-0.0676884537127427,-0.0478815779520039,3.59834652389255e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB14,DnaJ homolog subfamily B member 14,37378,0.0715027415417467,0.00626237032498005,0.0592284957047858,0.0837769873787076,4.6767847771454e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,37378,0.0715876461581091,0.0062738510543119,0.0592908980916578,0.0838843942245604,5.08581501432541e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN4,CCN family member 4,40026,0.0438226642830601,0.00384406597692277,0.0362882949682915,0.0513570335978287,5.43825622380152e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB27B,Ras-related protein Rab-27B,37433,0.0898824165077582,0.0078830490377474,0.0744316403937733,0.105333192621743,5.59492514777611e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERP29,Endoplasmic reticulum resident protein 29,37120,0.131115036494083,0.0115014664252389,0.108572162300615,0.153657910687551,5.77468176201789e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTUD6B,Deubiquitinase OTUD6B,37378,0.0640566496907118,0.00562220805502793,0.053037121902857,0.0750761774785665,6.16947863860345e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ING1,Inhibitor of growth protein 1,39449,0.0491308023099112,0.00431779012080839,0.0406679336731268,0.0575936709466957,7.00487967822058e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLG4,Disks large homolog 4,37384,0.078628255246075,0.0069083340971093,0.0650879204157407,0.0921685900764092,7.05808139477295e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA2,Carbonic anhydrase 2,39817,0.0741462577147446,0.00652095203024227,0.0613651917354697,0.0869273236940194,7.64388987341614e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN8,Septin-8,37353,0.0349186377213148,0.00307146965167839,0.0288985572040252,0.0409387182386045,8.18133316949605e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDC,Nuclear migration protein nudC,40054,0.0701392193845096,0.00617275810683951,0.0580406134951041,0.082237825273915,8.31656899696192e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBCB,Tubulin-folding cofactor B,39745,0.110502632054048,0.00972671832980077,0.0914382641276383,0.129566999980457,8.54781581806259e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TACSTD2,Tumor-associated calcium signal transducer 2,38019,-0.0335168267299322,0.00295067294455054,-0.0393001457012512,-0.0277335077586131,8.99695590170852e-30
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX3,Probable E3 ubiquitin-protein ligase DTX3,39784,0.0253818780336254,0.00223870835060726,0.0209940096664351,0.0297697464008156,1.10886860210494e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RFC4,Replication factor C subunit 4,37364,0.0233480063776651,0.00206004962658964,0.0193103091095494,0.0273857036457808,1.21594121072877e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA2_BOLA2B,BolA-like protein 2,37039,0.0596682063708829,0.00527115966662088,0.0493367334243059,0.0699996793174598,1.4345978383523e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSCAR,Osteoclast-associated immunoglobulin-like receptor,39881,0.0359916556215843,0.0031817931583936,0.0297553410311328,0.0422279702120357,1.48571458623001e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAC1,Zinc phosphodiesterase ELAC protein 1,37408,0.0931616105857293,0.00823401370331237,0.077022943727237,0.109300277444221,1.51378649253031e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD28,T-cell-specific surface glycoprotein CD28,39473,0.0382400322425772,0.00338167232313574,0.0316119544892311,0.0448681099959232,1.56009530961006e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD163,Scavenger receptor cysteine-rich type 1 protein M130,39927,0.0460726241716478,0.00407878885646757,0.0380781980129714,0.0540670503303243,1.78066029709472e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,39928,0.12156662808438,0.0107627098728803,0.100471716733535,0.142661539435225,1.7905902810018e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSM,Oncostatin-M,39781,0.0772735094464921,0.00685665549262309,0.0638344646809508,0.0907125542120333,2.38794835215308e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,37052,0.0491921216864026,0.00436581979401336,0.0406351148901365,0.0577491284826688,2.58283271870655e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA2,Pulmonary surfactant-associated protein A2,39473,0.0531851492577728,0.00473270936665333,0.0439090388991323,0.0624612596164133,3.44281482471164e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MERTK,Tyrosine-protein kinase Mer,40054,0.0273101653272507,0.0024310194913041,0.0225453671242947,0.0320749635302068,3.55776007192821e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRN1,Secernin-1,39862,0.0606420285649171,0.00539845763721382,0.050061051595978,0.0712230055338562,3.60151824151097e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPR,Nucleoprotein TPR,37017,0.0509385680701825,0.00453330113122217,0.042053297852987,0.0598238382873779,3.662665714116e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB1,Leukocyte elastase inhibitor,39807,0.0963216487662063,0.00859712998638032,0.0794712739929009,0.113172023539512,5.00636051049919e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT8,"Alpha-(1,6)-fucosyltransferase",39745,0.062045895464913,0.00553956911823311,0.0511883399931761,0.0729034509366499,5.20805281201117e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNST,Consortin,39864,0.116266138646757,0.0103863951897678,0.0959088040748124,0.136623473218702,5.58533515645863e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGF,Pro-epidermal growth factor,39804,0.111585372763821,0.0099695885826926,0.0920449791417435,0.131125766385898,5.68546533693293e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THTPA,Thiamine-triphosphatase,37341,0.0952156455354839,0.0085138506665412,0.0785284982290632,0.111902792841905,6.57422945206815e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,39473,0.0704319014849895,0.00630394799204343,0.0580761634205844,0.0827876395493946,7.14043935493779e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF23,Fibroblast growth factor 23,40004,0.0625930222098251,0.00560457750157482,0.0516080503067385,0.0735779941129118,7.44432152747344e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REEP4,Receptor expression-enhancing protein 4,37408,0.0670969065556752,0.00600805007063573,0.0553211284172292,0.0788726846941212,7.82927398812657e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,36842,0.0353150263023963,0.0031643362808385,0.0291129271919529,0.0415171254128398,8.62013286764886e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QPCT,Glutaminyl-peptide cyclotransferase,39858,0.0282849709775736,0.00253677647102756,0.0233128890943596,0.0332570528607876,9.14423149416034e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTA,Lymphotoxin-alpha,39862,0.042248128210879,0.00378936053863433,0.0348209815551557,0.0496752748666023,9.22780658206371e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,37364,0.0520225131863707,0.00466462387543202,0.042879850390524,0.0611651759822175,9.29066986673552e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO3,R-spondin-3,40026,0.0288249972863075,0.00258599830634743,0.0237564406058665,0.0338935539667485,9.47375264405387e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,37364,0.0385283454480715,0.00345539325274659,0.0317557746726882,0.0453009162234548,9.53785043075717e-29
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD5,Mothers against decapentaplegic homolog 5,39784,0.0219277945269316,0.00196825151441432,0.0180700215586795,0.0257855674951837,1.01451759606362e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBS,Cystathionine beta-synthase,37039,0.0545244823199473,0.00489870554690816,0.0449230194480073,0.0641259451918873,1.19750500354355e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAMP5,Vesicle-associated membrane protein 5,39581,0.056432759074242,0.00507637245801724,0.0464830690565282,0.0663824490919558,1.32929909795286e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLMAP,Sarcolemmal membrane-associated protein,37378,0.0898008304019443,0.00807552179792385,0.0739728076780136,0.105628853125875,1.33229611921002e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",39784,0.0362600916830593,0.00326197313458082,0.0298666243392809,0.0426535590268377,1.3362579197683e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,37120,0.0451312575230501,0.00406051368679222,0.0371726506969373,0.0530898643491628,1.42340156864967e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTN,Pleiotrophin,39581,0.0537165934509697,0.00484132365031417,0.044227599096354,0.0632055878055855,1.68437790138284e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL8,Interleukin-8,39746,0.0703504898159994,0.00634131943559745,0.0579215037222284,0.0827794759097704,1.70744149182907e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,37378,0.126844060878127,0.0114308440233629,0.104439606592336,0.149248515163918,1.72877865052085e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,37165,0.113523562284088,0.0102466254360003,0.0934401764295271,0.133606948138648,2.10870420677517e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAVS,Mitochondrial antiviral-signaling protein,39473,0.0983694114928423,0.00889182945181189,0.080941425767291,0.115797397218394,2.419603644727e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS7_LGALS7B,Galectin-7,39818,0.0431826151131194,0.00390433706213118,0.0355301144713423,0.0508351157548965,2.48092962387586e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGR,Tyrosine-protein kinase Fgr,39485,0.0598133925593152,0.00541022883590928,0.0492093440409331,0.0704174410776974,2.62222106178831e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDAP1,28 kDa heat- and acid-stable phosphoprotein,37433,0.104958785913306,0.00949354440656447,0.0863514388764399,0.123566132950173,2.71339649835774e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",39709,0.102468983535936,0.00927445460315408,0.0842910525137541,0.120646914558118,2.82653526881819e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPPK1,Epiplakin,37039,0.0792006229220388,0.00716882053307284,0.0651497346772161,0.0932515111668616,2.98443245642279e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC27A4,Long-chain fatty acid transport protein 4,39485,0.0715403927561135,0.00649199640383226,0.0588160798046023,0.0842647057076247,3.8946466230609e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,37039,0.0814404738522581,0.00739238969580368,0.0669513900484829,0.0959295576560333,4.205764573621e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FEN1,Flap endonuclease 1,39473,0.0659686068921624,0.00599169799643364,0.0542248788191524,0.0777123349651723,4.33863751334988e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP1,Interstitial collagenase,39310,0.096831664035446,0.00879983331666172,0.0795839907347891,0.114079337336103,4.65652074342236e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NBL1,Neuroblastoma suppressor of tumorigenicity 1,39909,0.0269738100349903,0.00245211568344206,0.0221676632954438,0.0317799567745367,4.80112961893258e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",37433,0.078340316798784,0.00712444621090598,0.0643764022254083,0.0923042313721597,5.24459534074195e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP45,Rho GTPase-activating protein 45,37120,0.0876245379636811,0.00797606031401476,0.0719914597482121,0.10325761617915,5.89365735323958e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPHN1,Oligophrenin-1,37384,0.114175986162039,0.0104077811425482,0.0937767351226449,0.134575237201434,6.96298863803677e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUGT1,Protein SGT1 homolog,39473,0.0853774086104038,0.00778774412772897,0.070113430120055,0.100641387100753,7.26917468279898e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBFOX3,RNA binding protein fox-1 homolog 3,37408,0.0390424506047761,0.00356442498882974,0.0320561776266698,0.0460287235828824,8.37386515059023e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR3,Small proline-rich protein 3,37384,0.0691501351690315,0.00631410388021551,0.0567744915638091,0.0815257787742539,8.53251555187127e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCT5,T-complex protein 1 subunit epsilon,39473,0.0470685889934159,0.00430189765950094,0.038636869580794,0.0555003084060377,9.21973973616931e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGN,Biglycan,39444,-0.125284648958015,0.0114562527276519,-0.147738904304212,-0.102830393611817,9.78913096480344e-28
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCYT2,Ethanolamine-phosphate cytidylyltransferase,37378,0.0809008453100398,0.00740105898369615,0.0663947697019953,0.0954069209180842,1.07024770127565e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGES2,Prostaglandin E synthase 2,36957,0.0586372482290265,0.00536412988685501,0.0481235536507907,0.0691509428072623,1.07494094547652e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XIAP,E3 ubiquitin-protein ligase XIAP,37052,0.0617547134942117,0.00565049224527492,0.0506797486934729,0.0728296782949506,1.0998354221732e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM172A,Cotranscriptional regulator FAM172A,37039,0.0649319815226158,0.00594445925667837,0.0532808413795262,0.0765831216657054,1.17429409890278e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC26,Anaphase-promoting complex subunit CDC26,37358,0.0748048898671107,0.00685234508610429,0.0613742934983463,0.0882354862358751,1.25154367716561e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARA5,Scavenger receptor class A member 5,40005,0.0305454366530735,0.00280032144646068,0.0250568066180106,0.0360340666881364,1.32006494622431e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,39784,0.0993389584571597,0.00911453938428934,0.0814744612639526,0.117203455650367,1.45879305751992e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,39854,0.0377829453340613,0.00346783016083331,0.030985998218828,0.0445798924492946,1.51714435504837e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL7,Interleukin-7,39862,0.0681403130615558,0.00625845485415547,0.055873741547411,0.0804068845757005,1.64708010582837e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,37408,0.10442689986398,0.00959259805321167,0.0856254076796849,0.123228392048275,1.74300667566013e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPB1,Heat shock protein beta-1,39613,0.0726570778844922,0.00669601699250715,0.0595328845791782,0.0857812711898062,2.47004991622003e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,37052,0.0501817183754696,0.00462363509984989,0.0411193935797639,0.0592440431711754,2.50913623481336e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,37433,0.0416793061192279,0.00384166848612793,0.0341496358864171,0.0492089763520386,2.60194939929628e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP1,Syntaxin-binding protein 1,37408,0.0814979796183229,0.00753481285934091,0.0667297464140147,0.0962662128226311,3.72469524862346e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS4B,Vacuolar protein sorting-associated protein 4B,37364,0.0986913758948121,0.00913174318518747,0.0807931592518447,0.11658959253778,4.09468343490726e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MARS1,"Methionine--tRNA ligase, cytoplasmic",37084,0.0899134158145775,0.00832721415372027,0.0735920760732858,0.106234755555869,4.58460968749185e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",37433,0.0560396181433864,0.0051939307138714,0.0458595139441984,0.0662197223425743,4.97005617415753e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BP1,SH3 domain-binding protein 1,37378,0.0498985817588501,0.00462536832974167,0.0408328598325564,0.0589643036851438,5.05189340354647e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADD1,Alpha-adducin,37120,0.071614895918176,0.00664639122709598,0.0585879691130679,0.0846418227232842,5.84147633210005e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECAP2,Adaptin ear-binding coat-associated protein 2,37017,0.067278352687681,0.00625583813065173,0.0550169099516036,0.0795397954237584,7.29902388052955e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R2,Interleukin-1 receptor type 2,39826,0.0202430555662137,0.00188503063535137,0.0165483955209251,0.0239377156115024,8.25700272423807e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP1,Peptidoglycan recognition protein 1,39958,0.0432073855271407,0.0040246107967095,0.0353191483655901,0.0510956226886913,8.51802883172691e-27
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX7,Syntaxin-7,37052,0.051063428112554,0.00476164986278481,0.0417305943814958,0.0603962618436122,1.01307541531207e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2L,Ataxin-2-like protein,37408,0.0496165598390576,0.0046299708011953,0.0405418170687148,0.0586913026094003,1.09072826192418e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPXM2,Inactive carboxypeptidase-like protein X2,37433,0.0247064439896904,0.00230774932115278,0.0201832553202309,0.0292296326591498,1.22036826688517e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENAH,Protein enabled homolog,39583,0.0493533557210371,0.00461279621885331,0.0403122751320846,0.0583944363099896,1.26735210903014e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP25,Rho GTPase-activating protein 25,39473,0.061957615415974,0.00580072321950875,0.0505881979057368,0.0733270329262111,1.54240508245974e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MOG,Myelin-oligodendrocyte glycoprotein,40026,0.0325874291912047,0.00305188929171148,0.0266057261794502,0.0385691322029592,1.58514000570074e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SWAP70,Switch-associated protein 70,37378,0.0369571602703095,0.00346057521877316,0.0301744328415141,0.0437398876991049,1.61966205832319e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FADD,FAS-associated death domain protein,39864,0.0787730514770866,0.00739612142049521,0.0642766534929159,0.0932694494612572,2.12384324755779e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BDNF,Brain-derived neurotrophic factor,37433,0.0845701248262709,0.00793867761545712,0.0690103166999749,0.100129932952567,2.1481729469175e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6,Interleukin-6,39784,0.0724285786711091,0.00680124551796559,0.0590981374558965,0.0857590198863216,2.15519180826593e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH1,Neurogenic locus notch homolog protein 1,40048,0.0160094018949907,0.00150348611855495,0.013062569102623,0.0189562346873584,2.17394852603764e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA2,Ephrin type-A receptor 2,39244,0.0300110510075053,0.00282175170228926,0.0244804176710184,0.0355416843439923,2.51186203234707e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPRIP,Myosin phosphatase Rho-interacting protein,37334,0.0460433091867402,0.00433080913822309,0.037554923275823,0.0545316950976575,2.70110354690903e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CIT,Citron Rho-interacting kinase,37035,0.0465174801946109,0.00438174905988984,0.0379292520372269,0.055105708351995,3.19796333215444e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STXBP3,Syntaxin-binding protein 3,39473,0.0450669215540742,0.00424674341414737,0.0367433044623453,0.0533905386458031,3.21538229331053e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC25,Leucine-rich repeat-containing protein 25,39784,0.0395299515165964,0.00372653311039153,0.0322259466202291,0.0468339564129638,3.35627028527534e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP8,Caspase-8,39980,0.0627729395030948,0.0059201741028521,0.0511693982615047,0.0743764807446849,3.51117590340537e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC4,Apical endosomal glycoprotein,37364,0.0570133532759972,0.00537630231927752,0.0464758007302133,0.0675509058217812,3.59658911009992e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM40,E3 ubiquitin ligase TRIM40,37035,0.0745500957439052,0.00703106893719206,0.0607692006270087,0.0883309908608016,3.68022872284196e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN6,Dynactin subunit 6,39485,0.0721834515521776,0.0068149406869196,0.0588261678058152,0.08554073529854,3.98278267297098e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMT,Catechol O-methyltransferase,39399,0.0867298654596469,0.00819270132951633,0.0706721708537949,0.102787560065499,4.23598734411359e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOXO3,Forkhead box protein O3,39473,0.0992710600451468,0.00938411055251369,0.08087820336222,0.117663916728074,4.58703305103308e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASEH2A,Ribonuclease H2 subunit A,37408,0.0502281777836331,0.00475268779997547,0.0409129096956812,0.0595434458715851,5.27282107381236e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGA,Fibrinogen alpha chain,37145,0.0312713202179592,0.00295980990038531,0.025470092813204,0.0370725476227145,5.47117453941473e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP1,Inositol polyphosphate 1-phosphatase,39784,0.0547194346977797,0.00518322153756714,0.0445603204841481,0.0648785489114113,5.74290693692404e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED8,Protein TMED8,37378,0.105425840027389,0.00998415121560471,0.085856903644804,0.124994776409974,5.80532394161531e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LARP1,La-related protein 1,37364,0.0652163498023565,0.00618385945280308,0.0530959852748625,0.0773367143298506,6.66796652345953e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FXYD5,FXYD domain-containing ion transport regulator 5,39583,0.0663011637562851,0.00628891237307939,0.0539748955050495,0.0786274320075207,6.70961093092091e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESM1,Endothelial cell-specific molecule 1,39858,-0.0345244983006452,0.00327733998663477,-0.0409480846744494,-0.0281009119268411,7.29490458710477e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MASP1,Mannan-binding lectin serine protease 1,39709,0.0238000855909123,0.00226168052902652,0.0193671917540203,0.0282329794278042,8.21762891169425e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO9B,Unconventional myosin-IXb,39583,0.0668530174230048,0.00635392570668016,0.0543993230379117,0.0793067118080979,8.3754880251153e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,39473,0.0689279964937641,0.0065564596978635,0.0560773354859517,0.0817786575015765,9.17668005404472e-26
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRK5,G protein-coupled receptor kinase 5,39581,0.0534970753471714,0.00509547313910221,0.0435099479945311,0.0634842026998117,1.06246744489517e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDLIM5,PDZ and LIM domain protein 5,37408,0.121191851885165,0.0115399819011853,0.0985734873588422,0.143810216411488,1.0625129027114e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP2,Integrin beta-1-binding protein 2,39581,0.113403054072068,0.0108058716269453,0.0922235456832555,0.134582562460881,1.11237090994063e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NID2,Nidogen-2,39854,0.0731387631573434,0.00698300260676238,0.0594520780480891,0.0868254482665977,1.37873321562117e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PILRB,Paired immunoglobulin-like type 2 receptor beta,39864,0.0572020788357399,0.00546187781848534,0.0464967983115087,0.0679073593599712,1.39103901102965e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",39583,0.0600754696973145,0.00574467876503928,0.0488158993178376,0.0713350400767915,1.64009668847031e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRAP,BRCA1-associated protein,37245,0.111109249528149,0.0106224877747165,0.0902891734897048,0.131929325566594,1.656839159301e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMAD3,Mothers against decapentaplegic homolog 3,37364,0.0514352408001683,0.00492222248243118,0.0417876847346032,0.0610827968657334,1.84014007836021e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD23B,UV excision repair protein RAD23 homolog B,39473,0.0472436328803413,0.00453063872283543,0.0383635809835839,0.0561236847770988,2.24788789640901e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD226,CD226 antigen,37052,0.0421849070951056,0.00404444071207223,0.034257803299444,0.0501120108907671,2.26200531879329e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDHD2,Phospholipase DDHD2,37408,0.0670493383349957,0.00643126244752907,0.0544440639378387,0.0796546127321526,2.36441804403407e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,40030,0.0265360918509372,0.00254940111142708,0.0215392656725401,0.0315329180293343,2.71846530152322e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,39751,0.0240469640548405,0.00231125193605635,0.0195169102601701,0.028577017849511,2.85686394357544e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGACT,Gamma-glutamylaminecyclotransferase,37433,0.0714622298093087,0.00686753776472302,0.0580018557904516,0.0849226038281659,2.90335531794496e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",37384,0.0983233076070278,0.00945135447092601,0.0797986528440129,0.116847962370043,2.98879851805401e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACYBP,Calcyclin-binding protein,37084,0.103924542662765,0.0100061617195754,0.0843124656923968,0.123536619633132,3.58613485639248e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POSTN,Periostin,37433,-0.0371445128904968,0.00357727308669657,-0.0441559681404221,-0.0301330576405716,3.66281723180127e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX9,Sorting nexin-9,39864,0.0692199343177162,0.00667082856272253,0.05614511033478,0.0822947583006524,3.81078853706703e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPO,Myeloperoxidase,39854,0.0451735633099095,0.00435484049423368,0.0366380759412115,0.0537090506786075,3.94543384816857e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC22D1,TSC22 domain family protein 1,37408,0.0676697344734203,0.0065337403750469,0.0548636033383284,0.0804758656085122,4.82500390637008e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD40LG,CD40 ligand,40054,0.0772478212326413,0.00746662411903552,0.0626132379593317,0.0918824045059509,5.23427149963488e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEMIP2,Cell surface hyaluronidase,37052,0.031962123358924,0.00308891078673417,0.025907858216925,0.038016388500923,5.36003748268838e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM5,Tripartite motif-containing protein 5,39862,0.085665360435586,0.0082868909063393,0.069423054259161,0.101907666612011,5.71652587355057e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRBP,Acrosin-binding protein,37364,0.0382489279620749,0.00370448911836561,0.0309881292900783,0.0455097266340715,6.72127641428605e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF2,TNF receptor-associated factor 2,39862,0.0702937717866457,0.00682089209129807,0.0569248232877014,0.0836627202855899,7.94388672004675e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCS,Copper chaperone for superoxide dismutase,39745,0.0466947923126889,0.00453527193430006,0.0378056593214608,0.055583925303917,8.79580985037986e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VPS28,Vacuolar protein sorting-associated protein 28 homolog,37165,0.0666772772395174,0.00647829031362857,0.0539798282248053,0.0793747262542294,9.43998460831386e-25
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG6,Large proline-rich protein BAG6,39581,0.0365503221079561,0.00355522313861805,0.0295820847562647,0.0435185594596475,1.03057975773419e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,39473,0.0570205838524768,0.00554829926945191,0.046145917284351,0.0678952504206025,1.07097724652827e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVR,Poliovirus receptor,40005,0.0366483670243807,0.00357050804841614,0.0296501712494851,0.0436465627992763,1.21640069133801e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOLA1,BolA-like protein 1,36987,0.0545610284874216,0.00531468728312613,0.0441442414124944,0.0649778155623488,1.2414534514931e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMVK,Phosphomevalonate kinase,39476,0.109358460168754,0.0106590765199827,0.0884666701895876,0.13025025014792,1.28197824830597e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDR1,Epithelial discoidin domain-containing receptor 1,40005,0.0229114825247379,0.00223539993067044,0.0185300986606239,0.027292866388852,1.41640041247343e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHI3L1,Chitinase-3-like protein 1,39541,0.0739944294964113,0.00721996222932527,0.0598433035269338,0.0881455554658888,1.4353903802242e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,39473,0.084004678889158,0.00819867420009128,0.0679352774569791,0.100074080321337,1.47326882230233e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR5,Complement factor H-related protein 5,37263,0.0407735220946201,0.00397935292646506,0.0329739903587485,0.0485730538304916,1.51500218440484e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,39678,0.0313675056587735,0.00306314761495114,0.0253637363334693,0.0373712749840778,1.56080226391487e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GOT1,"Aspartate aminotransferase, cytoplasmic",37433,0.0415244554117097,0.00405657885922819,0.0335735608476225,0.049475349975797,1.67336890998624e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F12,Coagulation factor XII,37449,0.0408181464172537,0.00399063699842374,0.0329964979003431,0.0486397949341642,1.81304090579514e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,37052,0.0566412912298629,0.00553874035396077,0.0457853601360998,0.067497222323626,1.86370010959383e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XRCC4,DNA repair protein XRCC4,39485,0.0364577043613866,0.00356724344259802,0.0294659072138945,0.0434495015088787,1.9233617602047e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF1R,Insulin-like growth factor 1 receptor,39784,0.0212902549643339,0.00208546273259387,0.0172027480084499,0.0253777619202179,2.15105757674586e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANF,Mesencephalic astrocyte-derived neurotrophic factor,39927,0.118418865704222,0.0116013568301233,0.0956802063171804,0.141157525091264,2.18231181696938e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP7,Caspase-7,37384,0.083066789181994,0.00813623122772388,0.0671197759756552,0.0990138023883328,2.20412345389927e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA9,Serpin A9,39711,0.0713032385562742,0.00698718042762109,0.0576083649181368,0.0849981121944115,2.24323932602832e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECI2,Enoyl-CoA delta isomerase 2,37017,0.060833725820243,0.00596540061343361,0.0491415406179131,0.0725259110225729,2.49894247475846e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRC,Receptor-type tyrosine-protein phosphatase C,37433,0.0218570335156128,0.00214582305297744,0.017651220331777,0.0260628466994486,2.80417776372693e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTPBP2,GTP-binding protein 2,37035,0.0797322846290627,0.00783007685774093,0.0643853339878905,0.0950792352702349,2.90967147514508e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRL,Appetite-regulating hormone,39864,0.0751228236425402,0.00738321581359273,0.0606517206478984,0.0895939266371819,3.04477482994401e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC1,WAP four-disulfide core domain protein 1,37119,0.0515752055834889,0.00507167895631684,0.0416347148291079,0.0615156963378699,3.33680118524356e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,39581,0.0470793130604027,0.00463895349739668,0.0379869642055053,0.0561716619153002,3.98545905764551e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RA,Interleukin-2 receptor subunit alpha,39728,0.0381962183107995,0.0037658193138038,0.0308152124557441,0.0455772241658549,4.22204649093957e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GET3,ATPase GET3,37433,0.0546305511448217,0.00538846131048028,0.0440691669762803,0.065191935313363,4.54436684344668e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD69,Early activation antigen CD69,39781,0.0856598060432268,0.00845446793199157,0.0690890488965233,0.10223056318993,4.71776905672397e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHM,Rab proteins geranylgeranyltransferase component A 1,37035,0.059838551366067,0.00592861016660452,0.0482184754395221,0.0714586272926119,7.23098973329513e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAGR1,PAXIP1-associated glutamate-rich protein 1,37039,0.0421821551705818,0.00418374411241942,0.0339820167102397,0.0503822936309238,8.06368143629576e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,40005,0.0430435442876445,0.00427311988484925,0.0346682293133399,0.051418859261949,8.54213562192477e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYZL1,Quinone oxidoreductase-like protein 1,37039,0.0895644017282189,0.0088942942479531,0.0721315850022309,0.106997218454207,9.15031964776767e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTD1,D-aminoacyl-tRNA deacylase 1,37120,0.0856204005643687,0.00850539750378474,0.0689498214569506,0.102290979671787,9.44639237153086e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAM,Peptidyl-glycine alpha-amidating monooxygenase,39952,0.0268221076899623,0.00266663068028643,0.0215955115566009,0.0320487038233237,9.91150717628261e-24
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMP1,Dentin matrix acidic phosphoprotein 1,37039,-0.0584795504293843,0.00582083314481441,-0.0698883833932205,-0.047070717465548,1.1569648725227e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB6,Ephrin type-B receptor 6,39709,0.0291629655512769,0.00290533640640918,0.0234685061947149,0.0348574249078389,1.22419407555609e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT3,RAC-gamma serine/threonine-protein kinase,39387,0.0562132528715738,0.00560825781299621,0.0452210675581012,0.0672054381850464,1.42018690056854e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK6,Serine protease inhibitor Kazal-type 6,40026,0.0520255991426902,0.00519172599120585,0.0418498161999267,0.0622013820854536,1.4459396268036e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JAM2,Junctional adhesion molecule B,40005,0.0241011752381986,0.00240685233028622,0.0193837446708376,0.0288186058055596,1.55638109810534e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPKAPK2,MAP kinase-activated protein kinase 2,37165,0.0709764046031298,0.00708681418883807,0.0570862487930072,0.0848665604132524,1.5821455438833e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL25,C-C motif chemokine 25,40054,0.0478848027953342,0.00478566722407798,0.0385048950361414,0.057264710554527,1.68054580356068e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,39865,0.0554013765895866,0.00554260816946633,0.0445378645774326,0.0662648886017406,1.86767382031005e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC37,Hsp90 co-chaperone Cdc37,39909,0.0804001247124692,0.00804749983779363,0.0646270250303936,0.0961732243945447,1.95984968044102e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA2,Carboxypeptidase A2,39929,0.0618365966027407,0.00619080272616767,0.0497026232594521,0.0739705699460293,2.00385252179115e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFT20,Intraflagellar transport protein 20 homolog,37035,0.0421219374999622,0.00421561435369533,0.0338593333667193,0.050384541633205,2.00404760700235e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP5,Platelet glycoprotein V,37120,0.0348469102277564,0.00348764894046864,0.0280111183044378,0.0416827021510749,2.00896541909184e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L1,Bcl-2-like protein 1,37384,0.0963805560736996,0.00965409827239744,0.0774585234598006,0.115302588687599,2.17140621403662e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,39745,0.0331887730625648,0.00332798954126449,0.0266659135616864,0.0397116325634433,2.35270018071894e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP1BB,Platelet glycoprotein Ib beta chain,37017,0.0650200948775421,0.00653072012525796,0.0522198834320365,0.0778203063230477,2.86851676754898e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS27,Serine protease 27,39814,0.0384485568389373,0.00386464568503079,0.030873851296277,0.0460232623815977,2.98345766718007e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP2,Caspase-2,39862,0.065291119920907,0.0065630305519005,0.052427580039182,0.0781546598026319,2.99619909230141e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL2,C-C motif chemokine 2,39716,0.049367687533382,0.00496561883051804,0.0396350746255667,0.0591003004411974,3.19899028218299e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD7,T-cell antigen CD7,37033,0.0410405923813313,0.00412860435520923,0.0329485278451212,0.0491326569175414,3.3468539952912e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGMT,Methylated-DNA--protein-cysteine methyltransferase,39862,0.116754118035275,0.0117706243932215,0.0936836942245606,0.139824541845989,4.00916616682355e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LGALS4,Galectin-4,39858,0.0503319450012067,0.0050742904387354,0.0403863357412853,0.0602775542611281,4.01325497391433e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",37408,0.0449856695719721,0.00453478714466594,0.0360974867684268,0.0538738523755173,4.08024900086135e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GMFG,Glia maturation factor gamma,37433,0.0685828697508787,0.00693177209569862,0.0549965964433094,0.082169143058448,5.28835226567311e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RARRES1,Retinoic acid receptor responder protein 1,39473,0.0322038205796988,0.00325636884881883,0.0258213376360139,0.0385863035233837,5.40250979635538e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPL14,60S ribosomal protein L14,37039,0.038490872668616,0.00389165926195365,0.0308632205151868,0.0461185248220452,5.49791931495813e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPCAL1,Hippocalcin-like protein 1,40054,0.0704004764605613,0.00712067948166005,0.0564439446765076,0.084357008244615,5.5198216881269e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZB1,Marginal zone B- and B1-cell-specific protein,39904,0.0467382243388901,0.00472807368850016,0.0374711999094298,0.0560052487683504,5.61080820486605e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP10,Stromelysin-2,39853,-0.0558163463560239,0.00564924359943516,-0.0668888638109168,-0.044743828901131,5.89519671373737e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD48,CD48 antigen,39904,0.0274982791569072,0.00278493812200688,0.0220398004377737,0.0329567578760407,6.2780576871759e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC134,Coiled-coil domain-containing protein 134,37364,0.0463703059280899,0.00469622227914784,0.0371657102609602,0.0555749015952197,6.45551711212301e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZBP1,Z-DNA-binding protein 1,37052,0.0392730533581266,0.00397762278630121,0.0314769126969762,0.0470691940192769,6.51233131832591e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCF2,Neutrophil cytosol factor 2,39839,0.0786028003761426,0.00797345709865714,0.0629748244627747,0.0942307762895106,7.35123388556311e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TADA3,Transcriptional adapter 3,37364,0.0376933906004677,0.00382400032536102,0.0301983499627601,0.0451884312381753,7.63048849074134e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP6,Platelet glycoprotein VI,39832,0.0839323885510707,0.00852696801588808,0.06721953123993,0.100645245862211,8.51800659528473e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD9,26S proteasome non-ATPase regulatory subunit 9,39784,0.0508883921137252,0.00517079541727148,0.0407536330958731,0.0610231511315773,8.66340447212824e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D5,TBC1 domain family member 5,39862,0.0736308836309821,0.00748445910565187,0.0589613437839045,0.0883004234780598,8.97635216570619e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NARS1,"Asparagine--tRNA ligase, cytoplasmic",37408,0.0446571078067035,0.00453888081389587,0.0357609014114676,0.0535533142019394,9.13371997018683e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA6,Integrin alpha-6,39862,0.0501217514121853,0.00509573013158401,0.0401341203542807,0.06010938247009,9.13798797114305e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A11,Protein S100-A11,39699,0.0429795587117456,0.00437044405839796,0.0344134883572856,0.0515456290662056,9.32426971836374e-23
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A12,Protein S100-A12,39611,0.0705407322075915,0.00717871475262531,0.0564704512924459,0.0846110131227371,1.00754992753662e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRR,Receptor-type tyrosine-protein phosphatase R,37384,0.0338123880616401,0.00344271209662717,0.0270646723522508,0.0405601037710293,1.08414566482459e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,39973,0.0971471596827493,0.00990232378273762,0.0777386050685836,0.116555714296915,1.17380006378961e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIABLO,"Diablo homolog, mitochondrial",39814,0.103566317545072,0.0105726452184341,0.0828439329169409,0.124288702173203,1.36060321714072e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICALL2,MICAL-like protein 2,37035,0.0645086724370619,0.00658548097515836,0.0516011297257515,0.0774162151483723,1.40447976152958e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",37433,0.0826986110091783,0.00845399452586663,0.0661287817384797,0.0992684402798769,1.59366586949196e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL2,ADAMTS-like protein 2,37433,0.0298943900834651,0.00305848867913711,0.0238997522723563,0.0358890278945738,1.72304961682461e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASS1,Argininosuccinate synthase,37017,0.0751427952444386,0.00770708860763939,0.0600369015734655,0.0902486889154119,2.19998915290893e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA1,Paraneoplastic antigen Ma1,37039,0.0532286272223456,0.00548520841917676,0.0424776187207592,0.0639796357239321,3.4385499690237e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRD1,Adhesion G-protein coupled receptor D1,37120,0.0363892003847081,0.00375056179111009,0.0290380992741323,0.0437403014952839,3.49218837561664e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA7A,Semaphorin-7A,39998,0.0250641148188228,0.00258482988316295,0.0199978482478234,0.0301303813898222,3.58236998159973e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCN1,Ficolin-1,37426,0.0525664657779508,0.00542220970697133,0.041938934752287,0.0631939968036146,3.74872951863495e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,39864,0.0455357768674213,0.00470148556317358,0.0363208651636011,0.0547506885712415,4.00042828662043e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSNAX,Translin-associated protein X,37017,0.0366337514797488,0.00378175970961004,0.0292215024489132,0.0440460005105845,4.06081771064441e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPME1,Protein phosphatase methylesterase 1,39784,0.0557052258480623,0.00575416603106372,0.0444270604271774,0.0669833912689472,4.18440295670239e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBR,Tumor necrosis factor receptor superfamily member 3,39782,0.0249311207067942,0.002575502202968,0.0198831363889769,0.0299791050246114,4.21513188402026e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3R,Granulocyte colony-stimulating factor receptor,37052,0.0292116592365598,0.00302248734432428,0.0232875840416842,0.0351357344314354,5.03445634937522e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE1,Ribonuclease pancreatic,37441,0.0208435639742686,0.00215751071795,0.0166148429670866,0.0250722849814506,5.20062862501294e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACOT13,Acyl-coenzyme A thioesterase 13,37378,0.10646376482007,0.011021991306705,0.0848606618589281,0.128066867781212,5.29200093673389e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRI1,Methylthioribose-1-phosphate isomerase,37035,0.062887952868533,0.00652352832698066,0.0501018373476509,0.0756740683894151,6.39031424551511e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AK2,"Adenylate kinase 2, mitochondrial",37384,0.0991187797077487,0.0102884569593468,0.0789534040674289,0.119284155348068,6.7559850540372e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CWC15,Spliceosome-associated protein CWC15 homolog,37320,0.0568995725167763,0.00590876216165077,0.0453183986799408,0.0684807463536118,7.04710953634695e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1F,V-type proton ATPase subunit F,39449,0.0611034596497976,0.00635607215802056,0.0486455582200773,0.0735613610795179,8.06900767017704e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APLP1,Amyloid-like protein 1,39864,-0.0473709535800717,0.00492857858387585,-0.0570309676044684,-0.037710939555675,8.19013579067476e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG4,Regenerating islet-derived protein 4,39881,0.0434535752210124,0.00452162997308916,0.0345911804737576,0.0523159699682671,8.29454444937267e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBN1,Drebrin,37052,0.0485918681898432,0.00506003425814543,0.0386742010438781,0.0585095353358082,9.14155343509076e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCRIB,Protein scribble homolog,37039,0.0833554331858389,0.00868181609775324,0.0663390736342426,0.100371792737435,9.31370560241933e-22
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRSF1,G-rich sequence factor 1,36870,0.0747374904487208,0.00779338341142637,0.0594624589623251,0.0900125219351164,1.0405096860713e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP1,Secreted frizzled-related protein 1,39685,0.0391635959328244,0.00408534932844087,0.0311563112490803,0.0471708806165685,1.04526167101322e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY9,T-lymphocyte surface antigen Ly-9,39695,0.0261132483842712,0.00272479885932201,0.02077264262,0.0314538541485423,1.07375160476356e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL24,C-C motif chemokine 24,39904,0.0760233792271946,0.00793472282425493,0.0604713224916549,0.0915754359627342,1.09745301978599e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL2,Fc receptor-like protein 2,39986,0.0425579588683406,0.00444549731369887,0.0338447841334908,0.0512711336031904,1.18253012826865e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APRT,Adenine phosphoribosyltransferase,39734,0.0441634142540532,0.00462453357744522,0.0350993284422606,0.0532275000658459,1.48468646853767e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VAV3,Guanine nucleotide exchange factor VAV3,36987,0.0918982417906482,0.00963100826673483,0.073021465587848,0.110775017993449,1.64648462448546e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTproBNP,N-terminal prohormone of brain natriuretic peptide,39864,-0.0850206376000792,0.00892455282881848,-0.102512761144563,-0.067528514055595,1.85266662332076e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDNF,Glial cell line-derived neurotrophic factor,39485,0.0350407367924176,0.00368061079117072,0.0278267396417229,0.0422547339431122,1.97291532574642e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC5,Glypican-5,39745,0.0510344758143353,0.00537262910983945,0.04050412275905,0.0615648288696207,2.41503432945087e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B4GAT1,"Beta-1,4-glucuronyltransferase 1",39854,0.022181186307673,0.00234355887189789,0.0175878109187532,0.0267745616965929,3.34379209969717e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTF2,Transcription termination factor 2,37035,0.0450825571610997,0.004763942731107,0.0357452294081299,0.0544198849140694,3.48395652173691e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPE,Ribulose-phosphate 3-epimerase,37165,0.0649862512608279,0.00687087894316012,0.0515193285322341,0.0784531739894218,3.6504335777829e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPA,Inosine triphosphate pyrophosphatase,37017,0.0618288162936877,0.00653761042587048,0.0490150998589816,0.0746425327283938,3.68500758457333e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD84,SLAM family member 5,39862,0.0282482461878121,0.00299278325433533,0.0223823910093148,0.0341141013663093,4.27887567628335e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH7,Protocadherin-7,37378,0.0305837634778767,0.00324178962278418,0.0242298558172197,0.0369376711385337,4.57255106796671e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCN3,CCN family member 3,40038,0.0292999510633912,0.00310803823169195,0.023208196129275,0.0353917059975074,4.77156825094402e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX6,Syntaxin-6,39473,0.0617945850195636,0.0065578787135329,0.0489411427410391,0.074648027298088,4.98755827063182e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1B,Interleukin-1 beta,39474,0.0504893926705065,0.00536577058686528,0.0399724823202506,0.0610063030207624,5.66317837234759e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTD,Deoxycytidylate deaminase,37120,0.0869063292905116,0.00923548593217995,0.0688047768634389,0.105007881717584,5.76467449930867e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC79,Protein unc-79 homolog,36958,0.0512418632351256,0.00544918181735825,0.0405614668731034,0.0619222595971478,6.13854368466406e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX5,"Peroxiredoxin-5, mitochondrial",40054,0.0623049142218686,0.00664631178839447,0.0492781431166154,0.0753316853271218,7.85871119511589e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNPEP,Aspartyl aminopeptidase,37384,0.0534594450574666,0.00570129400152538,0.0422849088144769,0.0646339813004564,7.87155788514995e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1R,Complement C1r subcomponent,37449,0.0174231426188323,0.00186285355418603,0.0137719496526277,0.0210743355850369,9.83931834620152e-21
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN2,Matrilin-2,39881,0.0267622094145628,0.00286369355746266,0.021149370041936,0.0323750487871897,1.03400084767682e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",39473,0.0726704524831148,0.00778263544936529,0.0574164870023588,0.0879244179638707,1.1164903957942e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP3,Caspase-3,40048,0.0797083145091051,0.00854234831890176,0.0629653118040577,0.0964513172141526,1.18212009565001e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",37378,0.0930677843438411,0.00997530207820617,0.073516192270557,0.112619376417125,1.22318496098097e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA3,Protein disulfide-isomerase A3,37120,0.0227843494231568,0.0024434522709621,0.0179951829720711,0.0275735158742425,1.2874108349362e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB33A,Ras-related protein Rab-33A,37017,0.0603857409243735,0.00647761063798697,0.0476896240739191,0.073081857774828,1.31854551754032e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXN,Thioredoxin,37285,0.0387917087081296,0.00416425034375718,0.0306297780343655,0.0469536393818936,1.40131216945317e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAG3,BAG family molecular chaperone regulator 3,39716,0.035395203262582,0.00380210944235393,0.0279430687555683,0.0428473377695957,1.45104204889599e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLN,Mesothelin,39762,0.046899011753093,0.0050434396556027,0.0370138700281117,0.0567841534780743,1.59800786989064e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B1,Aldo-keto reductase family 1 member B1,39473,0.068747409065648,0.00739419559609856,0.0542547856972948,0.0832400324340012,1.62462284857432e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APPL2,DCC-interacting protein 13-beta,37120,0.101186412821671,0.0109051304350764,0.079812357168921,0.12256046847442,1.97641356075656e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGED1,Melanoma-associated antigen D1,39473,0.0431801871761359,0.00465578732825835,0.0340548440127495,0.0523055303395223,2.01326245001268e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRD2,Protein ZNRD2,37378,0.0607990494110431,0.00655762362575502,0.0479461071045633,0.0736519917175229,2.10953660210493e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEK7,Serine/threonine-protein kinase Nek7,37165,0.0662741535953403,0.00714972070528393,0.0522607010129837,0.0802876061776968,2.15462511198021e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFASC,Neurofascin,40054,0.0246437377496674,0.00266032456865986,0.0194295015950941,0.0298579739042408,2.22290797006522e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAP1L4,Nucleosome assembly protein 1-like 4,37358,0.0362724643520296,0.00391676284896004,0.0285956091680679,0.0439493195359913,2.3305919635839e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF13,Tumor necrosis factor ligand superfamily member 13,39927,0.0234111965707822,0.0025289452086317,0.018454463961864,0.0283679291797003,2.35582853400918e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INHBB,Inhibin beta B chain,37120,0.0441302200119248,0.00477206248963869,0.034776977532233,0.0534834624916166,2.64171827183078e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,39862,0.107323766305867,0.0116106057911619,0.08456697895519,0.130080553656545,2.67742619508284e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPCAM,Epithelial cell adhesion molecule,39863,-0.0845084690922004,0.00915155335178063,-0.10244551366169,-0.0665714245227104,2.9182562752312e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECAM1,Platelet endothelial cell adhesion molecule,39854,0.0266503682832146,0.00288718461387152,0.0209914864400264,0.0323092501264028,3.02210956193422e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEPR,Leptin receptor,39864,-0.0274652576174638,0.00297568216969889,-0.0332975946700737,-0.021632920564854,3.04075397604719e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS6,Growth arrest-specific protein 6,39943,-0.0225798685913789,0.0024500587694131,-0.0273819837794286,-0.0177777534033292,3.45587807624642e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,39473,0.0524545810362991,0.00569769568405579,0.0412870974955497,0.0636220645770485,3.79643736034809e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HYAL1,Hyaluronidase-1,39743,0.0201708297205555,0.00219253981304117,0.0158734516869948,0.0244682077541162,4.02487068403125e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FNDC1,Fibronectin type III domain-containing protein 1,37384,0.0408666300193271,0.00444344097484819,0.0321574857086247,0.0495757743300296,4.20937660436764e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKT2,RAC-beta serine/threonine-protein kinase,37408,0.112744922625686,0.012263744958701,0.088707982506632,0.13678186274474,4.35546134057863e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP6,Lysophosphatidic acid phosphatase type 6,40007,0.0576944335173847,0.00627792501241713,0.0453897004930471,0.0699991665417223,4.39486325389131e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHCHD6,MICOS complex subunit MIC25,37364,0.0257562619045685,0.00280525084346192,0.0202579702513831,0.0312545535577538,4.86380333925352e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7orf50,Uncharacterized protein C7orf50,37384,0.019393046696888,0.002115295817608,0.0152470668943763,0.0235390264993997,5.50464523959202e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DMD,Dystrophin,37039,0.045682178550283,0.00498475026584996,0.0359120680292171,0.0554522890713489,5.7111529636866e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK13,Kallikrein-13,39486,0.0371737985476745,0.00405874194463378,0.0292186643361923,0.0451289327591567,5.87844608227661e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,37120,0.0590830459120572,0.0064493532696881,0.0464423135034685,0.0717237783206459,5.88285341778576e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTGR1,Prostaglandin reductase 1,37433,0.0702175101562238,0.00766730469044846,0.0551895929629448,0.0852454273495027,6.03094256675003e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC6,Sialic acid-binding Ig-like lectin 6,40026,0.0290812454340437,0.00317889281197301,0.0228506155225766,0.0353118753455108,6.463584481841e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNAP25,Synaptosomal-associated protein 25,36987,0.0418129446718967,0.00457635711894111,0.0328432847187721,0.0507826046250213,7.36952067511641e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE3,Eosinophil cationic protein,39787,0.0945372682054582,0.0103522009257351,0.0742469543910174,0.114827582019899,7.51033816462143e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,39862,0.0883458299425098,0.00967676286104524,0.0693793747348611,0.107312285150158,7.67420088504458e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA4,Annexin A4,39779,0.0636515768625435,0.00697325812759997,0.0499839909324475,0.0773191627926394,7.80198761061045e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JPT2,Jupiter microtubule associated homolog 2,37378,0.077823524562362,0.00852483868589791,0.0611148407380021,0.0945322083867219,7.87866472339081e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRSK2,Serine/threonine-protein kinase BRSK2,37408,0.0339376536269916,0.00371972044689699,0.0266470015510735,0.0412283057029097,8.27055562869112e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS10,Regulator of G-protein signaling 10,37408,0.0527057288629396,0.00578088066249151,0.0413752027644563,0.064036254961423,8.77550400671915e-20
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,39485,0.0984448207457218,0.0108294315023659,0.0772191350010845,0.119670506490359,1.10225001421477e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF10,Rho guanine nucleotide exchange factor 10,37408,0.0821537588467256,0.00903689824325742,0.064441438289941,0.0998660794035101,1.11671558293942e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPP,Lipoma-preferred partner,37017,0.058844992516903,0.00647643676815268,0.0461511764513238,0.0715388085824823,1.17242502734601e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFC1,Cryptic protein,39473,0.0407655101349367,0.0044893155695228,0.031966451618672,0.0495645686512014,1.20708554835997e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EHD3,EH domain-containing protein 3,37039,0.102708525948604,0.011315085619915,0.080530958133571,0.124886093763638,1.27119993721105e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,37408,0.0587827218656697,0.00648969180690176,0.0460629259241423,0.0715025178071972,1.51006692040811e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASRGL1,Isoaspartyl peptidase/L-asparaginase,37039,0.0892428887864456,0.00985463423046344,0.0699278056947373,0.108557971878154,1.54227494794253e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",37120,0.0782264419956881,0.00864032562926482,0.0612914037623291,0.0951614802290472,1.57347088608101e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP170,Centrosomal protein of 170 kDa,37039,0.0671634229415451,0.0074255225833976,0.0526093986780858,0.0817174472050044,1.70450886488472e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFCAB2,Dynein regulatory complex protein 8,37165,0.0305637467186817,0.00338334710527234,0.0239323863923479,0.0371951070450154,1.88764191140428e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBP1,"Fructose-1,6-bisphosphatase 1",39864,0.0632111672774869,0.00700165262004941,0.0494879281421901,0.0769344064127838,1.94315626615608e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,39745,0.0612567081363863,0.00678531702893965,0.0479574867596646,0.074555929513108,1.94827601393122e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,37027,0.024392326433722,0.00270355261449392,0.0190933633093139,0.0296912895581301,2.09362178296798e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",37120,0.090853019865627,0.0100951413648508,0.0710665427905194,0.110639496940735,2.56833288549002e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP6,Gastrotropin,39560,0.0468158978103457,0.00520347375788342,0.0366170892448942,0.0570147063757972,2.57937028516742e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELOB,Elongin-B,37017,0.0340545315211603,0.00378762291138234,0.0266307906148509,0.0414782724274697,2.78076733116118e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,39473,0.0850482244391469,0.00946160016899922,0.0665034881079085,0.103592960770385,2.78154967891424e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDF1,Endothelial differentiation-related factor 1,37408,0.0597457538438244,0.00664573753522633,0.0467201082747808,0.072771399412868,2.7937435076431e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEMP1,Mast cell-expressed membrane protein 1,37052,0.0781797418589534,0.00870849639241278,0.0611110889298243,0.0952483947880824,3.14321782960643e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AARSD1,Alanyl-tRNA editing protein Aarsd1,39784,0.0469902493871858,0.00524680252510264,0.0367065164379846,0.0572739823363869,3.73330679523709e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP6,Bone morphogenetic protein 6,39564,0.0360062027381745,0.00402385829584233,0.0281194404783235,0.0438929649980255,4.0110366585386e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAT,Catalase,37248,0.0455472665578082,0.00509324512638204,0.0355645061100994,0.055530027005517,4.29089208828185e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,36705,0.0941799189867049,0.0105531539751765,0.073495737195359,0.114864100778051,5.08588956371808e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PARD3,Partitioning defective 3 homolog,37165,0.0637483054299899,0.00714592280163754,0.0497422967387803,0.0777543141211995,5.22104597214545e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SGSH,N-sulphoglucosamine sulphohydrolase,37261,0.0474057883507944,0.00531604064929922,0.036986348678168,0.0578252280234209,5.37984161646402e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL13B,ADP-ribosylation factor-like protein 13B,37017,0.0597358621095852,0.00669964259478696,0.0466045626238027,0.0728671615953676,5.45132756721797e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOK1,Docking protein 1,37384,0.117847579980725,0.0132478284943169,0.091881836131864,0.143813323829586,6.53864424540369e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTL1,Cytokine-like protein 1,37433,0.0196001766720079,0.00220441579160108,0.0152795217204698,0.023920831623546,6.79173075774633e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",39449,0.0401006838652766,0.00451234538771719,0.0312564869053509,0.0489448808252023,6.96102378403915e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMTN,Smoothelin,37338,0.082659758842636,0.00930236551439373,0.0644271224344243,0.100892395250848,7.13624450722827e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLR1,Oxidized low-density lipoprotein receptor 1,39717,0.0501374808875498,0.00564953957578487,0.0390643833190115,0.0612105784560882,7.75521361558418e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB2B,Ras-related protein Rab-2B,37364,0.0537167046054974,0.00605790885968371,0.0418432032405174,0.0655902059704775,8.43074087411644e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARAF,Serine/threonine-protein kinase A-Raf,37165,0.057322080573552,0.00646564925929927,0.0446494080253255,0.0699947531217786,8.56447000060294e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",37039,0.0428634263920918,0.00483831582774834,0.033380327369705,0.0523465254144785,9.08362496614787e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA13,Carbonic anhydrase 13,39653,0.0898903055311441,0.0101509667002663,0.0699944107986221,0.109786200263666,9.21521332510474e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNDA,Myeloid cell nuclear differentiation antigen,39837,0.0830226476459562,0.00938454489409142,0.064628939653537,0.101416355638375,9.93859401038933e-19
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK6,Kallikrein-6,39885,0.0251269970714112,0.00284290826174569,0.0195548968783897,0.0306990972644328,1.06943381703694e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",37039,0.066209982054979,0.00749022964502967,0.0515291319507209,0.0808908321592372,1.08209706747339e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPYL1,Testis-specific Y-encoded-like protein 1,37052,0.0347062626159282,0.00392781961849625,0.0270077361636755,0.0424047890681808,1.11619388951553e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDGF,Hepatoma-derived growth factor,40010,0.0795526713290698,0.00902117583571552,0.0618711666910674,0.0972341759670722,1.27725148311955e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F2,Prothrombin,37449,0.0124712220040089,0.00141481813304374,0.00969817846324313,0.0152442655447746,1.34406128018848e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDZD2,PDZ domain-containing protein 2,37017,0.0510126638946068,0.00578705387923089,0.0396700382913143,0.0623552894978994,1.34612621942254e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,37052,0.0682420003302281,0.00775945120829349,0.0530334759619729,0.0834505246984834,1.61054378899912e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MGLL,Monoglyceride lipase,39904,0.0738382811454932,0.00841074407536273,0.0573532227577822,0.0903233395332041,1.81238589078021e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC2,PDZ domain-containing protein GIPC2,37384,0.0243191590879808,0.00277037366892126,0.0188892266968952,0.0297490914790665,1.85673017094283e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO2,Gamma-enolase,40005,0.0556992609767101,0.00635805342483978,0.0432374762640241,0.068161045689396,2.13528013739511e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BIN2,Bridging integrator 2,39854,0.0754260471543471,0.0086276940670465,0.058515766782936,0.0923363275257583,2.50729098330223e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTC,Probetacellulin,39473,0.0621712575736205,0.00712048002879077,0.0482151167171906,0.0761273984300505,2.76830222673336e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SART1,U4/U6.U5 tri-snRNP-associated protein 1,37017,0.0300822706948417,0.00345282657316991,0.0233147306114287,0.0368498107782548,3.32854143056592e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NT5C3A,Cytosolic 5'-nucleotidase 3A,39825,0.0740268244378217,0.00850098400922614,0.0573648957797384,0.0906887530959049,3.39036098849946e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC16A1,Monocarboxylate transporter 1,39485,0.048522056929267,0.00557220807420172,0.0376005291038316,0.0594435847547024,3.40195349574961e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,37408,0.0497689325953656,0.00572446527387854,0.0385489806585636,0.0609888845321675,3.89467428596815e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,37017,0.0231811869082622,0.00266644648264484,0.0179549518022783,0.0284074220142461,3.92125992152183e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FIS1,Mitochondrial fission 1 protein,39851,0.0654130382886227,0.00753050894633149,0.050653240753813,0.0801728358234324,4.09762225761426e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",39473,0.0427134844690754,0.00492871441377918,0.0330532042180682,0.0523737647200826,4.89812828493571e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPA1,Inositol monophosphatase 1,39745,0.0510718130652875,0.00589692974201364,0.0395138307709408,0.0626297953596342,5.13136420110476e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF2,Fibroblast growth factor 2,39862,0.0554677166216045,0.00640701034882241,0.0429099763379125,0.0680254569052964,5.28241723287429e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO1A,Coronin-1A,39516,0.0742529214943115,0.00858827998493376,0.0574198927238413,0.0910859502647816,5.85158270309484e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,39927,0.0344380869660763,0.00398680227613011,0.0266239545048612,0.0422522194272913,6.2497160078337e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,39862,0.0306821853903303,0.00355247839115517,0.0237193277436662,0.0376450430369944,6.31670433410455e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,37378,0.0399072848434064,0.00462511055309724,0.0308420681593359,0.048972501527477,6.90969856872154e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1F,Protein phosphatase 1F,37433,0.0442389123607219,0.00512941479474236,0.0341852593630269,0.0542925653584169,7.1413353690306e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO2,Amphoterin-induced protein 2,39784,0.0186020859542113,0.00216048631721144,0.0143675327724769,0.0228366391359458,7.97109965667031e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP8,Neutrophil collagenase,39981,0.0591939946982983,0.00688328639893464,0.0457027533563864,0.0726852360402102,8.71973913463521e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPC3,PDZ domain-containing protein GIPC3,37378,0.0822587534406509,0.0095639167340103,0.0635134766419908,0.101004030239311,8.76858118729553e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SV2A,Synaptic vesicle glycoprotein 2A,37035,0.0511521088443312,0.00594721539950645,0.0394955666612986,0.0628086510273638,8.78682870179608e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA1,Carbonic anhydrase 1,39527,0.0490350301761747,0.00570545678319187,0.0378523348811186,0.0602177254712308,9.14960104752619e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G4A,Cytosolic phospholipase A2,39927,0.072899788730577,0.00849110659357067,0.0562572198071784,0.0895423576539755,9.86805537031414e-18
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIP,Gastric inhibitory polypeptide,37039,0.0359136294789745,0.00419749096513032,0.0276865471873191,0.0441407117706299,1.29690346293034e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIT2,Slit homolog 2 protein,39485,0.0424103676230675,0.00495804269835581,0.0326926039342901,0.0521281313118449,1.29960216944145e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C5,Complement C5,37449,0.0125438991974623,0.00146620320019248,0.00967014092508502,0.0154176574698396,1.29970968496299e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP1,Ran-specific GTPase-activating protein,37039,0.043055004158747,0.00503387531494871,0.0331886085414475,0.0529213997760464,1.32998693844728e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF5,E3 ubiquitin-protein ligase RNF5,37039,0.0605386445445361,0.00707995921066289,0.0466619244916369,0.0744153645974354,1.35717435244878e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TINAGL1,Tubulointerstitial nephritis antigen-like,39840,0.0183056121184694,0.0021422287223272,0.0141068438227081,0.0225043804142308,1.39847832698297e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COX6B1,Cytochrome c oxidase subunit 6B1,37433,0.0263419773117982,0.00308257017156446,0.0203001397755318,0.0323838148480645,1.415669055581e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP1,Rho GTPase-activating protein 1,39473,0.0385595844506881,0.0045132553376816,0.0297136039888321,0.047405564912544,1.41944906182207e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABCA2,ATP-binding cassette sub-family A member 2,37017,0.0302464857319423,0.00354647168882445,0.0232954012218464,0.0371975702420382,1.64164973598079e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VGF,Neurosecretory protein VGF,37408,0.0240460897168316,0.0028220941593746,0.0185147851644574,0.0295773942692059,1.75265168597426e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN3,Calsyntenin-3,37384,0.0248635494446196,0.00291920715684573,0.019141903417202,0.0305851954720372,1.80532664481955e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMFR,E3 ubiquitin-protein ligase AMFR,39485,0.0529236794221295,0.00621628739213867,0.0407397561335377,0.0651076027107213,1.83599146798321e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLVRB,Flavin reductase,39854,0.052675989795444,0.00620108859726789,0.0405218561447989,0.064830123446089,2.15819821386128e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC7A,C-type lectin domain family 7 member A,40054,0.0466576826496131,0.00549991859656828,0.0358778422003393,0.0574375230988869,2.37500137685428e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSNK1D,Casein kinase I isoform delta,37052,0.0528631892803258,0.00624703755613673,0.0406189956702978,0.0651073828903538,2.90029317254848e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THY1,Thy-1 membrane glycoprotein,40005,0.0219492442839173,0.00259476145031878,0.0168635118412925,0.0270349767265421,2.92354024097612e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF22,Kinesin-like protein KIF22,37017,0.0988840468830427,0.0117025306706913,0.0759470867684878,0.121821006997598,3.22234450682397e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRK1,Protein BRICK1,39485,0.0361130604040814,0.00427679006773095,0.0277305518713287,0.0444955689368341,3.33419934228748e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSP,Alpha-hemoglobin-stabilizing protein,39832,0.0691050963065833,0.00820724750474714,0.0530188911972789,0.0851913014158877,4.08071941498352e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,39745,0.0235539484063378,0.00280521630263147,0.0180557244531801,0.0290521723594954,4.98467046720008e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERBB4,Receptor tyrosine-protein kinase erbB-4,39909,-0.0192278423673404,0.0022903484723148,-0.0237169253730774,-0.0147387593616034,5.03670639184429e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARFIP1,Arfaptin-1,37408,0.0561420109810854,0.006686259812377,0.0430369417488265,0.0692470802133443,5.04778474210779e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAX,Apoptosis regulator BAX,39452,0.0738572514938156,0.00879773640458314,0.0566136881408326,0.0911008148467986,5.05401501018429e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR1,Folate receptor alpha,39805,0.0220928847628169,0.0026366205692722,0.0169251084470434,0.0272606610785904,5.76624299276891e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,37035,0.0426381007994396,0.00509834641743533,0.0326453418212663,0.0526308597776128,6.71748770837344e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK2,SLIT and NTRK-like protein 2,40026,0.0309789791271232,0.00371093559515865,0.0237055453606122,0.0382524128936341,7.49726498882755e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2,Apoptosis regulator Bcl-2,37378,0.0407180654447948,0.00488616239492468,0.0311411871507424,0.0502949437388471,8.61155159765609e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",37433,0.0495549624022101,0.00594861257447269,0.0378956817562436,0.0612142430481765,8.81597670308081e-17
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRGN,Neurogranin,37441,0.0735001802882485,0.00884334067672699,0.0561672325618636,0.0908331280146334,1.03528807855666e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RB,Interleukin-17 receptor B,39640,-0.0429455419748315,0.00517983959254751,-0.0530980275762246,-0.0327930563734384,1.21364926709304e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BGLAP,Osteocalcin,37433,0.0689089811794769,0.00833308777079901,0.0525761291487108,0.085241833210243,1.47166005582021e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,37408,0.0528332117546966,0.00639069370982951,0.0403074520834307,0.0653589714259624,1.49805029037033e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200R1,Cell surface glycoprotein CD200 receptor 1,39805,0.0274918012856623,0.00332625303277199,0.0209723453414292,0.0340112572298954,1.50465540565263e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP3,"Fatty acid-binding protein, heart",37433,0.039053670473605,0.00472571442441818,0.0297912702017453,0.0483160707454646,1.53746846142818e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPACAM2,HEPACAM family member 2,37384,-0.0333629094015351,0.00404448824209386,-0.041290106356039,-0.0254357124470311,1.74410041808758e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD8A,T-cell surface glycoprotein CD8 alpha chain,40005,0.0372646886537524,0.00452653332919812,0.028392683328524,0.0461366939789807,1.97231602311688e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBAC1,Ubiquitin-associated domain-containing protein 1,39784,0.0271116306243659,0.00330681906497149,0.0206302652570218,0.0335929959917101,2.61349851233006e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX16,Syntaxin-16,39473,0.0459575619488643,0.00560731073380309,0.0349672329106103,0.0569478909871184,2.67637257536448e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFP,Alpha-fetoprotein,39695,0.0532417891081371,0.00650118897458345,0.0404994587179536,0.0659841194983207,2.82046234194378e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINC1,Antithrombin-III,37420,0.0114907489774562,0.00140341010600626,0.00874006516968391,0.0142414327852284,2.8981566071318e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,39858,0.0233793037884497,0.00285761103982369,0.0177783861503953,0.0289802214265042,3.01439193787139e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDAR,Tumor necrosis factor receptor superfamily member EDAR,39862,0.0728471247437289,0.00890418719743545,0.0553949178367555,0.0902993316507024,3.01918839942239e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAV,Integrin alpha-V,40026,-0.0130044592874781,0.00159006874308419,-0.0161209940239231,-0.00988792455103306,3.08429608705105e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,39881,0.0210091321696633,0.0025698913521767,0.015972145119397,0.0260461192199297,3.17540856024341e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY6D,Lymphocyte antigen 6D,39757,0.0283420689140971,0.00348175962993596,0.0215178200394227,0.0351663177887716,4.23781581812929e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,39473,0.0339618580512695,0.0041844907409856,0.0257602561989377,0.0421634599036013,5.16905098669507e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPMT,Thiopurine S-methyltransferase,39473,0.0567973500635025,0.00700173378028943,0.0430739518541352,0.0705207482728697,5.35142671891798e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSG1,Pregnancy-specific beta-1-glycoprotein 1,39745,-0.0861424311180229,0.010629203262099,-0.106975669511737,-0.0653091927243089,5.68747709469309e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2CD2L,Phospholipid transfer protein C2CD2L,39449,0.0325755858252225,0.00402160374013477,0.0246932424945583,0.0404579291558866,5.89273372904682e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEK,Angiopoietin-1 receptor,39909,0.016883341238185,0.00208439813817065,0.0127979208873705,0.0209687615889994,5.8944951059907e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6R,Interleukin-6 receptor subunit alpha,39801,0.0262014130411976,0.00323605650765017,0.0198587422862033,0.0325440837961919,6.05141899350421e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHCY,Adenosylhomocysteinase,39864,0.0528629006576451,0.00652965317213315,0.0400647804402641,0.0656610208750261,6.09399332983179e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTN2,Dynactin subunit 2,39784,0.0738373414291595,0.00912047263846825,0.0559612150577617,0.0917134678005572,6.09811640164614e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTR1,Endosome-associated-trafficking regulator 1,37039,0.0466673268770702,0.00576605904769359,0.0353658511435908,0.0579688026105496,6.30529419840838e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,39449,0.0368894699974228,0.00456887867793245,0.0279344677886752,0.0458444722061704,7.29225054940463e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJC21,DnaJ homolog subfamily C member 21,37384,0.0299566283757086,0.00371390282237358,0.0226773788438564,0.0372358779075608,7.86688440737283e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF8,SLAM family member 8,39473,0.0403419622837568,0.00500633048283709,0.0305295545373961,0.0501543700301175,8.29962198012032e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB10,Ras-related protein Rab-10,37433,0.0415641323847353,0.00515825256578968,0.0314539573557875,0.051674307413683,8.41348879628282e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,39862,-0.0300377118223912,0.00373187016549479,-0.037352177346761,-0.0227232462980214,8.93152873309534e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",39838,0.0489321112044494,0.00608888346154119,0.0369978996198286,0.0608663227890701,9.90144391099706e-16
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSTN,Growth/differentiation factor 8,39581,0.0401072123990328,0.00499326457476599,0.0303204138324915,0.0498940109655742,1.02429314383076e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15RA,Interleukin-15 receptor subunit alpha,39583,0.0265022411640931,0.00330109227216457,0.0200321003106506,0.0329723820175357,1.05755594097182e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS22,Brain-specific serine protease 4,37052,0.0260883310189266,0.00325064812433221,0.0197170606952354,0.0324596013426177,1.09550674050615e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WAS,Wiskott-Aldrich syndrome protein,39583,0.0520603784958445,0.00649093082113942,0.0393381540864113,0.0647826029052778,1.12704868515357e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SORBS1,Sorbin and SH3 domain-containing protein 1,37408,0.0292838999297817,0.00365703736203774,0.0221161067001877,0.0364516931593756,1.26508331529296e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRM,Receptor-type tyrosine-protein phosphatase mu,39841,0.0186703560165215,0.00233465833160138,0.0140944256865828,0.0232462863464602,1.36113055330567e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAST,Gastrin,37384,0.0895527119678826,0.0112158051570621,0.0675697338600409,0.111535690075724,1.52409058987014e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA2,Glucosamine-6-phosphate isomerase 2,37120,0.0285093986319846,0.00357158239716685,0.0215090971335376,0.0355097001304316,1.55403984144475e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN1,Contactin-1,40048,-0.0204006029304542,0.00256012689339204,-0.0254184516415026,-0.0153827542194058,1.7111036373252e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,39958,0.0263117354117583,0.00330607598919513,0.0198318264729358,0.0327916443505807,1.85513833677521e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,39473,0.0360448177655696,0.00453255111238908,0.027161017585287,0.0449286179458522,1.95333843384797e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD248,Endosialin,37433,-0.030403864477121,0.00382320800791299,-0.0378973521726305,-0.0229103767816116,1.97250038936451e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,37039,0.0326343561389015,0.00410763076823962,0.0245833998331519,0.0406853124446512,2.10200765848634e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN4,Nectin-4,39909,0.0224774066808513,0.00282998294669167,0.0169306401053356,0.0280241732563669,2.11034845298193e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB9,Serpin B9,39745,0.0255335673258304,0.00321532687729699,0.0192315266463283,0.0318356080053325,2.13544712681514e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC5,Sialic acid-binding Ig-like lectin 5,39854,0.0906298377791651,0.0114140687712601,0.0682582629874953,0.113001412570835,2.15202594833228e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DARS1,"Aspartate--tRNA ligase, cytoplasmic",39709,0.0559721319118237,0.00705953253454767,0.0421354481441103,0.0698088156795371,2.36330946700017e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL2,Podocalyxin-like protein 2,39909,0.0209414928636285,0.00264405596761667,0.0157591431670998,0.0261238425601571,2.52536080105008e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,37165,0.0291071048760273,0.00367541432978651,0.0219032927896458,0.0363109169624089,2.57491545353495e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,39904,0.0585213863508513,0.00739294028207757,0.0440312233979793,0.0730115493037233,2.61532687440807e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11D,Transmembrane protease serine 11D,37353,0.0276661480866071,0.00349500697418787,0.0208159344171988,0.0345163617560153,2.64529480386863e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRCAM,Neuronal cell adhesion molecule,39864,0.0210596925169935,0.00266737048342868,0.0158316463694733,0.0262877386645137,3.08285806230041e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGER,Advanced glycosylation end product-specific receptor,39813,0.0300748076225206,0.00381414785600443,0.0225990778247519,0.0375505374202893,3.34595053201717e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKN3,Serine/threonine-protein kinase N3,37165,0.0579069766926974,0.00734796991994351,0.0435049556496081,0.0723089977357867,3.50818169298421e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,39842,0.0239888623581655,0.00304538088899884,0.0180199158157278,0.0299578089006032,3.56409505903196e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMH,Granzyme H,39581,0.0570819689386988,0.00725240613616538,0.0428672529118146,0.0712966849655829,3.75338690995845e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RAP,Interleukin-1 receptor accessory protein,39854,-0.0324234691171551,0.00412398875679451,-0.0405064870804724,-0.0243404511538379,4.01501209008725e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMOTL2,Angiomotin-like protein 2,37329,0.0367715726395749,0.00467800737458935,0.0276026781853798,0.04594046709377,4.1147670921852e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCAR,Immunoglobulin alpha Fc receptor,39862,0.0352674315242442,0.00449789849892919,0.026451550466343,0.0440833125821454,4.75489963319041e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPLAH,5-oxoprolinase,37039,0.0522491477958103,0.00668104140814897,0.0391543066358383,0.0653439889557823,5.65962295170588e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XG,Glycoprotein Xg,39981,0.0225768667949067,0.00288884344505495,0.016914733642599,0.0282389999472144,5.824839597356e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP9,Matrix metalloproteinase-9,39839,0.045511590970913,0.0058306818341484,0.0340834545759821,0.0569397273658439,6.29020405254098e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,37364,0.0814168500017927,0.010439067106491,0.0609562784730703,0.101877421530515,6.68290548537179e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STK4,Serine/threonine-protein kinase 4,39864,0.0655404872142927,0.00840600941434356,0.0490647087621793,0.0820162656664061,6.73545199431036e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFAT5,Nuclear factor of activated T-cells 5,37052,0.0650611532886191,0.00834757595724001,0.0486999044124287,0.0814224021648096,6.97574116743804e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFYA,Nuclear transcription factor Y subunit alpha,37017,0.0284594969936355,0.00365349476561467,0.0212986472530308,0.0356203467342403,7.22057109640429e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,37052,0.0273796676431764,0.00352574611189007,0.0204692052638718,0.0342901300224809,8.72103861819331e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP8,GTPase IMAP family member 8,36958,0.0371620908305567,0.0047854895717716,0.0277825312698844,0.046541650391229,8.72959904403719e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERI1,3'-5' exoribonuclease 1,37165,0.0251205052082257,0.00323648988560173,0.0187769850324464,0.0314640253840051,8.99299105758416e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFB,Vascular endothelial growth factor B,37052,0.0212644849299382,0.00274008293830439,0.0158939223708616,0.0266350474890148,9.07821085002755e-15
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHPS,Deoxyhypusine synthase,37364,0.0306389641843654,0.00395992215133432,0.0228775167677501,0.0384004116009807,1.08764225115414e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREML1,Trem-like transcript 1 protein,37441,0.0395303355116612,0.00511466585698482,0.029505590431971,0.0495550805913515,1.16147089834714e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMM2,Phosphomannomutase 2,37017,0.0448949382417038,0.00581038239555529,0.0335065887464155,0.0562832877369922,1.18368627520191e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRC,Proto-oncogene tyrosine-protein kinase Src,39883,0.0890477047093465,0.0115473769437408,0.0664148458996146,0.111680563519078,1.31615612138159e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,37384,0.0360244582796835,0.00467130278308783,0.0268687048248314,0.0451802117345357,1.32633118773508e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH3,Cadherin-3,40005,0.0256541649117789,0.00332949345090312,0.0191283577480088,0.032179972075549,1.38280484473145e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,37039,-0.0258990846474901,0.00336097459565996,-0.0324865948549836,-0.0193115744399965,1.39274987838935e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIP,Pancreatic triacylglycerol lipase,37441,0.045504423631076,0.00590730685708146,0.0339261021911963,0.0570827450709556,1.42005670997638e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD101,Immunoglobulin superfamily member 2,37378,0.0313574404138458,0.00407166622435274,0.0233769746141145,0.0393379062135772,1.43940278238675e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF1R,Macrophage colony-stimulating factor 1 receptor,37441,0.0293074639834317,0.00380756142389032,0.0218446435926066,0.0367702843742567,1.48686363368598e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,39485,0.0476350141279115,0.00619020518783564,0.0355022119597536,0.0597678162960693,1.49657560216899e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,37165,0.0623238498205884,0.00810184694611537,0.0464442298062023,0.0782034698349745,1.54351754101482e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAA10,N-alpha-acetyltransferase 10,37017,0.0374945298282748,0.00488247406378563,0.0279248806632549,0.0470641789932946,1.71084499296167e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCP1,Plastin-2,37433,0.0346967335612285,0.00452462070708428,0.0258284769753433,0.0435649901471137,1.85930533286033e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFD,Complement factor D,37449,0.0134865223659066,0.00176033382506469,0.0100362680687798,0.0169367766630334,1.96421644624995e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP4,Guanylate-binding protein 4,39485,0.0359657226918216,0.00469821606051952,0.0267572192132033,0.0451742261704398,2.04285563882196e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,37017,0.0299020931371827,0.0039060375148444,0.0222462596080877,0.0375579266662777,2.06198095953916e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI3,Elafin,39590,0.0388945812143846,0.00508219670638709,0.0289334756698659,0.0488556867589033,2.07532267764749e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIMAP7,GTPase IMAP family member 7,37120,-0.024090937847178,0.00314931638973512,-0.0302635979710588,-0.0179182777232972,2.15518226654278e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLB,Beta-klotho,39485,-0.0541251532476533,0.00707737273148788,-0.0679968038013695,-0.040253502693937,2.1659953603552e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAYN,Layilin,39709,0.0236848702398381,0.00310343489332599,0.0176021378489192,0.029767602630757,2.44590387830825e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIT,Mast/stem cell growth factor receptor Kit,39904,-0.0210971783282635,0.0027646547191629,-0.0265159015778228,-0.0156784550787043,2.45921941097818e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR3,Toll-like receptor 3,40054,0.0446474284061484,0.00585810249234729,0.0331655475211478,0.0561293092911491,2.64623532786111e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH1,Cadherin-1,39311,0.0295957427895376,0.00388352510988902,0.0219840335741551,0.0372074520049201,2.66616406349712e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT19,"Keratin, type I cytoskeletal 19",39838,0.0477397522916971,0.00628696012211028,0.0354173104523609,0.0600621941310332,3.28663530065791e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT1,Kunitz-type protease inhibitor 1,39790,0.0189598558214412,0.00250092466476875,0.0140580434784945,0.023861668164388,3.61361712441861e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD2,"Superoxide dismutase [Mn], mitochondrial",39854,0.0271949240265815,0.00359093725796737,0.0201566870009654,0.0342331610521975,3.83956707409734e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSR,Insulin receptor,37052,0.0121678456931749,0.00160832208161788,0.00901553441320386,0.015320156973146,4.11767169936833e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3LG,Fms-related tyrosine kinase 3 ligand,40054,0.0241417993192072,0.0032023884796975,0.0178651178990001,0.0304184807394143,4.9981368847037e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM4,Intercellular adhesion molecule 4,39862,-0.0378657145230145,0.00504240940141217,-0.0477488369497823,-0.0279825920962466,6.25030873265666e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNAS,Neuroendocrine secretory protein 55,37408,0.0654829244332113,0.00872623792061109,0.0483794981088136,0.0825863507576091,6.56829887339449e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA14,Carbonic anhydrase 14,40026,-0.0253299571137522,0.00337639668087091,-0.0319476946082592,-0.0187122196192452,6.60789542270482e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATRAID,All-trans retinoic acid-induced differentiation factor,37378,0.0196517046238102,0.00261959864072544,0.0145172912879884,0.0247861179596321,6.68713880326555e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD4B,FERM domain-containing protein 4B,37017,0.0509401370200765,0.0067922920677742,0.0376272445672391,0.0642530294729139,6.80604423350797e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSC,Dipeptidyl peptidase 1,39852,0.0308758874190943,0.00411945685032029,0.0228017519924665,0.038950022845722,6.96924025483378e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNM1,Dynamin-1,37378,0.0830422011027206,0.0110795212258182,0.061326339500117,0.104758062705324,7.03586706537839e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRF1,Killer cell lectin-like receptor subfamily F member 1,37052,0.030742257361816,0.00410292969602168,0.0227005151576135,0.0387839995660185,7.17313422846239e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,39581,0.040784401015977,0.00545886973504134,0.030085016335296,0.0514837856966581,8.36296360542709e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PER3,Period circadian protein homolog 3,37052,0.0847293687014121,0.011358078951717,0.0624675339560468,0.106991203446777,9.20457038076557e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRLB,Fc receptor-like B,39473,0.04152288660844,0.00556997140620498,0.0306057426522782,0.0524400305646017,9.47404377577093e-14
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",37408,0.050492700914255,0.00678908804651127,0.0371860883430929,0.0637993134854171,1.0890989021726e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSE,Cathepsin E,37120,0.0378753784108237,0.00510144753417537,0.02787654124384,0.0478742155778074,1.20165940991299e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFRP4,Secreted frizzled-related protein 4,37120,0.0297487955585786,0.00400832004321222,0.0218924882738827,0.0376051028432746,1.22609231542766e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,XPNPEP2,Xaa-Pro aminopeptidase 2,39909,0.0705192370829105,0.00952723479414412,0.051845856886388,0.089192617279433,1.40943731420326e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF2,Trefoil factor 2,39904,0.0405696893131204,0.00549280232067357,0.0298037967646002,0.0513355818616406,1.58776410493603e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST7,Cystatin-F,39878,0.0655464007262225,0.00888424406453008,0.0481332823597436,0.0829595190927015,1.68777028767019e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMS,Spermine synthase,36987,0.0458033587271374,0.00621626371646805,0.03361948184286,0.0579872356114148,1.8312885873073e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MZT1,Mitotic-spindle organizing protein 1,39473,0.0377811775203938,0.00513678013051098,0.0277130884645923,0.0478492665761953,2.00361946227929e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",39695,0.0284918288054633,0.00387606865896254,0.0208947342338967,0.0360889233770299,2.06795636219309e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAMPT,Nicotinamide phosphoribosyltransferase,39473,0.0360578955255246,0.00491479577693267,0.0264248958027365,0.0456908952483126,2.29857188025301e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM3,Myomesin-3,37120,-0.0662287268515333,0.00904359509011722,-0.083954173228163,-0.0485032804749035,2.55952095848037e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNLT3,Dynein light chain Tctex-type 3,37364,0.0309624955941887,0.00422896786152614,0.0226737185855975,0.0392512726027799,2.59035293625956e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",39581,0.0625176156147046,0.00854145880035828,0.0457763563660024,0.0792588748634068,2.61294884800611e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",37039,0.0494272235283519,0.0067594026864447,0.0361787942629203,0.0626756527937835,2.77625238972783e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,37017,0.0396396219371346,0.00542110476258261,0.0290142566024727,0.0502649872717965,2.7821298788994e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD55,Complement decay-accelerating factor,39311,0.0178934451921982,0.00244767305647593,0.0130960060015054,0.022690884382891,2.79414042303436e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,37378,0.0355329853228461,0.00486363057991098,0.0260002693862206,0.0450657012594716,2.9093981731219e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR2,Interferon gamma receptor 2,39745,0.0365594355488038,0.00500886417421148,0.0267420617673493,0.0463768093302583,3.0375021136408e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,37378,0.0150778098736751,0.00206561830763455,0.0110291979907114,0.0191264217566388,3.05149116801777e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,37120,0.0273488581763191,0.00375585868173709,0.0199873751601144,0.0347103411925238,3.4834521605597e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMARCA2,Probable global transcription activator SNF2L2,39485,0.0515352789700093,0.00708180728253563,0.0376549366962394,0.0654156212437791,3.57191139438218e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCOR1,REST corepressor 1,39581,0.0314702872824328,0.00432953541112286,0.022984397876632,0.0399561766882336,3.79907443269136e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP9,Caspase-9,37052,0.0443270646688321,0.00612236635237858,0.0323272266181701,0.0563269027194941,4.72888968144288e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAPK2,Death-associated protein kinase 2,37052,0.0372726058317525,0.00514816589156389,0.0271822006842873,0.0473630109792178,4.73609543395569e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",39862,0.0306163296565587,0.00423017427700314,0.0223251880736325,0.0389074712394848,4.77409490050506e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYAR,Cell growth-regulating nucleolar protein,39473,0.0358880428470291,0.00496261883610708,0.0261613099282592,0.0456147757657989,4.99210902393418e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENR,Density-regulated protein,37052,0.0404011409717494,0.00558916550137254,0.0294463765890593,0.0513559053544396,5.1532504439198e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP1,Caspase-1,39485,0.0464073529618321,0.00642647073199891,0.0338114703271142,0.05900323559655,5.38738904608476e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNG,Interferon gamma,39583,0.0795253012264202,0.0110126908318684,0.0579404271959581,0.101110175256882,5.38744700591849e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17D,Interleukin-17D,39583,0.0235445004683665,0.00326255508867502,0.0171498924945634,0.0299391084421695,5.57453632001669e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOL1,Apolipoprotein L1,37441,0.0427376142371595,0.00592135725626475,0.0311317540148806,0.0543434744594384,5.57478587722206e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD1LG2,Programmed cell death 1 ligand 2,39784,0.0213419121587925,0.00296043468113547,0.015539460183767,0.027144364133818,5.88751125850646e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL1A1,Collagen alpha-1(I) chain,40048,-0.0171389795011473,0.00237949539101887,-0.0218027904675443,-0.0124751685347504,6.15937596356232e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBPL1,Insulin-like growth factor-binding protein-like 1,39864,0.0228042117772761,0.0031674055117449,0.0165960969742561,0.0290123265802961,6.30501756171956e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",37433,0.0207043312843054,0.00288553319567142,0.0150486862207895,0.0263599763478214,7.59367527522092e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGN,Mimecan,39854,0.027216191361464,0.00380051370323937,0.0197671845031149,0.0346651982198132,8.34625503326874e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRK1,NKG2-D type II integral membrane protein,37384,0.0306649506706904,0.00428926761464073,0.0222579861459946,0.0390719151953862,9.17455009151147e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYM,Ketimine reductase mu-crystallin,36987,0.0530762034996287,0.00743426507875347,0.0385050439452719,0.0676473630539855,9.86696867399011e-13
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFIC,Nuclear factor 1 C-type,37408,0.028908770979635,0.00405132833603984,0.020968167440997,0.0368493745182731,1.01243711768839e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNAR1,Interferon alpha/beta receptor 1,37378,0.0175617263004095,0.00246534620897336,0.0127296477308217,0.0223938048699973,1.10598527907241e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRZB,Secreted frizzled-related protein 3,39691,0.0180597313586637,0.00253676698418153,0.0130876680696679,0.0230317946476595,1.1322542757559e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,39745,0.0699622173655871,0.00984085617150718,0.050674139269433,0.0892502954617412,1.21543347472083e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C2orf69,UPF0565 protein C2orf69,37035,0.0401932808404259,0.00566378755326528,0.0290922572360259,0.0512943044448258,1.34465704160476e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOR1AIP1,Torsin-1A-interacting protein 1,37039,0.0344368221133277,0.00486275399371559,0.0249058242856451,0.0439678199410103,1.49561571861675e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPD,Pulmonary surfactant-associated protein D,39864,0.0449408382233735,0.00635177283753759,0.0324913634617998,0.0573903129849472,1.55282315278999e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSC2,Desmocollin-2,39669,0.0226394293679597,0.00320369430240545,0.0163601885352451,0.0289186702006744,1.65331497383583e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALY,RNA-binding protein Raly,37364,0.0332166980903683,0.00470601803295227,0.0239929027457818,0.0424404934349547,1.7672306324419e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF3,Granulocyte colony-stimulating factor,39583,0.0325816568768663,0.00461853678951312,0.0235293247694206,0.041633988984312,1.80394490193112e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA3G,Semaphorin-3G,37120,0.0298347767560457,0.00423104891497308,0.0215419208826985,0.038127632629393,1.85914241934431e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMD,Osteomodulin,39927,-0.0294895261410344,0.00418873498258159,-0.0376994467068943,-0.0212796055751744,1.99734986257528e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,40048,0.0185120502671699,0.00263240179533562,0.0133525427483121,0.0236715577860277,2.1115808405584e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPCAT2,Lysophosphatidylcholine acyltransferase 2,39784,0.0259105545293646,0.00368525908278227,0.0186874467271113,0.0331336623316179,2.13597371721353e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPAG1,Sperm-associated antigen 1,37408,0.0395841471278205,0.00563365432848514,0.0285421846439897,0.0506261096116514,2.22101379954809e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE1,Adhesion G protein-coupled receptor E1,37378,0.0363648891093814,0.0051876261430626,0.0261971418689787,0.0465326363497841,2.49750663172648e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FES,Tyrosine-protein kinase Fes/Fps,39473,0.0319425140763571,0.00455957088543759,0.0230057551408994,0.0408792730118148,2.55983615274756e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAPRT,Nicotinate phosphoribosyltransferase,37384,0.0221262116583723,0.00315814951613105,0.0159362386067554,0.0283161847099891,2.56704441493445e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEFL,Neurofilament light polypeptide,39434,0.0292545552983878,0.00418107826627684,0.0210596418964852,0.0374494687002904,2.72368081212212e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX2,Sorting nexin-2,37364,0.0545159053874683,0.00779378942415895,0.0392400781161167,0.0697917326588198,2.7816685956412e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRDT,Bromodomain testis-specific protein,37017,0.0246790718707562,0.00353134759539794,0.0177576305837763,0.0316005131577362,2.91078871124891e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSPA2,Heat shock-related 70 kDa protein 2,37364,0.0227226887645247,0.00326950903172257,0.0163144510623484,0.0291309264667009,3.82375522820865e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPF,Centromere protein F,37165,0.0362501404988117,0.00521836073689519,0.0260221534544972,0.0464781275431263,3.91445135572068e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGT,Angiotensinogen,37441,0.0150216468593328,0.00216355410666245,0.0107810808102744,0.0192622129083912,4.01180368803184e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR2,Complement factor H-related protein 2,37360,0.0377104137096141,0.00543321353066437,0.0270613151895119,0.0483595122297163,4.07915094966512e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA6,Corticosteroid-binding globulin,37449,0.0117372587520601,0.00169564964830363,0.00841378544138503,0.0150607320627353,4.65341175612273e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM2,Neural cell adhesion molecule 2,39854,-0.0176885630981606,0.00257231664416224,-0.0227303037207186,-0.0126468224756026,6.36065535034452e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",39909,0.022877665464118,0.00332816024735725,0.0163544713792978,0.0294008595489382,6.4740103284611e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAM,Integrin alpha-M,39854,-0.0208373292737174,0.00303613565135251,-0.0267881551503683,-0.0148865033970665,6.98524196043258e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDP1,Tyrosyl-DNA phosphodiesterase 1,37364,0.0457754959043643,0.00667693948351003,0.0326886945166846,0.0588622972920439,7.4015794195326e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,37052,0.0400489879087663,0.00584455663184719,0.0285936569103458,0.0515043189071867,7.58684651458545e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAN2B2,Epididymis-specific alpha-mannosidase,37433,0.0389122944010495,0.00567927304470028,0.027780919233437,0.0500436695686621,7.61594272294642e-12
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH1,Protocadherin-1,40014,0.0135823823849237,0.00199945281216278,0.00966345487308465,0.0175013098967628,1.13619153606228e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,37039,0.0398545695448105,0.00587790190429947,0.0283338818123835,0.0513752572772374,1.24943616303281e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGREF1,Cell growth regulator with EF hand domain protein 1,39864,0.0272431238908176,0.00403543600239679,0.0193336693261199,0.0351525784555153,1.51903530094587e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADA2,Adenosine deaminase 2,39778,0.0267510287232779,0.00396614641673889,0.0189773817464697,0.0345246757000862,1.58469552641222e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,37165,0.0467747162840907,0.0069414553764487,0.0331694637462512,0.0603799688219301,1.66664081505561e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK11,Kallikrein-11,39775,0.0188902324393675,0.00280445214216043,0.0133935062407331,0.024386958638002,1.68614105735799e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGOLN2,Trans-Golgi network integral membrane protein 2,37441,0.0161201472481549,0.00239306870946291,0.0114297325776076,0.0208105619187023,1.69148442516446e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD1C,T-cell surface glycoprotein CD1c,39909,0.0152002322240437,0.00225865820075858,0.0107732621505569,0.0196272022975305,1.75692843869143e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL2A1,Collagen alpha-1(II) chain,37039,0.0521808365202343,0.00775283386923155,0.0369852821365404,0.0673763909039281,1.76015573764222e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GCLM,Glutamate--cysteine ligase regulatory subunit,37017,0.0287040462107086,0.00427002200069452,0.0203348030893474,0.0370732893320699,1.86351315114811e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMG4,Proteasome assembly chaperone 4,37052,0.0360070128040029,0.00535878925199972,0.0255037858700835,0.0465102397379224,1.90168950418525e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEPH,Hephaestin,37433,0.0169740955135832,0.00253866278800868,0.0119983164490862,0.0219498745780803,2.37940046808943e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLIN3,Perilipin-3,39864,0.0276417235596898,0.0041396992519188,0.019527913025929,0.0357555340934506,2.51512611728753e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGCR6,Protein DGCR6,36987,0.0279901875941058,0.00420069389680935,0.0197568275563595,0.0362235476318521,2.78564358694324e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AXL,Tyrosine-protein kinase receptor UFO,39927,0.0174401054802864,0.00262231437194304,0.0123003693112781,0.0225798416492948,3.01205732344558e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBC1D17,TBC1 domain family member 17,39485,0.0281149038869607,0.0042285091821823,0.0198270258898834,0.036402781884038,3.05094663635327e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,37384,0.0559072248377445,0.0084114110171495,0.0394208592441315,0.0723935904313575,3.11452423914068e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL46,"39S ribosomal protein L46, mitochondrial",39485,0.0173808796698298,0.00262128332870073,0.0122431643455764,0.0225185949940832,3.45109724566706e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX5,Sorting nexin-5,37039,0.0194638699656847,0.00293578485492317,0.0137097316500353,0.0252180082813341,3.49073272056578e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCTS1,Malignant T-cell-amplified sequence 1,37378,0.0159744369493844,0.00241145607468012,0.0112479830430114,0.0207008908557575,3.61867551371203e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLIF,Cobalamin binding intrinsic factor,39842,0.0437561625812394,0.00661303021311811,0.030794623363528,0.0567177017989509,3.7908391121556e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,39980,0.0216125134821408,0.00326859964094582,0.015206058185887,0.0280189687783946,3.9064332475968e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGR2,Anterior gradient protein 2 homolog,39360,0.0636483387306051,0.00963876140506912,0.0447563663766696,0.0825403110845406,4.14975322269879e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,37384,0.0394984868401807,0.00598141603252825,0.0277749114164254,0.0512220622639361,4.16464004458395e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF1C,Kinesin-like protein KIF1C,37017,0.0233364018492956,0.00353405385811901,0.0164096562873823,0.0302631474112089,4.17559935935542e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GC,Vitamin D-binding protein,37449,0.0164367256779899,0.00249307444030447,0.0115502997749931,0.0213231515809866,4.47083298496547e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,37364,0.0239839118113568,0.00364462733361371,0.016840442237474,0.0311273813852397,4.85770560174441e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB1A1,Uteroglobin,39899,0.0346682871303884,0.00527144084639007,0.0243362630714639,0.045000311189313,4.96122533958847e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID4B,AT-rich interactive domain-containing protein 4B,39485,0.0255805034787822,0.00390120437678369,0.0179341429002862,0.0332268640572783,5.65932215956379e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRRT3,Proline-rich transmembrane protein 3,37039,0.022875405089087,0.00349365229592418,0.0160278465890756,0.0297229635890984,6.05938589651869e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYT1,Synaptotagmin-1,37384,0.0234002444563656,0.00357841141887434,0.0163865580753719,0.0304139308373593,6.40352102887583e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNGR1,Interferon gamma receptor 1,39927,0.0126826647282033,0.00194516189598691,0.00887014741206896,0.0164951820443377,7.23517200660112e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BAMBI,BMP and activin membrane-bound inhibitor homolog,39473,0.0187864164413565,0.00288897122451588,0.0131240328413054,0.0244488000414077,8.12303634777434e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDA,Cytidine deaminase,37418,0.0291001247541354,0.00447458413290144,0.0203299398536486,0.0378703096546222,8.12637934954902e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLPS,Colipase,39832,0.0432923433944923,0.00666562807310476,0.0302277123712069,0.0563569744177776,8.55635879435577e-11
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR1,Complement receptor type 1,37416,0.0222230338321137,0.00344039213134999,0.0154798652546678,0.0289662024095597,1.08672339680534e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A13,Protein S100-A13,37052,0.0217115662202845,0.00336138585927048,0.0151232499361143,0.0282998825044546,1.09014078260271e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,40026,0.0156267752467726,0.0024244575909894,0.0108748383684334,0.0203787121251118,1.18502944552985e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4R,Interleukin-4 receptor subunit alpha,39862,0.022134613429992,0.00343919995593306,0.0153937815163632,0.0288754453436208,1.26169749960663e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM1,V-set and transmembrane domain-containing protein 1,39485,0.029857672808983,0.00464302209844528,0.0207573494960303,0.0389579961219357,1.30744388104306e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC37A2,Leucine-rich repeat-containing protein 37A2,37378,0.0263035508644923,0.00409234812249288,0.0182825485444062,0.0343245531845783,1.34076735291174e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNDC15,Thioredoxin domain-containing protein 15,39909,0.016756657545131,0.00261357312228386,0.0116340542254547,0.0218792608648074,1.48217728989172e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSDE1,Cold shock domain-containing protein E1,37017,0.0741821766165596,0.0115743813191328,0.0514963892310593,0.0968679640020598,1.51304365844579e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTLC1,Serine palmitoyltransferase 1,37384,0.0221372333469435,0.00345514839989987,0.0153651424831397,0.0289093242107472,1.53298407928489e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY75,Lymphocyte antigen 75,39862,0.0237785523191016,0.00371764100797436,0.0164919759434719,0.0310651286947314,1.63775191555543e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",37039,0.0228719931589988,0.00358605495072264,0.0158433254555825,0.0299006608624152,1.85362058261028e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMP1,Lysosome-associated membrane glycoprotein 1,37093,0.0174225188083355,0.0027330669612395,0.0120657075643061,0.0227793300523649,1.89389279725767e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAS2,Growth arrest-specific protein 2,37165,0.0326238257726747,0.00512405681504234,0.0225806744151918,0.0426669771301577,1.99357098392533e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA12,Serpin A12,39401,0.0722404302321757,0.0113854088448004,0.049925028896367,0.0945558315679845,2.28581695463385e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI2,Serpin I2,37378,0.0350766887161851,0.00553659448055725,0.0242249635342929,0.0459284138980773,2.44186808996787e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFF1,Trefoil factor 1,39785,0.0457831839831091,0.00724345339498325,0.0315860153289419,0.0599803526372763,2.67429757575987e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CFHR4,Complement factor H-related protein 4,37405,0.0438431384707816,0.00694142835279748,0.0302379388992986,0.0574483380422647,2.76530699609674e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMNB1,Lamin-B1,37344,0.0353785838275632,0.00560460360032657,0.0243935607709231,0.0463636068842033,2.83318472792849e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REPS1,RalBP1-associated Eps domain-containing protein 1,37052,0.0234301252661807,0.00371406731652707,0.0161505533257876,0.0307096972065737,2.90787648013648e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,39808,0.0355217833417822,0.00563602395550656,0.0244751763889893,0.046568390294575,3.00319494989537e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GZMB,Granzyme B,39862,0.0388304481437065,0.00616494965917927,0.0267471468117152,0.0509137494756979,3.08220926374877e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD5L,CD5 antigen-like,37376,0.0283939152972324,0.00451059818217443,0.0195531428601706,0.0372346877342943,3.17035657651166e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEBPA,CCAAT/enhancer-binding protein alpha,37052,0.0229986560699945,0.00365711696568025,0.0158307068172613,0.0301666053227278,3.30151528892299e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL5,Insulin-like peptide INSL5,37378,0.0588963871090326,0.00936985038923374,0.0405314803461344,0.0772612938719307,3.36332623410902e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WNT9A,Protein Wnt-9a,39583,0.0170228937439113,0.00270939502629203,0.0117124794923789,0.0223333079954437,3.41031249399003e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR15L,Protein GPR15L,37378,0.0372155595385017,0.00593548701682381,0.025582004985527,0.0488491140914764,3.72007691147578e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1BP1,Integrin beta-1-binding protein 1,39473,0.0244430819308213,0.00390824952700347,0.0167829128578945,0.0321032510037481,4.09886408077281e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PECR,Peroxisomal trans-2-enoyl-CoA reductase,37039,0.0168642158971417,0.00269717649670757,0.0115777499635949,0.0221506818306886,4.16283598889105e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SFTPA1,Pulmonary surfactant-associated protein A1,39473,0.0348032108911866,0.00556739124660658,0.0238911240478378,0.0457152977345355,4.17732024382027e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINI1,Neuroserpin,37084,0.0185294571449192,0.00297713676562577,0.0126942690842927,0.0243646452055457,4.99535532364468e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG2,V-set and immunoglobulin domain-containing protein 2,37364,0.03210158352003,0.00516019027434581,0.0219876105823122,0.0422155564577478,5.08552978585224e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TREH,Trehalase,37433,0.0451703545216265,0.00727112352062008,0.0309189524212111,0.0594217566220418,5.37416500939457e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAM,Signal transducing adapter molecule 1,37364,0.0218571399141945,0.00352099378130111,0.0149559921028443,0.0287582877255446,5.53526126998408e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LUZP2,Leucine zipper protein 2,37364,0.026227410148423,0.00422699372455028,0.0179425024483044,0.0345123178485415,5.63868497396846e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNLY,Granulysin,39854,0.0303925228492226,0.00490661272512819,0.0207755619079714,0.0400094837904738,6.00156706933527e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF11,Tumor necrosis factor ligand superfamily member 11,39862,0.036670795207776,0.00592189485914905,0.0250638812838438,0.0482777091317081,6.06980378157193e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARTN,Artemin,39583,0.0266869128700521,0.00431685195018411,0.0182258830476912,0.0351479426924129,6.48442831342042e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANPEP,Aminopeptidase N,39887,0.0166034446461626,0.00268773434537833,0.0113354853292211,0.0218714039631041,6.67022805137994e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,37302,0.0181463168877377,0.00293829080167074,0.0123872669164631,0.0239053668590124,6.77230026261248e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN4B,Sodium channel subunit beta-4,37039,0.0246668405757329,0.0039941273543385,0.0168383509612294,0.0324953301902364,6.7774082491172e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIF,Leukemia inhibitory factor,39485,0.0304179741716268,0.0049392566343334,0.0207370311683333,0.0400989171749203,7.52763449089591e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],39784,0.0340546995085322,0.00554337786892684,0.0231896788854356,0.0449197201316288,8.27397942853887e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN2,Calsyntenin-2,40054,-0.0232651061316123,0.00378942006104507,-0.0306923694512607,-0.015837842811964,8.47172635502451e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,37052,0.0194046209101207,0.00316498441314452,0.0132012514603575,0.025607990359884,8.98020381977388e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMBS,Porphobilinogen deaminase,40026,0.0253319936188485,0.00413501158033328,0.0172273709213953,0.0334366163163017,9.20751108624196e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,37165,0.0211899972198276,0.00346263180715213,0.0144032388778094,0.0279767555618457,9.64315470266739e-10
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD1,26S proteasome non-ATPase regulatory subunit 1,37408,0.0285021592744936,0.00466306629864542,0.0193625493291486,0.0376417692198387,1.00886743309663e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PVALB,Parvalbumin alpha,39967,0.0671163352406578,0.0109833724962685,0.0455889251479715,0.088643745333344,1.01464045581039e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,40005,-0.0261580734501658,0.00428715213208647,-0.0345608916290553,-0.0177552552712763,1.07473569237179e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOBR,Apolipoprotein B receptor,37039,-0.0249319191135695,0.00409944239404618,-0.0329668262059,-0.016897012021239,1.2214150819487e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIE1,Tyrosine-protein kinase receptor Tie-1,40048,0.0240149777943562,0.00395017398863893,0.0162726367766239,0.0317573188120885,1.23283646110152e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,37364,0.0313353305597004,0.00517317375892088,0.0211959099922155,0.0414747511271854,1.42125625295961e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC9,Sialic acid-binding Ig-like lectin 9,39999,0.0176222879497225,0.00291177281198063,0.0119152132382404,0.0233293626612045,1.46147320620988e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",39980,0.041078836099142,0.00679973732480124,0.0277513509425316,0.0544063212557524,1.56297473966729e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PREB,Prolactin regulatory element-binding protein,39583,0.016608495294613,0.00275664124604135,0.0112054784523719,0.022011512136854,1.72985460940033e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,37433,-0.014991767747063,0.00249477045442389,-0.0198815178377339,-0.0101020176563922,1.91124927123075e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL1,Interferon lambda-1,39485,0.025896592193668,0.00431822734936644,0.0174328665889097,0.0343603177984262,2.05372350527564e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH1,Neurexophilin-1,39485,0.0216495496607595,0.00361122111783759,0.0145715562697979,0.0287275430517212,2.07865462673272e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEO1,RNA polymerase-associated protein LEO1,37408,0.0162020730982203,0.00270312592091144,0.0109039462932339,0.0215001999032068,2.10163688761815e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,39583,0.024351491199256,0.0040641444735345,0.0163857680311284,0.0323172143673836,2.12076397465276e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJB8,DnaJ homolog subfamily B member 8,39581,0.032877948229514,0.0054904146083849,0.0221167355970796,0.0436391608619484,2.16736610352453e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYGD,Gamma-crystallin D,37384,0.0556418557415232,0.00930997949115419,0.037394295938861,0.0738894155441854,2.33600866603608e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTK7,Inactive tyrosine-protein kinase 7,39485,0.0221000263480059,0.00369983922362179,0.0148483414697072,0.0293517112263047,2.37634299062846e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TF,Serotransferrin,37449,0.0125656236389427,0.00210673126663363,0.00843643035634078,0.0166948169215446,2.51461069265557e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI4,Protein-arginine deiminase type-4,39452,0.040307307667998,0.00676384943519338,0.027050162775019,0.053564452560977,2.58895190703056e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGHMBP2,DNA-binding protein SMUBP-2,37017,0.0324171225824798,0.00544503822638055,0.0217448476587739,0.0430893975061856,2.69128416700367e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NINJ1,Ninjurin-1,39473,0.0321733922134558,0.00543560616782842,0.0215196041245121,0.0428271803023995,3.30675807128066e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSH,Pro-cathepsin H,39542,0.0411386631876748,0.00697092441110514,0.0274756513419088,0.0548016750334409,3.67715785255314e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSAB1,Tryptase alpha/beta-1,40034,0.0296114875816621,0.00502794499653177,0.0197567153884598,0.0394662597748644,3.95326541806295e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRLF1,Cytokine receptor-like factor 1,39927,0.0147999128862404,0.00251441309352802,0.00987166322292553,0.0197281625495554,4.03456529451703e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEP1B,Meprin A subunit beta,39864,0.0653373272304717,0.0111073589703876,0.0435669036485119,0.0871077508124314,4.12557346818859e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL19,Interleukin-19,39415,0.0387851252390324,0.00661211436607007,0.0258253810815351,0.0517448693965297,4.56132584030949e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCTPP1,dCTP pyrophosphatase 1,39864,0.0179126475107878,0.00305706026108519,0.0119208093990608,0.0239044856225148,4.73563084016453e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPB2,Coatomer subunit beta',37017,0.0241636788373985,0.00413140427704616,0.016066126454388,0.0322612312204089,5.06953071088219e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA4C,Semaphorin-4C,39784,0.0159349950959627,0.00272749791222726,0.0105890991879973,0.0212808910039281,5.24740020593723e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F11,Coagulation factor XI,37245,0.017557814327402,0.0030228892024526,0.0116329514905949,0.0234826771642091,6.45484236951991e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFHD1,EF-hand domain-containing protein D1,37408,0.0193545844790611,0.00333481776238942,0.0128183416647779,0.0258908272933444,6.62828375339807e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AZU1,Azurocidin,39340,0.0427621226912184,0.00736892042489223,0.0283190386584296,0.0572052067240071,6.63973325567656e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10,Interleukin-10,39583,0.0441906605526937,0.00762694768449506,0.0292418430910834,0.059139478014304,7.00372527944207e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",39485,0.0168511606619762,0.00291429094160185,0.0111391504164365,0.0225631709075158,7.51153183759569e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAEA,E3 ubiquitin-protein transferase MAEA,39473,0.022246934261391,0.00385952042786678,0.0146822742227721,0.0298115943000099,8.36094746510924e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP9,Fatty acid-binding protein 9,39862,0.0306569131821619,0.00532392198275912,0.020222026095954,0.0410918002683698,8.6507027737172e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1A,Protein phosphatase 1A,39473,0.0169076544701733,0.00294125291083634,0.0111427987649341,0.0226725101754126,9.17456890576888e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX6,Peroxiredoxin-6,40026,-0.0326915186965005,0.00569036964174033,-0.0438446431943116,-0.0215383941986895,9.35412175070561e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPP,"Alkaline phosphatase, placental type",39784,0.058375088559334,0.0101659167944941,0.0384498916421256,0.0783002854765425,9.51381937698116e-09
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFAP,Glial fibrillary acidic protein,39449,0.0240897715381637,0.00420964782578392,0.0158388617996272,0.0323406812767002,1.0688756924476e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGBL1,Integrin beta-like protein 1,37433,0.0197072114793564,0.00344680594522328,0.0129514718267187,0.026462951131994,1.10360593651857e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR2,Folate receptor beta,40005,0.0157942105245467,0.0027724078266551,0.0103602911843027,0.0212281298647907,1.24110952895458e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF4,Neurotrophin-4,39473,0.0217205968160467,0.00383047394068467,0.0142128678923048,0.0292283257397887,1.44925297005078e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG4,Chondroitin sulfate proteoglycan 4,37433,-0.0179755493412373,0.00317059680362417,-0.0241899190763407,-0.0117611796061339,1.46172610427174e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL1,Angiopoietin-related protein 1,39613,0.0159756673613709,0.00282263368346615,0.0104433053417772,0.0215080293809645,1.54149063259933e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,37378,0.0211131151961293,0.0037385769895064,0.0137855042966968,0.0284407260955619,1.66206206176046e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3,"TNF receptor-associated factor 3, Isoform 2",37052,0.0195870200358049,0.00347294407533265,0.0127800496481529,0.0263939904234569,1.73654683520643e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA3A,Chymotrypsin-like elastase family member 3A,40030,0.0301843942298184,0.00535985606481482,0.0196790763427814,0.0406897121168555,1.81549042542081e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNXB,Tenascin-X,39854,-0.0139369490493067,0.00247678474290484,-0.0187914471454002,-0.00908245095321322,1.86409643351388e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP4,Dipeptidyl peptidase 4,39571,0.0161819620951021,0.00288330749577097,0.010530679403391,0.0218332447868132,2.03038221610952e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOM,Apolipoprotein M,39904,-0.0143565413009391,0.00256211133480534,-0.0193782795171576,-0.00933480308472069,2.13639758981106e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,40005,0.0144412507561784,0.00257766681566072,0.00938902379748338,0.0194934777148734,2.14792759964525e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,39862,0.0450209861075163,0.00803598902071103,0.0292704476269227,0.0607715245881099,2.14861479005839e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLMP,CXADR-like membrane protein,40026,0.0110424666846633,0.00197115477677797,0.00717900332217849,0.0149059300471481,2.15310037387828e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN4,Contactin-4,39854,-0.0128607858817394,0.00229833012484771,-0.0173655129264409,-0.00835605883703787,2.23326613149172e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SDK2,Protein sidekick-2,37120,0.0200848131806168,0.00359050986188503,0.0130474138513222,0.0271222125099115,2.26469213384863e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP7,Retinoid-binding protein 7,37378,0.0325963472458871,0.00583016689581667,0.0211692201300865,0.0440234743616878,2.30164651539728e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALDH2,"Aldehyde dehydrogenase, mitochondrial",37364,0.0275780714896686,0.00493283991253442,0.0179097052611011,0.0372464377182361,2.30528377021148e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEDD9,Enhancer of filamentation 1,37052,0.0179865217041259,0.0032304914412801,0.0116547584792169,0.0243182849290349,2.6311130459914e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN2,Transcobalamin-2,40008,0.0156393484984637,0.00281250046162331,0.010126847593682,0.0211518494032454,2.73022360020553e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL2L15,Bcl-2-like protein 15,37052,0.030416783618235,0.00547070187008047,0.0196942079528773,0.0411393592835928,2.75106292163324e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYMP,Thymidine phosphorylase,39760,0.0361775525638311,0.00653168030733785,0.023375459161449,0.0489796459662133,3.09411734997914e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTB,Lymphotoxin-beta,37364,0.0182970154646111,0.00330495185101592,0.0118193098366199,0.0247747210926023,3.14794595551906e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO2,Roundabout homolog 2,40005,0.0121065816315523,0.00218712341876155,0.00781981973077963,0.0163933435323249,3.15372789281632e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB37,Ras-related protein Rab-37,39583,0.0441864561149193,0.00803157817514094,0.0284445628916431,0.0599283493381956,3.82257994529457e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFR4,Fibroblast growth factor receptor 4,37120,0.02804935932782,0.00509885086893396,0.0180556116247094,0.0380431070309305,3.84394296452552e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL3,Angiopoietin-related protein 3,39888,0.0186182163476909,0.00338888196639871,0.0119760076935495,0.0252604250018324,3.99117786067682e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLURP1,Secreted Ly-6/uPAR-related protein 1,37366,0.0195057738592923,0.00355296732604038,0.0125419579002531,0.0264695898183314,4.09200036323149e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMOX1,Heme oxygenase 1,39687,-0.025100681780029,0.00459200545670325,-0.0341010124751674,-0.0161003510848907,4.66820511997789e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LY96,Lymphocyte antigen 96,39745,0.018547048161013,0.00340097780678094,0.0118811316597223,0.0252129646623036,5.01408837432839e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DGKZ,Diacylglycerol kinase zeta,39583,0.0188756435132071,0.00346800009899896,0.0120783633191691,0.025672923707245,5.32339302358547e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBA,Lysosomal acid glucosylceramidase,37035,0.0277821535682221,0.00510958538537367,0.0177673662128897,0.0377969409235545,5.50699165739679e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASF3,Wiskott-Aldrich syndrome protein family member 3,39485,0.0439742750591983,0.00809087829403592,0.0281161536028879,0.0598323965155087,5.56041129694876e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL3,Fc receptor-like protein 3,39583,0.0272813220132124,0.00502390616512793,0.0174344659295617,0.0371281780968631,5.70941384963178e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM3D,Protein FAM3D,37378,0.0438306244855819,0.00807243533033117,0.0280086512381328,0.059652597733031,5.7434954663023e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAGA,Alpha-N-acetylgalactosaminidase,37033,0.0316723027776756,0.00583664648942478,0.020232475658403,0.0431121298969481,5.85008817521421e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL5,Fc receptor-like protein 5,39854,0.0291554328208882,0.00538136845372532,0.0186079506515866,0.0397029149901898,6.11930741863677e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIPR1,Vasoactive intestinal polypeptide receptor 1,37039,-0.0135776540443115,0.00250614761590503,-0.0184897033714853,-0.00866560471713761,6.14177915342926e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD209,CD209 antigen,39881,-0.0202416202673931,0.00373782784421955,-0.0275677628420634,-0.0129154776927227,6.20526869483423e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSV,Cathepsin L2,39963,-0.0213426624854559,0.00394251357221759,-0.0290699890870024,-0.0136153358839094,6.27013304627575e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDI2,Protein DDI1 homolog 2,37120,0.0393161435597751,0.00726276896289587,0.0250811163924992,0.053551170727051,6.29217888932837e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",39784,-0.0222903785891751,0.00412254155763784,-0.0303705600421453,-0.0142101971362049,6.50305622618138e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLYR1,Putative oxidoreductase GLYR1,37364,0.0312044734119119,0.0057718088084666,0.0198917281473174,0.0425172186765065,6.54122275219609e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JUN,Transcription factor AP-1,39583,0.0268170993041686,0.00500213104724118,0.0170129224515759,0.0366212761567613,8.3868346550802e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AFAP1,Actin filament-associated protein 1,37120,0.0439322715209485,0.00820120501923762,0.0278579096832427,0.0600066333586542,8.61206964852585e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMS1,PMS1 protein homolog 1,37035,0.0258201152096672,0.0048248707439169,0.0163633685515901,0.0352768618677443,8.87075206504436e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROCR,Endothelial protein C receptor,37017,-0.0188978438929012,0.00353171724405111,-0.0258200096912413,-0.011975678094561,8.89882253925615e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCRL6,Fc receptor-like protein 6,39862,0.0339334752645264,0.00634847638987516,0.0214904615403711,0.0463764889886817,9.15874698738327e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP2,Guanylate-binding protein 2,39583,0.030511098411107,0.00571313481114053,0.0193133541812716,0.0417088426409425,9.39704809927915e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRH,Receptor-type tyrosine-protein phosphatase H,37378,0.025173747168158,0.00471916289857204,0.0159241878869568,0.0344233064493592,9.74238867353818e-08
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA7,Carbonic anhydrase 7,37165,-0.0173620228942448,0.00325917067600588,-0.0237499974192163,-0.0109740483692733,1.01402885743717e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5,Eukaryotic translation initiation factor 5,37017,0.0226698594384926,0.00426041687572867,0.0143194423620644,0.0310202765149208,1.04866719367915e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,37039,-0.0185127140960429,0.00348043515306503,-0.0253343669960503,-0.0116910611960354,1.05998566774182e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX2,"Ferredoxin-2, mitochondrial",37017,0.028857658038795,0.00544541816472578,0.0181846384359325,0.0395306776416575,1.18034894343124e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4M,C-type lectin domain family 4 member M,37406,-0.0247284734147199,0.00467158871712091,-0.0338847873002769,-0.0155721595291629,1.21953316626349e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSBP1,Heat shock factor-binding protein 1,37039,0.0492472512334777,0.00931475013881765,0.0309903409613951,0.0675041615055603,1.26312150358815e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD86,T-lymphocyte activation antigen CD86,37378,0.0149745714769261,0.00283495551073823,0.00941805867587916,0.020531084277973,1.2967934710275e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSMB,Beta-microseminoprotein,39776,0.0340974641119786,0.00645642864701915,0.0214428639638211,0.0467520642601362,1.30053559583433e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",37052,0.0231982243564817,0.00441018222672831,0.0145542671920942,0.0318421815208692,1.46188672478704e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHL1,Neural cell adhesion molecule L1-like protein,39896,-0.0157633565331119,0.00299901498414397,-0.0216414259020341,-0.0098852871641897,1.48964899737233e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,37433,0.0172057467350795,0.00328851201663231,0.0107602631824802,0.0236512302876789,1.70111569326304e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALB1,Calbindin,39784,0.0211122517905245,0.00403610193021913,0.013201492007295,0.0290230115737539,1.70867743051194e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CILP,Cartilage intermediate layer protein 1,37433,0.0271378397741264,0.00518800483331573,0.0169693503008276,0.0373063292474252,1.7121266056316e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POMC,Pro-opiomelanocortin,37039,0.0357648053376069,0.00684470178481593,0.0223491898393677,0.0491804208358461,1.76639247048337e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK4,Serine protease inhibitor Kazal-type 4,39862,0.0310737127837957,0.0059750401429895,0.0193626341035363,0.0427847914640551,2.01108773991691e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENSA,Alpha-endosulfine,37364,0.0264285117554602,0.00508306512969199,0.0164657041012639,0.0363913194096565,2.02933293114305e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA1,Annexin A1,37068,0.0219397750602314,0.00422726977826302,0.0136543262948359,0.0302252238256269,2.13345967096723e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,36987,0.0310381901931639,0.00598485216882952,0.019307879942258,0.0427685004440697,2.17909126271355e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP3,Tubulin polymerization-promoting protein family member 3,39485,0.0193671017619406,0.00374025591215831,0.0120362001741103,0.0266980033497708,2.2704212696435e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACP1,Low molecular weight phosphotyrosine protein phosphatase,37052,0.0216081697210319,0.00419955743974725,0.0133770371391273,0.0298393023029365,2.70863544934129e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL12,Stromal cell-derived factor 1,39583,0.019704527271733,0.0038419958089174,0.0121742154862549,0.0272348390572111,2.95182577464038e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RABEPK,Rab9 effector protein with kelch motifs,39473,0.0296517915834619,0.0057910662457923,0.018301301741709,0.0410022814252148,3.08735057380029e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMPD3,AMP deaminase 3,37384,0.034943918869724,0.00684522017898952,0.0215272873189046,0.0483605504205435,3.35526845251227e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,39581,-0.0105558899093182,0.0020696594827077,-0.0146124224954252,-0.00649935732321108,3.43054706784771e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PBK,Lymphokine-activated killer T-cell-originated protein kinase,36958,-0.0149902763933446,0.00294421459539363,-0.0207609370003161,-0.00921961578637311,3.60296236761224e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHX2,Bifunctional epoxide hydrolase 2,39581,0.030081329948071,0.00591510994251491,0.0184877144607418,0.0416749454354002,3.70862812969892e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLC2,Immunoglobulin lambda constant 2,37418,0.0119672464169454,0.0023545818098004,0.00735226606973666,0.0165822267641542,3.77387745628678e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX2,Peroxiredoxin-2,37245,0.0298448130198926,0.00587411713296724,0.0183315434392768,0.0413580826005083,3.81047989603572e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG4,Desmoglein-4,39721,0.0240241392370444,0.00472907119120704,0.0147551597022786,0.0332931187718102,3.81524848282917e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CR2,Complement receptor type 2,39927,0.0221577628267604,0.00436508949747893,0.0136021874117017,0.0307133382418191,3.89502416112939e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VEGFD,Vascular endothelial growth factor D,40020,-0.0173090377058793,0.00341698242555673,-0.0240063232599705,-0.0106117521517881,4.11619357504974e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTX3,Pentraxin-related protein PTX3,39862,-0.0242125005510946,0.00478450801024924,-0.0335901362511831,-0.014834864851006,4.22562786942785e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BOC,Brother of CDO,39581,-0.011414715467491,0.00225839806732757,-0.0158411756794531,-0.006988255255529,4.3672750674515e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL2,Protein kinase C-binding protein NELL2,39927,0.0136557259297095,0.00271464853752767,0.00833501479615528,0.0189764370632637,4.94776827410676e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNPY2,Protein canopy homolog 2,39581,0.0292049974635768,0.00580963314726364,0.0178181164949401,0.0405918784322136,5.03703273265211e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD8,Frizzled-8,36987,0.0207501981382213,0.00412906267309021,0.0126572352989645,0.0288431609774781,5.08993265014648e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG1,Arginase-1,39750,0.0249766233418251,0.004980317324303,0.0152152013861912,0.034738045297459,5.35864994898541e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1G2,V-type proton ATPase subunit G 2,37017,0.0476338051618099,0.00952780511104518,0.0289593071441614,0.0663083031794585,5.82335320025043e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLGN,Calmegin,37035,0.0211559578229063,0.0042350955632604,0.0128551705189159,0.0294567451268967,5.94691217669536e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RHOC,Rho-related GTP-binding protein RhoC,39668,0.0566342978284313,0.011360841321071,0.0343670488391321,0.0789015468177304,6.26033421805342e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1C4,Aldo-keto reductase family 1 member C4,39581,0.0253574477024328,0.00508963799099483,0.015381757240083,0.0353331381647827,6.35425365654062e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RSPO1,R-spondin-1,39745,0.0169216003867364,0.00339667208552907,0.0102641230990994,0.0235790776743734,6.36516977866765e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB103A_DEFB103B,Beta-defensin 103,36996,0.0193751980494933,0.00388990212502116,0.0117509898844519,0.0269994062145348,6.40948658470543e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L,Seizure 6-like protein,39909,0.0129186873458705,0.00259431138924264,0.00783383702295492,0.0180035376687861,6.4370348800356e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMB1,Laminin subunit beta-1,37039,0.0146053084234229,0.00293276347995259,0.00885709200271585,0.02035352484413,6.43725590970471e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ODAM,Odontogenic ameloblast-associated protein,39452,0.0245200250402819,0.00492734360407601,0.0148624315762929,0.0341776185042709,6.54962284776893e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLU,Clusterin,37449,0.0152993426822335,0.00307548288980766,0.00927139621821048,0.0213272891462565,6.61766120957337e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2,Granulocyte-macrophage colony-stimulating factor,37017,0.0168741022642326,0.00339247140532348,0.0102248583097986,0.0235233462186666,6.6418098786082e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RA,Interleukin-20 receptor subunit alpha,39583,0.0218053327823198,0.00439296420096844,0.0131951229484217,0.030415542616218,6.98886420871356e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFB2,Transforming growth factor beta-2 proprotein,37364,0.025263866272744,0.00508985172232307,0.0152877568969908,0.0352399756484972,7.00508719383622e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1B,Lithostathine-1-beta,40048,0.0259377501447424,0.0052266755519375,0.015693466062945,0.0361820342265399,7.02725694248137e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DRAXIN,Draxin,39745,0.0200871994812582,0.00404851436331016,0.0121521113291703,0.0280222876333461,7.06298842353538e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTXR,Neuronal pentraxin receptor,39864,0.016191891802221,0.00328008543414485,0.0097629243512971,0.0226208592531449,8.03690345247686e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP7,Dipeptidyl peptidase 2,39750,0.0286016784716696,0.00579702011081349,0.0172395190544751,0.039963837888864,8.14364763401239e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP2,Dipeptidase 2,39784,0.0137424123808151,0.00280071967401642,0.00825300181974286,0.0192318229418872,9.35163375748965e-07
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3A,Regenerating islet-derived protein 3-alpha,40048,0.0275949466328657,0.00564581391503543,0.0165291513593963,0.0386607419063352,1.03006911180807e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL3,Insulin-like 3,37384,0.0342295109181816,0.00701041826126108,0.0204890911261099,0.0479699307102533,1.05858442119731e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN2,Ataxin-2,36987,0.0527116930960575,0.0107980607324482,0.031547494060459,0.073875892131656,1.06472356311681e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN2,Prefoldin subunit 2,39485,0.0260468871609033,0.00537099249694021,0.0155197418669005,0.0365740324549062,1.24934245356311e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,37017,0.0306337023277267,0.00634161668945952,0.0182041336163861,0.0430632710390674,1.37668306562784e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDGF1,Teratocarcinoma-derived growth factor 1,39485,0.0651942208701923,0.0136101242373088,0.038518377365067,0.0918700643753176,1.68205927445762e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSB,Cathepsin B,39843,-0.023589854596803,0.00493453568613488,-0.0332615445416273,-0.0139181646519786,1.76362176980489e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDN1,Endothelin-1,37039,0.0129391300843409,0.00270858205563119,0.00763030925530372,0.018247950913378,1.79770100100781e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTN3,Myeloblastin,39417,0.0212547990063406,0.00444968286866579,0.0125334205837556,0.0299761774289255,1.79820737058501e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPING1,Plasma protease C1 inhibitor,37420,0.00867365461390206,0.00181635157934592,0.00511360551838406,0.0122337037094201,1.81300658897602e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST5,Cystatin-D,39555,0.0248843681404865,0.00522462725318866,0.0146440987242367,0.0351246375567363,1.92537986615531e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSHB,Thyrotropin subunit beta,39864,0.034401082344907,0.00722378144205403,0.0202424707184811,0.0485596939713329,1.93172763365291e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDC,Aromatic-L-amino-acid decarboxylase,39842,-0.0223177548227032,0.00468952551580829,-0.0315092248336874,-0.0131262848117189,1.96194225711681e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22RA1,Interleukin-22 receptor subunit alpha-1,39583,0.0197006452081376,0.00415141141422308,0.0115638788362604,0.0278374115800148,2.09791407777703e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMTOR5,Ragulator complex protein LAMTOR5,37364,0.0189941423637028,0.00400410314900263,0.0111461001916576,0.0268421845357479,2.12029150886205e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,37035,0.0460399023160722,0.00973134845763638,0.0269664593391049,0.0651133452930395,2.25634570009024e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",37364,0.0167407550070287,0.00354073618267081,0.0098009120889939,0.0236805979250635,2.28984329103067e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFSF8,Tumor necrosis factor ligand superfamily member 8,37433,0.0162002646389371,0.00343658527405439,0.0094645575017905,0.0229359717760837,2.45244300680137e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRUNE2,Protein prune homolog 2,37165,0.0129988837952668,0.00275910103228975,0.00759104577197889,0.0184067218185547,2.48662375997585e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FDX1,"Adrenodoxin, mitochondrial",37017,0.0287483351776563,0.00613642527370111,0.0167209416412021,0.0407757287141105,2.82946902981515e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CABP2,Calcium-binding protein 2,37035,0.029833278576548,0.00638409581950572,0.0173204507703168,0.0423461063827792,2.99679755350069e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,37039,-0.00943496144684245,0.00201962852777001,-0.0133934333612717,-0.00547648953241323,3.01770279599295e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD58,Lymphocyte function-associated antigen 3,39831,-0.00782706065305582,0.001679496636833,-0.0111188740612485,-0.00453524724486313,3.18205039272531e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTPN,Myotrophin,39581,0.0145142345042039,0.00312818376650654,0.00838299432185109,0.0206454746865567,3.51512773098096e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA2,GDNF family receptor alpha-2,39784,0.00930075061337176,0.00200519021236497,0.00537057779713643,0.0132309234296071,3.54015603026177e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TDO2,"Tryptophan 2,3-dioxygenase",37035,0.0175348450843179,0.00379997696576805,0.0100868902314125,0.0249827999372233,3.97834347455754e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACAN,Aggrecan core protein,39726,0.0125433025314011,0.00271874404226898,0.00721456420855393,0.0178720408542483,3.9877521982235e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,39583,0.0158797331293213,0.00345515214307841,0.00910763492888764,0.022651831329755,4.34116497205771e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB44,Ras-related protein Rab-44,37364,0.0187546748536565,0.00408688649610095,0.0107443773212986,0.0267649723860144,4.494110978103e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAM,Cytotoxic and regulatory T-cell molecule,39745,0.0217435636541871,0.00476101637143805,0.0124119715661685,0.0310751557422057,4.98470409746205e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL10RA,Interleukin-10 receptor subunit alpha,39583,0.0257051373211546,0.00563158721135748,0.0146672263868939,0.0367430482554152,5.0458241198744e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA0319,Dyslexia-associated protein KIAA0319,37384,0.0133227070669137,0.00293027541029402,0.00757936726273738,0.0190660468710899,5.50000440573028e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PROK1,Prokineticin-1,39862,0.0283029524402768,0.00623415139890639,0.0160840156984203,0.0405218891821333,5.66684334430126e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP10,Bone morphogenetic protein 10,37120,-0.0123997477538124,0.00273339716349129,-0.0177572061942553,-0.00704228931336946,5.77283182039579e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGA4,Pepsin A-4,37441,0.0272446106974869,0.00600853457022372,0.0154678829398484,0.0390213384551253,5.8283995739446e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA4,DnaJ homolog subfamily A member 4,37384,0.030440641070113,0.006738188048356,0.0172337924953352,0.0436474896448907,6.306518942077e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTT2B,Glutathione S-transferase theta-2B,37384,0.104250516609706,0.0231172102677274,0.0589407844849607,0.149560248734452,6.548098641101e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAFB2,Scaffold attachment factor B2,37408,0.0119045167048625,0.00264951236419533,0.00671147247103966,0.0170975609386853,7.07758185558809e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOD3,Extracellular superoxide dismutase,37441,-0.0263808579560994,0.00588322174020433,-0.0379119725668999,-0.0148497433452989,7.38280582301501e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRELP,Prolargin,39858,0.00953532757661698,0.00213904392202943,0.00534280148943931,0.0137278536637947,8.33866540146423e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSHB,Follitropin subunit beta,37039,0.028078041210532,0.00631143748053263,0.015707623748688,0.040448458672376,8.70769731564287e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLH1,Glutamate carboxypeptidase 2,37052,0.0471417691039846,0.0106058341744361,0.0263543341220898,0.0679292040858794,8.86541187711196e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL6ST,Interleukin-6 receptor subunit beta,39864,0.00753603440585962,0.00169581714131934,0.00421223280887371,0.0108598360028455,8.89377096391355e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD4,Sushi domain-containing protein 4,37364,0.0179465329245096,0.00403923137116138,0.0100296394370333,0.0258634264119859,8.93955305965408e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPPB,Natriuretic peptides B,39581,-0.0542405119115217,0.0122096194992869,-0.078171366130124,-0.0303096576929195,8.95513915364593e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRDX1,Peroxiredoxin-1,39430,-0.0387832379287717,0.00873457318567797,-0.0559030013727005,-0.0216634744848428,9.04943957238478e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYZL2,Lysozyme-like protein 2,36958,0.0154746265076657,0.00348610239749888,0.00864186580856787,0.0223073872067635,9.11387236705906e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRG,Histidine-rich glycoprotein,37376,0.0135711490391901,0.00305750192079,0.00757844527444169,0.0195638528039385,9.12461601500488e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MKI67,Proliferation marker protein Ki-67,37052,0.0168520489564492,0.00380221906467775,0.00939969958968079,0.0243043983232176,9.40458475989998e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA5,Annexin A5,39411,0.0128987133985434,0.00291069516092293,0.00719375088313443,0.0186036759139523,9.42245072255888e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,37433,0.0313141343728254,0.00707981921894846,0.0174376887036864,0.0451905800419644,9.80909830618722e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA3,Carbonic anhydrase 3,40013,0.0256129199954887,0.00579390007974875,0.0142568758391811,0.0369689641517962,9.90369745913538e-06
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MST1,Hepatocyte growth factor-like protein,37267,0.0269258042249942,0.006094564920518,0.0149804569807789,0.0388711514692095,1.00398391339183e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGB,Secretogranin-1,39948,0.0166788553889585,0.00379760793342516,0.00923554383944517,0.0241221669384718,1.13062578396036e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,36958,0.0287900912191526,0.00656432823487654,0.0159240078787946,0.0416561745595106,1.16441109606997e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG2,Adhesion G-protein coupled receptor G2,39864,-0.0113433900719954,0.00258865969165695,-0.016417163067643,-0.00626961707634776,1.1836763455295e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPS,Calcyphosin,37384,0.0368387572648152,0.00841519856918182,0.0203449680692188,0.0533325464604116,1.20868625789831e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICOSLG,ICOS ligand,39784,0.00793600707881128,0.00181592336896011,0.00437679727564946,0.0114952168819731,1.24900091657785e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN1,Tetraspanin-1,39581,0.0169965969664428,0.00389260002793274,0.00936710091169462,0.024626093021191,1.27126048160793e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,37052,0.0152878979122452,0.00350785737670527,0.00841249745390285,0.0221632983705875,1.32136484731025e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM3,Intercellular adhesion molecule 3,40048,0.0106119567409775,0.00243678738672906,0.00583585346298859,0.0153880600189665,1.3394775648471e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UXS1,UDP-glucuronic acid decarboxylase 1,39473,0.0218754599042791,0.00503670804642042,0.0120035121332951,0.0317474076752631,1.41303839649566e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH17,Protocadherin-17,39864,0.0145794114290012,0.00337346999608653,0.00796741023667161,0.0211914126213308,1.55706272378422e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN8,Tetraspanin-8,37378,0.0409491066169291,0.00948081277144029,0.0223667135849062,0.0595314996489521,1.5774434453149e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAEP,Glycodelin,39745,-0.0600501501771562,0.0139464343856166,-0.0873851615729647,-0.0327151387813478,1.67402954680018e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TK1,"Thymidine kinase, cytosolic",37165,0.0191536721866033,0.0044611860599237,0.0104097475091529,0.0278975968640538,1.77201018841003e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSD17B3,Testosterone 17-beta-dehydrogenase 3,37017,0.0197846130248698,0.00460887051004061,0.0107512268251902,0.0288179992245494,1.77757082370203e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC12A,C-type lectin domain family 12 member A,37052,0.00834755445813815,0.0019493040404006,0.00452691853895297,0.0121681903773233,1.86258392028081e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK2B,Divergent protein kinase domain 2B,37120,0.0117288849207439,0.00274162406069854,0.00635530176177474,0.017102468079713,1.89834517874086e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUCA1,Tissue alpha-L-fucosidase,39924,0.0329961917528389,0.00775061232901415,0.0178049915879712,0.0481873919177066,2.08144178744794e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIL1,Nucleotide exchange factor SIL1,37039,0.0136818195250655,0.00321886472521433,0.00737284466364542,0.0199907943864856,2.14751237490067e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C7,Complement component C7,37145,-0.0131536517893606,0.00309813191098861,-0.0192259903348983,-0.00708131324382295,2.1942063412739e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17RA,Interleukin-17 receptor A,39854,0.0179987849049801,0.00424591175574492,0.00967679786372006,0.0263207719462402,2.25690797214164e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPOCK1,Testican-1,39745,0.0103507853822884,0.00244489858041756,0.00555878416466994,0.0151427865999068,2.31246147664101e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRC38,Leucine-rich repeat-containing protein 38,37035,0.0197944081840501,0.00468534998425169,0.0106111222149168,0.0289776941531834,2.4082056951891e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,37052,0.0127827698534937,0.0030322238431495,0.00683961112092071,0.0187259285860668,2.50728071230773e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH5,Cadherin-5,40048,-0.0123593426110936,0.00293431349833337,-0.018110597067827,-0.00660808815436021,2.54483203163633e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,F3,Tissue factor,39927,-0.0109957063313189,0.00261636354241898,-0.0161237788744601,-0.00586763378817772,2.65213241060428e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA3,Alpha-1-antichymotrypsin,37403,0.0058686375589756,0.0013969661933533,0.00313058382000314,0.00860669129794806,2.67454978566629e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATXN10,Ataxin-10,39485,0.0295544945204809,0.0070402178163476,0.0157556676004396,0.0433533214405222,2.70830350786051e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AREG,Amphiregulin,39784,0.0188890402449882,0.0045041155254487,0.0100609738151087,0.0277171066748676,2.75889775304864e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM2,Myomesin-2,37017,-0.0208568193217877,0.00498033699779581,-0.0306182798374675,-0.0110953588061079,2.83465087934082e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP3,Dual specificity protein phosphatase 3,39485,0.0341264458653585,0.00816525373607702,0.0181225485426476,0.0501303431880695,2.93777029959979e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSPN,Persephin,39862,0.0378696318230353,0.00907291260429111,0.0200867231186247,0.0556525405274459,3.00982514683295e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LHB,Lutropin subunit beta,39473,0.0355788962946674,0.00852612694376802,0.0188676874848821,0.0522901051044528,3.02340400038028e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OLFM4,Olfactomedin-4,36650,0.0495498421469814,0.0118869801085405,0.0262513611342419,0.0728483231597209,3.08747059038364e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC4,MANSC domain-containing protein 4,37017,0.0249679125535284,0.00602241024274734,0.0131639884777436,0.0367718366293132,3.40701442849471e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSN,Gelsolin,37379,-0.00745991772887159,0.00180114417312171,-0.0109901603081901,-0.00392967514955304,3.46736259907657e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT1,Vascular endothelial growth factor receptor 1,39751,0.00922282588658624,0.00222789107151692,0.00485615938641308,0.0135894923867594,3.49536987022966e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAP,Prolyl endopeptidase FAP,40048,0.0108696121994639,0.00262573475734125,0.00572317207507509,0.0160160523238528,3.49603542649223e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RCC1,Regulator of chromosome condensation,37364,0.0201722735008342,0.00490138526430938,0.0105655583827878,0.0297789886188806,3.88421543715104e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM1,U6 snRNA-associated Sm-like protein LSm1,39473,0.0215907277160369,0.00526942059436818,0.0112626633510753,0.0319187920809985,4.19993725105411e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOB,Apolipoprotein B-100,37441,0.00894212102903398,0.00218910297132093,0.00465147920524496,0.013232762852823,4.4361581225731e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HPGDS,Hematopoietic prostaglandin D synthase,39473,0.0146036507090019,0.0035815575854147,0.00758379784158912,0.0216235035764147,4.57564226345208e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD2,Sushi domain-containing protein 2,39854,-0.0110643610456091,0.00271529843415259,-0.0163863459765482,-0.00574237611467003,4.62715721866689e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC16,Mucin-16,39784,0.0729828566211369,0.0179201371185605,0.0378593878687583,0.108106325373516,4.67015288729172e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL3,Myosin light chain 3,37039,-0.0285899166939353,0.00702455906161661,-0.0423580524547038,-0.0148217809331667,4.7288490045594e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL24A1,Collagen alpha-1(XXIV) chain,37378,0.021800472860391,0.00535969135359079,0.011295477807353,0.0323054679134289,4.77925465866714e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SATB1,DNA-binding protein SATB1,37408,0.0117777509754578,0.00290052291945136,0.00609272605333317,0.0174627758975825,4.9230220778041e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPEP1,Dipeptidase 1,39709,-0.0185107856095202,0.00456357877859555,-0.0274554000155675,-0.00956617120347292,5.01164234555315e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPNMB,Transmembrane glycoprotein NMB,39440,0.0110284849680757,0.00272345488090861,0.00569051340149482,0.0163664565346566,5.15873152487176e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF43,E3 ubiquitin-protein ligase RNF43,37165,0.0230866398797114,0.00570504393947038,0.0119047537583495,0.0342685260010734,5.22368897756038e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",37408,0.0163020424054462,0.00403213995293087,0.00839904809770172,0.0242050367131907,5.30579290577137e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",39881,-0.0129560255769189,0.00320787565227202,-0.019243461855372,-0.0066685892984657,5.3971515931189e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL34,Interleukin-34,39452,0.0138887004783255,0.0034440177870937,0.0071384256156218,0.0206389753410291,5.54014092549411e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFLAM,Pikachurin,37378,0.0119552594537526,0.00296521258365869,0.00614344278978161,0.0177670761177237,5.56457644974642e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENO1,Alpha-enolase,39826,0.0306471150676219,0.00760670749907328,0.0157379683694382,0.0455562617658055,5.62837869348575e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC10A,C-type lectin domain family 10 member A,39745,-0.0139701208701814,0.00346946268109018,-0.0207702677251181,-0.00716997401524463,5.68532465299003e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDM1,Nuclear protein MDM1,37035,0.012190081630438,0.00303662679469626,0.00623829311283334,0.0181418701480427,5.99400347668157e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD276,CD276 antigen,39858,-0.0135842105676454,0.00339394824137486,-0.0202363491207401,-0.00693207201455069,6.2964491695341e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC11A,C-type lectin domain family 11 member A,39818,0.0182480257410111,0.00456066220557204,0.0093091278180899,0.0271869236639323,6.33121532822317e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,37165,0.025013221174229,0.006256348751942,0.0127507776204227,0.0372756647280353,6.42101806302043e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FMR1,Synaptic functional regulator FMR1,39473,0.0137005908846952,0.00343068308668509,0.00697645203479241,0.0204247297345979,6.53905786982685e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC4C,C-type lectin domain family 4 member C,39862,0.0176443540387349,0.00442893951520722,0.00896363258892878,0.0263250754885411,6.80999481753075e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,39581,0.0140076302444341,0.0035320586204412,0.00708479534836933,0.0209304651404988,7.34575122017459e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",36987,0.0122452714776445,0.00309640641946131,0.00617631489550028,0.0183142280597886,7.70421952630295e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK8,Kallikrein-8,39312,0.0132604494572324,0.00335817667976648,0.00667842316489014,0.0198424757495747,7.89234988628587e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,40005,0.0269449562737247,0.00682654746220456,0.0135649232478038,0.0403249892996457,7.9444001051451e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,40048,0.0102271631456534,0.00259234186915954,0.00514617308210074,0.0153081532092061,8.00882795246984e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOSB,Protein fosB,39485,0.0148310634042915,0.0037598735835904,0.00746171118045435,0.0222004156281287,8.02943576510081e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTSF,Cathepsin F,39909,0.0153564422722338,0.00389721143272516,0.00771790786409244,0.0229949766803751,8.17016948513599e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC1A,C-type lectin domain family 1 member A,39581,0.0121711193401566,0.00308919850575987,0.00611629026886727,0.018225948411446,8.18693926944208e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON1,Spondin-1,39881,0.0120974489058502,0.00307178998945115,0.00607674052652598,0.0181181572851745,8.24286924322102e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,37035,0.020772556430467,0.00527846502184925,0.0104267649876425,0.0311183478732915,8.35055452957539e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,37089,-0.0186627928306153,0.00474386951337729,-0.0279607770768348,-0.00936480858439579,8.3940355115184e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLP1R,Glucagon-like peptide 1 receptor,36987,-0.0144336858944352,0.00367759218771894,-0.0216417665823643,-0.00722560520650611,8.72573210998154e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,39347,-0.0322502934436596,0.00821984824263799,-0.04836119599923,-0.0161393908880891,8.76610720807265e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREBZF,CREB/ATF bZIP transcription factor,36958,-0.00994666303147639,0.00253941261808393,-0.0149239117629209,-0.00496941430003187,9.014458019321e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",37384,0.0208590891677463,0.00534924721863663,0.0103745646192185,0.0313436137162741,9.68798079704547e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAPPA,Pappalysin-1,39583,0.0178334896550197,0.00457380703435336,0.00886882786768713,0.0267981514423523,9.69730988516856e-05
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANXA10,Annexin A10,39485,0.0292855724729249,0.00754169087360355,0.0145038583606619,0.0440672865851879,0.000103533191569547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMBN,Ameloblastin,39583,-0.0106813909348659,0.00275106178869301,-0.0160734720407041,-0.00528930982902756,0.000103749628149706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPVL,Probable serine carboxypeptidase CPVL,39986,0.0150233606139911,0.00387262231536283,0.00743302087587991,0.0226137003521022,0.000105140594754245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCP2,Non-specific lipid-transfer protein,39473,0.029141480684094,0.00751349387578678,0.0144150326875519,0.0438679286806361,0.000105510749626665
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POF1B,Protein POF1B,37052,0.0169747976188527,0.00437874083669638,0.0083924655789278,0.0255571296587776,0.000106422498459865
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYO6,Unconventional myosin-VI,37408,0.0142883300985372,0.0036900179274527,0.00705589496072989,0.0215207652363445,0.0001083830102018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME3,Nucleoside diphosphate kinase 3,39881,0.00889209855806891,0.00229831689575345,0.00438739744239214,0.0133967996737457,0.000109732817860594
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECE1,Endothelin-converting enzyme 1,39485,0.0129831381288924,0.00336596853694319,0.00638583979648376,0.019580436461301,0.000115164170340709
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL4,ADAMTS-like protein 4,37039,0.00895198968649433,0.00233502452990959,0.00437534160787153,0.0135286377651171,0.000126771635229348
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN2,Alpha-actinin-2,37017,-0.0218817266707972,0.00571090199805993,-0.0330750945869946,-0.0106883587545997,0.000127919490136596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCL28,C-C motif chemokine 28,39811,0.021969743631714,0.00573625226312999,0.0107266891959792,0.0332127980674488,0.000128643038419558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRB,Platelet-derived growth factor receptor beta,40048,0.0127710272178304,0.00335535633170697,0.00619452880768478,0.0193475256279761,0.000141660265256326
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS1,Nephrin,37052,0.012620654502476,0.00331624229393908,0.00612081960635538,0.0191204893985966,0.000142037328890725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT8,"Keratin, type II cytoskeletal 8",36987,0.0240288120477329,0.006322735249062,0.0116362509595714,0.0364213731358945,0.000145125626759461
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,37165,0.0159072207171642,0.00418730656609002,0.00770009984762779,0.0241143415867007,0.000145977882143192
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTA2,"Actin, aortic smooth muscle",39581,0.0157847691762968,0.00416550914090543,0.00762037126012218,0.0239491670924715,0.000151576550123519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRAL,GDNF family receptor alpha-like,36938,-0.0228435947375669,0.00603319806830439,-0.0346686629514436,-0.0110185265236903,0.000153580887001225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ELAVL4,ELAV-like protein 4,36987,0.0310333503140489,0.00819834082175033,0.0149646023034182,0.0471020983246795,0.00015419360542704
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKLR,Pyruvate kinase PKLR,39877,0.0233283344270861,0.00616881613490634,0.0112374548026696,0.0354192140515025,0.000156355186035088
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALCB,Calcitonin gene-related peptide 2,37384,0.0143614853818512,0.0038074431280885,0.00689889685079776,0.0218240739129047,0.000162667094216617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UROS,Uroporphyrinogen-III synthase,37035,0.0250488499404797,0.00665236974681094,0.0120102052367303,0.0380874946442292,0.000167003799585405
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHB4,Ephrin type-B receptor 4,40048,0.00844893141457004,0.00226093505955516,0.00401749869784193,0.0128803641312981,0.000186929151031596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP3,Stromelysin-1,39854,-0.0171245228396281,0.00459412572923651,-0.0261290092689317,-0.00812003641032454,0.000194068532906359
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGA,Glycoprotein hormones alpha chain,39854,0.0317454315358122,0.00852430162856316,0.0150378003438284,0.048453062727796,0.000196679102886083
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",37017,-0.0146692246066818,0.00394700521196545,-0.0224053548221341,-0.00693309439122949,0.000202802220616997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP28,Ubiquitin carboxyl-terminal hydrolase 28,37384,0.0129830783275786,0.00349352474724455,0.00613576982297928,0.0198303868321779,0.000202955146818661
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPARCL1,SPARC-like protein 1,39867,-0.00974366885442567,0.00262308653355149,-0.0148849184601866,-0.00460241924866475,0.000204231984574263
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT1,NAD-dependent protein deacetylase sirtuin-1,37052,0.0322354835006526,0.00870005245578804,0.015183380687308,0.0492875863139971,0.000212082306953827
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,40054,0.012230383777084,0.00330543709868258,0.00575172706366616,0.0187090404905019,0.000216244457966844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VNN2,Vascular non-inflammatory molecule 2,39784,0.0164746508478445,0.00445419199660679,0.00774443453449518,0.0252048671611938,0.000217448355884466
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PADI2,Protein-arginine deiminase type-2,39583,0.0202878500825267,0.00549494886565961,0.00951775030583385,0.0310579498592195,0.00022317025739183
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPE,Carboxypeptidase E,39902,-0.0136953063015882,0.00371526347051146,-0.0209772227037907,-0.00641338989938575,0.000228352864843203
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSB,Lupus La protein,39485,0.0215134711186355,0.00584221829623684,0.0100627232580113,0.0329642189792597,0.000231813650591178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAD51,DNA repair protein RAD51 homolog 1,37165,0.0187951312710226,0.00510506012494896,0.00878921342612266,0.0288010491159226,0.00023263043747834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA5,Protein disulfide-isomerase A5,36958,0.0218540549858453,0.00594109550394565,0.0102095077981118,0.0334986021735787,0.000235590387704697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT2,Thialysine N-epsilon-acetyltransferase,37165,0.0253301547907951,0.00689257482071009,0.0118207081422033,0.0388396014393869,0.000238791597069981
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRG1,Adhesion G-protein coupled receptor G1,39784,0.0192308196855057,0.00523889749582386,0.00896258059369088,0.0294990587773204,0.000242605223338273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5PO,"ATP synthase subunit O, mitochondrial",39485,0.0153855930607649,0.00419301641650826,0.00716728088440871,0.0236039052371211,0.00024398830929742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMI,N-myc-interactor,37307,0.0255880404593948,0.00697946384281434,0.0119082913274787,0.0392677895913109,0.000247139369666834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LACRT,Extracellular glycoprotein lacritin,37335,0.01708971603502,0.00466904746712995,0.00793838299944534,0.0262410490705947,0.000252966809725213
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",37017,0.0176774402097008,0.0048486503370621,0.00817408554905909,0.0271807948703425,0.00026753945247923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",37165,0.0247936932422791,0.00680341185384801,0.011459006008737,0.0381283804758212,0.000269138172364079
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDA2R,Tumor necrosis factor receptor superfamily member 27,40026,0.0124599250559453,0.00342143416068863,0.00575391410099563,0.0191659360108951,0.000271662449446866
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GART,Trifunctional purine biosynthetic protein adenosine-3,37408,0.00940413538926126,0.00258597269537455,0.00433562890632715,0.0144726418721954,0.000277290349337964
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,39909,-0.0159014364171321,0.00437466551183925,-0.024475780820337,-0.00732709201392713,0.000278966121896455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD33,Myeloid cell surface antigen CD33,39909,0.0274296188858038,0.00756401726183227,0.0126041450526126,0.042255092718995,0.000288368843034473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC13A1,Solute carrier family 13 member 1,37364,0.0209714417371575,0.00578772643888858,0.0096274979169359,0.0323153855573791,0.000291785075509415
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST1,Cystatin-SN,35636,0.0353020535701986,0.00975469073274418,0.01618285973402,0.0544212474063772,0.000297003199950969
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD3,Bromodomain-containing protein 3,37017,0.0161902759259092,0.00448584981865709,0.00739801028134134,0.0249825415704771,0.000308297019207486
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS4,Thrombospondin-4,39888,0.0155265363592835,0.00430326822570342,0.00709213063690481,0.0239609420816622,0.00030940998878939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,L1CAM,Neural cell adhesion molecule L1,39909,-0.00992757036444583,0.00275523046874828,-0.0153278220831925,-0.00452731864569919,0.000315307382032671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOC1,Apolipoprotein C-I,37420,-0.012996871552633,0.00361708098846052,-0.0200863502900156,-0.00590739281525038,0.000327807032267249
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF16,Fibroblast growth factor 16,37052,0.0167961132097186,0.00467441899265578,0.00763425198411324,0.0259579744353239,0.000327833507057169
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RALB,Ras-related protein Ral-B,37052,0.0101684843751875,0.00283109626493177,0.00461953569592121,0.0157174330544538,0.000329706246739767
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP6V1D,V-type proton ATPase subunit D,39784,0.00899991840155479,0.00250854697928029,0.00408316632216541,0.0139166704809442,0.000334605943569125
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBPMS,RNA-binding protein with multiple splicing,37052,0.0225425189331311,0.00628404083421377,0.0102257988980721,0.0348592389681901,0.000335374092521991
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNC5D,Netrin receptor UNC5D,37052,0.00920867359206195,0.00257570921852806,0.00416028352374695,0.0142570636603769,0.00035121185221871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDGFRA,Platelet-derived growth factor receptor alpha,39864,-0.00966848726640313,0.00270784583201503,-0.0149758650971526,-0.00436110943565367,0.000357282296281912
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK7,Kallikrein-7,36814,0.0134820933291243,0.00377603866418827,0.00608105754731525,0.0208831291109333,0.000357681997055977
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,39581,0.00924630854574222,0.00259399677403638,0.00416207486863092,0.0143305422228535,0.000365627395181174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MNAT1,CDK-activating kinase assembly factor MAT1,37165,0.0150889804985127,0.00423868307339416,0.00678116167466015,0.0233967993223653,0.000372392267552898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CELA2A,Chymotrypsin-like elastase family member 2A,37433,0.0203663236321985,0.00572918520646405,0.00913712062752901,0.0315955266368681,0.000379498195724602
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKD2,Serine/threonine-protein kinase D2,37017,0.0157176612957878,0.00442178794493773,0.00705095692370981,0.0243843656678657,0.000379890360596861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPA2,Replication protein A 32 kDa subunit,37052,0.0109809069235349,0.00309096773656355,0.00492261015987032,0.0170392036871994,0.000382805678533838
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBLN2,Fibulin-2,37433,0.0103660408824226,0.00292269010431335,0.00463756827796839,0.0160945134868767,0.000391334316865649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN4,Cerebellin-4,40026,0.010569865323826,0.00298609490014972,0.00471711931953252,0.0164226113281194,0.000401714708328448
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SRPX,Sushi repeat-containing protein SRPX,37433,-0.0116564498484813,0.00329380683079556,-0.0181123112368406,-0.00520058846012205,0.00040314264311799
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A2,Collagen alpha-2(IX) chain,37165,0.0158044377269438,0.00446738892904313,0.0070483554260193,0.0245605200278683,0.000404949636757692
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,39581,0.0108844946399632,0.00307719831732715,0.00485318593800201,0.0169158033419244,0.00040564357261826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NELL1,Protein kinase C-binding protein NELL1,39909,-0.013921781897955,0.0039360536921536,-0.0216364471345761,-0.00620711666133395,0.000405856930992938
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM5,Intercellular adhesion molecule 5,39864,0.0150447705084811,0.00425761758239087,0.00669984004699496,0.0233897009699672,0.000411077162497848
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,37378,0.0286930485636973,0.00813811223990941,0.0127423485734748,0.0446437485539197,0.000423663693444609
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAP,Cartilage-associated protein,37035,0.0168705460801413,0.00479619044461476,0.00747001280869642,0.0262710793515863,0.000437117479661723
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTBP2,Latent-transforming growth factor beta-binding protein 2,40048,-0.0104160860913316,0.00296725706586705,-0.016231909940431,-0.00460026224223217,0.000448748009133747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171B,Protein FAM171B,37364,0.00940907307584971,0.00268259178029384,0.00415119318647378,0.0146669529652256,0.000453883113493112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELL,L-selectin,37449,0.00765104530665136,0.00218375027181573,0.00337089477389253,0.0119311958394102,0.00046044477587437
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD1,Bromodomain-containing protein 1,37165,-0.0104209472210268,0.00298008438399406,-0.0162619126136551,-0.00457998182839843,0.000472298619841006
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCA2A,Guanylin,39792,0.0108607058196654,0.0031089219511971,0.00476721879531912,0.0169541928440117,0.000478206688838297
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,39862,0.0501690532528003,0.0143759437968076,0.0219922034110575,0.0783459030945431,0.000484697411303531
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C9orf40,Uncharacterized protein C9orf40,37378,0.0267800411516368,0.00767492400786137,0.0117371900962285,0.0418228922070451,0.000485846160340976
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GDF2,Growth/differentiation factor 2,39864,0.0118787031349893,0.00340550782454065,0.00520390779888958,0.0185534984710889,0.000487798632229837
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL15,Interleukin-15,39862,0.0108896384835056,0.0031258627012991,0.00476294758895936,0.0170163293780518,0.000495813722130399
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA1,Alpha-1-antitrypsin,37243,0.00271304692117915,0.000780336903907566,0.00118358658952032,0.00424250725283798,0.000509115609574483
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAP,Gamma-aminobutyric acid receptor-associated protein,37364,0.0164357717221252,0.00472825049476244,0.00716840075239084,0.0257031426918596,0.000510401536573784
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX1B,Syntaxin-1B,37035,0.0143264178318319,0.00412441488149034,0.00624256466411078,0.0224102709995529,0.00051524531398196
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDRG1,Protein NDRG1,39485,0.023144442034846,0.00666794985768619,0.0100752603137811,0.0362136237559109,0.00051992790865381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLASP1,CLIP-associating protein 1,36958,0.0245686099937867,0.00708468478704765,0.0106826278111734,0.0384545921764001,0.000526328860627738
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,39904,0.0298678495953079,0.00864882233191689,0.0129161578247508,0.046819541365865,0.000554994631052837
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP6,Dipeptidyl aminopeptidase-like protein 6,39784,-0.010981967982961,0.00318806075160271,-0.0172305670561023,-0.00473336890981969,0.000573129584970832
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG3G,Regenerating islet-derived protein 3-gamma,37364,0.0130250431126746,0.00378740996952983,0.00560171957239613,0.0204483666529531,0.000585550146244563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FASLG,Tumor necrosis factor ligand superfamily member 6,40054,0.0121345728159612,0.00353221473086358,0.00521143194346863,0.0190577136884539,0.000593162070877365
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEPE,Matrix extracellular phosphoglycoprotein,39858,0.00817122520239493,0.00238031266342408,0.00350581238208374,0.0128366380227061,0.000598813219687013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC39A14,Zinc transporter ZIP14,39485,0.0107746978182653,0.00314321977572526,0.00461398705784378,0.0169354085786868,0.000609798486035936
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3E,T-cell surface glycoprotein CD3 epsilon chain,37165,0.0113750286947633,0.00331857911783537,0.00487061362380597,0.0178794437657206,0.000610604463072667
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20,Interleukin-20,39583,0.0160686044930895,0.00470770781873951,0.00684149716836007,0.0252957118178189,0.000643538388920853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL33,Interleukin-33,39583,0.0127170929051136,0.00377341933932151,0.00532119100004346,0.0201129948101838,0.000753004538302572
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN2,Prorelaxin H2,37091,0.0462201409123493,0.0137239111354944,0.0193212750867802,0.0731190067379184,0.00075971456609492
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROBO4,Roundabout homolog 4,37039,-0.00579502312034252,0.00172083742296811,-0.00916786446936002,-0.00242218177132502,0.000760535542787698
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCSK7,Proprotein convertase subtilisin/kexin type 7,37364,0.0144530404033655,0.00429566755797073,0.00603353198974292,0.0228725488169882,0.000768786075474361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN5,Contactin-5,39893,-0.0115591916956742,0.00346500441590417,-0.0183506003508463,-0.00476778304050199,0.000851917543669723
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3,Microfibril-associated glycoprotein 3,39581,0.0157750666237842,0.00473054102359842,0.00650320621753125,0.0250469270300371,0.000855804123979765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,37017,0.0163036928136578,0.00488899572434131,0.00672126119394881,0.0258861244333667,0.000856049049252635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDHB15,Protocadherin beta-15,37364,-0.0128199915903615,0.00384664854367538,-0.0203594227359652,-0.00528056044475771,0.000862173003720178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGMA,Repulsive guidance molecule A,40005,-0.0099313426789943,0.00298023133342494,-0.0157725960925072,-0.00409008926548141,0.000862917508638174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKKL1,Dickkopf-like protein 1,39784,-0.0269409515737413,0.00810917910482315,-0.0428349426191947,-0.011046960528288,0.00089486581558802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6A,Ras-related protein Rab-6A,39862,-0.0148036632201271,0.00445605512387556,-0.0235375312629232,-0.00606979517733098,0.000895282635833165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSPN,Claspin,39449,0.0110066306325514,0.00331586174641682,0.00450754160957443,0.0175057196555284,0.000904219420125231
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPA4,Carboxypeptidase A4,36864,0.0139159956948219,0.00421027056601952,0.00566386538542363,0.0221681260042202,0.000951485741596217
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NMRK2,Nicotinamide riboside kinase 2,36958,-0.0130527867303437,0.0039496644730806,-0.0207941290975817,-0.00531144436310572,0.000953049434592193
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549,UPF0606 protein KIAA1549,37165,0.0219969398698628,0.00665678538560398,0.00894964051407903,0.0350442392256466,0.000954182074640613
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL4,Interleukin-4,39583,0.028688777577666,0.00870382645021041,0.0116292777352536,0.0457482774200784,0.000982504220271485
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTTG1,Securin,37165,0.0133141282681185,0.00404154081021567,0.00539270828009583,0.0212355482561413,0.000989178898798526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGA2,Integrin alpha-2,37120,0.0106982832437516,0.00325284206882579,0.00432271278885308,0.0170738536986502,0.00100840590001365
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAA4,Serum amyloid A-4 protein,37449,0.0104800678666093,0.00318760089580587,0.00423237011082979,0.0167277656223888,0.00101244164791907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH23,Cadherin-23,37384,-0.00853429561071731,0.00259807137152093,-0.0136265154988983,-0.00344207572253628,0.0010229322530546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",36958,0.0180124313977099,0.00549161348336582,0.00724886897031294,0.0287759938251069,0.00104082236871871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIT,Vitrin,37433,0.0116412549500964,0.00355062587045517,0.00468202824400425,0.0186004816561885,0.00104567817696117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD3,Ly6/PLAUR domain-containing protein 3,39790,0.0108774460964348,0.00332042893280449,0.00436940538813805,0.0173854868047316,0.00105544954309687
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,39745,0.0190015527758652,0.00580294185647703,0.00762778673717026,0.0303753188145602,0.00106087263078211
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EP300,Histone acetyltransferase p300,37052,0.00937070193771788,0.00286466230617509,0.0037559638176147,0.0149854400578211,0.00107391074293884
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX5,Syntaxin-5,37052,0.0128672021182438,0.00394164197437684,0.00514158384846521,0.0205928203880224,0.00109965171913783
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEF,Thyrotroph embryonic factor,37017,0.0133351912390899,0.00410143882207577,0.00529637114782137,0.0213740113303584,0.00115149569798847
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGB2A2,Mammaglobin-A,37017,-0.00984001014950058,0.00303745373918978,-0.0157934194783126,-0.00388660082068861,0.00120012007042976
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DKK3,Dickkopf-related protein 3,40048,-0.00894698099225839,0.00276465785163058,-0.0143657103814543,-0.00352825160306245,0.00121376695233395
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRAME,Melanoma antigen preferentially expressed in tumors,36958,-0.00800031604804648,0.00247915817450703,-0.0128594660700803,-0.00314116602601269,0.00125390198100416
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERC2,ERC protein 2,37035,0.0234371763710236,0.00727619910208242,0.00917582613094207,0.0376985266111052,0.00128021177680881
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNN,Tenascin-N,37433,0.0133272729864223,0.00414905099505809,0.00519513303610846,0.0214594129367362,0.00132064063272769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,40048,0.0215221510720842,0.00671457329052458,0.00836158742265606,0.0346827147215124,0.00135188485160259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VIM,Vimentin,39581,0.0361438808008496,0.0112999513162839,0.0139959762209332,0.058291785380766,0.0013837648930589
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH17,Cadherin-17,39864,-0.0203818390127487,0.00640946882881922,-0.0329443979172343,-0.00781928010826297,0.00147577339126418
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",37039,0.00994537840155383,0.00313193111908181,0.00380679340815348,0.0160839633949542,0.00149934316877794
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,37165,0.0208598211672661,0.00657966780219703,0.00796367227495993,0.0337559700595723,0.00152602918847948
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CUZD1,CUB and zona pellucida-like domain-containing protein 1,37035,0.0111917905942071,0.0035390647462171,0.00425522369162159,0.0181283574967926,0.00156851924198409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX9,Transcription factor SOX-9,37035,0.00828534876970848,0.00262244973392366,0.0031453472912181,0.0134253502481989,0.00158455672670316
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF2,Cyclic AMP-dependent transcription factor ATF-2,39485,0.0209613885234894,0.00664026160059183,0.00794647578632941,0.0339763012606494,0.00159862438765426
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUP50,Nuclear pore complex protein Nup50,37017,-0.0100555483043367,0.00319740752403827,-0.0163224670514517,-0.00378862955722173,0.00166509614101085
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNASE10,Inactive ribonuclease-like protein 10,37039,0.014193107147299,0.00452211769083927,0.005329756473254,0.0230564578213439,0.0017013291492657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPR1,Atrial natriuretic peptide receptor 1,37017,-0.0125677313434469,0.0040150365863206,-0.0204372030526353,-0.00469825963425857,0.00175089708320185
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX1,Neuronal pentraxin-1,39854,0.0123224821553549,0.00393684283257561,0.0046062702035067,0.0200386941072031,0.00175095969443049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPC1,Glypican-1,40026,0.00873086578095324,0.00279266839113277,0.00325723573433302,0.0142044958275735,0.00177302957487888
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,39877,0.0147360093667762,0.0047391308676335,0.00544731286621458,0.0240247058673379,0.00187775561243663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHNAK2,Protein AHNAK2,37039,0.00880071196019992,0.00283118935030441,0.00325158083360327,0.0143498430867966,0.00188449022351857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BMP4,Bone morphogenetic protein 4,39716,-0.0137616055572956,0.00442872247678654,-0.0224419016117973,-0.00508130950279401,0.00189104187627063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STX3,Syntaxin-3,37384,0.0114284096556948,0.00367797987231556,0.00421956910595628,0.0186372502054333,0.00189226664536157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGM2,Phosphoglucomutase-2,37035,0.018199690910151,0.00587713179758146,0.00668051258689136,0.0297188692334107,0.00196101380706604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,METAP1,Methionine aminopeptidase 1,39485,0.00907807960996507,0.00293440381785185,0.00332664812697544,0.0148295110929547,0.00198045477497273
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP1,Retinol-binding protein 1,37035,0.0210618137105124,0.0068177218356141,0.00769907891270873,0.034424548508316,0.00201063700674721
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRSS53,Serine protease 53,37384,0.0111151649282628,0.0036085463699621,0.00404241404313704,0.0181879158133885,0.00207253440462806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPM3,Tropomyosin alpha-3 chain,37017,-0.0132176282149847,0.00429204192203778,-0.0216300303821788,-0.00480522604779067,0.00207729313240633
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX25,ATP-dependent RNA helicase DDX25,37035,-0.0111899475899063,0.00363847873457065,-0.0183213659096648,-0.00405852927014781,0.0021061787336422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPO,Erythropoietin,39862,0.0228584196394017,0.00743402637603599,0.00828772794237116,0.0374291113364322,0.00210972407123147
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP5,Rho GTPase-activating protein 5,36958,0.0219434802423206,0.00715999853523599,0.00790988311325807,0.0359770773713832,0.00218307815662606
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWC2L,von Willebrand factor C domain-containing protein 2-like,37408,0.0140848722236146,0.00460391803385449,0.00506119287725976,0.0231085515699694,0.00222271178185519
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,39873,0.0168114198055472,0.00549676774767694,0.00603775502010038,0.027585084590994,0.00222875407135708
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",37408,0.0190175079846384,0.00627059761382993,0.00672713666153172,0.031307879307745,0.00242749501599121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPLA2,Acyl-protein thioesterase 2,36987,0.0309458503769637,0.0102065103670552,0.0109410900575354,0.0509506106963919,0.00243435979627781
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIPF,Gastric triacylglycerol lipase,37039,-0.0174945949997011,0.00577716576221648,-0.0288178398936454,-0.00617135010575681,0.00246465453577396
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,M6PR,Cation-dependent mannose-6-phosphate receptor,37039,0.0120232017318774,0.00397679761650249,0.00422867840353252,0.0198177250602223,0.00250483930917663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENDOU,Poly(U)-specific endoribonuclease,36426,0.0151128104774384,0.00500916948830575,0.00529483828035913,0.0249307826745177,0.00255776158085639
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,39581,-0.00889726710843492,0.00295193565198601,-0.0146830609863275,-0.00311147323054235,0.00258200389380052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RG,Cytokine receptor common subunit gamma,37364,0.010980763933627,0.00364816292991763,0.0038303645909884,0.0181311632762655,0.002617788534244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLL4,Delta-like protein 4,37039,0.0249856259546072,0.00830683825680652,0.00870422297126637,0.0412670289379479,0.00263609673377547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNX18,Sorting nexin-18,37378,0.0131404866281862,0.00437707660531773,0.00456141648176345,0.021719556774609,0.00268600876408771
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEO1,Neogenin,37408,0.00627236955846866,0.00208953849800956,0.00217687410236993,0.0103678650145674,0.00268880539876973
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRTN,Neurturin,39583,0.0143628116571592,0.00478680511082907,0.00498067363993421,0.0237449496743842,0.00269958757885105
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA9,Carbonic anhydrase 9,40026,-0.012492033755943,0.00416860037726975,-0.0206624904953917,-0.00432157701649428,0.00273335708413988
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA1549L,UPF0606 protein KIAA1549L,37165,-0.00800354415144563,0.00267778950885952,-0.0132520115888103,-0.00275507671408097,0.00280529769531642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REG1A,Lithostathine-1-alpha,39800,0.0133655686936777,0.0044720502835259,0.00460035013796694,0.0221307872493885,0.00280603960316765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL4,Myosin light chain 4,37039,0.0149646130291006,0.00500799875131802,0.00514893547651728,0.0247802905816839,0.00281195956627268
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZPR1,Zinc finger protein ZPR1,36987,0.0278524814355836,0.0093212472588814,0.00958283680817607,0.0461221260629911,0.00281270222151463
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD1,Glutamate decarboxylase 1,36958,-0.0074923178522295,0.0025090138342832,-0.0124099849674246,-0.00257465073703442,0.00283026843915562
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,QSOX1,Sulfhydryl oxidase 1,37182,0.0120627290858567,0.00406035674354561,0.00410442986850734,0.0200210283032061,0.00297502395087419
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REN,Renin,39864,0.0188974644433566,0.00636189399686797,0.00642815220949538,0.0313667766772178,0.00297839330075844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HSP90B1,Endoplasmin,39401,0.0192751548763733,0.00649265089913818,0.00654955911406249,0.0320007506386842,0.00299455324349442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,37364,0.0193362022890183,0.00653581385578998,0.00652600713166992,0.0321463974463667,0.00309676724169554
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP2,Cysteine-rich secretory protein 2,40026,-0.0159291010892659,0.00539864831521969,-0.0265104517870965,-0.00534775039143531,0.00317640913861407
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THAP12,52 kDa repressor of the inhibitor of the protein kinase,36927,0.0250541567793395,0.00849467043877851,0.0084046027193336,0.0417037108393454,0.00318958699593188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDDC2,5'-deoxynucleotidase HDDC2,37378,0.0123323424088565,0.00418525055373242,0.00412925132354093,0.020535433494172,0.00321816257098099
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPS10,40S ribosomal protein S10,37017,-0.0122180759606762,0.00415129408141502,-0.0203546123602496,-0.00408153956110274,0.00325409009166307
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_A,,37408,0.00918556497227993,0.0031225153755402,0.00306543483622115,0.0153056951083387,0.00326947763431118
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR158,Probable G-protein coupled receptor 158,37408,0.0101387037913424,0.00345045645548112,0.00337580913859943,0.0169015984440854,0.0033050353370444
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRO3,Tyrosine-protein kinase receptor TYRO3,39864,0.00797584106908265,0.00271783764448894,0.00264887928588433,0.013302802852281,0.00334422681305496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL28A1,Collagen alpha-1(XXVIII) chain,37035,0.0220767811994143,0.00752949454962473,0.00731897188214986,0.0368345905166788,0.00337322293916474
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARB1,Scavenger receptor class B member 1,39485,0.0160163220345355,0.00548618829496725,0.00526339297639969,0.0267692510926713,0.00351218081953145
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,37120,0.0105691066988967,0.00362919762868508,0.00345587934667397,0.0176823340511195,0.00359441282904887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNR,Tenascin-R,39745,-0.0117675227475742,0.00404214511782107,-0.0196901271785035,-0.00384491831664489,0.00360535396462414
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFBP7,Insulin-like growth factor-binding protein 7,40048,0.0081660605482024,0.0028222353334164,0.00263447929470625,0.0136976418016986,0.00381515830124654
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPQ,Carboxypeptidase Q,37426,0.0105482486120895,0.00364720890456121,0.00339971915914951,0.0176967780650295,0.00383232221774662
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTR,Methionine synthase,37017,0.018005693100168,0.00622863054060844,0.00579757724057546,0.0302138089597606,0.00384897522706621
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKCQ,Protein kinase C theta type,39583,0.0120887607845282,0.00418220927174085,0.0038916306119161,0.0202858909571402,0.0038513099147825
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DPP10,Inactive dipeptidyl peptidase 10,39862,0.00963588035494261,0.00333638989845462,0.00309655615397154,0.0161752045559137,0.00388076689171907
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL24,"39S ribosomal protein L24, mitochondrial",37017,0.0110868410734103,0.00383905689185878,0.00356228956536712,0.0186113925814535,0.00388446090995733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCT,Secretin,37035,0.0123819616002038,0.00428852976224253,0.00397644326620846,0.0207874799341992,0.00389285060001015
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,37017,-0.00851923024890222,0.00297415487716958,-0.0143485738081546,-0.00268988668964985,0.0041843410278114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF1,Signaling lymphocytic activation molecule,39583,0.0161327822547711,0.00564619472633651,0.00506624059115154,0.0271993239183907,0.00427843932971229
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VASN,Vasorin,39638,0.00751254850032949,0.00263919555576781,0.00233972521102457,0.0126853717896344,0.00442556199880502
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CST6,Cystatin-M,39520,0.0128281106573397,0.00450893374135604,0.00399060052428184,0.0216656207903975,0.00444630211178064
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,37165,0.0143247486365709,0.00504356481505076,0.00443936159907145,0.0242101356740704,0.00451532287803555
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL52,"39S ribosomal protein L52, mitochondrial",36938,0.00692655557544467,0.00244692202782576,0.00213058840090617,0.0117225227499832,0.00465139329476833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC3B,Tetranectin,37134,0.00577728473283947,0.00204201206373009,0.0017749410879285,0.00977962837775045,0.00467327857019978
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFRA3,GDNF family receptor alpha-3,39705,-0.00746286231860672,0.00266357575632089,-0.0126834708009957,-0.00224225383621778,0.00508767091517056
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DBH,Dopamine beta-hydroxylase,37426,-0.0293930579961109,0.0105316772978738,-0.0500351454999435,-0.00875097049227834,0.00526320556707898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA4,Ephrin type-A receptor 4,37120,0.00758051064525295,0.00272316390882286,0.00224310938396014,0.0129179119065458,0.00538164272347002
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP2,Contactin-associated protein-like 2,39862,0.0109731111114937,0.00394602795682774,0.00323889631611133,0.0187073259068761,0.00542886623054222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HNF1A,Hepatocyte nuclear factor 1-alpha,37035,0.0191552804150452,0.00689431136980957,0.00564243013021839,0.0326681306998719,0.00547015767426384
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,USP47,Ubiquitin carboxyl-terminal hydrolase 47,37017,0.0234039852157933,0.00842529342160362,0.00689041010945021,0.0399175603221364,0.00548016973397635
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRH,Corticoliberin,39451,0.0230631740750368,0.00838243591107675,0.00663359968932634,0.0394927484607472,0.00594152801478891
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB118,Beta-defensin 118,36987,0.0153975997036942,0.00563879017908876,0.00434557095268024,0.0264496284547082,0.00632926547445761
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBE2B,Ubiquitin-conjugating enzyme E2 B,37364,0.00750974008070185,0.00275216791340938,0.00211549097041946,0.0129039891909842,0.00636738485423117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",39485,0.0129599777741023,0.00476434529511932,0.0036218609956684,0.0222980945525361,0.00653143574854299
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEMA6C,Semaphorin-6C,37052,0.00689100408903148,0.00253434695368315,0.0019236840598125,0.0118583241182505,0.00655562780545394
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DSG3,Desmoglein-3,39960,0.00870032665518221,0.00321067926548051,0.00240739529484042,0.014993258015524,0.00673932898459793
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL2,Kin of IRRE-like protein 2,39485,0.0103307584706728,0.00381236526541174,0.0028585225504658,0.0178029943908798,0.0067396636930179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,37018,0.0102088157243929,0.00376763145716031,0.00282425806835871,0.0175933733804271,0.00674493933682744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEAR1,Platelet endothelial aggregation receptor 1,40048,0.00590385553346363,0.00217909965107485,0.00163282021735693,0.0101748908495703,0.00674943385439349
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALM3,Paralemmin-3,37017,0.0198196083928962,0.00731749578324052,0.00547731665774474,0.0341619001280476,0.00676707547831957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1RL1,Interleukin-1 receptor-like 1,39998,-0.0122026322529971,0.00450774559698167,-0.0210378136230811,-0.00336745088291299,0.00679582094963111
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP290,Centrosomal protein of 290 kDa,37165,0.0135086366446741,0.00502523755151643,0.00365917104370189,0.0233581022456463,0.00719366469176429
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUC2,Mucin-2,37433,0.0234079650330689,0.00871199095180658,0.00633246276752795,0.0404834672986098,0.0072213418695935
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CENPJ,Centromere protein J,37165,0.0187744406043792,0.00703431759423488,0.00498717811967885,0.0325617030890796,0.00761746847034441
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",39485,0.0140392372493193,0.00526696484496229,0.00371598615319321,0.0243624883454454,0.00769467900423629
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC2,Plexin domain-containing protein 2,37384,-0.00686750409760816,0.00259410327419506,-0.0119519465150305,-0.00178306168018585,0.00812189510256458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,39877,0.0123433226426495,0.00469705643931184,0.00313709202159827,0.0215495532637007,0.00859995534003199
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNLIPRP2,Pancreatic lipase-related protein 2,39858,0.0745434235645671,0.0283691070954043,0.0189399736575746,0.13014687347156,0.00860648588880548
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,39927,-0.0107985241558835,0.00411362260035195,-0.0188612244525733,-0.0027358238591937,0.00867146108123803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17A,Interleukin-17A,39554,0.0106530306877975,0.00408255803155047,0.00265121694595855,0.0186548444296364,0.00907869705909934
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,39473,0.0187587684833809,0.00719377366238036,0.00465897210511543,0.0328585648616464,0.00912556562608747
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRIM26,Tripartite motif-containing protein 26,36958,0.0140487882228156,0.00540345817948775,0.00345801019101957,0.0246395662546115,0.00933386147444908
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD109,CD109 antigen,39854,-0.00844744808672969,0.00325159298380434,-0.0148205703349862,-0.00207432583847317,0.00938704543413828
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD99,CD99 antigen,39854,-0.00477227053281648,0.00184515412853214,-0.00838877262473948,-0.00115576844089348,0.00970773148510024
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUMF1,Formylglycine-generating enzyme,37052,0.017070553040231,0.00661871712915221,0.00409786746709269,0.0300432386133694,0.00991558542234691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANBP2,E3 SUMO-protein ligase RanBP2,36987,-0.00844382728893988,0.00327775142713533,-0.0148682200861251,-0.00201943449175463,0.010002899277178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF75D,Zinc finger protein 75D,37165,0.0146971224215446,0.00572723331574226,0.00347174512268972,0.0259224997203994,0.0102933345189355
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7B,B-cell CLL/lymphoma 7 protein family member B,37364,0.0111925242690043,0.00438731716598518,0.00259338262367333,0.0197916659143352,0.0107490019254133
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMOD4,Tropomodulin-4,36958,-0.00999191973235134,0.00394655734570698,-0.017727172129937,-0.00225666733476565,0.0113592479733716
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",39583,0.0295415892562662,0.0116845780627716,0.00663981625323376,0.0524433622592986,0.0114728210047738
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDRG1,p53 and DNA damage-regulated protein 1,37035,0.0130130201750164,0.0051530155625123,0.00291310967249234,0.0231129306775405,0.0115708850813456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNPDA1,Glucosamine-6-phosphate isomerase 1,37039,0.00797971118832936,0.00316745672350144,0.00177149601026653,0.0141879263663922,0.0117712308408406
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2B,Sodium channel subunit beta-2,37035,-0.00704173964342122,0.00279845059410108,-0.0125267028078593,-0.0015567764789831,0.0118712209443833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM25,Transmembrane protein 25,37408,-0.0108787238328066,0.00432875778628793,-0.019363089093931,-0.00239435857168228,0.0119780902480498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIF1L,Allograft inflammatory factor 1-like,37039,0.0141898004947627,0.00565696677053887,0.00310214562450654,0.0252774553650189,0.01214066141374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC28A1,Sodium/nucleoside cotransporter 1,36958,0.0144615682164609,0.00576649872996705,0.00315923070572552,0.0257639057271964,0.01215849365579
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DHODH,Dihydroorotate dehydrogenase,37017,0.0112584013185621,0.00448949363268914,0.00245899379849134,0.0200578088386328,0.0121631717824056
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,39473,0.0306759551730484,0.0122344142837874,0.00669650317682502,0.0546554071692717,0.0121741001316943
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10,V-set and immunoglobulin domain-containing protein 10,37364,0.00880046491768557,0.00352444553918111,0.0018925516608906,0.0157083781744805,0.0125374687327814
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIF1A,Hypoxia-inducible factor 1-alpha,37052,0.0164938107706637,0.00662072514261441,0.00351718949113948,0.029470432050188,0.0127420270813042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF31,E3 ubiquitin-protein ligase RNF31,37052,0.00901202197089616,0.0036286703929477,0.00189982800071867,0.0161242159410737,0.0130199523242534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPT,Microtubule-associated protein tau,39485,0.0125676213069705,0.00506933549272154,0.00263172374123629,0.0225035188727047,0.0131802178955808
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF5,Fibroblast growth factor 5,39583,-0.00789598777348057,0.00319347608967359,-0.0141552009092408,-0.00163677463772033,0.0134262809183705
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SNU13,NHP2-like protein 1,37017,0.0147905856556081,0.00598747169967374,0.00305514112424756,0.0265260301869686,0.013514238535302
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR1,TGF-beta receptor type-1,37052,0.00519269114287669,0.00210817437630104,0.00106066936532665,0.00932471292042673,0.0137859704399656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDI2,Isopentenyl-diphosphate delta-isomerase 2,39485,0.0111042150597225,0.00451261324782255,0.00225949309399026,0.0199489370254546,0.0138771253446259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMCN2,Hemicentin-2,37096,-0.0135197685202225,0.00549529889936664,-0.0242905543629811,-0.00274898267746386,0.0138969942332425
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NECTIN1,Nectin-1,37052,0.00763901136207846,0.00310622748397706,0.00155080549348343,0.0137272172306735,0.013935236631465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGT5,Glutathione hydrolase 5 proenzyme,39745,0.00543613302455859,0.00221317033038008,0.00109831917701364,0.00977394687210354,0.0140495792038244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCLRE1C,Protein artemis,36958,-0.00736988885470187,0.00300264767393805,-0.0132550782956204,-0.0014846994137833,0.0141224183535879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",37384,-0.00601332945951364,0.00245274938050112,-0.0108207182452958,-0.00120594067373144,0.0142320985766225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR1,Toll-like receptor 1,37052,0.00617374624694788,0.00252606169709055,0.0012226653206504,0.0111248271732453,0.0145376112812982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACE,Angiotensin-converting enzyme,37441,-0.0060448098687989,0.00247845575273695,-0.0109025831441633,-0.00118703659343447,0.0147430495999504
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGL1,Fibrinogen-like protein 1,37441,-0.014595026731957,0.00598625554444926,-0.0263280875990775,-0.00286196586483643,0.0147778505557467
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANK2,Ankyrin-2,37017,0.0167172167946397,0.00687012327493836,0.00325177517576049,0.0301826584135189,0.0149742472422041
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRISP3,Cysteine-rich secretory protein 3,37321,-0.00630268120884244,0.00259826016799029,-0.0113952711381034,-0.00121009127958146,0.015290630429052
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYB5A,Cytochrome b5,36958,0.0167262879692536,0.00693389450712551,0.00313585473528761,0.0303167212032196,0.0158680558932478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCD6,Programmed cell death protein 6,39864,-0.016118147442087,0.0067257295630992,-0.0293005773857615,-0.00293571749841261,0.016564322901691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BATF,Basic leucine zipper transcriptional factor ATF-like,37035,0.0194534680175073,0.00814875202092833,0.00348191405648779,0.0354250219785268,0.0169869188847711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LIFR,Leukemia inhibitory factor receptor,39862,-0.00559543487474165,0.00234961959819378,-0.0102006892872015,-0.000990180462281844,0.0172575840324668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPON2,Spondin-2,39771,-0.00770336638221135,0.00323823337564285,-0.0140503037984713,-0.00135642896595137,0.0173770869459785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,37017,-0.0132574971268453,0.00557351337426439,-0.0241815833404035,-0.00233341091328715,0.0173898474125035
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPS16,"28S ribosomal protein S16, mitochondrial",37052,0.0068351507310994,0.0028784806795097,0.00119332859926039,0.0124769728629384,0.0175836758860255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SULT1A1,Sulfotransferase 1A1,40005,-0.0294852750362366,0.0124208486057223,-0.0538301383034522,-0.00514041176902091,0.0176151617812446
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSH1,Chorionic somatomammotropin hormone 1,37441,0.00797829656821808,0.0033641211383966,0.00138461913696074,0.0145719739994754,0.0177258733499333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS5,Transmembrane protease serine 5,39663,-0.00869035150174042,0.00366662992550353,-0.0158769461557273,-0.0015037568477535,0.0177942666405175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD3,Sphingomyelin phosphodiesterase 3,37052,0.0137753959017621,0.0058203637157952,0.0023674830188035,0.0251833087847207,0.0179589899002224
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOP56,Nucleolar protein 56,37017,0.0252134617111358,0.0106724789395114,0.0042954029896935,0.0461315204325781,0.0181678503793037
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSH3,Protein phosphatase Slingshot homolog 3,36958,0.00676856880494127,0.00286797534708172,0.00114733712466109,0.0123898004852215,0.018286989631912
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAG,S-arrestin,36987,-0.0121220649486946,0.00515893597067021,-0.0222335794512082,-0.00201055044618099,0.0188021708307305
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",37052,0.0136048628324264,0.00579875043307787,0.00223931198359377,0.024970413681259,0.018982099225227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL5A1,Collagen alpha-1(V) chain,37120,0.00897185945281477,0.00382689283311254,0.00147114949991418,0.0164725694057153,0.0190711683388604
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FBN2,Fibrillin-2,37035,0.0136628857530812,0.00583480796130969,0.00222666214891418,0.0250991093572481,0.0192152241886413
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHP1,Calcineurin B homologous protein 1,36987,0.0164974394990712,0.00704541975612898,0.00268841677705844,0.0303064622210841,0.0192169981395773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDNRB,Endothelin receptor type B,37052,0.0105474879619036,0.00451579702279901,0.00169652579721753,0.0193984501265897,0.0195224705239387
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNC,Tenascin,39927,-0.0105887627242678,0.00453363304574059,-0.0194746834939194,-0.00170284195461624,0.0195242294621849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCN,Decorin,39581,-0.00487477101049001,0.00209631321625037,-0.00898354491434074,-0.000765997106639279,0.0200631322057225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPR101,Probable G-protein coupled receptor 101,36987,-0.0141419017092612,0.00608309017507476,-0.0260647584524077,-0.00221904496611464,0.0200984122826313
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMA1,Proteasome subunit alpha type-1,39473,0.0103744409441631,0.00448002200165318,0.00159359782092287,0.0191552840674034,0.0205868870911678
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,39784,0.00987939889504974,0.00426991160728189,0.00151037214477724,0.0182484256453222,0.0206955101364446
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB6,Integrin beta-6,39583,0.00661545887607334,0.00286091528034485,0.00100806492659744,0.0122228528255492,0.0207708415749933
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,39485,0.0109074843803792,0.00471709401983383,0.0016619801015049,0.0201529886592535,0.0207723619598352
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,37017,0.0109274387018211,0.00473665993100483,0.00164358523705159,0.0202112921665905,0.0210706929237939
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCARF2,Scavenger receptor class F member 2,40005,-0.00623640410193697,0.00270897916756344,-0.0115460032703613,-0.000926804933512636,0.0213408809788779
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD2,T-cell surface antigen CD2,37017,0.0085385331125363,0.00371239247579649,0.00126224385997517,0.0158148223650974,0.0214633311466991
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NME1,Nucleoside diphosphate kinase A,37052,-0.00485781843432726,0.00211359013151504,-0.00900045509209673,-0.000715181776557781,0.021556133168585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRTAC1,Cartilage acidic protein 1,40048,-0.00664339349757737,0.00289762230591784,-0.0123227332171763,-0.000964053777978406,0.0218777510813953
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSC1,Hamartin,37052,0.016935492999338,0.00739902740976937,0.00243339927618999,0.0314375867224859,0.0221019993004179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAN,Neurocan core protein,40005,0.0080762935237832,0.00353363409382649,0.00115037069988328,0.0150022163476831,0.0222935627782676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB5,Integrin beta-5,39909,-0.00834454026430313,0.00365832535892974,-0.0155148579678054,-0.00117422256080084,0.0225631061122306
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFRC,Transferrin receptor protein 1,39914,0.00858364580399516,0.00376511765170859,0.00120401520664632,0.015963276401344,0.0226337037778806
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR4,Toll-like receptor 4,37052,0.00607337388943675,0.00266915978487754,0.000841820711076779,0.0113049270677967,0.0228986371422851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSMR,Oncostatin-M-specific receptor subunit beta,39945,0.00442130160244239,0.00194635439113635,0.000606446995815142,0.00823615620906965,0.0231249807472459
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,37364,0.0213676180493437,0.00944879008458848,0.00284798948355027,0.0398872466151371,0.023749522951649
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,37433,0.00705668265692761,0.00312778751294667,0.000926219131552126,0.0131871461823031,0.0240785891356574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH7B,Myosin-7B,36958,-0.00958989594104548,0.00425715393275572,-0.0179339176492467,-0.00124587423284426,0.0242974392702069
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SKIV2L,Helicase SKI2W,37017,0.00876584757529619,0.00389391219236547,0.00113377967825988,0.0163979154723325,0.0243913810648659
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC12A2,Solute carrier family 12 member 2,37017,-0.00605789773273917,0.00269419106236259,-0.0113385122149698,-0.000777283250508493,0.0245605901739655
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRP2,Neuropilin-2,39854,0.00617197278378743,0.0027492831158504,0.00078337787672064,0.0115605676908542,0.0247856598329119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,37449,-0.00414846968075363,0.00185077754960239,-0.00777599367797432,-0.000520945683532937,0.0250114663169478
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BABAM1,BRISC and BRCA1-A complex member 1,37052,0.00642084665984065,0.00287576516207439,0.000784346942174844,0.0120573463775065,0.025582559670563
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOE,Apolipoprotein E,37449,0.0154898769033205,0.00700571742905451,0.00175867074237365,0.0292210830642674,0.0270500951008735
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GHRHR,Growth hormone-releasing hormone receptor,39485,0.0114242584866278,0.00519685274629672,0.00123842710388619,0.0216100898693693,0.02794211057072
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBX2,Chromobox protein homolog 2,37017,-0.00856623574668487,0.00391257480034415,-0.0162348823553594,-0.000897589138010349,0.0285844577108271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHIT1,Chitotriosidase-1,39902,0.0314434587538335,0.0145028988940606,0.00301777692147464,0.0598691405861924,0.0301671812329472
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL11,Interleukin-11,39583,0.0129872809122806,0.00600070369503909,0.00122590167000396,0.0247486601545572,0.0304568745292366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SELENOP,Selenoprotein P,37449,-0.00464229552795896,0.002146695791073,-0.00884981927846205,-0.000434771777455867,0.0305946830763973
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NENF,Neudesin,37364,0.0229306699066591,0.0106303908436539,0.00209510385309741,0.0437662359602208,0.0310165323821394
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,39864,0.00635153568547324,0.00296645439513286,0.00053728507101284,0.0121657862999336,0.0322793983487095
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB39B,Ras-related protein Rab-39B,37017,0.0182952777557015,0.00858167568209646,0.00147519341879247,0.0351153620926106,0.0330335067245867
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GGA1,ADP-ribosylation factor-binding protein GGA1,39485,0.0143740884709469,0.00674441019241808,0.00115504449380752,0.0275931324480864,0.0330833294881982
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZCCHC8,Zinc finger CCHC domain-containing protein 8,37017,0.0121108435927239,0.00569229544809446,0.000953944514458807,0.0232677426709891,0.0333900316491739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36G,Interleukin-36 gamma,37017,0.0138571238838825,0.00652243155055187,0.00107315804480087,0.0266410897229642,0.033644155643656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CINP,Cyclin-dependent kinase 2-interacting protein,37165,0.00893196604538512,0.00421262069367842,0.000675229485775414,0.0171887026049948,0.0340002802931833
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TERF1,Telomeric repeat-binding factor 1,37052,-0.00598410832636533,0.00282888480825959,-0.0115287225505541,-0.000439494102176545,0.0344180120435259
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FABP2,"Fatty acid-binding protein, intestinal",39864,-0.0158482217590047,0.00751251148425272,-0.0305727442681401,-0.0011236992498694,0.0349102886671225
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COPE,Coatomer subunit epsilon,39485,0.00960110416498565,0.00455509212985103,0.000673123590477631,0.0185290847394937,0.0350664395289619
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGFBP2,Fibroblast growth factor-binding protein 2,37433,-0.0101068000361322,0.00479674097255589,-0.0195084123423417,-0.000705187729922665,0.0351346713852803
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MATN3,Matrilin-3,39716,-0.00635153251620119,0.00301976768619224,-0.012270277181138,-0.00043278785126441,0.0354536720185279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDK1,Cyclin-dependent kinase 1,36958,0.00734847268275548,0.00350277631504207,0.000483031105273023,0.0142139142602379,0.0359331344675722
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSF2RB,Cytokine receptor common subunit beta,37052,0.00879846291961035,0.00419839355641732,0.000569611549032411,0.0170273142901883,0.0361301570301209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPM1B,Protein phosphatase 1B,37052,0.012934678894759,0.00617282535221142,0.00083594120442467,0.0250334165850934,0.0361524395454534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PI16,Peptidase inhibitor 16,37441,-0.0048317891246387,0.00230729105930091,-0.00935407960086848,-0.000309498648408923,0.0362660528410022
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPK13,Mitogen-activated protein kinase 13,36958,0.00863048468684461,0.00412715801399726,0.000541254979409989,0.0167197143942792,0.0365343119982931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCNE1,G1/S-specific cyclin-E1,37052,0.0193580984773915,0.00926266254355873,0.00120327989201637,0.0375129170627666,0.0366453030581341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RGS8,Regulator of G-protein signaling 8,39583,0.0130844649984544,0.00634311378835395,0.000651961973280631,0.0255169680236281,0.0391496681377388
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACTN4,Alpha-actinin-4,39583,0.00622460995033204,0.00302808266892457,0.000289567919239892,0.0121596519814242,0.039834913257882
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PKD1,Polycystin-1,37433,0.00519209184719409,0.00252991373203592,0.000233460932403681,0.0101507227619845,0.0401615760089167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHD,SH2 domain-containing adapter protein D,36998,0.0165020458361899,0.00804455936832413,0.000734709474274575,0.0322693821981052,0.0402546070802927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2RB,Interleukin-2 receptor subunit beta,39583,0.00718008504305672,0.00350086555867172,0.00031838854806015,0.0140417815380533,0.0402887750186764
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2A,Pancreatic alpha-amylase,39242,0.00927031202240832,0.00452652357277539,0.000398325819768544,0.0181422982250481,0.0405771199193577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31RA,Interleukin-31 receptor subunit alpha,37011,0.0079168527881907,0.00386828997593137,0.000335004435365225,0.0154987011410162,0.040716944896811
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB104A_DEFB104B,Beta-defensin 104,36987,0.0115909491800935,0.00566855321530641,0.000480584878092926,0.0227013134820941,0.0408963679342328
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD70,CD70 antigen,39862,0.00827627754408456,0.00406922926633738,0.000300588182063294,0.0162519669061058,0.0419813091281053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH15,Cadherin-15,39969,0.0104796217394903,0.00516274040374242,0.00036065054815514,0.0205985929308254,0.0423875373760702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D2,DCN1-like protein 2,36958,-0.0157786663175541,0.00778057909041236,-0.0310286013347623,-0.00052873130034586,0.0425850141803353
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HLA_DRA,,39795,0.00692729238577793,0.00341758913817798,0.000228817674949079,0.0136257670966068,0.0426838405743917
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTN1A1,Butyrophilin subfamily 1 member A1,37344,0.00804116782300582,0.00396922020514314,0.00026149622092526,0.0158208394250864,0.0427966320281656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOA4,Apolipoprotein A-IV,37449,-0.00690045423708973,0.00341957362782763,-0.0136028185476319,-0.000198089926547575,0.043618348075202
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ICAM2,Intercellular adhesion molecule 2,40048,0.0060809532671769,0.00301467559955231,0.000172189092054369,0.0119897174422994,0.0436997841525532
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNC4,Potassium voltage-gated channel subfamily C member 4,36987,0.0109736484061138,0.00544392793719836,0.000303549649204982,0.0216437471630226,0.0438454869149818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD8,Ly6/PLAUR domain-containing protein 8,39473,0.0101599956181017,0.0050612310052074,0.000239982847895143,0.0200800083883082,0.044722597398957
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,37039,-0.00514181979299716,0.00256386450999997,-0.0101669942325971,-0.000116645353397213,0.0449304627260819
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART3,Ecto-ADP-ribosyltransferase 3,39927,0.00637730514642007,0.00318023266686893,0.000144049119356973,0.0126105611734832,0.0449482427104392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTX2,Neuronal pentraxin-2,37433,-0.00650414383220339,0.00325585026176729,-0.0128856103452673,-0.000122677319139498,0.0457713898265107
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECM1,Extracellular matrix protein 1,37102,0.00698961700947777,0.00350117242026483,0.000127319065758697,0.0138519149531968,0.0459146795466534
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A16,Protein S100-A16,39452,-0.0119135318347643,0.00598362483092612,-0.0236414365033795,-0.000185627166149161,0.0464958329350901
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HIP1,Huntingtin-interacting protein 1,37017,0.0064434777390512,0.00324435817894677,8.45357083155435e-05,0.0128024197697869,0.0470477987226631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCGN,Secretagogin,39583,-0.00823988385868506,0.00415640194717737,-0.0163864316751527,-9.33360422174113e-05,0.0474456085809567
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QA,Complement C1q subcomponent subunit A,39967,-0.00437635591642693,0.00220897759158592,-0.00870595199593533,-4.67598369185279e-05,0.0475894048793756
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,37017,-0.00785482488543268,0.00398115572633468,-0.0156578901090486,-5.17596618167075e-05,0.0485163283309366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,40048,0.00430558948165561,0.00218435944711293,2.42449653142631e-05,0.00858693399799696,0.0487295201832714
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOM1,Myomesin-1,36987,0.00905286734582183,0.00460071585593217,3.54642681947692e-05,0.0180702704234489,0.049122615285851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC3,Membrane primary amine oxidase,39927,-0.00569533228921251,0.00289445393799802,-0.0113684620076886,-2.2202570736385e-05,0.0491231092891969
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BEX3,Protein BEX3,36958,-0.00890775128596495,0.00452886638822891,-0.0177843294068936,-3.11731650362839e-05,0.0492177530682853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6L2,Seizure 6-like protein 2,39784,-0.00454025960519406,0.00231442877813733,-0.00907654001034322,-3.97920004489068e-06,0.0498125679306557
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AIDA,"Axin interactor, dorsalization-associated protein",37035,0.016079262780971,0.00822023092730912,-3.23898365548678e-05,0.0321909153984969,0.050479217028059
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5RA,Interleukin-5 receptor subunit alpha,39862,-0.0102213795655886,0.00522779937892989,-0.0204678663482911,2.51072171140072e-05,0.050577161428283
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ASPN,Asporin,37433,0.00509235945987084,0.00260495307860915,-1.33485742030929e-05,0.0101980674939448,0.0506182406801788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSAP,Gamma-secretase-activating protein,39473,0.0165791008380812,0.00848210808997808,-4.58310182758388e-05,0.0332040326944383,0.0506485078634327
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",37408,0.00818948621299834,0.00419137683709711,-2.56123877119853e-05,0.0164045848137087,0.0507348615771555
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,37378,-0.0321973619111072,0.0164839217369479,-0.064505848515525,0.00011112469331058,0.0508095614753556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NAAA,N-acylethanolamine-hydrolyzing acid amidase,39670,0.0110658266431253,0.00569184257794354,-9.01848096439891e-05,0.0222218380958947,0.051894425542019
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGEF5,Rho guanine nucleotide exchange factor 5,36987,0.0140793746630606,0.00725459743051665,-0.000139636300752024,0.0282983856268732,0.0523097425409535
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13,Interleukin-13,39583,0.009080225966642,0.00470078613838857,-0.000133314864599585,0.0182937667978836,0.0534219185726574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPH3,Neurexophilin-3,37052,0.00555095651969595,0.00287752658969256,-8.89955961014743e-05,0.0111909086354934,0.0537433257414078
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OBP2B,Odorant-binding protein 2b,39697,-0.0116961517828307,0.00606884525591178,-0.0235910884844178,0.00019878491875638,0.0539669679402573
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGLON5,IgLON family member 5,36958,0.0171901337670187,0.00892389568737254,-0.000300701780231477,0.0346809693142689,0.0540880708604154
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ECSCR,Endothelial cell-specific chemotaxis regulator,36987,0.00917746761976653,0.00476981254380173,-0.000171364966084855,0.0185263002056179,0.0543670260077117
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,36671,0.00904645499936161,0.00472843635336976,-0.000221280253243118,0.0183141902519663,0.0557444340267396
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",36987,-0.0100013617330116,0.00523402450717356,-0.0202600497670718,0.000257326301048572,0.0560474371464144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRIM1,Cysteine-rich motor neuron 1 protein,39927,-0.00369111113943542,0.00194400013936521,-0.00750135141259124,0.000119129133720395,0.0576192532188045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,39900,-0.0117418784835161,0.00620947143557646,-0.0239124424972459,0.000428685530213795,0.0586473357200993
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRNN,Cornulin,39393,0.0117386297940982,0.00624124181650673,-0.000494204166254978,0.0239714637544514,0.0600155934769853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALPI,Intestinal-type alkaline phosphatase,37052,-0.0220249619268048,0.0117110364419081,-0.0449785933529446,0.000928669499335014,0.0600345668726784
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT7,N-acetylgalactosaminyltransferase 7,39784,0.00374390857015375,0.00199562973506655,-0.000167525710576681,0.00765534285088418,0.0606661821893878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLK,STE20-like serine/threonine-protein kinase,37165,0.0138567960073893,0.00743227168574035,-0.000710456496661811,0.0284240485114404,0.0622862599852236
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTNAP4,Contactin-associated protein-like 4,37035,0.0186746063353439,0.0100414050780136,-0.00100654761756279,0.0383557602882506,0.0629417207396934
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSD1,Tryptase delta,37408,0.00658054404866557,0.00353863529752258,-0.000355181134478686,0.0135162692318098,0.0629598842129974
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,37017,-0.00911734137283862,0.00491089939635523,-0.0187427041896949,0.000508021444017626,0.0633972182359423
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNER,Delta and Notch-like epidermal growth factor-related receptor,39817,-0.00454406950616596,0.00244940776369001,-0.00934490872299838,0.000256769710666462,0.063590284477298
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMY2B,Alpha-amylase 2B,38828,0.00855316963583367,0.00462387218144109,-0.000509619839790858,0.0176159591114582,0.0643642342302195
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L2,Mortality factor 4-like protein 2,36958,-0.00664594743218031,0.00359419323098434,-0.0136905661649096,0.000398671300548996,0.0644689155443162
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UGDH,UDP-glucose 6-dehydrogenase,37017,0.0178739053065532,0.00968712064984593,-0.00111285116714483,0.0368606617802512,0.065042463840585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCPKMT,Protein-lysine methyltransferase METTL21D,36958,0.0153418631110647,0.00836548908290824,-0.00105449549143545,0.0317382217135648,0.0666845454815926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LYPD1,Ly6/PLAUR domain-containing protein 1,39485,0.011330204537043,0.00622131896813394,-0.0008635806404995,0.0235239897145855,0.0685970784084188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPT1,Palmitoyl-protein thioesterase 1,37035,0.0138091415270268,0.00758588793628232,-0.00105919882808655,0.0286774818821401,0.0687249791180066
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRPV3,Transient receptor potential cation channel subfamily V member 3,37017,-0.00910994296856364,0.00500525624395503,-0.0189202452067155,0.000700359269588209,0.0687702577819769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AOC1,Amiloride-sensitive amine oxidase [copper-containing],39583,0.00959396113206137,0.00527508979894761,-0.00074521487387596,0.0199331371379987,0.0689717323839857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OTOA,Otoancorin,36987,0.00933978466332418,0.00514351888980336,-0.000741512360690411,0.0194210816873388,0.0694183991019945
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBZ,Hemoglobin subunit zeta,37433,0.018482225121811,0.0101837806001826,-0.00147798485454703,0.0384424350981689,0.0695661454965706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,37408,0.00558073584247763,0.00308325166783589,-0.000462437426480706,0.011623909111436,0.0703154041786849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK15,Kallikrein-15,37347,0.00882025368513076,0.00487691878570434,-0.000738507134849737,0.0183790145051113,0.0705399450163333
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT14,"Keratin, type I cytoskeletal 14",39060,0.00504611965024999,0.00279017257843352,-0.000422618603479705,0.0105148579039797,0.0705433124675182
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENPEP,Glutamyl aminopeptidase,37017,0.00728531168809316,0.00405202231526997,-0.000656652049835986,0.0152272754260223,0.0722087026304319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SH3GL3,Endophilin-A3,37079,0.0143419648298046,0.00799236897846469,-0.00132307836798616,0.0300070080275954,0.0727630493195329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WIF1,Wnt inhibitory factor 1,40026,-0.00578261289951533,0.00322814530569891,-0.0121097776986852,0.000544551899654547,0.0732620663275702
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HBQ1,Hemoglobin subunit theta-1,40026,0.0103479446644896,0.005777179187219,-0.000975326542459663,0.0216712158714388,0.0732837578235667
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCLN,Nicalin,39583,0.00909760966715216,0.00508351664478283,-0.000866082956622185,0.0190613022909265,0.0735327846612114
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,37165,0.0109548556090816,0.00612556856190099,-0.00105125877224435,0.0229609699904075,0.0737371689123765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DTX2,Probable E3 ubiquitin-protein ligase DTX2,37035,-0.010892544980048,0.00609197371680574,-0.0228328134649873,0.00104772350489125,0.0737964393809353
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,APOH,Beta-2-glycoprotein 1,39854,0.00611347002643963,0.00342260270545533,-0.000594831276252823,0.0128217713291321,0.0740850106438381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",36958,0.00872937950194319,0.00491130305588683,-0.000896774487595007,0.0183555334914814,0.0755246636687638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDA1,DET1- and DDB1-associated protein 1,37017,0.00680495015777921,0.00384328021934802,-0.000727879072142903,0.0143377793877013,0.0766487383816678
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS2,"Nitric oxide synthase, inducible",37017,0.00677052308981542,0.00382761941269905,-0.000731610959074719,0.0142726571387055,0.0769403960592561
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMG,Oligodendrocyte-myelin glycoprotein,39784,-0.0110552974205677,0.00625660131222291,-0.0233182359925246,0.00120764115138916,0.0772505145966226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENG,Endoglin,40048,-0.00287590258869542,0.00163110656980693,-0.00607287146551699,0.000321066288126162,0.0778922966904063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESR1,Estrogen receptor,37052,0.0101452659720298,0.00575609853505404,-0.00113668715667612,0.0214272191007357,0.078003836332807
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAP18,Histone deacetylase complex subunit SAP18,37165,0.012459713091354,0.00707577857047708,-0.00140881290678112,0.026328239089489,0.078278906539073
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,36987,0.0123033607218485,0.00700697202129674,-0.00143030443989313,0.0260370258835901,0.0791332266930409
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REST,RE1-silencing transcription factor,36958,-0.00606411661620008,0.00345370439971176,-0.0128333772396351,0.000705144007234978,0.0791408697495522
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK14,Kallikrein-14,40026,0.00762618673620143,0.00434816548203122,-0.00089621760857975,0.0161485910809826,0.0794689838694733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1,DNA topoisomerase 1,37378,-0.0193131354223203,0.0110180177017787,-0.0409084501178065,0.00228217927316593,0.0796472599469049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GH2,Growth hormone variant,39473,0.0277603335972628,0.0158444961442417,-0.00329487884545098,0.0588155460399766,0.0797850133496155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP112,Centrosomal protein of 112 kDa,37017,0.00788283026014292,0.00451328934359863,-0.00096321685331039,0.0167288773735962,0.0807331940365439
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PALLD,Palladin,37052,0.00688292714326493,0.00394410062043527,-0.000847510072788208,0.0146133643593181,0.0809873429663069
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPA33,Cell surface A33 antigen,39784,-0.0220748089755747,0.0126544853731934,-0.0468776003070338,0.00272798235588448,0.0811041873038943
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,37449,0.00313887991368058,0.00179954859615691,-0.000388235334786964,0.00666599516214812,0.0811364424254113
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF10,Multiple epidermal growth factor-like domains protein 10,39858,0.00671304302099548,0.00386975462593993,-0.000871676045846778,0.0142977620878377,0.0828049883968666
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRM1,Muscarinic acetylcholine receptor M1,37035,-0.00618012805375101,0.00356549972562801,-0.0131685075159819,0.000808251408479887,0.0830633966114119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACRV1,Acrosomal protein SP-10,37052,0.0122373515156751,0.00706529424483945,-0.00161062520421017,0.0260853282355605,0.0832903380126599
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAPRE3,Microtubule-associated protein RP/EB family member 3,36958,0.0240905597284991,0.0139324404217794,-0.00321702349818865,0.0513981429551868,0.0838150571215013
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEND1,Cell cycle exit and neuronal differentiation protein 1,36987,0.00983709325710353,0.0057006243133037,-0.00133613039697172,0.0210103169111788,0.0844399029625576
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,37408,0.0193006363077049,0.0111887598074209,-0.00262933291484013,0.0412306055302498,0.0845498655904437
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIAA2013,Uncharacterized protein KIAA2013,37364,0.00953429191350901,0.00554966888472263,-0.00134305910054735,0.0204116429275654,0.0858208286638278
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRXN3,Neurexin-3,37035,0.0058485384309401,0.00340545614693115,-0.000826155617044954,0.0125232324789251,0.0859291805136796
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1QL2,Complement C1q-like protein 2,37052,0.00696825928081476,0.00406395638853556,-0.000997095240714937,0.0149336138023445,0.0864330624715677
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,39243,0.0101592265224394,0.00592980973884585,-0.00146320056569845,0.0217816536105773,0.0866873262323901
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C8B,Complement component C8 beta chain,37449,0.00499757159544343,0.00292902785207948,-0.000743322994632355,0.0107384661855192,0.0879896141928389
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSBPL2,Oxysterol-binding protein-related protein 2,37384,0.00635411721339964,0.00372447961802603,-0.000945862837931382,0.0136540972647307,0.0880232926533049
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX101,Testis-expressed protein 101,37035,0.00803415291794303,0.00472082592019937,-0.00121866588564774,0.0172869717215338,0.0888064747962754
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLB1,"Phospholipase B1, membrane-associated",37384,-0.00985204110570829,0.00579275123968757,-0.0212058335354959,0.00150175132407934,0.0890123015312795
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC8,Histone deacetylase 8,37052,0.0104061405233834,0.00611861652575929,-0.00158634786710479,0.0223986289138716,0.0890164743519197
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHEK2,Serine/threonine-protein kinase Chk2,39581,0.00546460449122693,0.00323097739446784,-0.000868111201930027,0.0117973201843839,0.0907962431435481
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGR,Progesterone receptor,37052,0.0170825979244868,0.0101706937353756,-0.00285196179684941,0.0370171576458229,0.0930607476101921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC5A,C-type lectin domain family 5 member A,39814,-0.00458526649217605,0.00273756878186295,-0.00995090130462744,0.000780368320275331,0.0939653852000201
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYH4,Myosin-4,37017,-0.00773630861109832,0.00462212936926962,-0.0167956821748668,0.00132306495267013,0.0942026801063582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA12,Carbonic anhydrase 12,39784,-0.0051271100147088,0.00307030295446123,-0.0111449038054528,0.000890683776035201,0.0949580887187142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53BP1,TP53-binding protein 1,37052,0.0141607716622714,0.00851705899034337,-0.00253266395880162,0.0308542072833444,0.0964090116608011
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGM2,Protein-glutamine gamma-glutamyltransferase 2,39831,0.0116731345449447,0.00702530354021308,-0.00209646039387295,0.0254427294837623,0.0966157661952725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SIGLEC15,Sialic acid-binding Ig-like lectin 15,39485,0.0126905629120602,0.00765524938266628,-0.00231372587796574,0.0276948517020861,0.0973860794401616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKR1B10,Aldo-keto reductase family 1 member B10,37035,0.00978414238764583,0.00590931781420247,-0.00179812052819101,0.0213664053034827,0.0978034924981271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACHE,Acetylcholinesterase,37120,-0.00521297676707359,0.00316331888215265,-0.0114130817760928,0.000987128241945599,0.0993875704161059
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTNNA1,Catenin alpha-1,36987,-0.00558904127100546,0.00340997735973389,-0.0122725968960839,0.00109451435407296,0.101231825865565
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UNG,Uracil-DNA glycosylase,37364,0.00549401220207822,0.0033583692048378,-0.00108839143940386,0.0120764158435603,0.101880331066235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASA1,Ras GTPase-activating protein 1,39485,0.00514062588090782,0.00314386285928511,-0.00102134532329099,0.0113025970851066,0.102041848173218
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC34A3,Sodium-dependent phosphate transport protein 2C,36958,-0.0076785544640847,0.00469785478813668,-0.0168863498488326,0.00152924092066319,0.102181920982284
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",37052,0.00559960887431367,0.00342934818413108,-0.00112191356658325,0.0123211313152106,0.102524555285401
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLC,Galectin-10,39837,0.0104723406494958,0.00643014426299551,-0.00213074210597536,0.023075423404967,0.103410597921165
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ENOPH1,Enolase-phosphatase E1,37364,0.00879661831025955,0.00540301904573098,-0.00179329901937316,0.0193865356398923,0.10352846336511
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MB,Myoglobin,40048,0.00812019882695149,0.00499162565757806,-0.0016633874619015,0.0179037851158045,0.103806612468773
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,37433,0.0211298707045948,0.0129912614180954,-0.00433300167487208,0.0465927430840618,0.103873353837509
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXTL1,Exostosin-like 1,37017,0.00751107306690564,0.00461838821152469,-0.00154096782768276,0.016563113961494,0.103901130404189
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD1,Leiomodin-1,37408,-0.0055388322504561,0.00340755035034062,-0.0122176309371237,0.00113996643621151,0.104088123685544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3D,T-cell surface glycoprotein CD3 delta chain,36987,-0.00543024232215799,0.00335355003056463,-0.0120032003820647,0.00114271573774868,0.105417093579453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RRP15,RRP15-like protein,36987,0.0141486160622799,0.00877563903658535,-0.0030516364494274,0.0313488685739872,0.106929307342821
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPN1,Epsin-1,37165,0.00672566703159343,0.0041716832666275,-0.00145083217099646,0.0149021662341833,0.106938009727629
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CADPS,Calcium-dependent secretion activator 1,37035,-0.00676653757907076,0.00420774941446815,-0.0150137264314283,0.00148065127328682,0.107834339258788
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL20RB,Interleukin-20 receptor subunit beta,37052,-0.00669539565182004,0.0041823550785181,-0.0148928116057155,0.00150202030207543,0.109430249281484
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOS1,"Nitric oxide synthase, brain",39485,0.00829879144097797,0.00519742960028691,-0.00188817057558438,0.0184857534575403,0.110350432510356
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH6,Cadherin-6,39864,-0.00586088695134279,0.00367180584402729,-0.0130576264056363,0.0013358525029507,0.110466903086218
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRR1B,Cornifin-B,37165,0.0135220944297533,0.00849225624675933,-0.00312272781389502,0.0301669166734016,0.111344379490526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXNL1,Thioredoxin-like protein 1,36967,0.015110899542453,0.0094950763044303,-0.00349945001423033,0.0337212490991364,0.111533394170341
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCN1,Transcobalamin-1,37231,0.00525994961577141,0.00331117032915851,-0.00122994422937928,0.0117498434609221,0.112186350990809
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPTL4,Angiopoietin-related protein 4,39904,0.00689578487244103,0.00436247792140538,-0.00165467185351351,0.0154462415983956,0.11396552073971
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,39210,-0.00574274459348874,0.00363729479395834,-0.0128718423896471,0.00138635320266962,0.114390964501058
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",37035,-0.00738706050980701,0.00468808360738747,-0.0165757043802864,0.00180158336067243,0.115116647491538
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSTM2B,V-set and transmembrane domain-containing protein 2B,37165,0.00633033845760979,0.00402045855611011,-0.00154976031236603,0.0142104372275856,0.115388411892695
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBP2,Retinol-binding protein 2,39784,-0.0115905626114848,0.00736389896856455,-0.0260238045898714,0.00284267936690167,0.115514045753115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1R1,Interleukin-1 receptor type 1,39822,0.00340210062804576,0.00216675274133,-0.000844734744961043,0.00764893600105255,0.116402851138784
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP350,Centrosome-associated protein 350,36958,-0.0054890166223196,0.00350246478791164,-0.0123538476066264,0.00137581436198722,0.117095189367984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RUVBL1,RuvB-like 1,39473,0.015330555772544,0.0097906730983784,-0.00385916350027765,0.0345202750453657,0.117408062698453
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF830,Zinc finger protein 830,37364,-0.0121805846067934,0.00780311329796042,-0.0274746866707958,0.00311351745720899,0.118549459536851
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD177,CD177 antigen,39840,0.0187555678262421,0.0120274120798111,-0.00481815985018754,0.0423292955026718,0.118921117663981
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITM2A,Integral membrane protein 2A,39862,-0.0088460039335054,0.00569339363041323,-0.0200050554491153,0.00231304758210452,0.120268297829053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FHIP2A,FHF complex subunit HOOK interacting protein 2A,37017,0.00693167333662081,0.00448011049103316,-0.00184934322580419,0.0157126898990458,0.121836581601292
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,37378,-0.0105024726271121,0.006816075998458,-0.0238619815840898,0.0028570363298656,0.123379492374045
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP4,Microfibril-associated glycoprotein 4,37120,-0.00473930679484954,0.00308127715275473,-0.0107786100142488,0.00129999642454973,0.124048470402496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF12,Fibroblast growth factor 12,37052,0.00697471745414182,0.00453744641394405,-0.00191867751718852,0.0158681124254722,0.12428155162141
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NFKB2,Nuclear factor NF-kappa-B p100 subunit,37165,0.00864552910310251,0.00565457171136174,-0.00243743145116649,0.0197284896573715,0.126301853628771
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",37052,0.00411165744078724,0.00268970880218962,-0.00116017181150441,0.00938348669307889,0.126372066831661
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EIF5A,Eukaryotic translation initiation factor 5A-1,39583,0.00444145820315567,0.00290652326227473,-0.0012553273909028,0.0101382437972141,0.126507826920955
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTHRC1,Collagen triple helix repeat-containing protein 1,37433,0.00396729125994535,0.00259682386889251,-0.00112248352308397,0.00905706604297468,0.126598535401969
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,37035,-0.00762686095352079,0.00501236764001025,-0.0174511015279409,0.00219737962089929,0.128131217859188
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,C1GALT1C1,C1GALT1-specific chaperone 1,37017,0.00479117464251468,0.00316429203544368,-0.00141083774695494,0.0109931870319843,0.13001487716603
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMP,Cartilage oligomeric matrix protein,39725,-0.00486656277782676,0.00322433469589762,-0.0111862587817861,0.00145313322613258,0.131236153136591
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC50,Coiled-coil domain-containing protein 50,37408,0.011270321873682,0.0074758538317006,-0.00338235163645118,0.0259229953838152,0.131689682442256
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PEPD,Xaa-Pro dipeptidase,37441,0.00372454363872278,0.00248403547374891,-0.00114416588982508,0.00859325316727064,0.133795136470624
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN2A,Sodium channel protein type 2 subunit alpha,36987,0.00706097081817864,0.00471193389998454,-0.00217441962579105,0.0162963612621483,0.134019842498267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2BP,LRP2-binding protein,37035,0.0115908184284932,0.00774247587969786,-0.00358443429571463,0.026766071152701,0.134406054705707
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LBP,Lipopolysaccharide-binding protein,39927,0.00834494884374908,0.00557852771091575,-0.00258896546964579,0.019278863157144,0.134697991353641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN7,Septin-7,37165,0.00742516715473697,0.00497134542970536,-0.00231866988748553,0.0171690041969595,0.135305721084287
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MED21,Mediator of RNA polymerase II transcription subunit 21,37017,0.00708142492208994,0.00475010941199721,-0.0022287895254246,0.0163916393696045,0.136040096070789
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRND,Prion-like protein doppel,37384,0.00730966814758851,0.00491504867329169,-0.00232382725206319,0.0169431635472402,0.136984892431625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,REXO2,"Oligoribonuclease, mitochondrial",37017,-0.00686543546460296,0.00462103044298766,-0.0159226551328588,0.00219178420365286,0.137384137423372
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB6B,Ras-related protein Rab-6B,39485,0.0067226266500825,0.00452861763913388,-0.0021534639226199,0.0155987172227849,0.137702714325142
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSAPL1,Proactivator polypeptide-like 1,37378,0.00713115894161144,0.00481513883994881,-0.00230651318468823,0.0165688310679111,0.138633293703524
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUOX2,Dual oxidase 2,39581,0.0101710744787345,0.00687748162052691,-0.00330878949749821,0.0236509384549673,0.139188365043255
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYOC,Myocilin,39854,-0.00654463773527265,0.00442887247283881,-0.0152252277820367,0.00213595231149142,0.139502169296699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK4,Kallikrein-4,40026,-0.00856016921547737,0.00579653207133164,-0.0199213720752874,0.00280103364433264,0.139755644052349
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL1A,Interleukin-1 alpha,39583,0.00759644870652114,0.00514972622347247,-0.0024970146914849,0.0176899121045272,0.140201113594672
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMC3,Structural maintenance of chromosomes protein 3,36958,0.00752220750131836,0.0051189304864413,-0.00251089625210659,0.0175553112547433,0.141724461323418
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPD1,Sphingomyelin phosphodiesterase,39908,0.00693755989528814,0.00472274769752167,-0.00231902559185434,0.0161941453824306,0.141861377169809
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ABO,Histo-blood group ABO system transferase,37441,0.0202939766475766,0.0138664598646881,-0.00688428468721218,0.0474722379823654,0.143345620449785
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ACSL1,Long-chain-fatty-acid--CoA ligase 1,37017,-0.00517345622647949,0.00353504672515867,-0.0121021478077905,0.0017552353548315,0.143361050699653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HGFAC,Hepatocyte growth factor activator,37314,-0.0040069040331452,0.00273923031097,-0.00937579544264641,0.00136198737635601,0.143549675616657
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAMTSL5,ADAMTS-like protein 5,37433,-0.00553667939848242,0.00378636654487767,-0.0129579578264427,0.00188459902947782,0.14369117056109
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SBSN,Suprabasin,37416,-0.00476317538093779,0.00328025584586686,-0.0111924768388368,0.00166612607696126,0.146504075892843
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A14,Protein S100-A14,37408,0.00716296676316768,0.00494266091864002,-0.00252464863736675,0.0168505821637021,0.147301349348423
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TUBB3,Tubulin beta-3 chain,36987,-0.00395811464237115,0.00273269884621164,-0.00931420438094596,0.00139797509620366,0.147521567931073
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPHA10,Ephrin type-A receptor 10,39485,0.00891977505483772,0.00617687759543733,-0.00318690503221944,0.0210264551418949,0.148742458595973
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,36987,-0.00851010245621484,0.00594506299043651,-0.0201624259174704,0.00314222100504071,0.15232306880777
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP1,Prolow-density lipoprotein receptor-related protein 1,39784,-0.00364978069659559,0.00255325168055436,-0.00865415399048215,0.00135459259729096,0.15289060680505
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB7,Integrin beta-7,40026,-0.00618808715831273,0.00438252073311121,-0.0147778277952107,0.00240165347858524,0.157971366918152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC1,"Myosin-binding protein C, slow-type",37433,-0.00930090516957766,0.00659360089425484,-0.0222243629223171,0.00362255258316184,0.158386773036148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SUSD5,Sushi domain-containing protein 5,37060,0.00462402018266657,0.00327953964669318,-0.00180387752485206,0.0110519178901852,0.158575013912078
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF3,Fibroblast growth factor 3,37052,0.00419625566773813,0.00298052046226025,-0.00164556443829195,0.0100380757737682,0.159186143641336
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMD5,26S proteasome non-ATPase regulatory subunit 5,37035,0.007553888371016,0.00537859408694743,-0.00298815603940097,0.018095932781433,0.160212785329832
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,37408,0.00497100467429935,0.00355819226220467,-0.0020030521596218,0.0119450615082205,0.1624186978741
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ID4,DNA-binding protein inhibitor ID-4,37165,-0.00597662813156179,0.00428857753704865,-0.0143822401041771,0.00242898384105355,0.163457022382379
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,37364,0.00825455125667188,0.00592765026128632,-0.00336364325544931,0.0198727457687931,0.163778743148179
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC14A,C-type lectin domain family 14 member A,39854,0.00404383544571739,0.00291313171294672,-0.00166590271165817,0.00975357360309296,0.165113670394547
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EXOSC10,Exosome component 10,37017,0.00816055109909425,0.0058967830936713,-0.00339714376450149,0.01971824596269,0.166412916759533
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COMMD9,COMM domain-containing protein 9,37364,-0.00524099194542778,0.00380056990602048,-0.0126901089612279,0.00220812507037236,0.167917102741449
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYTH3,Cytohesin-3,36958,0.00957797685665522,0.0069971351664465,-0.00413640806957991,0.0232923617828904,0.171071948366659
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAG3,Lymphocyte activation gene 3 protein,39784,0.00535509686475509,0.00391571879040799,-0.00231971196444456,0.0130299056939547,0.171459828729029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,37017,0.00616926696340967,0.00451707779523839,-0.00268420551525757,0.0150227394420769,0.172036066867664
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRB3,Adhesion G protein-coupled receptor B3,39716,0.00433074093194749,0.00318326472854362,-0.00190845793599799,0.010569939799893,0.173700105575653
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,37017,-0.00439762182340293,0.00323614707560221,-0.0107404700915833,0.0019452264447774,0.174199461280626
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTF3,Neurotrophin-3,39862,0.0043775530687571,0.00324283599442866,-0.00197840548032308,0.0107335116178373,0.177062332262769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GKN1,Gastrokine-1,39119,0.00364917810266744,0.00270725005070604,-0.0016570319967164,0.00895538820205129,0.177701556621493
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSLP,Thymic stromal lymphopoietin,39581,0.00779594858634397,0.00579327540446951,-0.00355887120641627,0.0191507683791042,0.178422152948383
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSCA,Prostate stem cell antigen,37378,0.033026931803232,0.0245674351516034,-0.0151252410939106,0.0811791047003747,0.178861734883281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TG,Thyroglobulin,37364,0.0140758271976961,0.0105212439717751,-0.00654581098698308,0.0346974653823753,0.180968458069233
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRX,Cone-rod homeobox protein,39581,0.0139244801022809,0.0104297536166256,-0.00651783698630526,0.0343667971908671,0.181871860828544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF6,Fibroblast growth factor 6,37052,0.00528742198873268,0.00396839789321625,-0.00249063788197118,0.0130654818594365,0.182757702867787
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK1,Kallikrein-1,39716,-0.0161296280381742,0.0121068493842604,-0.0398590528313246,0.00759979675497612,0.182789657007257
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDHR1,Cadherin-related family member 1,39485,0.0054577525088717,0.00411190563406633,-0.00260158253389831,0.0135170875516417,0.184427235813897
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THBS2,Thrombospondin-2,39854,0.00460148965820221,0.00347355579065946,-0.00220667969149034,0.0114096590078948,0.185282884474292
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G1B,Phospholipase A2,40027,0.00520828914417059,0.00393270205209766,-0.00249980687794082,0.012916385166282,0.185404272049834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TGFBR3,Transforming growth factor beta receptor type 3,40048,-0.00402328982918182,0.0030429140596982,-0.0099874013861903,0.00194082172782666,0.186125837309622
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MBL2,Mannose-binding protein C,37253,-0.0137290565308862,0.0103842636254107,-0.0340822132366912,0.00662410017491874,0.18615674051878
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STC2,Stanniocalcin-2,39827,0.00337120900702485,0.00255067395682899,-0.00162811194835998,0.00837052996240968,0.186289193900621
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPB41L5,Band 4.1-like protein 5,37035,0.00823095624212096,0.00623528279866401,-0.0039901980432605,0.0204521105275024,0.18683744746741
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,36987,-0.00845090128525327,0.00640750544326952,-0.0210096119540615,0.004107809383555,0.187223343082366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,36987,0.00731749746125179,0.00560126729908878,-0.00366098644496222,0.0182959813674658,0.191439341427345
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SAT1,Diamine acetyltransferase 1,37017,-0.00627023370127675,0.00480519853413756,-0.0156884228281864,0.00314795542563287,0.191954674502681
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MN1,Transcriptional activator MN1,37035,-0.00749354900913769,0.00574622020720152,-0.0187561406152527,0.00376904259697729,0.192228012376742
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IKZF2,Zinc finger protein Helios,39473,0.0118022449513429,0.00906588504935217,-0.00596688974538733,0.0295713796480732,0.192993568472053
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DENND2B,DENN domain-containing protein 2B,37017,-0.00646745970604982,0.00498769014794894,-0.0162433323960298,0.0033084129839301,0.194762560306029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINT3,Kunitz-type protease inhibitor 3,37378,0.0182522701779828,0.0141077341537662,-0.00939888876339883,0.0459034291193645,0.195764363033845
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LEG1,Protein LEG1 homolog,36699,-0.00875744054981913,0.00677893202421449,-0.0220441473172795,0.00452926621764126,0.196428404319017
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRME1,Break repair meiotic recombinase recruitment factor 1,36987,-0.0051051009227981,0.00395251071783286,-0.0128520219297505,0.00264182008415432,0.196515106798596
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ART5,Ecto-ADP-ribosyltransferase 5,36987,-0.00772062059881275,0.0059802376191759,-0.0194418863323975,0.00400064513477201,0.19671865238047
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHLHE40,Class E basic helix-loop-helix protein 40,36987,-0.00888833584771356,0.00692908519970217,-0.0224693428391298,0.00469267114370269,0.199599704898846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,37364,-0.00952307036371964,0.0074255761932376,-0.0240771997024653,0.00503105897502605,0.199700229354511
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLAU,Urokinase-type plasminogen activator,39854,0.00352646078154969,0.0027574356892028,-0.0018781131692878,0.00893103473238718,0.20095385762422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17F,Interleukin-17F,39583,0.00954405012729931,0.00746513774611142,-0.00508761985507907,0.0241757201096777,0.201098120735238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIF20B,Kinesin-like protein KIF20B,36987,0.00931204237446784,0.00729088444895825,-0.00497809114549034,0.023602175894426,0.201548197188992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLNS1A,Methylosome subunit pICln,37035,0.00417550851710342,0.0032697622025503,-0.00223322539989517,0.010584242434102,0.201622357040941
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,39910,-0.00369779457615005,0.00289588246120485,-0.00937372420011157,0.00197813504781146,0.201650874376057
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCL1B,T-cell leukemia/lymphoma protein 1B,39581,0.00963442135566274,0.00756558367089265,-0.00519412263928685,0.0244629653506123,0.20287588129844
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TLR2,Toll-like receptor 2,37165,0.00278535661530258,0.00219858541783725,-0.00152387080365843,0.00709458403426358,0.205218307700791
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RANGAP1,Ran GTPase-activating protein 1,39473,0.0060207152081733,0.00477319908819471,-0.00333475500468832,0.0153761854210349,0.207198561279115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HEBP1,Heme-binding protein 1,39581,0.00653254282617276,0.00518257612481029,-0.00362530637845541,0.0166903920308009,0.207514321083396
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STOML2,"Stomatin-like protein 2, mitochondrial",36958,0.0112653771895066,0.008971092732121,-0.00631796456545056,0.0288487189444638,0.209231956058443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JCHAIN,Immunoglobulin J chain,39583,0.00732682480962226,0.00583916976538402,-0.00411794793053043,0.0187715975497749,0.209580309792712
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAM,Basal cell adhesion molecule,39854,0.00284697331377829,0.00226975889121508,-0.00160175411300326,0.00729570074055984,0.209748955407921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK1,SLIT and NTRK-like protein 1,37052,0.00387297211185552,0.00309289250799427,-0.00218909720381326,0.00993504142752429,0.210513057598005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP53INP1,Tumor protein p53-inducible nuclear protein 1,39581,0.00383877569594498,0.0030701374846684,-0.00217869377400509,0.00985624516589504,0.211186847605362
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPT1,Translationally-controlled tumor protein,39583,0.00782236036678596,0.00629205796329358,-0.00451007324126945,0.0201547939748414,0.213808352904129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",36987,-0.00559421500379086,0.00450098796244337,-0.0144161514101799,0.00322772140259815,0.213932038412919
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,37433,-0.00306324830115784,0.00246531043264908,-0.00789525674915003,0.00176876014683436,0.214058636995977
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNNI3,"Troponin I, cardiac muscle",39581,0.0100750436940101,0.00811774909543134,-0.00583574453303528,0.0259858319210556,0.214582537524178
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRHR1,Corticotropin-releasing factor receptor 1,39581,0.00741930805664419,0.00598562312646577,-0.00431251327122872,0.0191511293845171,0.21517096537209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDKL5,Cyclin-dependent kinase-like 5,36987,-0.00632953385707674,0.00511531098370017,-0.0163555433851291,0.0036964756709756,0.215971774905332
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,37017,0.00618816909870614,0.00501393033864397,-0.00363913436503605,0.0160154725624483,0.217152194202115
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NTRK2,BDNF/NT-3 growth factors receptor,39864,0.00303239948094692,0.00246616371491247,-0.00180128140028152,0.00786608036217535,0.218864310815447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX39A,ATP-dependent RNA helicase DDX39A,37052,0.00267221629722998,0.00218148591234158,-0.00160349609095952,0.00694792868541947,0.220615045412262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NRN1,Neuritin,37408,-0.00417209664639757,0.00340605497201158,-0.0108479643915403,0.00250377109874513,0.220631993752642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPA,Apolipoprotein(a),37182,0.0207122782763003,0.0169819448469877,-0.0125723336237956,0.0539968901763962,0.222613609392219
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTLA4,Cytotoxic T-lymphocyte protein 4,37433,-0.00348451826090388,0.00285973809089371,-0.00908960491905555,0.00212056839724778,0.223064844923855
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE5,Adhesion G protein-coupled receptor E5,39958,0.0034882054266827,0.00286350309342487,-0.00212426063643004,0.00910067148979545,0.223180963790947
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRF,Receptor-type tyrosine-protein phosphatase F,40048,0.00334387332374401,0.00275417672591084,-0.00205431305904123,0.00874205970652926,0.224723458625136
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRL,Prolactin,40005,-0.00883034372652862,0.00729978218125099,-0.0231379168017806,0.00547722934872333,0.226422405172443
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AMIGO1,Amphoterin-induced protein 1,37035,0.00584241341832569,0.00484892709741958,-0.00366148369261668,0.0153463105292681,0.228268235952863
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CAPN3,Calpain-3,37364,-0.00439020728819943,0.00364509952050395,-0.0115346023483872,0.00275418777198831,0.22845088251175
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,39745,-0.00326067775437964,0.00271200714271233,-0.00857621175409581,0.00205485624533653,0.229260730746276
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,39473,-0.00404310559547388,0.00336326525100978,-0.0106351054874531,0.0025488942965053,0.229328685613149
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNH2,Potassium voltage-gated channel subfamily H member 2,37035,0.00908543881266805,0.00756621880990728,-0.00574435005475022,0.0239152276800863,0.229854314799805
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCAR2,Cell cycle and apoptosis regulator protein 2,37384,0.00663403613503882,0.00556160474539383,-0.00426670916593309,0.0175347814360107,0.23295779046824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PTPRS,Receptor-type tyrosine-protein phosphatase S,40048,0.00280293918427544,0.00235123076672992,-0.00180547311851521,0.0074113514870661,0.233233344753324
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINB5,Serpin B5,39581,0.00559320268475202,0.00469243604356953,-0.00360397196064425,0.0147903773301483,0.233294369336587
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",37052,0.00579544415024595,0.00487587284811478,-0.00376126663205903,0.0153521549325509,0.234619982844146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",37135,-0.00740309977609271,0.00624723333270124,-0.0196476771081871,0.00484147755600172,0.236030541985422
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP152,Centrosomal protein of 152 kDa,36958,0.0047756204113559,0.0040375625534238,-0.00313800219335474,0.0126892430160665,0.236910731960875
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RELB,Transcription factor RelB,37052,0.00561615166051303,0.00476293742182044,-0.00371920568625503,0.0149515090072811,0.238365234137282
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL17C,Interleukin-17C,39583,0.00754347114659613,0.00640662786491595,-0.00501351946863913,0.0201004617618314,0.239034564740279
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MET,Hepatocyte growth factor receptor,39875,0.00220479014081847,0.00187852856418156,-0.00147712584497739,0.00588670612661433,0.24054094776542
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ESPL1,Separin,36958,-0.00610299548342988,0.00520678709834714,-0.0163082981961903,0.00410230722933052,0.241168951943761
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL5,Interleukin-5,39583,0.0162987006107595,0.0139156213062954,-0.0109759171495796,0.0435733183710986,0.241515210188736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLAMF7,SLAM family member 7,39862,0.00650301209013123,0.0055588012391274,-0.00439223833855847,0.0173982625188209,0.24207525288699
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX53,Probable ATP-dependent RNA helicase DDX53,37035,0.00398872653734513,0.00341689672741169,-0.00270839104838179,0.010685844123072,0.243088746132823
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PXDNL,Peroxidasin-like protein,37364,0.00670948972029732,0.0057627108028932,-0.00458542345337334,0.018004402893968,0.244325448416029
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",37017,-0.00722237358357565,0.00625013429426873,-0.0194726368003424,0.00502788963319106,0.247884230595861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",39805,-0.00728176602360868,0.00632782597430487,-0.0196843049332462,0.00512077288602886,0.249851037624733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC123,Cell division cycle protein 123 homolog,36958,-0.00706290075568965,0.00615726330265994,-0.0191311368289031,0.00500533531752384,0.251367688298992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLITRK6,SLIT and NTRK-like protein 6,39581,-0.00367331213320291,0.00320520177938015,-0.009955507620788,0.00260888335438218,0.251793117173678
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNAJA1,DnaJ homolog subfamily A member 1,36958,-0.00509878808117756,0.00446961102386762,-0.0138592256879581,0.00366164952560297,0.253987444729456
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PNMA2,Paraneoplastic antigen Ma2,36987,-0.00479174989870769,0.00421595618062007,-0.013055024012723,0.00347152421530765,0.255736793018455
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP15,Matrix metalloproteinase-15,37433,0.00543421518016353,0.0047831143175469,-0.00394068888222839,0.0148091192425555,0.255924362982473
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MEGF11,Multiple epidermal growth factor-like domains protein 11,37017,0.00347090450110902,0.00306285555942557,-0.00253229239536509,0.00947410139758314,0.257140426047157
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EFNB2,Ephrin-B2,37035,0.00662060665183412,0.00584904473921971,-0.00484352103703651,0.0180847343407048,0.257691838336337
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,37017,-0.00219836389728399,0.00195109609121957,-0.00602251223607435,0.00162578444150636,0.259876033457915
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1B,5-hydroxytryptamine receptor 1B,36987,-0.00465595265458856,0.00415758216530892,-0.012804813698594,0.00349290838941693,0.262789538847063
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTLA,B- and T-lymphocyte attenuator,36958,0.00939850190666048,0.00839364812203188,-0.007053048412522,0.025850052225843,0.262855346456068
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GBP6,Guanylate-binding protein 6,37017,-0.00499743599157303,0.00446713248548989,-0.0137530156631332,0.00375814367998716,0.263283326559128
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WFDC12,WAP four-disulfide core domain protein 12,39986,0.00666905677075984,0.00599197568251174,-0.00507521556696317,0.0184133291084829,0.265725891670245
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUCY2C,Heat-stable enterotoxin receptor,37165,-0.00923341959237454,0.00829678516889908,-0.0254951185234167,0.00702827933866766,0.265775245918706
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASP4,Caspase-4,37165,0.0177366417736796,0.0159710832875761,-0.0135666814699696,0.0490399650173288,0.266783371409139
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN4,Prefoldin subunit 4,36958,0.0058241827863382,0.00526552080702494,-0.00449623799543068,0.0161446035681071,0.268704357505269
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL2,Interleukin-2,39583,-0.00332407375373468,0.00300543009753741,-0.00921471674490801,0.00256656923743865,0.268733639377571
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH22,Cadherin-22,37165,-0.00310202749486383,0.00280810582390051,-0.00860591490970883,0.00240185991998117,0.269323010459585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCARE,Photoreceptor cilium actin regulator,36987,-0.00912695900848673,0.00827931794118549,-0.0253544221732103,0.00710050415623683,0.270316476984101
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GPHA2,Glycoprotein hormone alpha-2,37378,0.00494835933398731,0.00450469544189626,-0.00388084373212936,0.013777562400104,0.272010491438458
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCL7A,B-cell CLL/lymphoma 7 protein family member A,36958,-0.00674209885610523,0.00616442917180789,-0.0188243800328487,0.00534018232063824,0.274102227552698
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PODXL,Podocalyxin,39784,0.00158009929506958,0.00144938703374443,-0.0012606992910695,0.00442089788120866,0.275648371071922
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CORO6,Coronin-6,36987,-0.00400511562318185,0.00367982713800166,-0.0112175768136651,0.0032073455673014,0.276439530239739
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHH,Sonic hedgehog protein,37052,-0.00458817863253169,0.00422571383827312,-0.012870577755547,0.00369422049048364,0.277597950837586
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TTN,Titin,37017,-0.00717109741307422,0.00661685867595412,-0.0201401404179443,0.00579794559179585,0.278490370161042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DEFB116,Beta-defensin 116,36987,-0.00811860837451413,0.00751388073899745,-0.0228458146229491,0.00660859787392087,0.279947715614055
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LPO,Lactoperoxidase,39340,-0.00621093027516915,0.00576155655974645,-0.0175035811322722,0.00508172058193388,0.281052699018071
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGN,Cingulin,37035,0.00402994659164096,0.00377344623873264,-0.00336600803627501,0.0114259012195569,0.285551315505772
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",37052,-0.00473283850031073,0.00444401297874559,-0.0134431039386521,0.00397742693803063,0.286899018458891
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD34,Hematopoietic progenitor cell antigen CD34,39941,-0.00245061159959498,0.00231476537314118,-0.0069875517309517,0.00208632853176174,0.289758332656736
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDSN,Corneodesmosin,39988,0.00430557743512711,0.00407357432307657,-0.00367862823810297,0.0122897831083572,0.290548775920958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLINT1,Clathrin interactor 1,36958,-0.00499811853014239,0.0047336659049352,-0.0142761037038154,0.0042798666435306,0.291048755322906
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MMP13,Collagenase 3,39485,-0.00325868792066438,0.00308968004558855,-0.00931446081001793,0.00279708496868917,0.291578508006001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,36987,-0.00328134334152681,0.00312740749109075,-0.00941106202406467,0.00284837534101106,0.294095477808159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HRAS,GTPase Hras,37157,0.00992857698238725,0.00946834548298688,-0.00862938016426704,0.0284865341290415,0.294377914917073
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TXK,Tyrosine-protein kinase TXK,37165,0.00751265676272213,0.00718883095566408,-0.00657745191037948,0.0216027654358237,0.296020841643871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCNA,Proliferating cell nuclear antigen,36958,0.00643558963196973,0.00618686727126185,-0.00569067021970349,0.018561849483643,0.298265418939854
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAGLN3,Transgelin-3,36958,-0.00599877743782207,0.00578368152010419,-0.0173347932172263,0.00533723834158215,0.299666400099899
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,37378,0.00295629661545588,0.00285549379976153,-0.00264047123207672,0.00855306446298847,0.300546714482883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM19,Probable RNA-binding protein 19,37017,-0.00473914845187752,0.00459898788316254,-0.0137531647028761,0.00427486779912106,0.302805370046883
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FZD10,Frizzled-10,37035,0.00597687355629148,0.00581517812719867,-0.00542087557301791,0.0173746226856009,0.304060076589471
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERCC1,DNA excision repair protein ERCC-1,36958,0.00326849000473538,0.00318256216851188,-0.0029693318455479,0.00950631185501867,0.304439627998498
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORC3,MORC family CW-type zinc finger protein 3,37384,0.0027534371186301,0.00270800960190014,-0.00255426170109418,0.00806113593835437,0.309278551557826
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PGLYRP4,Peptidoglycan recognition protein 4,37017,0.00613267046090871,0.00603980026171047,-0.0057053380520438,0.0179706789738612,0.309945124220899
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CASQ2,Calsequestrin-2,37017,0.00477746940041,0.00471731566445106,-0.00446846930191407,0.0140234081027341,0.311197406038937
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMMR,Hyaluronan mediated motility receptor,36938,0.0046096115254355,0.00459391984925614,-0.00439447137910654,0.0136136944299775,0.315678873446155
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPTP,Ceramide-1-phosphate transfer protein,37017,-0.00385071351274834,0.00384160031926603,-0.0113802501385097,0.00367882311301308,0.316182279105499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EGFR,Epidermal growth factor receptor,40048,0.00154665008243366,0.00154392318322312,-0.00147943935668365,0.00457273952155097,0.316471492066112
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CREB3,Cyclic AMP-responsive element-binding protein 3,36958,-0.00543982370639126,0.00543617708730442,-0.0160947307975079,0.00521508338472541,0.317004471920391
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KCNIP4,Kv channel-interacting protein 4,39485,0.00505071471632671,0.0050512688977612,-0.00484977232328525,0.0149512017559387,0.317379088815496
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPPP2,Tubulin polymerization-promoting protein family member 2,37165,0.00756514683294555,0.00758914847883184,-0.00730958418556485,0.0224398778514559,0.318861582897018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,36958,0.0080419717975557,0.00807862816151618,-0.00779213939901602,0.0238760829941274,0.319529738836665
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCAM1,Neural cell adhesion molecule 1,39927,-0.00284591428898148,0.00288666385545693,-0.00850377544567705,0.0028119468677141,0.324205126332926
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FH,"Fumarate hydratase, mitochondrial",36987,0.00788794496983164,0.00802977536074608,-0.00785041473723068,0.023626304676894,0.325951985215854
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EBI3_IL27,Interleukin-27,40007,0.00290417388805631,0.00296545102960544,-0.00290811012997036,0.00871645790608298,0.327428504473986
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEPTIN3,Neuronal-specific septin-3,37408,0.00718189368636596,0.007383562569608,-0.00728988895006572,0.0216536763227976,0.33072636429286
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,39927,0.00398927684760875,0.0041480466151977,-0.00414089451817873,0.0121194482133962,0.336202631539763
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNDP1,Beta-Ala-His dipeptidase,39927,-0.00421996005274228,0.00438824664731524,-0.0128209234814802,0.00438100337599559,0.33623961307958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCG3,Secretogranin-3,39881,0.00300613482391156,0.00312776213243429,-0.00312427895565964,0.00913654860348276,0.336509541024264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPP1,Osteopontin,40008,-0.0041435836716783,0.00433183158263708,-0.012633973573647,0.00434680623029038,0.338812232939361
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PMCH,Pro-MCH,37017,0.00766332552724134,0.00801749252632493,-0.00805095982435552,0.0233776108788382,0.339177855624744
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",37035,0.00713194163869418,0.00746558888925152,-0.0075006125842388,0.0217644958616272,0.339439162285012
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FAM171A2,Protein FAM171A2,37408,0.0144721815532382,0.0152001137972827,-0.0153200414894359,0.0442644045959124,0.341058143251487
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,37035,-0.00435581680922149,0.00458341947174178,-0.0133393189738354,0.00462768535539241,0.34195585026412
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAMDC2,MAM domain-containing protein 2,37433,0.00302263365274361,0.0031919093933021,-0.0032335087581285,0.00927877606361572,0.343672327044392
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100G,Protein S100-G,37408,-0.00411397941446392,0.00434646701692152,-0.0126330547676301,0.00440509593870225,0.343904828257167
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC44A4,Choline transporter-like protein 4,37035,0.00618545717418646,0.00658393539425527,-0.00671905619855387,0.0190899705469268,0.347503017247003
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTM4,Glutathione S-transferase Mu 4,37017,0.00650637729638687,0.0069279605108855,-0.00707242530494872,0.0200851798977225,0.347672222504876
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPRING1,SREBP regulating gene protein,36958,0.00543387082378885,0.0057947084426372,-0.00592375772378005,0.0167914993713577,0.348400572588612
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,37408,-0.00230407077135908,0.00248321840633964,-0.00717117884778476,0.00256303730506661,0.353498450679872
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MILR1,Allergin-1,39583,-0.00441912350948923,0.00477418949299252,-0.0137765349157546,0.0049382878967761,0.354653539401393
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,37441,0.0041796855718778,0.0045197293285946,-0.00467898391216762,0.0130383550559232,0.35510481203818
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIRREL1,Kin of IRRE-like protein 1,36987,0.00537871691157044,0.00584793749976955,-0.00608324058797788,0.0168406744111188,0.357713489900913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3B,Sodium channel subunit beta-3,36987,0.00394159052170837,0.00431800549163289,-0.0045217002418921,0.0124048812853088,0.361350479647731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PITHD1,PITH domain-containing protein 1,36927,0.0069367841574134,0.00765344151050741,-0.00806396120318112,0.0219375295180079,0.364761295515438
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SEZ6,Seizure protein 6 homolog,37035,-0.00272293947593728,0.00301881490713473,-0.00863981669392136,0.00319393774204679,0.367078912066546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NOTCH2,Neurogenic locus notch homolog protein 2,37433,0.0018934994701862,0.00210179629703402,-0.00222602127200048,0.00601302021237287,0.367659705502515
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCIN,Adseverin,36987,0.00638283029283033,0.00717704188961899,-0.0076841718108229,0.0204498323964835,0.373836687802119
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRTG,Protogenin,40026,-0.00213145618665096,0.00239840219523871,-0.00683232448931882,0.00256941211601691,0.37417841565205
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IMPG1,Interphotoreceptor matrix proteoglycan 1,36987,-0.00257921021156667,0.00291508127099814,-0.00829276950272303,0.00313434907958969,0.376290651788121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MELTF,Melanotransferrin,37433,0.00246648847347168,0.00280482871275896,-0.00303097580353587,0.00796395275047924,0.379215053244099
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARMCX2,Armadillo repeat-containing X-linked protein 2,36987,0.00534252311456351,0.00607634094632553,-0.00656710514023452,0.0172521513693615,0.379290724882856
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CALY,Neuron-specific vesicular protein calcyon,37017,-0.00320594406540612,0.00366416454306949,-0.0103877065698223,0.00397581843901007,0.381619563265633
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED4,Transmembrane emp24 domain-containing protein 4,37017,-0.00475697544519767,0.00544513676062122,-0.0154294434960153,0.00591549260561991,0.382341668749971
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL31,Interleukin-31,37052,-0.00484221425603013,0.00556326905535724,-0.0157462216045303,0.00606179309247006,0.38410309774913
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,36958,-0.00474879652194807,0.00545696628411998,-0.0154444504388232,0.00594685739492709,0.384192599277312
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRG1,Leucine-rich alpha-2-glycoprotein,37449,-0.00213368182993326,0.00245559859257411,-0.00694665507137852,0.002679291411512,0.384914454792761
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NXPE4,NXPE family member 4,37017,-0.00293019226099611,0.00338068213230514,-0.00955632924031419,0.00369594471832196,0.386097075062091
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP5F1D,"ATP synthase subunit delta, mitochondrial",37017,0.00423809246693895,0.00491467397032967,-0.00539466851490721,0.0138708534487851,0.388519240771638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF168,E3 ubiquitin-protein ligase RNF168,37052,0.00345789347058082,0.00401255257872018,-0.00440670958371074,0.0113224965248724,0.388830304389704
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,37017,0.00536115093223453,0.00623157729108824,-0.00685274055829842,0.0175750424227675,0.389628315721889
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRC,Chymotrypsin-C,39852,0.00508535757060745,0.00596166378407665,-0.00659950344618278,0.0167702185873977,0.393666650701578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LTO1,Protein LTO1 homolog,39583,0.00330730496494841,0.00389153780500547,-0.00432010913286231,0.0109347190627591,0.39540977386597
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLSTN1,Calsyntenin-1,39485,0.00410609376099529,0.00484876392019868,-0.00539748352259412,0.0136096710445847,0.397101128023151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,37017,-0.00543908893297935,0.00653421070752901,-0.0182461419197362,0.0073679640537775,0.40519727937979
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,39745,0.00561211217799164,0.00675407555465611,-0.00762587590913434,0.0188501002651176,0.406029998427891
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN7,Tetraspanin-7,36987,0.00751458933645356,0.00914824786012291,-0.0104159764693873,0.0254451551422945,0.411419778543484
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORN4,MORN repeat-containing protein 4,36958,0.0063291979114586,0.00771810852676844,-0.00879829480100754,0.0214566906239247,0.412205258277062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TBR1,T-box brain protein 1,37035,-0.00382743336315772,0.00468060455888802,-0.0130014182985782,0.0053465515722628,0.413530727843238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GSTP1,Glutathione S-transferase P,39389,0.00546037957071641,0.00668068217938135,-0.00763375750087103,0.0185545166423038,0.413747480085447
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THSD1,Thrombospondin type-1 domain-containing protein 1,36971,-0.0027286279410346,0.0033422887619485,-0.00927951391445365,0.00382225803238446,0.414289069562449
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEP164,Centrosomal protein of 164 kDa,39583,0.00473895250924879,0.00584027475747886,-0.00670798601540977,0.0161858910339073,0.417133186722879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK12,Kallikrein-12,39473,-0.0106421991111865,0.0132786746005484,-0.0366684013282614,0.0153840031058883,0.422883142512664
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLXDC1,Plexin domain-containing protein 1,39473,-0.00265207394972573,0.00331764843961599,-0.00915466489137307,0.0038505169919216,0.42408014351966
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCC,Netrin receptor DCC,37035,0.0017459753428751,0.0021958734976055,-0.00255793671243167,0.00604988739818187,0.426560036253777
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,37035,-0.00242452114489998,0.00308351337706104,-0.00846820736393963,0.00361916507413967,0.431714522263737
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PSMC3,26S proteasome regulatory subunit 6A,36958,-0.00224030661862826,0.00290049204310509,-0.00792527102311423,0.00344465778585771,0.439898315617861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGSF21,Immunoglobulin superfamily member 21,37039,0.00293526835952324,0.00381943303136742,-0.0045508203819569,0.0104213571010034,0.442198663091464
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IDS,Iduronate 2-sulfatase,40054,0.000665259495613272,0.00086723518029681,-0.00103452145776848,0.00236504044899502,0.443030922067663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHAD,Chondroadherin,37120,0.00373637449161284,0.00487667783039177,-0.00582191405595503,0.0132946630391807,0.443587545825938
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL3A1,Collagen alpha-1(III) chain,37433,0.00171397547329487,0.00224619126304708,-0.0026885594022774,0.00611651034886713,0.445441733520731
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL13RA2,Interleukin-13 receptor subunit alpha-2,36987,-0.00211032100921311,0.0027957664812896,-0.00759002331254073,0.00336938129411452,0.450366121685582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYL6B,Myosin light chain 6B,37035,0.00674801172800333,0.00897760878426671,-0.0108481014891594,0.0243441249451661,0.452275523117151
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA11,Carbonic anhydrase-related protein 11,39473,0.00226371914529162,0.00302467147962309,-0.00366463695476963,0.00819207524535288,0.454219229454751
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LXN,Latexin,39678,-0.00479912991600397,0.00644072802915848,-0.0174229568531546,0.00782469702114665,0.456208875626428
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAP1A,Ras-related protein Rap-1A,37052,0.00486609890527436,0.00658450282074873,-0.00803952662339315,0.0177717244339419,0.459906191122946
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,37017,-0.00337421972055059,0.00457642413149043,-0.0123440110182718,0.00559557157717065,0.460950129747271
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MORF4L1,Mortality factor 4-like protein 1,37165,-0.00287914704651338,0.00390781099137272,-0.0105384565896039,0.00478016249657714,0.461276910456874
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,36958,0.00186186137870016,0.00253963538410045,-0.00311582397413673,0.00683954673153704,0.463497429888638
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ALMS1,Alstrom syndrome protein 1,37165,0.00316542458784285,0.00433904922739444,-0.00533911189785024,0.0116699610735359,0.465696284051887
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,37165,0.00462138435757806,0.00634633045473195,-0.00781742333369656,0.0170601920488527,0.46650528120556
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MFAP3L,Microfibrillar-associated protein 3-like,37035,-0.0045499494587526,0.00625796463276053,-0.0168155601389632,0.00771566122145804,0.467198821348812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VTCN1,V-set domain-containing T-cell activation inhibitor 1,39473,-0.00225473093258998,0.0031161220767472,-0.00836233020301449,0.00385286833783453,0.469340904221324
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD164L2,CD164 sialomucin-like 2 protein,37035,0.00258646123979293,0.00357554767877723,-0.00442161221061044,0.00959453469019629,0.469462464929642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAGE2A,G antigen 2A,36958,0.00425550332488304,0.00590320893087813,-0.00731478617963809,0.0158257928294042,0.470996415876018
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPHS2,Podocin,37052,-0.00712163594625946,0.00988153737965269,-0.0264894492103787,0.0122461773178598,0.471106138201567
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TJP3,Tight junction protein ZO-3,36987,-0.00303034337335112,0.00421887180563851,-0.0112993321124026,0.00523864536570035,0.472595670038857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GLI2,Zinc finger protein GLI2,37052,-0.00237270828419398,0.00333118406715853,-0.00890182905582469,0.00415641248743674,0.476309114441267
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX1,ATP-dependent RNA helicase DDX1,37378,0.00343989259099943,0.00484019412730995,-0.00604688789852808,0.0129266730805269,0.477286694583733
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TCP11,T-complex protein 11 homolog,37165,-0.00409424134739533,0.00576934400570513,-0.0154021555985774,0.00721367290378673,0.477930805933387
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,37378,-0.00226517391714788,0.00319975354808065,-0.00853669087138595,0.0040063430370902,0.479006293046438
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL24,Interleukin-24,39583,0.00322208119326838,0.00455388542505151,-0.00570353423983258,0.0121476966263693,0.479238027480644
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TOP1MT,"DNA topoisomerase I, mitochondrial",36958,-0.00331944740285369,0.00472146923438654,-0.0125735271022513,0.00593463229654393,0.482034649741386
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DLGAP5,Disks large-associated protein 5,37408,-0.00355867970968348,0.00507583400195353,-0.0135073143535124,0.00638995493414544,0.483251116157014
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HTR1A,5-hydroxytryptamine receptor 1A,36987,0.00513168666380473,0.00736513227074165,-0.00930397258684891,0.0195673459144584,0.485968985936765
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,36958,-0.00291962543308649,0.00421083523969656,-0.0111728625028917,0.00533361163671878,0.488095846717159
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NPTN,Neuroplastin,39473,0.00560773597221084,0.00809436140215689,-0.0102572123760167,0.0214726843204383,0.488448292715849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNW1,Interferon omega-1,37017,0.00235098242428181,0.00342569317265423,-0.00436337619412048,0.0090653410426841,0.49254907267707
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BTNL10,Butyrophilin-like protein 10,36958,-0.00260975725493177,0.00382020216688881,-0.0100973535020338,0.0048778389921703,0.494526438224001
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP1B4,Protein ATP1B4,36958,-0.00274684165726572,0.0040531921620253,-0.0106910982948353,0.00519741498030387,0.497974940693956
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLEC2L,C-type lectin domain family 2 member L,37035,0.00335805517237598,0.00495774661486541,-0.00635912819276021,0.0130752385375122,0.498205338852431
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,INSL4,Early placenta insulin-like peptide,37364,0.00349811011368775,0.00517650641185011,-0.00664784245353847,0.013644062680914,0.499200418501345
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDDM3B,Epididymal secretory protein E3-beta,37364,0.0033542036012272,0.00498568153525868,-0.00641773220787981,0.0131261394103342,0.501106843779924
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OPTC,Opticin,39784,0.00281017704207496,0.00425176577894543,-0.00552328388465808,0.011143637968808,0.508658096550704
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MSLNL,Mesothelin-like protein,37035,-0.00231768339804447,0.00352315878508726,-0.0092230746168155,0.00458770782072657,0.510650868879005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARID3A,AT-rich interactive domain-containing protein 3A,36987,0.00253704912400148,0.003865346462123,-0.0050390299417596,0.0101131281897626,0.511605636561937
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SOX2,Transcription factor SOX-2,37388,0.00150337130662059,0.00229681799129736,-0.00299839195632224,0.00600513456956342,0.512771711896228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TET2,Methylcytosine dioxygenase TET2,37157,0.00626891940181593,0.0095800851328638,-0.0125080474585971,0.025045886262229,0.512884835861261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SCN3A,Sodium channel protein type 3 subunit alpha,37035,-0.00243024746998115,0.00372561979716711,-0.0097324622724287,0.00487196733246639,0.5142145951144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOC2B,Double C2-like domain-containing protein beta,37035,0.00229573152870335,0.00352850015300435,-0.00462012877118518,0.00921159182859188,0.515299729606712
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,37408,0.00149846332373444,0.00231065234568898,-0.00303041527381596,0.00602734192128483,0.516671125278028
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMPRSS11B,Transmembrane protease serine 11B,36987,0.00482891131867713,0.00745127830925154,-0.00977559416745588,0.0194334168048101,0.51695436293262
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CRYBB2,Beta-crystallin B2,37384,0.00355525925165219,0.00549527333690452,-0.00721547648868066,0.014325994991985,0.517664429200254
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,40005,0.00287008541254596,0.00447588044241344,-0.00590264025458438,0.0116428110796763,0.521379954598343
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FLT3,Receptor-type tyrosine-protein kinase FLT3,39473,-0.00187111106154021,0.00293746155916684,-0.00762853571750723,0.0038863135944268,0.524145703090558
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHPK,Sedoheptulokinase,37165,0.00252079848205999,0.00405517157714846,-0.00542733780915099,0.010468934773271,0.534198731434673
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,YY1,Transcriptional repressor protein YY1,37052,0.00165920036028799,0.00268859410990211,-0.00361044409512015,0.00692884481569614,0.537162508894381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DNLZ,DNL-type zinc finger protein,36987,-0.00529432305101892,0.00872038350646664,-0.0223862747236935,0.0117976286216557,0.543781488571526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MUCL3,Mucin-like protein 3,36958,-0.00261244244122207,0.00434398308099295,-0.0111266492799682,0.00590176439752411,0.547588449533038
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RBM25,RNA-binding protein 25,36958,-0.00264916148496206,0.00441927717516823,-0.0113109447482918,0.00601262177836768,0.548879322389374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MLLT1,Protein ENL,36958,0.00413690721511613,0.0069075796452151,-0.00940194888950547,0.0176757633197377,0.549254006329734
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KEL,Kell blood group glycoprotein,39485,-0.0020354198270305,0.00341660823654802,-0.00873197197066463,0.00466113231660362,0.551355676427232
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CLIC5,Chloride intracellular channel protein 5,37035,0.00185298562097653,0.00311326217619896,-0.00424900824437343,0.0079549794863265,0.551726029525319
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HK2,Hexokinase-2,39581,0.00155444492545405,0.00263735893970165,-0.00361477859636118,0.00672366844726929,0.555605116442977
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3RA,Interleukin-3 receptor subunit alpha,39583,0.0017424400919058,0.00295771974580179,-0.00405469060986571,0.00753957079367731,0.555791909727814
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,37035,0.00239170453505363,0.00406345950134491,-0.00557267608758239,0.0103560851576897,0.556147604994344
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HDAC9,Histone deacetylase 9,36987,0.00366495344327197,0.00623623049401979,-0.00855805832500682,0.0158879652115508,0.556752312334388
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT6C,"Keratin, type II cytoskeletal 6C",37017,0.00229060539980064,0.00389842526434087,-0.00535030811830746,0.00993151891790874,0.556829715491858
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KRT17,"Keratin, type I cytoskeletal 17",37017,-0.00221569518492857,0.00377242983641371,-0.00960965766429944,0.00517826729444231,0.55698612896146
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HCG22,Protein PBMUCL2,37017,-0.00305068007786538,0.00524177527623791,-0.0133245596192917,0.00722319946356093,0.560580910307929
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD200,OX-2 membrane glycoprotein,39862,0.00143113979519113,0.00247820621791812,-0.00342614439192838,0.00628842398231064,0.56361648439031
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARHGAP30,Rho GTPase-activating protein 30,37165,0.00219275977970554,0.00381114991050995,-0.00527709404489396,0.00966261360430504,0.565061737782479
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG2,Bone marrow proteoglycan,37433,-0.00280846143643627,0.00489838568362078,-0.012409297376333,0.00679237450346046,0.566421105070668
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CPLX2,Complexin-2,36958,0.00164925284955294,0.002902965850209,-0.0040405602168567,0.00733906591596258,0.569958574883214
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DOCK9,Dedicator of cytokinesis protein 9,36987,0.00640928954044777,0.0113116599742778,-0.0157615640091367,0.0285801430900322,0.570989474368863
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK8,Serine protease inhibitor Kazal-type 8,37017,0.0020422838744104,0.00360993845773611,-0.00503319550275238,0.00911776325157318,0.57158069720812
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CX3CL1,Fractalkine,39745,-0.00178496070533091,0.00319729073348969,-0.0080516505429707,0.00448172913230887,0.576665929441792
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GUK1,Guanylate kinase,37017,-0.00223043415344591,0.00400813775977289,-0.0100863841626008,0.00562551585570895,0.577894673536064
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDH4,Cadherin-4,36987,0.00252835409095918,0.00454426162900992,-0.00637839870190026,0.0114351068838186,0.577957914157289
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RNF4,E3 ubiquitin-protein ligase RNF4,37165,0.00352437874317933,0.00635704136410415,-0.0089354223304648,0.0159841798168235,0.579310676182772
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD3G,T-cell surface glycoprotein CD3 gamma chain,37052,0.00478709053309453,0.00880967745211184,-0.0124798772730447,0.0220540583392337,0.586870498643873
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD93,Complement component C1q receptor,39234,-0.00160360624489617,0.00296478408049108,-0.00741458304265868,0.00420737055286635,0.588594917583721
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDC25A,M-phase inducer phosphatase 1,36958,0.00218014649042477,0.00403282646112369,-0.00572419337337766,0.0100844863542272,0.588792423901171
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AKAP12,A-kinase anchor protein 12,37120,-0.00109477003383182,0.00204020620652904,-0.00509357419862873,0.00290403413096509,0.591554509728486
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGFR,Tumor necrosis factor receptor superfamily member 16,37433,-0.00153453634652529,0.00288148739782549,-0.00718225164626325,0.00411317895321267,0.594353783385351
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,36987,-0.00302310085713652,0.00570394149678157,-0.0142028261908284,0.00815662447655535,0.596119452776231
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED1,Transmembrane emp24 domain-containing protein 1,37165,-0.00277316318517246,0.00523351920900215,-0.0130308608348167,0.00748453446447175,0.596200527355577
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNGB3,Cyclic nucleotide-gated cation channel beta-3,36987,0.00281169050123919,0.00531081890802086,-0.00759751455848169,0.0132208955609601,0.59651828007766
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UHRF2,E3 ubiquitin-protein ligase UHRF2,37017,-0.00174612505511707,0.00334337728175634,-0.0082991445273595,0.00480689441712536,0.601495435531261
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,39473,-0.00600556241671152,0.0116010585383706,-0.028743637151918,0.0167325123184949,0.604693314339725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLK3,Prostate-specific antigen,37433,0.00393128742443696,0.00760254328361803,-0.0109696974114544,0.0188322722603283,0.605093651009209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSPG5,Chondroitin sulfate proteoglycan 5,36987,0.00243157764735555,0.00474717611856116,-0.00687288754502433,0.0117360428397354,0.608508746143738
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,37364,0.00220076400472337,0.00429840713567672,-0.00622411398120301,0.0106256419906497,0.608662711692845
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGFL4,Insulin growth factor-like family member 4,37052,0.00380834713593923,0.00743931389592821,-0.0107727081000801,0.0183894023719585,0.608714293082032
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF20,Fibroblast growth factor 20,37052,-0.00210704982784689,0.00416146983660199,-0.0102635307075868,0.00604943105189301,0.612638054200642
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANKRA2,Ankyrin repeat family A protein 2,36958,0.00266272168990817,0.00526042499481785,-0.00764771129993481,0.0129731546797512,0.612738844338578
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCDC28A,Coiled-coil domain-containing protein 28A,37035,0.00144683342503932,0.0028598584985085,-0.00415848923203735,0.00705215608211598,0.612927704085725
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL9,Interleukin-9,37165,-0.00279782784145072,0.00554527190542875,-0.0136665607760911,0.00807090509318963,0.613888244420546
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SERPINA11,Serpin A11,40048,-0.00197634445131509,0.00393826767341967,-0.00969534909121765,0.00574266018858747,0.615793293058565
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF9,Fibroblast growth factor 9,36927,0.00195661888515025,0.00392087118882031,-0.00572828864493757,0.00964152641523806,0.617769069651246
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,37433,0.00128701884515595,0.00258332219071667,-0.00377629264864872,0.00635033033896063,0.618349045940272
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATF4,Cyclic AMP-dependent transcription factor ATF-4,36958,-0.00158380360549494,0.00325081224365118,-0.00795539560305124,0.00478778839206137,0.626123040940625
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DIPK1C,Divergent protein kinase domain 1C,37035,0.00200060431591949,0.00415443695749871,-0.00614209212077798,0.010143300752617,0.630127630637949
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB1,Integrin beta-1,39858,-0.00100364758450993,0.00209281538738423,-0.00510556574378303,0.00309827057476317,0.631541060502366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL18RAP,Interleukin-18 receptor accessory protein,39635,0.00792666716721766,0.0165432820085504,-0.0244981655695412,0.0403514999039765,0.631840558775834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,36958,0.00266932283396113,0.00557393712819539,-0.00825559393730183,0.0135942396052241,0.632022316389087
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DAND5,DAN domain family member 5,37052,-0.00244125710091315,0.00519944826720082,-0.0126321757046268,0.00774966150280047,0.638704082749707
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPINK5,Serine protease inhibitor Kazal-type 5,39854,-0.00148038487781859,0.00320674533173893,-0.00776560572802689,0.00480483597238971,0.644340647266984
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARG2,"Arginase-2, mitochondrial",37364,0.00195082070592825,0.00424706146961468,-0.00637341977451653,0.010275061186373,0.646001564871075
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CD82,CD82 antigen,37165,-0.00187486374961276,0.00408306585069897,-0.00987767281698275,0.00612794531775723,0.646112136526646
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR5,Proline-rich protein 5,37052,-0.00210513508291727,0.00460995888918502,-0.0111406545057199,0.00693038433988537,0.647930565257296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,S100A3,Protein S100-A3,37364,0.00195794188311337,0.00437018620896414,-0.00660762308645636,0.0105235068526831,0.654144123908921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,36987,-0.00137140041228327,0.00314622708057528,-0.00753800549021082,0.00479520466564427,0.662925670967595
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,37039,-0.00171596948582985,0.00393718937707744,-0.00943286066490162,0.00600092169324192,0.662962747092942
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPSG1,Tryptase gamma,37052,0.00113469611126495,0.00260498458271185,-0.00397107367085027,0.00624046589338017,0.663143895601235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL9A1,Collagen alpha-1(IX) chain,39862,0.00182413297434403,0.00421135673603286,-0.00643012622828038,0.0100783921769684,0.664914432259972
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KDM3A,Lysine-specific demethylase 3A,37052,0.00389529679337285,0.00901686135404738,-0.01377775146056,0.0215683450473057,0.665747450966506
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAMT,Guanidinoacetate N-methyltransferase,37017,-0.00146841956410606,0.00356350063548612,-0.00845288080965886,0.00551604168144674,0.68029321389768
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP4,Zona pellucida sperm-binding protein 4,36958,0.0012755949237423,0.00311516649993721,-0.00483013141613462,0.00738132126361922,0.682194950769148
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL22,Interleukin-22,37364,0.00259539159136549,0.00633853194633328,-0.00982813102344775,0.0150189142061787,0.682206723039561
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,STEAP4,Metalloreductase STEAP4,36987,0.00298381800874637,0.0072965405262186,-0.0113174014226421,0.0172850374401348,0.6825933091442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PHLDB2,Pleckstrin homology-like domain family B member 2,36958,-0.00356797406974191,0.00884439739588597,-0.0209029929656784,0.0137670448261946,0.686648583053376
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRE2,Adhesion G protein-coupled receptor E2,39927,-0.00108802819926031,0.00270641119077679,-0.00639259413318281,0.00421653773466219,0.687675532590769
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CXCL14,C-X-C motif chemokine 14,39583,0.0023683241958989,0.00595960480872524,-0.00931250122920257,0.0140491496210004,0.691080725195794
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BSND,Barttin,36958,-0.00128120047023252,0.00326331779011497,-0.00767730333885787,0.00511490239839282,0.694616369576103
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRP2,Low-density lipoprotein receptor-related protein 2,37035,-0.00136096194077529,0.00347676804341529,-0.00817542730586926,0.00545350342431867,0.695474990175499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ARNT,Aryl hydrocarbon receptor nuclear translocator,39583,0.00140371498161913,0.00363851135843085,-0.00572776728090534,0.0085351972441436,0.69965463581879
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTN2,Contactin-2,40026,0.00164532948966512,0.00426901520064179,-0.0067219403035928,0.010012599282923,0.699937298411756
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZP3,Zona pellucida sperm-binding protein 3,37039,-0.0094321477413058,0.0249188886533731,-0.058273169501917,0.0394088740193054,0.705054906796491
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCUN1D1,DCN1-like protein 1,36987,0.0027367473954065,0.00727968427585075,-0.011531433785261,0.017004928576074,0.706965239952207
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC4A1,Band 3 anion transport protein,37433,-0.00169233294008868,0.00450557616234388,-0.0105232622182827,0.00713859633810533,0.707213801404442
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,37017,0.00131810524354324,0.00354820821287753,-0.00563638285369673,0.00827259334078321,0.710282493686637
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,37165,0.00257179543982935,0.00700975918578179,-0.011167332564303,0.0163109234439617,0.713708513248983
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3BL1,Uroplakin-3b-like protein 1,37145,0.00190383366474842,0.00525795030149538,-0.00840174892618253,0.0122094162556794,0.717293030991445
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,COL4A4,Collagen alpha-4(IV) chain,37143,-0.0018327000118211,0.0050755154247171,-0.0117807102442666,0.00811531022062441,0.718040540446121
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GIPR,Gastric inhibitory polypeptide receptor,37052,0.00158147209185106,0.00442435185749698,-0.00709025754884301,0.0102532017325451,0.720762780527616
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GJA8,Gap junction alpha-8 protein,36958,-0.00205214158654764,0.00578096891702227,-0.0133828406639113,0.009278557490816,0.722608574166143
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPESP1,Sperm equatorial segment protein 1,37433,0.000994430907062269,0.00281738762349421,-0.00452764883498639,0.00651651064911092,0.724122373643418
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMED10,Transmembrane emp24 domain-containing protein 10,37017,0.00171801520457925,0.00491478795842304,-0.00791496919392991,0.0113509996030884,0.726674235123749
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LMOD2,Leiomodin-2,36987,-0.00217609284749394,0.00622686795232589,-0.0143807540340527,0.0100285683390648,0.726743384458384
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,37165,0.00170556654559948,0.00493117793756654,-0.00795954221203095,0.0113706753032299,0.729442830798617
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LCN15,Lipocalin-15,37408,0.00206729144499537,0.00599759272163864,-0.00968799028941637,0.0138225731794071,0.730335142703067
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MRPL28,"39S ribosomal protein L28, mitochondrial",37408,0.00119608853253749,0.00348783578935416,-0.00564006961459667,0.00803224667967164,0.731655362944329
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,37408,0.000985617229874226,0.0028794599243888,-0.00465812422192783,0.00662935868167628,0.732136168986172
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DDX4,Probable ATP-dependent RNA helicase DDX4,37052,0.00181940889633541,0.00533780919444552,-0.00864269712477781,0.0122815149174486,0.733219589428801
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NEB,Nebulin,37017,0.00122477587525477,0.00363189795819004,-0.0058937441227977,0.00834329587330724,0.735950786119849
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ISM2,Isthmin-2,37433,-0.0014468900015327,0.0042979177329348,-0.00987080875808491,0.00697702875501952,0.736386666369144
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NGF,Beta-nerve growth factor,39745,0.000392878243023469,0.00118467832215615,-0.00192909126840258,0.00271484775444952,0.740170889733676
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CCND2,G1/S-specific cyclin-D2,37165,0.0011774932471819,0.00356432417716999,-0.00580858214007129,0.00816356863443508,0.741136742949927
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAM1,Vascular cell adhesion protein 1,39904,0.000844759313206719,0.00256905437846906,-0.00419058726859264,0.00588010589500608,0.742295197574581
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LAMA1,Laminin subunit alpha-1,37017,-0.00171456749593906,0.00524530095090205,-0.0119953573597071,0.00856622236782897,0.743766224657479
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADRA2A,Alpha-2A adrenergic receptor,37017,-0.00224346066857644,0.00693166803883861,-0.0158295300247001,0.0113426086875472,0.746205299606691
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL12RB2,Interleukin-12 receptor subunit beta-2,37052,0.00129126481679333,0.0040339737775379,-0.00661532378718094,0.00919785342076761,0.748899509842226
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KLHL41,Kelch-like protein 41,37408,0.00157871425035216,0.00494505653983682,-0.008113596567728,0.0112710250684323,0.749541107629585
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DUSP29,Dual specificity phosphatase 29,37035,-0.00202574055509426,0.00645248487254886,-0.01467261090529,0.0106211297951015,0.753565994193043
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LSM8,U6 snRNA-associated Sm-like protein LSm8,37165,0.00262604829855312,0.00838317033174081,-0.0138049655516589,0.0190570621487651,0.754093814379362
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TNPO1,Transportin-1,37165,-0.00107207665694199,0.00343071335420152,-0.00779627483117697,0.00565212151729298,0.754670170639152
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VCAN,Versican core protein,40005,0.000882928998431659,0.00284658894442489,-0.00469638533264114,0.00646224332950445,0.756435017002997
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MANSC1,MANSC domain-containing protein 1,39909,0.000789734246128556,0.00260508348498189,-0.00431622938443594,0.00589569787669306,0.761778548123671
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TFAP2A,Transcription factor AP-2-alpha,36987,0.00170582518265763,0.00575714451431155,-0.00957817806539301,0.0129898284307083,0.767007893175697
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GID8,Glucose-induced degradation protein 8 homolog,37408,0.000952724388953441,0.00323943985860384,-0.00539657773391008,0.00730202651181696,0.76868478715235
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHGA,Chromogranin-A,37433,0.00222325055994621,0.00757113071805865,-0.0126161656474487,0.0170626667673412,0.769031063315371
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA4,Carbonic anhydrase 4,40048,-0.00065579236725793,0.00225461986889719,-0.00507484731029642,0.00376326257578056,0.771157496476776
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PCDH12,Protocadherin-12,37408,0.000710376340671756,0.00244812294243894,-0.00408794462650857,0.00550869730785208,0.771689218678116
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAGEA3,Melanoma-associated antigen 3,37165,-0.00230202950976565,0.00811575568306345,-0.01820891064857,0.0136048516290387,0.776683462547227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,37017,0.000707236448015314,0.00250735417230063,-0.00420717772969392,0.00562165062572454,0.777898230776958
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPBGL,Trophoblast glycoprotein-like,37035,0.00110095089667974,0.00393643961757649,-0.00661447075377018,0.00881637254712965,0.77972595944002
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PFDN6,Prefoldin subunit 6,37035,0.00177815511795817,0.00640823663741237,-0.0107819886913701,0.0143382989272864,0.781416200072586
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TEX33,Testis-expressed protein 33,37165,-0.00105277996322112,0.00384735061962273,-0.00859358717768167,0.00648802725123943,0.784367348709903
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,39797,-0.00481357185529529,0.0180405798505455,-0.0401731083623645,0.0305459646517739,0.789611875157005
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ANGPT2,Angiopoietin-2,40026,-0.000963255730178408,0.00366987316584302,-0.00815620713523073,0.00622969567487392,0.792957389348296
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IFNL2,Interferon lambda-2,36987,0.00156282461617466,0.00601585441523279,-0.0102282500376816,0.0133538992700309,0.79503422487711
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RPGR,X-linked retinitis pigmentosa GTPase regulator,37035,-0.00101760133872647,0.0039676629763611,-0.00879422077239423,0.00675901809494128,0.797589064090824
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,WASL,Neural Wiskott-Aldrich syndrome protein,37052,-0.00148218423727061,0.00582516423378844,-0.012899506135496,0.00993513766095474,0.79915571261861
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",36987,0.00136822455693243,0.00545031492984801,-0.00931439270556966,0.0120508418194345,0.801790304920432
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",36958,0.00130948686945797,0.00529362365604166,-0.00906601549638368,0.0116849892352996,0.804625300935215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RYR1,Ryanodine receptor 1,37017,-0.000776043124882424,0.00327431487718026,-0.00719370028415573,0.00564161403439088,0.812653254055904
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MYBPC2,"Myosin-binding protein C, fast-type",37039,-0.00193366233826021,0.00821799328578639,-0.0180409291784015,0.0141736045018811,0.81398252409312
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRC1,Protein regulator of cytokinesis 1,37364,0.00100421740729634,0.00446870367549143,-0.00775444179666687,0.00976287661125955,0.822198708624209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWF,von Willebrand factor,40048,0.00157062631614554,0.00703424889794982,-0.0122165015238361,0.0153577541561272,0.823318282750253
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTAG1A_CTAG1B,Cancer/testis antigen 1,37131,0.00109270067599119,0.0049091953192056,-0.00852932214965179,0.0107147235016342,0.823863929280853
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOS,Proto-oncogene c-Fos,36927,-0.000760930843171102,0.0034193427475228,-0.00746284262831579,0.00594098094197358,0.823899222650961
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,36987,-0.00103764870392824,0.00467824869628053,-0.0102070161486381,0.0081317187407816,0.824470842599752
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OMP,Olfactory marker protein,36987,0.000985787873229948,0.00472008900638391,-0.00826558657928252,0.0102371623257424,0.834569027224222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GAD2,Glutamate decarboxylase 2,37052,0.000933449787753989,0.00451124033565417,-0.00790858127012819,0.00977548084563616,0.836078311045726
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,36987,-0.00112907085617549,0.00547684873360132,-0.0118636943740341,0.0096055526616831,0.836674303136694
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RICTOR,Rapamycin-insensitive companion of mTOR,37052,-0.000933099998035889,0.00463883508567878,-0.0100252167659663,0.00815901676989452,0.840584670789238
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRR4,Proline-rich protein 4,37027,-0.00133929301990908,0.00675016420783986,-0.0145696148672752,0.011891028827457,0.842728175579366
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL3,Interleukin-3,36958,-0.00112908975331151,0.00576887051856467,-0.0124360759696983,0.0101778964630752,0.84483149504501
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDIA2,Protein disulfide-isomerase A2,36958,0.000752085382061891,0.00384302435307861,-0.00678024234997218,0.00828441311409596,0.84484689665582
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BRD2,Bromodomain-containing protein 2,36987,0.00064220680808675,0.00328687330979134,-0.00580006487910428,0.00708447849527778,0.845094328607062
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SHC1,SHC-transforming protein 1,36958,0.00214642452123348,0.0111860903315775,-0.0197783125286585,0.0240711615711254,0.847836551932036
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVI2B,Protein EVI2B,36958,0.000763332428283811,0.00399071723307263,-0.00705847334853854,0.00858513820510616,0.848311542944095
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,AGBL2,Cytosolic carboxypeptidase 2,36987,0.00170102065737522,0.00889829812071483,-0.0157396436592259,0.0191416849739763,0.848401261499374
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,37364,0.00146426142209781,0.00810709077303392,-0.0144256364930487,0.0173541593372443,0.856672566890921
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",37017,-0.00148503911485222,0.00822365459593853,-0.0176034021228917,0.0146333238931873,0.856698932562164
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IZUMO1,Izumo sperm-egg fusion protein 1,36958,0.000871121924668354,0.00485055260814229,-0.00863596118729053,0.0103782050366272,0.857475424034633
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TP73,Tumor protein p73,37035,-0.000600930980163191,0.00336125373298131,-0.00718898829680655,0.00598712633648017,0.858111788425526
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,H2AP,Huntingtin-interacting protein M,36958,-0.000862386937755542,0.00484831324297215,-0.010365080893981,0.00864030701846988,0.858824993842611
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TSPAN15,Tetraspanin-15,37017,-0.000849379136315577,0.00477661797383786,-0.0102115503650378,0.00851279209240663,0.858866924817871
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL21R,Interleukin-21 receptor,37052,0.000932880787255679,0.0052642038285549,-0.00938495871671191,0.0112507202912233,0.859344486623641
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CSRP3,Cysteine and glycine-rich protein 3,37017,-0.0016532278249597,0.00942135814660433,-0.0201190897923042,0.0168126341423848,0.860707862194574
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN1,Neuroligin-1,37035,0.00114290131640579,0.00653269688331174,-0.0116611845748852,0.0139469872076968,0.861120888831656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RLN1,Prorelaxin H1,37408,-0.00135523664568292,0.00780354205185575,-0.0166501790673202,0.0139397057759544,0.862127863857104
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CHRDL2,Chordin-like protein 2,39864,0.000939335653576498,0.00543676492716432,-0.00971672360366556,0.0115953949108186,0.86283067683544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",37017,0.000706237736132101,0.00420087225681511,-0.00752747188722552,0.00893994735948972,0.866493876787221
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC1A4,Neutral amino acid transporter A,37035,0.000834878172446909,0.00498419184921912,-0.00893413785202257,0.0106038941969164,0.866975108260281
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGAX,Integrin alpha-X,37165,0.000854962037394965,0.0051224828279535,-0.0091851043053939,0.0108950283801838,0.867448250610672
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ZNF174,Zinc finger protein 174,37052,-0.000616391581287323,0.00369773964695221,-0.00786396128931365,0.00663117812673901,0.867613260584222
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PRG3,Proteoglycan 3,37433,0.000787479187622809,0.00482564478352731,-0.00867078458809072,0.0102457429633363,0.870374170656051
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ATP2B4,Plasma membrane calcium-transporting ATPase 4,37017,0.000997514479889948,0.00615877371270246,-0.0110736819970069,0.0130687109567868,0.87133479111264
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UPK3A,Uroplakin-3a,36987,-0.000744748520650056,0.00463322214150945,-0.00982586391800857,0.00833636687670846,0.8722999101517
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,37433,0.000609289573569941,0.00383458840357195,-0.00690650369743108,0.00812508284457096,0.873755474431347
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PPIE,Peptidyl-prolyl cis-trans isomerase E,37165,-0.000957414133686368,0.00605348093762613,-0.0128222367714336,0.0109074085040608,0.874333696805631
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TIMP2,Metalloproteinase inhibitor 2,37433,0.000384138470099584,0.00246211691470332,-0.00444161068271892,0.00520988762291809,0.876019900465174
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ITGB2,Integrin beta-2,39727,-0.000426561579011573,0.00276507448172241,-0.0058461075631875,0.00499298440516436,0.877400655071846
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,THRAP3,Thyroid hormone receptor-associated protein 3,37017,0.00169962661840262,0.0112067650749236,-0.0202656329284476,0.0236648861652528,0.879456825594156
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TMEM132A,Transmembrane protein 132A,37039,0.000873440372088546,0.00605177400406003,-0.0109880366758691,0.0127349174200462,0.885243684490898
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PLA2G2A,"Phospholipase A2, membrane associated",39822,-0.000719358064440862,0.00524636934596563,-0.0110022419825335,0.00956352585365177,0.890941304371215
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,MAG,Myelin-associated glycoprotein,37035,-0.000543915614146378,0.00448019424166427,-0.00932509632780835,0.0082372650995156,0.903372526789228
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TAP1,Antigen peptide transporter 1,37165,-0.000659947743678581,0.00569274443082464,-0.0118177268280949,0.0104978313407377,0.907711456075954
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LELP1,Late cornified envelope-like proline-rich protein 1,36987,0.000779641873122571,0.00711540942675696,-0.0131665606033211,0.0147258443495662,0.912751358469129
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,37035,-0.000498356684888314,0.00469277652405817,-0.00969619867204232,0.00869948530226569,0.915428023602362
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL36A,Interleukin-36 alpha,37052,-0.000603524924579851,0.00569860373962778,-0.0117727882542503,0.0105657384050906,0.915657346849544
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,37364,0.000486267074753246,0.00464918419457289,-0.00862613394660962,0.00959866809611611,0.916701184304834
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CNTF,Ciliary neurotrophic factor,36987,-0.000343161924750718,0.00329482888142568,-0.00680102653234506,0.00611470268284362,0.917050579539489
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,KHDC3L,KH domain-containing protein 3,36958,0.000662287520532654,0.00643427447112053,-0.0119488904428636,0.0132734654839289,0.918019159834378
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FOLR3,Folate receptor gamma,39854,0.00184625826028656,0.0182349900424579,-0.0338943222229309,0.037586838743504,0.919354776546472
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EPGN,Epigen,37364,0.000479555880919466,0.0048316085318151,-0.00899039684143813,0.00994950860327706,0.920938171273685
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CDAN1,Codanin-1,37384,0.00021348519761309,0.00218129011838294,-0.00406184343441748,0.00448881382964366,0.922036122952381
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,UBQLN3,Ubiquilin-3,37017,0.000381055553422751,0.00454534636502646,-0.00852782332202912,0.00928993442887462,0.933189517978923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,IL25,Interleukin-25,36899,0.000274397011790542,0.00332114009469923,-0.00623503757381995,0.00678383159740104,0.934153908584931
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,GRIK2,"Glutamate receptor ionotropic, kainate 2",37408,-0.000288681710802502,0.0038170290814479,-0.00777005871044038,0.00719269528883538,0.939714626344923
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RTKN2,Rhotekin-2,37017,-0.000360395339072848,0.00502754450322987,-0.0102143825654034,0.0094935918872577,0.942854346320588
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FGF7,Fibroblast growth factor 7,36958,-0.000533615172247311,0.00770211608554295,-0.0156297626999115,0.0145625323554169,0.944766503756158
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ADGRV1,Adhesion G-protein coupled receptor V1,36987,-0.000459137513235809,0.00673113360820189,-0.0136521593853115,0.0127338843588399,0.945618690759992
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDCL2,Phosducin-like protein 2,36958,0.000348430148559373,0.0051402353202194,-0.00972643107907065,0.0104232913761894,0.945957928033023
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CBLN1,Cerebellin-1,36987,-0.000616935729206922,0.00933595400385883,-0.0189154055767702,0.0176815341183564,0.947313785112126
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,NLGN2,Neuroligin-2,36987,0.000295445634049,0.00457652531368254,-0.00867454398076877,0.00926543524886677,0.948527898507663
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CA8,Carbonic anhydrase-related protein,37052,-0.000162126741009994,0.00252591729560635,-0.00511292464039843,0.00478867115837845,0.948823660458728
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,EVPL,Envoplakin,37165,-0.000189184113759628,0.00318907827184072,-0.00643977752656743,0.00606140929904818,0.952696126699599
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,RAC3,Ras-related C3 botulinum toxin substrate 3,37035,0.000391535652714819,0.00661503298634739,-0.0125739290005261,0.0133570003059557,0.952802653481857
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,DCDC2C,Doublecortin domain-containing protein 2C,36958,0.000317801753215545,0.00614251737334401,-0.0117215322985387,0.0123571358049698,0.958738222558042
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,BCAN,Brevican core protein,39745,-0.000140469143984672,0.00320818334489079,-0.00642850849997063,0.00614757021200129,0.965076623373845
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",37017,-0.000260737541183729,0.00598447848686643,-0.0119903153754419,0.0114688402930745,0.965248650708244
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,POLR2A,DNA-directed RNA polymerase II subunit RPB1,37052,-0.000112629519520715,0.00288384328767273,-0.00576496236335927,0.00553970332431784,0.968846847386802
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,ERVV_1,,37017,-0.0001748256731955,0.00465408888358098,-0.00929683988501422,0.00894718853862322,0.970035970749024
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,LRRN1,Leucine-rich repeat neuronal protein 1,39583,0.000139004576544346,0.00377132327251248,-0.00725278903758012,0.00753079819066882,0.97059845430552
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,36927,-0.000157200886141849,0.00509955497832847,-0.0101523286436657,0.00983792687138195,0.975408462600618
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OSTN,Osteocrin,37035,0.000114436931400184,0.00406101948438151,-0.00784516125798759,0.00807403512078795,0.97751952555331
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,VWA5A,von Willebrand factor A domain-containing protein 5A,36958,0.000181230436122174,0.00787931201743505,-0.0152622211180505,0.0156246819902949,0.981649989609499
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,TPRKB,EKC/KEOPS complex subunit TPRKB,36958,-0.000139814006743798,0.00637691427117147,-0.0126385659782399,0.0123589379647523,0.982508096243091
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FRMD7,FERM domain-containing protein 7,37035,5.60337673928091e-05,0.00326409063682525,-0.00634158388078467,0.00645365141557029,0.986303862675465
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,OFD1,Oral-facial-digital syndrome 1 protein,37165,-9.77159965761332e-05,0.0065866703510996,-0.0130075898847314,0.0128121578915791,0.98816370701656
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,SLC51B,Organic solute transporter subunit beta,37017,-0.000101853977246123,0.00733259899487669,-0.0144737480072044,0.0142700400527122,0.988917495924518
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,PYDC1,Pyrin domain-containing protein 1,37039,-5.38642766152473e-05,0.00398481069093669,-0.00786409323085116,0.00775636467762067,0.989215208972227
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,FSTL1,Follistatin-related protein 1,37039,2.08788603148239e-05,0.00221274270074078,-0.0043160968331371,0.00435785455376675,0.992471624890209
NMR metabolomics,X23589.Phospholipids to Total Lipids in Large VLDL percentage,CTRL,Chymotrypsin-like protease CTRL-1,37384,5.02500158349342e-05,0.00637116800523781,-0.0124372392744312,0.012537739306101,0.993707189179313
